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PREFACE 
 
This portfolio documents both the academic and practical journey taken over 
the past two years as a Trainee Health Psychologist. More specifically, it 
demonstrates how I have been able to utilise my academic and practical skills, in 
order to achieve the competencies necessary to qualify.  The individual 
competencies: Research, Consultancy, Behaviour Change Intervention, and 
Teaching and Training, as well as Generic Professional Competence, were all 
achieved while working as a Research Worker on a Cognitive Behaviour Therapy 
(CBT) trial for Persistent Physical Symptoms (PPS), at King’s College London.   
PPS, also known as Medically Unexplained Symptoms (MUS), are 
symptoms or syndromes that appear to be absent of a clear medical explanation. 
Examples of PPS include fibromyalgia, Irritable Bowel Syndrome (IBS), Chronic 
Fatigue Syndrome (CFS), functional neurological symptoms, non-cardiac chest pain 
and functional respiratory symptoms. Due to my role within my placement, as well 
as a specific interest within this research area, all competencies except for 
Consultancy and Teaching and Training are heavily focused within this field.  
The thesis, entitled “Exploring the Role of Culture on the Experience and 
Perception of Healthcare and Daily Life in Patients with Persistent Physical 
Symptoms”, was originally proposed following information that Guy’s and St. 
Thomas’ Charity, who had funded the CBT trial, were interested in conducting 
research with black and minority ethnic (BME) patients living with different PPS. It 
was proposed that qualitative interviews would be conducted with a sample of 
patients who had enrolled on the trial in order to understand their experiences of 
living with PPS, their experiences of healthcare, and the potential role of any cultural 
factors. Executing this large qualitative study was a challenge, but it was also a 
great and enjoyable experience. It also enriched my understanding of PPS from the 
 23 
 
patients’ perspective, which I consider to be a particularly valuable asset when 
working in a patient-facing role. The systematic review, which focuses on 
mindfulness-based cognitive therapy (MBCT) randomised controlled trials (RCTs) 
for patients with common PPS (IBS, CFS, chronic pain and fibromyalgia), enabled 
me to expand my knowledge of the existing literature for another type of 
psychological therapy becoming increasingly popular in treating PPS. The process 
of conducting the review also helped me to exercise and refine my analysis and 
critiquing of studies. 
The Consultancy project, entitled the “Health Status Assessment Project”, 
focused on the management of long-term conditions. This particular assignment 
aimed to understand the feasibility and necessity of a potential revolutionary and 
interactive mobile app that would help patients and healthcare professionals monitor 
and effectively manage chronic health conditions, such as diabetes, cancer and 
fibromyalgia. As this project was particularly complex, it was broken down into three 
distinct parts: the Scientific Perspective, Patient Perspective and Business 
Perspective. The scope of this assignment was therefore very wide, including the 
conduction of a review of existing mobile apps (Scientific perspective), conducting 
qualitative interviews with people living with long-term conditions and writing 
vignettes based on the findings (Patient perspective), and writing up the business 
plan (Business perspective). The breadth and depth of the project helped me to 
apply Health Psychology theory and existing research skills within new capacities. It 
also challenged me on many occasions to open my mind practically towards new 
skills and ways of working. 
The Behaviour Change Intervention, entitled “Cognitive Behaviour Therapy 
for Fibromyalgia”, was born out of a particular interest in fibromyalgia after speaking 
to many patients with it. In addition I already had an awareness and understanding 
of CBT principles, and was keen to use these theoretical and practical skills to try 
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and help this population. Following ethical approval, I attended local support groups 
and delivered a CBT-based leaflet directly to the target population. Although I had 
gained a lot of experience in patient contact through my role as a Research Worker, 
I saw this as a great opportunity to meet people with fibromyalgia outside of a 
clinical setting. It also really opened my eyes to the wider issues affecting 
individuals with fibromyalgia as well. 
For my first teaching case study, “Health Promotion: Individual-Level 
Interventions”, I prepared and delivered an MSc Health Psychology lecture as part 
of the Health Promotion module at City, University of London. The lecture was on 
how to effectively design, deliver and evaluate Individual-level Behaviour Change 
Interventions. Although I was confident in my knowledge of the topic, it was my very 
first experience of teaching at this level. It was an enjoyable experience being able 
to put together my own slides and activities, and I found it very rewarding. Within 
this lecture, I was keen to include my own examples of how real-life interventions 
had been designed and delivered within the London area. I felt that this really 
helped to bring to life the lecture and brought together well the academic and 
practical elements of the DPsych programme. This positive teaching experience led 
to the decision to integrate my own real-life practical experiences into teaching 
sessions wherever possible in the future. 
My second teaching case study, “The Patient with Medically Unexplained 
Symptoms”, was part of an all-day workshop delivered to nurse practitioners from 
St. George’s Hospital. My teaching, which was delivered right at the start of the 
workshop, covered introductory information on PPS, including a descriptive 
explanation, the prevalence of symptoms, which clinics they are likely to present in, 
and their debilitating impact upon both patients and healthcare services. Once 
again, this teaching opportunity enabled me to introduce some of my own 
experiences of working with PPS patients. This teaching session was conducted 
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with healthcare professionals, which was a very different experience. Expectations 
were generally higher, and the content needed to be particularly engaging and 
tailored towards them and what they were likely to encounter within their day-to-day 
roles. This was a very useful exercise for me as a Trainee Health Psychologist. 
The Training case study included within this portfolio, entitled “Qualitative 
Research Methods” was a workshop designed and run specifically for professionals 
who had little or no experience of conducting qualitative research. It was delivered 
in three distinct parts to a multidisciplinary team that included Clinical Psychologists, 
Cognitive Behaviour Therapists, psychiatrists and academic researchers based at 
the South London and Maudsley (SLaM) Hospital. As the training consisted of three 
individual sessions, it took a lot of time to properly research and design. As well as 
providing the right level of information, I was keen to include videos and training 
exercises in order to make the training course as enjoyable and influential as 
possible. For me, it was a rewarding experience, particularly as the audience all 
gained from it and learned something new. Furthermore, it received a very positive 
response from a highly respected and qualified team of professionals. 
During the course of the DPsych, I have also attended and presented at 
several conferences, including an oral presentation at the British Psychological 
Society (BPS) Division of Health Psychology annual conference in September 2017, 
which enabled me to disseminate my own research to a wider audience. In addition, 
I have gained further experience in preparing papers for publication which has 
greatly developed my academic style of writing. 
In conclusion, the DPsych programme has pushed me to new limits, and I 
have steadily observed myself grow as a Trainee Health Psychologist. This is not 
only in terms of my academic and research skills, but also in terms of my 
understanding of what it is to live with long-term health conditions, particularly PPS. 
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Perhaps most significantly, the DPsych training has given me the tools to take a 
reflexive and open-minded approach towards everything that I do day to day, 
including how I interact with both patients and healthcare professionals. Through the 
DPsych, I have learned that I will never stop learning, and I feel this has prepared 
me well for a career in Health Psychology. 
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ABSTRACT 
 
Objectives: PPS are common and incur large healthcare costs. BME populations 
experience relatively poor health, including higher rates of PPS, but are often 
difficult to reach. This research aims to understand BME experiences of living with 
PPS, of accessing and receiving healthcare, and the role and influence of cultural 
factors. The findings may be used to indicate whether current clinical guidelines and 
training may be in need of further review. 
Design: Using thematic analysis, qualitative data was collected using semi-
structured interviews.  
Methods: 30 patients, 15 white British and 15 BME, were recruited through the 
PRINCE Secondary trial. Interviews were audio-recorded, transcribed and analysed 
inductively using thematic analysis. An adapted version of the framework analysis 
method was employed to identify key differences between white British and BME 
participant responses. 
Results: Five themes emerged, entitled ‘Beliefs surrounding the symptoms’, 
‘Putting on a strong face’, ‘A need for social support’, ‘Quality of life has been 
stripped away’, and ‘Inconsistency within the NHS’. These were also split into 15 
sub-themes. BME participants had more complex symptoms; were more likely to 
retire from work; were less likely to report emotions as out of control; were less 
accepting of symptoms; were more religious; reported more frequent family 
conflicts; reported poorer experiences of healthcare, and had a greater preference 
for holistic therapies. 
Conclusion: Future training and guidelines for healthcare professionals may need 
further revision, in order to accommodate differences between white British and 
BME patients, and deliver a culturally sensitive service. Psychoeducation can 
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improve patients’ psychological wellbeing. CBT should be recommended for 
patients keen and able to return to work. ACT may also be of benefit to patients with 
PPS, particularly those demonstrating low self-efficacy and mental agility, but further 
robust evidence is required.  
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1. INTRODUCTION 
1.1. What are persistent physical symptoms? 
1.1.1   The different terms used in healthcare 
The term ‘persistent physical symptoms’ (PPS) refers to experienced 
symptoms that appear to be absent of any medical explanation. In practice, this 
means that any medical tests, such as blood tests or scans are confirmed as 
‘normal’, or at the very least, cannot sufficiently explain the experienced symptoms 
(Marks & Hunter, 2015).  Collectively, there are a number of terms that have 
previously been used to describe these types of symptoms. These include Medically 
Unexplained Symptoms (MUS) or Medically Unexplained Physical Symptoms 
(MUPS), Functional Disorder, Somatisation, Somatic Symptom Disorder, Complex 
Physical Symptoms, Bodily Distress Disorder and Idiopathic Symptoms (Marks & 
Hunter, 2015; Picariello, Ali, Moss-Morris & Chalder, 2015). Within the American 
Psychiatric Association’s Diagnostic Statistic Manual of Mental Disorders version 5 
(DSM-5), these types of symptoms have been updated from Somatoform Disorders 
to Somatic Symptom Disorder (American Psychiatric Association, 2013; Dimsdale, 
Creed, Escobar, Sharpe, Wulsin et al., 2013). They are also often referred to by 
their individual miscellaneous terms, including Chronic Fatigue Syndrome (CFS), 
fibromyalgia syndrome, and Irritable Bowel Syndrome (IBS) (Nimnuan, Hotopf & 
Wessely, 2001; Sharpe, 2002). 
While most individuals will experience PPS at some point in their lives, it is 
important to distinguish the difference between these types of symptoms, and those 
where a medical cause can be identified or where the symptoms quickly improve 
(Royal College of Psychiatrists, 2017).  To elaborate on this point further, the DSM-
5 states that in order to be classified as a Somatic Symptom Disorder (SSD), these 
unexplained symptoms are required to meet certain diagnostic criteria. Firstly, they 
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must be shown to have a significant effect upon a patient’s ability to function in their 
daily life and must be considered clinically significant. Secondly, they must be 
accompanied by excessive and disproportionate thoughts and behaviours about the 
symptoms. Finally, the symptoms must be present for a minimum of six months 
(American Psychiatric Association, 2013).  These are the types of symptoms that 
have been included within this thesis and they are referred to collectively here as 
PPS, following two recent patient surveys conducted within the United Kingdom 
(UK) that have reported this term preferable over MUS, Functional Disorder, Bodily 
Distress Disorder and Complex Physical Symptoms (Marks & Hunter, 2015; 
Picariello et al., 2015).  
 
1.1.2.  A breakdown of PPS 
Functional neurological symptoms, which are generally seen either in 
primary care or neurology departments within secondary care, cover a wide range 
of symptoms and are considered to be a result of poor neurological functioning 
(Stone, 2011). Individual symptoms that these patients may present with include 
weakness, complex regional pain and other sensory symptoms such as dizziness, 
numbness, tingling, weakness, dissociative seizures, involuntary movements, 
cognitive dysfunction, low mood, sleep disorders, paralysis, speech problems, 
sensory changes and visual problems (Fink, Hansen & Søndergaard, 2005).  A 
prospective cohort study of 300 neurology patients demonstrated that up to 30% of 
these presented with symptoms that were only “somewhat explained” or were “not 
at all explained” (Carson, Ringbauer, Stone, McKenzie, Warlow et al., 2000). 
Functional neurological symptoms can be very debilitating for patients physically 
and often have a poor prognosis (Ricciardi & Edwards, 2014). In addition, it can also 
be emotionally distressing. For example, Vroegop, Dijkgraff and Vermeulen (2013) 
conducted a study comparing patients with functional symptoms against patients 
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living with medically explained neurological conditions. Generally, patient quality of 
life was reported to be worse in those with functional symptoms. More specifically, 
patients with functional symptoms exhibited greater physical disability including 
more extreme levels of pain, as well as poorer psychological and social functioning.  
Functional respiratory symptoms are usually seen either in primary care or 
within respiratory clinics, and can present as chronic cough, dysfunctional breathing 
or hyperventilation, a dysfunction of the vocal cords, paroxysmal sneezing or 
frequent clearing of the throat (Butani & O’Connell, 1997). Chronic cough, also 
known as habit or idiopathic, is an unexplained persistent cough that has been 
present for at least eight weeks. In terms of prevalence within the UK, chronic cough 
is considered to account for approximately 12% of patients seen within respiratory 
clinics (Turner & Bothamley, 2016).  While it has generally reported to be more 
common amongst the younger generation, including children and adolescents 
(Butani & O’Connell, 1997), chronic cough is also reported to be more common 
amongst females of menopausal age, and may potentially be triggered by hormonal 
changes (McGarvey & Ing, 2004). Dysfunctional breathing, also known as over-
breathing, is another common condition seen within respiratory clinics.  Like with 
other functional symptoms, dysfunctional breathing frequently co-exists with 
medically explained conditions, such as asthma (Anbar & Hall, 2012; Thomas, 
McKinley, Freeman & Foy, 2001).   
Non-cardiac chest pain is frequently seen within primary care, cardiology 
clinics, and also within Accident and Emergency (A&E) departments. Individual 
symptoms are described as being very similar to the discomfort caused by heart 
disease or angina, and therefore patients presenting with these symptoms will 
almost always need to be thoroughly investigated (Schey, Villarreal & Fass, 2007). 
Often these symptoms are later attributed to Gastroesophagal Reflux Disease or 
‘acid reflux’, which is considered to be the most frequent cause of non-cardiac chest 
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pain (Karlaftis, Karamanolis, Triantafyllou, Polymeros, Gaglia et al., 2013). In 
comparison with patients presenting cardiac-related chest pain, other patients with 
non-cardiac related symptoms are generally much younger, and are far more likely 
suffer from anxiety (Fass & Achem, 2011).  
Fibromyalgia syndrome is typically seen in primary care or rheumatology 
clinics, and is primarily characterised by widespread pain and stiffness. However, 
there are often other accompanying symptoms, including fatigue, IBS, sleep 
disorders, headaches, low mood and poor cognitive functioning (Mease, 2005). 
Although often difficult to diagnose due to the absence of clear medical abnormality, 
fibromyalgia has been reported to affect at least one in 20 people (Jones, Atzeni, 
Beasley, Flüß, Sarzi-Puttini et al., 2015). It is also considered to be much more 
common amongst women, with around seven times more women presenting with 
the symptoms than men within a random sample (Wolfe, Ross, Anderson, Russell & 
Hebert, 1995). The true prevalence of fibromyalgia may be much higher though, as 
a systematic review and meta-analysis of seven studies has demonstrated that 
between 33% and 50% of all adults within the UK experience chronic pain, and 
between 14.2% and 16.1% live with chronic widespread pain (Fayaz, Croft, 
Langford, Donaldson & Jones, 2016). 
Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis 
or ME, is similar to fibromyalgia syndrome in that it is also characterised by extreme 
fatigue and may also include pain in the muscles, as well as cognitive dysfunction, 
sleep disturbance and low mood (Afari & Buchwald, 2003). While everyone may 
experience fatigue at some point, in the case of CFS the symptoms are generally 
more severe and difficult to live with on a day-to-day basis, having a significant 
impact upon an individual’s ability to carry out their usual daily activities (Larun & 
Malterud, 2007). It has also been proposed that symptoms are more likely to be 
relieved through the introduction of gentle exercise, rather than through rest alone 
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(Fulcher & White, 1997). Similarly to fibromyalgia, CFS is also more commonly 
diagnosed in women, and usually manifests between the ages of early 20s and 
early 40s (Capelli, Zola, Lorusso, Venturini, Sardi et al., 2010). CFS is also 
considered to be very common. A meta-analysis of fourteen studies has reported a 
pooled prevalence of CFS of 3.3%. However, it is possible that this figure is too high 
due to a reported discrepancy between self-report assessment (3.3%) and clinical 
assessment figures (0.8%) which were calculated separately (Johnston, Brenu, 
Staines & Marshall-Gradisnik, 2013).  
IBS, typically seen within either primary care or in gastroenterology clinics, is 
considered to be a disturbance of the digestive system and as stated earlier is often 
a symptom of fibromyalgia as well. The most common symptoms of IBS include 
diarrhoea, constipation, bloating and abdominal pain (Longstreth, Thompson, Chey, 
Houghton, Mearin et al., 2006). Other less common but associated symptoms 
include fatigue, low mood or anxiety, nausea, muscle or back pain, and heartburn. It 
is a common health complaint, with a meta-analysis of 81 population-based studies 
reporting a pooled prevalence of 11.2% (Lovell & Ford, 2012).  Similarly to 
fibromyalgia and CFS, IBS is also more common in women. This may be 
attributable to the more frequent hormonal changes experienced by women (Lee, 
Kim, Sung, Park, Jin et al., 2007).  Although a common condition, as demonstrated 
through qualitative interviews, for some individuals IBS is particularly chronic and 
debilitating, having a significant impact upon their lives (Rønnevig, Vandvick 
&Bergbom, 2009). 
Another common functional gastrointestinal disorder is non-ulcerative 
functional dyspepsia, or recurring symptoms of indigestion (dyspepsia) in the 
absence of inflammation, with normal levels of stomach acid. Similarly to medically 
explained dyspepsia, or ulcerative dyspepsia, functional dyspepsia is known to 
trigger a range of physical symptoms within the upper abdomen, including pain and 
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discomfort, flatulence, belching, nausea or vomiting, and bloating (Fujiwara & 
Arakawa, 2014). Despite the unpleasantness of the symptoms, they do not lead to 
any serious health conditions such as cancer. They can also be controlled 
somewhat by avoiding dairy, spicy food, food high in fat, caffeine and alcohol 
(Barbera, Feinle & Read, 1995; Feinle-Bisset & Azpiroz, 2013). A population-based 
cohort study has also reported an association between weight gain and the onset of 
dyspepsia symptoms (Cremonini, Locke, Schleck, Zinsmeister & Talley, 2006), 
which suggests that weight loss may also be helpful in reducing the symptoms of 
dyspepsia. 
 
1.1.3. The trans-diagnostic nature of PPS 
While the description of these symptoms and syndromes may have 
individual differences, there are also many overlapping features of PPS which 
support the case for taking a trans-diagnostic approach towards them. For example, 
Fink and Schroder (2010) conducted a review of 978 patients predominantly seen 
within primary care. Their aim was to identify whether fibromyalgia, hyperventilation 
syndrome or dysfunctional breathing, non-cardiac chest pain, CFS, IBS and pain 
syndrome could be successfully diagnosed under the diagnostic term ‘Bodily 
Distress Syndrome’. They reported a significant overlap between individual 
diagnostic categories of the symptoms and Bodily Distress Syndrome of 95%, 
demonstrating PPS to be multi-factorial, and suitable for grouping. In further support 
of taking a unifying approach towards PPS, Nimnuan, Hotopf and Wessely (2001) 
conducted a cross-sectional survey of 890 patients seen within seven specialist 
outpatient clinics in two London-based hospitals. They reported that patients 
presenting with PPS across clinics tended to have similar demographic 
representations, in that they were significantly more likely to be female and below 
the age of 55. Simplifying the terminology by using one specific term for all 
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symptoms could help to make any future clinical guidelines clearer, and also assist 
with the prompt recognition and treatment of symptoms (Rosendal, Hartman, 
Aamland, van der Horst, Lucassen et al., 2017).  
 
1.1.4. The impact of PPS on the patient 
While PPS are poorly understood in terms of their cause, they are 
nevertheless real symptoms that can severely impact upon an individual’s 
psychological well-being. Individuals are reported to experience emotional distress 
due to incessant worry about the potential cause of their symptoms (Royal College 
of Psychiatrists, 2017). Nettleton, O’Malley, Watt and Duffey (2004), who explored 
the narrative output from 20 neurology outpatients living with PPS, reported that 
patients experienced feelings of frustration due to 1) their uncertainty for the future, 
2) their frustration that their PPS are poorly understood and are often considered to 
be psychological in nature, and 3) their frustration that their symptoms could not 
easily be treated.  A meta-analytic review of 244 studies conducted by Henningsen, 
Zimmerman and Sattel (2003) that focused on four specific types of PPS including 
IBS, fibromyalgia, CFS and non-ulcer dyspepsia, reported that participants living 
with PPS are significantly more likely to exhibit symptoms of anxiety or depression 
than healthy patients, and even more likely than patients living with an organic 
medical condition. The findings from this review were later supported by Burton, 
McGorm, Weller and Sharpe (2011), who conducted a case-control study across 
five primary care practices in Scotland. They reported that depression and anxiety 
was present in 48% of patients who had been referred to secondary care, in 
comparison with 25% of controls. These findings are significant because they 
demonstrate a high prevalence of anxiety and depression amongst patients with 
PPS, but also show that PPS are likely to also be independent of anxiety and 
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depression. This discredits the perception that PPS may be a manifestation of an 
underlying psychological condition. 
The proposed link between PPS and poor psychological health is in itself 
distressing for patients. Aamland, Malterud and Werner (2013), who conducted two 
focus groups with a purposive sample of twelve participants living with PPS, found 
that patients were troubled by the added burden that comes with living day-to-day 
with symptoms seemingly absent of a recognised medical explanation. This is 
consistent with an earlier qualitative study conducted by Nettleton (2006), which 
found that patients with functional neurological symptoms had reported struggling 
with the uncertainty of their symptoms, the lack of validation that came with them, 
and the consideration that their symptoms may have a psychological basis. 
As well as functioning, there is evidence that PPS put a significant strain on 
patients’ personal relationships. Wong, Drossman, Weinland, Morris, Leserman et 
al., (2011) for example, utilised the Zarit Burden Interview as well as the 
Relationship Satisfaction Scale with 152 partners of IBS patients, with a control 
group for comparison. The findings from this study strongly indicated reported 
burden scores to be significantly higher in partners of IBS patients than controls, 
with scores relative to the reported severity of symptoms. There is also evidence to 
suggest that the direction of the impact of symptoms on relationships may be only 
one way, as suggested above.  Liu, Cohen, Schulz and Waldinger (2011) reviewed 
101 US-based couples, following the self-completion of the Relationship Scale 
Questionnaire and the Somatic Symptom Inventory as well as further questionnaires 
measuring depression, anger and conflict. Mediated by anger, it was reported that 
insecurity within relationships appeared to lead to manifestations of PPS. Arnold, 
Crofford, Mease, Burgess, Palmer et al., (2008) conducted focus groups with 48 
women living with a diagnosis of fibromyalgia, and reported that fibromyalgia had 
significantly impacted upon their romantic relationships, due to the added pressures 
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that it placed upon their partners in terms of work and running the home, as well as 
the loss of physical intimacy experienced due to the pain. 
The significant impact of PPS upon day-to-day functioning has also been 
highlighted within further studies. Arnold et al., (2008) argued that social 
engagements were hard for individuals with fibromyalgia to organise and become 
involved in, due to the erratic nature of their symptoms. A further study by Lidén, 
Björk-Brämberg and Svensson (2015), who conducted a phenomenological-
hermeneutic study with ten primary care patients, reported that narrative interviews 
had led to the identification of the theme ‘feeling that the symptoms overwhelm life’, 
describing how the onset of symptoms had led to big restrictive changes in terms of 
both independence and functioning. In addition, where there may not always be a 
significant relationship between symptoms and poor psychosocial functioning, 
certain PPS such as non-cardiac chest pain are likely to prompt severe anxiety, 
which is in itself linked to poor functioning (Shelby, Somers, Keefe, Silva, McKee et 
al., 2009).   
 
1.1.5. The impact of PPS on healthcare services 
PPS evidently has a significant impact upon healthcare services. Within 
primary care, they are estimated to account for anywhere between 33% and 45% of 
all consultations (Chew-Graham, Heyland, Kingstone, Shepherd, Buszewicz et al., 
2017; Royal College of Psychiatrists, 2017). Within secondary care, the percentage 
of consultations for patients with PPS is generally estimated to be much higher 
(Chew-Graham et al., 2017). However, estimates tend to vary between departments 
and specialist clinics. Shivaji and Ford (2014) for example reviewed the number of 
new patient referrals to a gastroenterology clinic over a three year period and 
reported that out of 613 referrals, 34.9% had a functional gastrointestinal disorder 
such as IBS. Chambers, Marks and Hunter (2015) reported that roughly 50% of 
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patients presenting with chest pains in A&E were later found to have non-cardiac 
chest pain. In primary care and rapid access chest pain clinics, up to 80% of cases 
were non-cardiac in origin. 
Due to the frequency of which PPS are seen, they place a significant strain 
upon services in terms of financial resource. Bermingham, Cohen, Hague and 
Parsonage (2010) conducted a review of existing literature to understand the overall 
financial cost of somatisation over one year, between 2008 and 2009. They reported 
the direct healthcare cost of PPS to be at £3 billion per year. These costs were 
further compounded by quality-adjusted life year costs, calculated at £9.3billion, and 
the cost of sick leave for businesses, estimated at £5.2 billion. Overall annual costs 
of PPS were therefore calculated at £18 billion in total (Bermingham et al., 2010; 
Chitnis, Dowrick, Byng, Turner & Shiers, 2014). The findings from this review were 
supported by another study focusing on the cost-of-illness and economic 
evaluations for patients with PPS. This review reported annual healthcare costs of 
between 432 and 5,353 USD per patient, with indirect costs such as disability 
allowance, accounting for a further 18,000 USD (Konnopka, Schaefert, Heinrich, 
Kaufmann, Luppa et al., 2012).  
 
1.1.6:  Treating patients with PPS 
Studies provide strong evidence that healthcare professionals struggle to 
treat patients with PPS (Carson, Stone, Warlow & Sharpe, 2004; Maatz, 
Wainwright, Russell, Macnaughton & Yiannakou, 2016; Salmon, 2007), with the 
uncertainty of exactly how to treat them being at least partly attributed to limitations 
within the NHS (Maatz et al., 2016). Qualitative research has provided some insight 
into the direct effect that this has upon healthcare professionals, particularly General 
Practitioners (GPs). Wileman, May and Chew-Graham, (2002) conducted 15 semi-
structured interviews with GPs to understand their attitudes towards treating 
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patients with PPS. The interviews uncovered feelings of inadequacy, as well as 
wariness and even resentment towards their patients. More recent studies suggest 
that there has been little to no change over the past 15 years, even within 
specialised clinics. Maatz et al., (2016) conducted 17 semi-structured qualitative 
interviews with senior healthcare professionals across hospitals in the North-East of 
England, and found that healthcare professionals considered consultations with 
PPS patients to be ‘difficult’ in terms of effectively communicating with the patient 
and understanding the nature of the symptoms and how to treat them. Within an 
earlier review by Salmon (2007), the narrative data provides some insight into the 
nature of these communication difficulties between doctor and patient. Firstly, there 
is a clash between patients’ understanding and awareness of their symptoms, and 
healthcare professionals’ knowledge of the absence of disease following all 
necessary investigations. This particular review recommended that healthcare 
professionals aim to find a common ground, whereby symptoms can be understood 
and approached from both sides. Nevertheless, it was recognised at the point of 
publication that this type of approach is not generally favourable amongst 
healthcare professionals and more recent studies, such as that conducted by Maatz 
et al., (2016), would suggest that this attitude has not changed within the past ten 
years. On the other hand, it is possible that difficulties in communication between 
healthcare professionals and patients, as discussed earlier, could be somewhat due 
to patients’ alexithymia, i.e. the inability to express themselves and their feelings 
(Deary et al., 2007). However, evidence to support this is currently inconsistent at 
best. 
New clinical guidelines have been published for commissioners including 
Clinical Commissioning Groups (CCGs), health service providers, and Health and 
Well-being Boards (HWBs) of how to treat patients with PPS. Within these 
guidelines, it states that healthcare professionals should assess patients’ physical 
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and mental functioning, deliver psychoeducation, prescribe medication, and refer 
them for psychodynamic therapy or Cognitive Behaviour Therapy (CBT). In addition, 
it states that carers should also be provided with support, and plans to discharge 
patients should be made (Joint Commissioning Panel for Mental Health, 2017).  
Psychoeducation refers to the provision of education and useful information 
to patients and caregivers, in order to help and support them towards changing their 
understanding and attitudes toward health conditions. This type of intervention can 
help those affected by a health condition to come to terms with it and cope with it 
more effectively (Oncology Nursing Society, 2016; Stafford & Colom, 2013). A 
flexible intervention, it can be delivered in a number of different formats, including 
individual or group face-to-face therapy, through printed booklets and leaflets, and 
even online (Oncology Nursing Society, 2016).  Research strongly suggests that if 
used appropriately, this type of informative approach can be a very effective 
treatment. Donker, Griffiths, Cujpers and Christensen (2009) conducted a meta-
analysis of five randomised controlled trials (RCTs) detailing four individual 
psychoeducational interventions aiming to treat anxiety, depression and distress. 
Pooled results demonstrated a significant reduction in the number of psychological 
symptoms overall. Further individual studies since then have also provided evidence 
for the effectiveness of psychoeducational interventions in improving psychological 
health (Chen, Maheshwari, Franks, Trolley, Robinson et al., 2013; Luciano, 
Martínez, Peñarrubia-María, Fernandez-Vergel, García-Campayo et al., 2011).  
CBT is a psychological therapy that focuses on the relationship between 
thoughts, or cognitions, and how they influence feelings or emotions and 
subsequently health-related behaviours (Mind, 2015). It has a particularly large 
evidence base across multiple health conditions, with systematic reviews 
demonstrating the effectiveness of CBT in treating psychological conditions such as 
anxiety (Hofmann & Smits, 2008), depression (Hofmann & Smits, 2008; Jennings & 
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Hewitt, 2015), schizophrenia (Jauhar, McKenna, Radua, Fung, Salvador et al., 
2014) and even sleep insomnia (Trauer, Qian, Doyle, Rajaratnam, & Cunnington, 
2015). In cases where co-morbid conditions exist, there is also evidence that CBT 
can significantly improve both physiological and psychological health. An example 
of this includes a trial for diabetes and depression, where both fasting glucose levels 
and depressive symptoms were significantly reduced following CBT treatment (Li, 
Xu, Hu, Tan, Zhang et al., 2017).   
CBT has also been shown to be effective in treating patients with PPS. 
Individual RCTs have demonstrated the effectiveness of CBT in treating IBS (Moss-
Morris, McAlpine, Didsbury & Spence, 2010) psychogenic non-epileptic seizures 
(Goldstein, Chalder, Chigwedere, Khondoker, Moriaty, Toone et al., 2010), and non-
cardiac chest pain (Marks, Chambers, Russell, Bryan & Hunter, 2014). In addition, it 
has been shown to be even more effective than Graded Exercise Therapy (GET) in 
cases where PPS co-exist with significant anxiety or depression (Castell, Kazantzis 
& Moss-Morris, 2011). CBT has also been shown to help improve daily functioning 
in those with PPS. Reme, Grasdal, Løvvik, Lie and Øverland (2015) conducted a 
CBT work-based intervention with staff that were either signed off sick, were 
currently receiving disability payments, or were considered at risk of being signed 
off from work. Participants that received CBT as opposed to usual care were 
significantly more likely to engage at work, which was also reported 18 months later 
demonstrating the approach to have a long-term benefit. A systematic review and 
meta-analysis of 23 investigating the effectiveness of CBT in treating unexplained 
lower back pain concluded that CBT demonstrated long-term benefits in terms of 
reducing symptom severity, and in improving functioning and quality of life 
(Richmond, Hall, Copsey, Hansen, Williamson et al., 2015). Regardless of this, CBT 
can require a lot of dedication as some patients may require up to 20 sessions 
(British Association for Behavioural and Cognitive Psychotherapies, 2017), which 
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may not be practical for all patients in need of therapy. A report released in 2015 by 
Integrated Access to Psychological Therapy (IAPT), who deliver CBT as 
recommended by National Institute of Health and Clinical Excellence (NICE), 
revealed that of 1,123,002 referrals that terminated, only 42% actually finished a 
course of treatment (IAPT, 2015). It is important therefore to ensure that everyone is 
able to access psychological therapy, and therefore other therapy options gaining 
momentum should at least be considered for future use. 
Acceptance and Commitment Therapy (ACT) is a relatively new therapeutic 
approach that emphasises the importance of behavioural change and commitment, 
integrating mindfulness principles with the need to reach a point of acceptance 
(British Association for Behavioural and Cognitive Therapies (BABCP), 2017). 
Mindfulness, which promotes the Buddhist principles of being present in the 
moment by paying greater attention to one’s own thoughts and feelings, has in itself 
been shown to be effective in improving psychological health outcomes (Gu, 
Strauss, Bond & Kavanagh, 2015).  Based originally on the Relational Frame 
Therapy, ACT has been described as “explicitly contextualistic... based on a basic 
experimental analysis of human language and cognition” (Hayes, 2004). RCTs have 
shown ACT to be effective in reducing anxiety and depression, as well as effective 
in increasing the self-efficacy of patients living with PPS (Veehof, Oskam, Schreurs 
& Bohlmeijer, 2011; Wicksell, Kemani, Jensen, Kosek, Kadetoff et al., 2013). 
Perhaps most significantly, it has been shown to increase mental agility on both a 
short-term and long-term scale (McCracken & Gutierrez-Martinez, 2011; Wicksell et 
al., 2012), which in theory would enable them to accept their current and potentially 
indefinite physical and psychological limitations.  
Despite clear recommendations having been published, there is still 
evidence that healthcare professionals are unaware of how to help patients with 
PPS. Yon, Nettleton, Walters, Lamahewa and Buszewicz (2015) conducted in-depth 
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interviews with junior doctors based in hospitals within the UK to explore their 
knowledge and awareness of PPS, as well as their recommendations of how to 
improve the quality of training. Participants reported a lack of awareness in terms of 
what PPS are, what investigations should be conducted and how extensively, the 
potential co-morbidity of depression or anxiety, how PPS could be appropriately 
explained to patients, and how they could assist the patient in managing their 
symptoms in future. Similarly to the findings of Maatz et al., (2016) and Wileman et 
al., (2002), this study revealed that when treating patients with PPS, junior doctors 
experienced feelings of frustration and anxiety and worried that they would be 
incompetent when attempting to treat patients. This often led them to conduct 
unnecessary investigations, and even avoid seeing particular patients altogether. 
Participants also revealed within these interviews that negativity towards patients 
with PPS were sometimes fed down from senior healthcare professionals, 
influencing their own attitudes and behaviours towards symptoms. Another recent 
qualitative study conducted with both junior doctors and consultants across 
gastroenterology, cardiology, neurology and rheumatology (Warner, Walters, 
Lamahewa & Buszewicz, 2017), replicated these findings. Within this study, it was 
believed that there are still no clear guidelines in place, and while some senior 
clinicians appeared to be able to appropriately manage and treat patients with PPS 
themselves, this was largely due to their experience rather than any specific training 
or clinical guidelines.  
Yon, Habermann, Rosenthal, Walters, Nettleton et al., (2017) administered 
web-based questionnaires to the directors of training programmes which concurred 
that there was very little training in place on PPS for healthcare professionals, and 
that there should be roughly up to three hours’ training per year. As part of the same 
study, workshops were run with a multidisciplinary team including junior doctors, 
from which it was recommended that future training should include real-life 
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examples, videos and role-plays, in order to make it clear what constituted good and 
bad medical consultations. Despite these recommendations and the publishing of 
new recommendations for commissioners in relation to treatment, the findings from 
Warner et al., (2017) suggest that the message has not yet being filtered down from 
commissioners to healthcare professionals. Whether these guidelines will eventually 
be followed as intended is yet to be seen. One potential limitation in relation to these 
guidelines however, is that they have not been influenced by any qualitative studies 
conducted with patients themselves. Obtaining a good understanding of patients’ 
expectations would have provided further insight on how to improve training for 
healthcare professionals. Research with patients is therefore needed in order to 
understand their experiences of accessing and using healthcare, and how they 
would expect any shortcomings in terms of healthcare to be addressed. The 
findings from this patient-led research may be used to help review clinical training 
and guidelines for the treatment of PPS, to make sure that patients receive the best 
possible treatment. 
 
1.2. Predisposing, precipitating and maintaining factors of symptoms 
1.2.1. Predisposing factors 
The potential causes for PPS are somewhat unclear and are potentially 
varied. However, several potential causes for PPS as a whole have been 
addressed. Predisposing factors may include genetic factors, personality traits such 
as neuroticism, physical or sexual abuse, chronic mental or physical illness, and the 
presence of illness within the family during childhood. In terms of predisposing 
factors, the support for childhood traumas such as child abuse is particularly strong. 
Maniglio (2009) conducted a systematic review of reviews involving 270,000 
subjects, studying the long-term consequences of childhood sexual abuse, and 
concluded participants subjected to abuse as a child were at a significantly greater 
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risk of developing medical and psychological disorders as adults. Within this review, 
childhood sexual abuse was demonstrated to precede a higher prevalence of 
chronic non-cyclic pelvic pain (Latthe, Mignini, Gray, Hills, & Khan, 2006), non-
epileptic seizures (Sharpe & Faye, 2006), and other ‘dissociative’ or ‘somatoform’ 
disorders (Jumper, 1995; Rind & Tromovitch, 1998). Häuser, Kosseva, Üceyler, 
Klose and Sommer (2011) gave further support to these findings following their 
review of fibromyalgia patients, where they reported significant links between 
childhood sexual and physical abuse, and fibromyalgia symptoms. However, the link 
between child sexual abuse and fibromyalgia specifically is somewhat compromised 
within this study, due to larger effect sizes being associated with poor quality 
studies. Hotopf, Mayou, Wadsworth and Wessely (1999) also reported a link 
between childhood experiences and PPS through their birth cohort study examining 
high risk factors in childhood. Within this study, a significant relationship was found 
between the health status of participants’ parents when they were aged 15, and the 
presence of PPS in their mid-30s. Nevertheless, cohort studies as a whole are 
subject to recall bias (Hotopf, 2002), which compromises study reliability. 
Adshead and Guthrie (2015) introduced human attachment theory into the 
debate to explain a link between childhood experiences and PPS. According to this 
theory, when young children are emotionally or physically upset, they instinctively 
exhibit certain behaviours that would be responded to by an attachment figure, in 
order to reduce these feelings of distress. Within a healthy parent-child relationship, 
the child would learn how to manage negative feelings themselves, and in 
adulthood would reflect back on their childhood attachment experiences, thus 
instigating their own sense of self-worth (Ainsworth & Bell, 1970). In the case of 
insecure attachment, relationships with attachment figures do not successfully 
reduce feelings of distress and when these children become adults, they are more 
likely to adopt the role of being the patient (Adshead & Guthrie, 2015). Taylor, 
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Marshall, Mann and Goldberg (2012), who conducted a cohort follow-up study of 
frequent attendees across ten primary care practices in the UK, supported this 
theory. Of the 18% of identified patients that were found to have PPS within this 
study, insecure styles of attachment were particularly high, identified both through 
questionnaires and a telephone interview, as well as more frequent primary care 
consultations. However, it should be noted that as well as the study being at risk of 
recall bias, only a brief self-report measure was used to capture information on 
participants’ attachment styles. Further research is therefore required to provide 
support for the relevance of human attachment theory. 
Kendler, Walters, Truett, Heath, Neale et al., (1995) provided evidence for 
the role of genetic factors in self-reported PPS, following utilisation of the ‘Virginia 
30,000’ twins sample. Despite a model being fitted to assess the variance for 80 
distinct relationships, genetic factors were reported to account for up to 49% of the 
total variance. Interestingly within this study, family environment was reported to 
have no effect upon the onset of symptoms. However, these findings should be 
viewed with caution, as it is not possible to say to what extent the family 
environment may have influenced twins’ behaviour. Further to this point, a more 
recent twin study focusing on the prevalence of IBS reported very little difference 
between the concordance rates of monozygotic twins (28%) and dizygotic twins 
(27%). Environmental factors on the other hand, including oral contraceptives or 
Hormone Replacement Therapy (HRT), excess alcohol intake and anticholinergic 
drug therapy, were found to be significantly linked (Mohammed, Cherkas, Riley, 
Spector & Trudgill, 2005). 
Certain personality traits have also been suggested to be a predisposing 
factor for PPS. Neuroticism for example, one of the main five personality traits, has 
been linked with PPS due to its associations with negative affect, general distress, 
increased sensitivity to stressful events, and depression and anxiety (Deary, 
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Chalder & Sharpe, 2007). There is support for this theory (Menon, 
Shanmuganathan, Thamizh, Arun, Kuppili et al.,2017; van Dijk, Hanssen, Naarding, 
Lucassen, Comijs et al., 2016), but it may be that neuroticism is linked more directly 
with psychological distress than PPS. Menon et al., (2017) who conducted a cross-
sectional study over a three-year period within a tertiary care facility, reported that a 
large percentage of the 171 patients with PPS (52.6%) were suffering from 
psychological distress. These patients were found to have significantly higher levels 
of neuroticism, compared with those who were not psychologically distressed. In 
further support of this, van Dijk et al., (2016) used a case-control study to compare 
PPS patients with controls, and reported that while the PPS patients demonstrated 
higher levels of neuroticism there was little difference in the personality profile of 
PPS patients and those with medically explained conditions.  
Another personality trait that has been linked with PPS is alexithymia, or the 
inability to express oneself including one’s feelings (Deary et al., 2007). While it is 
understandable in a practical sense how alexithymia could potentially inhibit 
progress with healthcare professionals and therefore indirectly exacerbate PPS, 
studies on this have produced non-significant findings. Kooiman, Bolk, Brand, 
Trijsburg and Rooijmans (2000) conducted a cross-sectional study with outpatients 
from an internal medicine clinic. Approximately half of the patients included within 
the study were identified as having PPS. However, self-report questionnaires and 
interviews failed to identify a significant difference in terms of the prevalence of 
alexithymia between patients with PPS and those without. Anuk and Bahadir (2018) 
examined the link between physical and emotional abuse and PPS, using interviews 
and self-report questionnaires.While this study did report higher rates of alexithymia 
amongst PPS patients exposed to childhood physical and emotional abuse, 
limitations such as the purposive sampling method and the reliance on retrospective 
data compromise the reliability of these findings. This study also indicates that 
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alexthymia is likely be a personality trait shaped by experience, rather than an 
innate one. 
Overall, the evidence for the role of predisposing factors is somewhat 
inconclusive. Generally there appears to be a stronger argument for the role of 
childhood experiences, rather than genetics and personality traits. Based on the 
limitations of the existing research, further longitudinal studies with large samples of 
patients with PPS are required in order to provide a more conclusive understanding 
of the role of predisposing factors. 
 
1.2.2   Precipitating factors 
Precipitating factors may include stressful life events, acute physical or 
mental illness, and environmental factors such as war and natural disasters. 
Stressful life events can include anything from divorce to acts of terrorism, and there 
is certainly evidence to support their role within the onset of symptoms (Hatcher & 
House, 2003; van den Berg, Grievink, Yzermans & Lebret, 2005). Hatcher and 
House (2003) conducted a case-control study to investigate the relationship 
between stressful life events and CFS. They found that those with CFS were 
significantly more likely to have experienced stressful life events either three months 
or a year prior to being examined. A review by van den Berg et al., (2005) reported 
that out of 22 studies comparing rates of PPS between survivors of natural disasters 
and controls, in 18 studies the survivors exhibited significantly higher rates of PPS. 
Due to differences in terms of study design within the review, it is unclear exactly 
how common PPS is amongst survivors. However, a recent longitudinal study 
examining the prevalence of somatic symptoms in young survivors of the Lushan 
earthquake in China supported these conclusions. Their findings, reported at three 
and six months after the earthquake, showed there to be unusually high rates of 
tiredness and fatigue (52.0 and 46.1%), sleeping problems (58.4 and 48.4%) and 
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functional abdominal pain (45.8 and 45.4%) amongst survivors (Zhang, Zhu, Du & 
Zhang, 2015). Despite the longitudinal design appearing to strengthen the study, 
symptoms were only assumed to be PPS rather than a result of any existing 
pathology. Furthermore, questionnaires were administered at three and six months 
following the earthquake, but baseline scores were unavailable making it difficult to 
ascertain whether PPS was actually triggered by the earthquake. 
Hickie, Davenport, Wakefield, Vollmer-Conna, Cameron et al., (2006) 
provided evidence for the link between acute infection and PPS. They followed 
patients for one year after acute infection with the Epstein Barr virus, the Ross River 
virus, or Coxiella Burnetii. Self-report, clinical assessment and patient interviews 
later demonstrated that 11% of participants had met the criteria for CFS at the six 
month follow-up. This was attributed most strongly to the severity of the acute 
infection, rather than any external factors. However, due to the small sample size, it 
was acknowledged that it was not possible to eliminate other risk factors for CFS. 
Nevertheless, the link between illness and PPS has been supported by other 
studies. Lombardi, Ruscetti, Das Gupta, Pfost, Hagen et al., (2009), identified traces 
of the Xenotropic Murine Leukaemia Virus (XMRV) in 67% of blood samples taken 
from CFS patients, in comparison with only 3.7% of blood samples taken from the 
healthy controls. Due to the overlap in symptoms, it is perhaps unsurprising that 
patients living with the Hepatitis C Virus (HCV) are more likely to present with 
fibromyalgia symptoms than healthy controls. Nevertheless, HCV patients were 
found to be significantly more likely to have fibromyalgia than patients with cirrhosis 
of the liver, suggesting that acute and severe infections are more likely to trigger 
PPS. 
There is also some evidence that environmental factors such as air 
pollutants can trigger PPS, particularly respiratory symptoms. Brooks, Mark, Weiss 
& Bernstein (1985) studied the effect of just one exposure to irritant substances 
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such as smoke or fumes in ten participants, and reported that most participants 
when tested at a later date had developed reactive airway dysfunction syndrome 
(RADS), which continued for more than a year after the initial exposure. Although 
this particular study used a very small sample, it does provide evidence of the 
potential impact of environmental pollutants upon functional symptoms. A later 
systematic review by Groneberg-Kloft, Kraus, van Mark, Wagner and Fischer (2006) 
provided similar conclusions, demonstrating that air pollutants can trigger chronic 
cough and asthma-like symptoms in the absence of respiratory disease.  
Functional respiratory symptoms, such as dysfunctional breathing, have also 
been linked with recognised respiratory disorders such as asthma, due to their 
frequent co-morbidity. Thomas, McKinley, Freeman, Foy and Price (2005) for 
example conducted a cross-sectional postal survey with patients from one GP 
practice. Positive screening scores for dysfunctional breathing, as reported through 
the Nijmegen questionnaire, were reported to be higher amongst asthmatic patients 
compared with patients not diagnosed with asthma. Nevertheless, it should be 
considered that within each of these studies, there is always the possibility that 
unexplained respiratory symptoms may have been simply misdiagnosed. 
Like with the predisposing factors, the studies producing support for the role 
of precipitating factors are not without limitations. However, the findings from these 
studies appear to be consistent with one another, suggesting a clear link between 
emotive events and environmental factors, with PPS. An overview of this evidence 
however does seem to suggest that precipitating factors may only be directly 
relevant to specific PPS types, such as CFS and fibromyalgia, and functional 
respiratory symptoms, and may not be able to explain all presentations of PPS. 
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1.2.3. Maintaining factors  
Maintaining factors may include unhelpful health-related behaviours on 
behalf of the patient such as a lack of exercise and poor sleep hygiene, health-
related beliefs, ethnic background - also a predisposing factor, and unhelpful 
behaviours from healthcare professionals. Specific examples of the latter may 
include the delivery of unhelpful or confusing information, or agreeing to send the 
patient for repeated clinical tests and investigations for their PPS (Price & Okai, 
2016). Page and Wessely (2003) suggested that a number of maintaining factors 
can occur just through the doctor-patient exchange. This can include the provision 
of conflicting messages from different healthcare professionals, repeated 
investigations and treatments which can reinforce the patient’s perception of their 
symptoms being organic in nature, and the assignation of a label which can validate 
symptoms for the patient. Kenny (2004) conducted interviews with 20 chronic pain 
patients and 22 pain specialists, and found that PPS was exacerbated by the 
continued miscommunication between healthcare professionals and patients who 
are more likely to approach patient symptoms from a psychological and biological 
standpoint respectively.  
Other maintaining factors may exist at biological level with evidence 
suggesting that increased sensitisation to certain stimuli can trigger physiological 
changes, leading to presentations of fibromyalgia and CFS (Deary, Chalder & 
Sharpe, 2007). Jerjes, Peters, Taylor, Wood, Wessely et al., (2006) monitored the 
urine samples of 15 CFS patients and 20 healthy controls over three hour intervals. 
The findings demonstrated there to be reduced hypothalamic-pituitary-adrenal 
(HPA) activity within CFS patients, due to lower cortisol levels. Results from this 
particular study however should be viewed with caution, due to the small sample 
size. Furthermore, another study with a large sample has since contradicted these 
findings. Claassen-van Dessell, van der Wouden, Dekker, Rosmalen and van der 
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Horst (2017) examined the relationship between Cortisol Awakening Response 
(CAR) and the severity and duration of symptoms, within a mixed PPS population. 
No significant relationships were found, suggesting that CAR cannot explain onset 
or presence of PPS. However, due to the cortisol sampling procedures failing to 
match up to guideline regulations within this study, and due to the conflicting results 
with studies, more robust research is required to understand the proposed link 
between external stimuli and physiological change, and the onset of PPS. 
Health-related beliefs are considered to be a predecessor of health-related 
behaviours, which can exacerbate poor health (Rosenstock, Strecher & Becker, 
1998). The Illness Perception Questionnaire (IPQ) was originally designed in order 
to understand these cognitive processes. Made up of five individual subscales, it 
assesses how patients recognise illness through the symptoms (Identity), what 
patients think may have caused their illness (Cause), the expected duration of their 
illness (Timeline), what they perceive will happen because of their illness 
(Consequences), and whether they think an illness can be managed or cured (Cure 
control) (Weinman, Petrie, Moss-Morris & Horne, 1996). A fairly recent systematic 
review and meta-analysis of 188 papers covering a wide range of conditions has 
already reported strong pooled correlations between the subcomponents of the 
Illness Perception Questionnaire (IPQ) and a range of health-related outcomes, 
including depression, anxiety, and quality of life (Broadbent, Wilkes, Koschwanez, 
Weinman, Norton et al., 2015). However, most included studies within the review 
were cross-sectional in design rather than longitudinal, employing a wide variety of 
measures likely to differ in terms of validity and reliability. Most significantly 
however, this large review does not focus specifically on PPS. Due to the level of 
complexity of PPS, it may be that the IPQ is too simplistic to explain the cognitive 
processes behind them.  
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Following this brief review of the associated causes of PPS, it is not 
surprising that for many living with these symptoms the causes are considered to be 
unknown, due to the complexity of symptoms. Taking a biological approach is likely 
to be overly simplistic and unhelpful. The biomedical model, which was once 
considered the go-to model for healthcare, assumes that poor health can only be 
the result of biological factors (Wade & Halligan, 2004). As demonstrated by the 
evidence, PPS challenges the adequacy of the biomedical model due to their 
complexity, therefore supporting the view that a biopsychosocial explanation for 
health and proposed treatment would be more appropriate (Wade & Halligan, 2004). 
The biopsychosocial model takes into account all potential biological, psychological 
and social factors that may affect symptoms, and is considered to be a much more 
effective approach when it comes to designing a plan of effective treatment 
(Edwards, Stern, Clarke, Ivbijaro & Kasney, 2010). Nevertheless, the wide scope of 
evidence regarding the potential causes of PPS present a challenge in terms of 
obtaining an accurate overview within individual consultations of what may have 
caused the symptoms. This is particularly poignant when considering the limited 
amount of time healthcare professionals in the UK are now able to spend with 
patients (Baird, Charles, Honeyman, Maguire & Das, 2016). 
 
1.2.4. The role of ethnicity upon health and PPS 
Ethnicity may also act as both a predisposing and maintaining factor, due to 
black and minority ethnic (BME) groups generally fairing significantly worse in terms 
of health and well-being in comparison with white British groups, even after 
controlling for social and economic factors (Stevenson & Rao, 2014). The Office for 
National Statistics (2013) state that BME groups report significantly lower scores in 
terms of well-being than their white British counterparts. This disparity between 
ethnic groups was reported to be particularly pronounced between black African 
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groups and white British groups, with average well-being scores reported of 6.7 and 
7.4 out of 10 respectively. Bangladeshi groups were also reported to have relatively 
low well-being scores with an average of 7.0 out of 10. Evidence suggests that BME 
groups are more prone than white British to both mental and physical health 
complaints (Missinne & Bracke, 2012; Parliamentary Office for Science and 
Technology, 2007). For example, with regards to mental health, white Irish groups 
present with higher rates of alcoholism and depression and are more likely to be 
admitted to hospital, while African Caribbean patients are up to five times more 
likely than other ethnic groups to be diagnosed and hospitalised with schizophrenia. 
It is also recognised that there is a much higher suicide rate amongst Asian women 
(Mental Health Foundation, 2017). This suggests that poor mental health is not 
always easily recognisable, and certain BME groups may be particularly vulnerable. 
In terms of PPS specifically, there is evidence of ethnic differences in terms 
of prevalence. Verhaak, Meijer, Visser and Volters (2006) conducted a survey of 
400,000 patients across 104 general practices in the Netherlands. Patients within 
this sample with PPS were more likely to be of non-Western origin than ‘average’ 
patients or those living with a diagnosed medical condition. Palmer, Macfarlane, 
Afzal, Esmail, Silman et al., (2007) conducted a large research study with 933 White 
Europeans and 1914 South Asians (1165 Indian, 401 Pakistani and 348 
Bangladeshi), recruited through 13 general practices located in Birmingham, 
Oldham, Bolton and Ashton-under-Lyne. Their findings showed all South Asian 
groups to have significantly higher rates of chronic widespread pain when compared 
with the white European group. A further systematic review and meta-analysis by 
Dinos, Khoshaba, Ashby, White, Nazroo et al., (2009) examining the relationship 
between CFS and ethnicity concluded that CFS is much more common amongst 
African Americans and native Americans than white Americans, with more severe 
symptoms.However, while PPS may be more common in BME groups, this is not 
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necessarily the case with all PPS. Kang (2005) reported within his review that while 
some studies had demonstrated higher rates of constipation amongst African 
Caribbean subjects compared with white American counterparts, other studies have 
reported higher rates of IBS amongst the white population. Bhopal, Cezard, Bansal, 
Ward and Bhala (2014) reviewed medical records in Scotland linking 4.65 million 
people from the 2001 Census to NHS hospitalisation and death records. Within this 
study, Poisson regression was used to calculate relative risk of IBS, which was 
found to be significantly more prevalent amongst white women than Pakistani 
women. This is despite the opposite being reported for organic gastrointestinal 
diseases such as ulcerative colitis. 
Reasons for reported ethnic differences may be due to variances in how 
symptoms are perceived, as well as understandings of what they mean and their 
significance. Rahim-Williams, Riley, Williams and Fillingim (2012) for example 
conducted a systematic review of quantitative evidence focusing on the differences 
in sensitivity to pain between white Americans and African Americans. The 26 
included studies were reported to have medium to large effect sizes, with tolerance 
to pain concluded to be much higher amongst white Americans. Similar findings 
have been reported when comparing South Asian males with white British males, 
with the former demonstrating a significantly lower threshold towards pain and being 
more likely to report it (Watson, Latif & Rowbotham, 2005). Kirmayer and Young 
(1998) examined illness narrative data across a mix of ethnic groups. They 
demonstrated within their review that PPS were understood to be either related to 
an organic disease or psychopathology, or were perceived to be an outward 
expression of inner conflict, social dissatisfaction or emotional distress. 
Some evidence suggests that discrepancies between ethnic groups in terms 
of health and well-being may be also due to differences in coping strategies. Lam 
and Zane (2004) argued that white Americans were more likely to exercise primary 
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control than Asian Americans, i.e. were more inclined to manipulate their current 
environment in order to fit with their needs. In comparison Asian Americans adhered 
to secondary style coping, and so were more likely to try to change their thoughts 
and behaviours in order to adapt to their environment. With this in mind, it is 
reasonable to assume that ethnicity is likely to play a mediating role upon adopted 
coping strategies in times of adversity (Bailey & Dua, 1999; Rothbaum, Weisz & 
Snyder, 1982). Another study comparing the coping styles of 238 older white 
Americans and 206 Korean Americans experiencing stressful life events strongly 
supports this suggestion. Within this study, white Americans were reported to adopt 
a more active approach utilising planning strategies in order to cope with stressors, 
whereas Korean Americans were shown to adopt avoidant and emotionally focused 
coping mechanisms (Lee & Mason, 2014). More specifically related to PPS, Njoku, 
Jason and Torres-Harding (2005) examined the coping strategies of European 
Americans, African Americans and Latin Americans living with chronic fatigue. 
Through the completion of Coping Orientation to Problems Experienced (COPE) 
scales, it was found that African and Latin Americans were more likely to adopt 
avoidant coping styles, including denial, and therefore demonstrate less ability to 
adapt. 
 
1.2.5. Ethnicity and religion  
Religious coping has been shown to some extent to also be a protective 
factor for health related problems. A critical review reported that religious activity, 
such as prayer, can help to boost immunity, reduce any feelings of anxiety, reduce 
symptom severity and even reduce the number of days spent in hospital (Coruh, 
Ayele, Pugh & Mulligan, 2005).  Religious beliefs are also known to influence 
health-related behaviours. Holt, Roth, Clark and Debnam (2014) adopted the 
Religion-Health Mediational Model in order to examine the relationship between 
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religion and health in African Americans. Their findings were that those who were 
more religiously engaged were more likely to avoid drinking alcohol, and more likely 
to eat healthier food.  A more recent literature review by Park, Masters, Salsman, 
Wachholtz, Clements et al. (2017) has also shown that religious coping has benefits 
in terms of mortality and can also positively influence behaviours, leading to better 
physical and mental health outcomes. Reviews conducted prior to this have also 
concluded that religious and spiritual beliefs can act as a protective factor and 
promote improved health outcomes (Cotton, Zebracki, Rosenthal, Tsevat & Drotar, 
2005; Chida, Steptoe & Powell, 2009). Despite the potential benefits, there is also 
evidence that some religious beliefs, such as believing that their poor health is a 
result of God punishing them, can have harmful effects on both mental and physical 
well-being (Lee, Nezu & Nezu, 2014). BME groups typically hold much stronger 
religious beliefs than those who identify as white British (Nandi & Platt, 2014). Njoku 
et al. (2005) reported differences in terms of religious coping styles between ethnic 
groups, with African Americans being significantly more likely to take comfort in their 
religious beliefs. Nevertheless, as BME groups on the whole evidently suffer much 
higher rates of poor health and well-being, as stated previously, it may be the case 
that ethnic minorities more regularly engage in negative religious coping behaviours. 
 
1.2.6. Ethnicity and social support 
Social support and relationships with healthcare services may contribute to 
the health discrepancies between ethnic groups. The presence of a good social 
support network has long been demonstrated to have beneficial effects upon both 
physical and mental health outcomes, both directly and by acting as a buffer 
(Carpenter, Fowler, Maxwell & Andersen, 2010; Shier, Ginsberg, Howell, Volland, 
Golden et al., 2013). As well as being shown to be helpful for the individual, social 
support has also been demonstrated to help reduce the burden on healthcare costs 
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(Shier et al., 2013). Ethnic differences in terms of social support have been 
detected. Das-Munshi, Becares, Dewey, Stansfeld and Prince (2010) reviewed the 
national survey data from 4281 patients belonging to a range of BME groups. 
Following multi-level logistic regression, they reported that individuals living in areas 
of a high own-group ethnic density were more likely to have better mental health, 
due to reduced incidence of ethnic discrimination and more social support. Cole, 
Matheson and Anisman (2007) examined the moderating effect of social support in 
white European and BME college students over one year. At the half-way point, 
BME students were less likely to succeed academically than white European 
students and demonstrate poorer well-being, due to having limited social support. 
The BME college students who did receive more positive social support enjoyed 
greater academic success.  
 
1.2.7. Experienced difficulties in treating BME patients with PPS 
BME groups are generally less likely to access healthcare services than their 
white British counterparts. A semi-structured qualitative interview study with hard-to-
reach groups including BME patients suffering from poor mental health identified 
several key factors that may go some distance to explain the lower rates of 
healthcare access. These include the patients’ own perceptions of their feelings of 
distress, their inability to discuss their health problems with their GP due to 
language barriers and not being able to use the services appropriately (e.g. not 
being aware of how to register with a local GP, or not knowing how to ring and book 
an appointment) (Bristow, Edwards, Funnel, Fischer, Gask, et al., 2011). 
Differences in terms of traditional medicinal practices are also likely to exist, which 
could also provide further explanation for BME populations being harder to reach 
(Struthers & Nicholls, 2004). Further studies conducted within the UK have 
demonstrated that BME groups consider their own religious and cultural values to 
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be somewhat undermined within NHS healthcare, due to healthcare professionals 
adopting a biomedical approach (Memon, Taylor, Mohebati, Sundin, Cooper et al., 
2016). Factors such as these on behalf of the patient, teamed with the notable 
difficulty that healthcare professionals face when treating patients, suggests that 
BME patients with PPS are at a higher risk of not receiving healthcare and support. 
More research is required on the role that particular cultural factors, including coping 
styles, religious beliefs and social environment, play in terms of how PPS are 
perceived by BME patients and how they feel these symptoms would be best 
managed. 
 
1.2.8. Proposed research and aims 
In order to gain a better understanding of the patients living with PPS, it would 
be useful to understand patients’ experiences in their own words. Due to the evident 
difficulties in treating PPS, it would also be useful to understand how symptoms 
have impacted upon day-to-day life, as well as their experiences of accessing and 
using healthcare in order to understand how this may potentially be improved. A 
detailed narrative comparison between white British and BME participants would 
help to expose key differences, thus provide some insight into how future treatment 
may need to be modified in order to be ethnically sensitive. The findings from this 
research could potentially be used to help design future interventions and written 
healthcare guidelines on how to effectively treat BME patients living with PPS. While 
adopting a more ethnically suitable approach may encourage patients to access 
healthcare services, healthcare professionals will be in a stronger and more 
informed position to advise BME patients with PPS on how to take an autonomous 
approach and actively make behaviour changes that benefit health. Providing this 
type of information shortly after patients first seek out help will mean that any health-
related issues are likely to be managed effectively earlier on, reducing the likelihood 
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of patients returning for repeated healthcare appointments and investigations. 
Based on this information, the aims of this thesis are to: 
1) Understand BME experiences of living with PPS 
2) Understand BME experiences of accessing and receiving healthcare 
3) Understand the role and influence of cultural factors amongst BME 
participants 
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CHAPTER 2:   METHODOLOGY 
 
2.1:  Qualitative methodology 
 The aims of this research are threefold. Firstly, it is to understand BME 
experiences of living with PPS; secondly, to understand their experiences of 
accessing and receiving healthcare, and thirdly, to understand the role and 
influence of cultural factors. The descriptive and explorative nature of the research 
aims are therefore best served by a qualitative approach (Ploeg, 1999), due to their 
scope for capturing rich and detailed information that cannot be acquired through 
the use of quantitative methodologies.  To elaborate further, the qualitative 
approach in general is described as a “naturalistic, interpretative approach 
concerned with understanding the meanings that people attach to actions, 
decisions, beliefs, values and the like within their social world, and understanding 
the mental mapping process that respondents use to make sense of and interpret 
the world around them” (Ritchie & Lewis, 2003).   
Qualitative research is flexible in that it can be used in a wide variety of 
contexts in psychology (Willig & Stainton-Rogers, 2008). The selected method and 
how it is utilised however is largely dependent upon the researcher themselves, in 
particular the researcher’s own experience and perceptions of how the desired 
information would be best obtained. However, qualitative methodologies are also 
selected on the basis of what the specific aims are of the research, who the targeted 
participants are, and who this research is being conducted for. This is both in terms 
of the prospective audience and who funded the research, if applicable (Ritchie & 
Lewis, 2003).  
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2.1.1:  Qualitative research interviews 
 Qualitative research interviews are particularly effective when aiming to obtain 
sensitive data, as participants may feel relieved after sharing their stories (Elmir, 
Schmied, Jackson & Wilkes, 2011). Furthermore, many participants may feel 
uncomfortable sharing personal information within a focus group. There are also 
benefits in that individual interviews are more flexible in terms of time and location. 
The ability to capture sensitive information and logistically adapt to suit the 
requirements of participants, were particularly important considerations when 
selecting the most appropriate methodology to use. Semi-structured interviews were 
the chosen methodology chosen for this study, as they allow the researcher to 
control the interviews through a list of questions, while also providing the participant 
with freedom to express themselves (Gill, Stewart, Treasure & Chadwick, 2008).  
 
2.1.2:  Rationale for using qualitative methods to examine differences between 
groups 
 Employing a qualitative methodology to look for similarities and differences 
between sub-groups enables the researcher to still capture and analyse rich and 
descriptive data, if further exploration and description is still required within this 
research area. Quantitative methodologies, such as RCTs and quasi-experimental 
research designs, can also be used to effectively compare sub-groups of data, and 
are frequently used in healthcare research to investigate the impact of health-
related interventions (White & Sabarwal, 2014). However, these quantitative 
methodologies take a deductive approach, with participant responses limited by pre-
determined variables, or existing hypotheses (White & Sabarwal, 2014). Due to the 
exploratory and descriptive nature of the research aims of this study, as well as the 
limited number of participants available for contact, a qualitative approach was 
considered more appropriate for this study.   
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The successful use of qualitative methodologies in studies performing sub-
group data comparisons, further justifies its use for this research. Tonkin-Crine, 
Coenen, Fernandez-Vandellos, Krawczyk et al., (2011) conducted 52 qualitative 
semi-structured interviews with GPs in five European countries, using a framework 
analysis method to compare responses across countries to strategies used to 
promote antibiotic prescription, although this study identified mostly consistencies 
across nations. Another study by Gwede, Jean-Francois, Quinn, Wilson, Tarver et 
al., (2011) used semi-structured interviews to explore attitudes towards colorectal 
cancer across three ethnic groups: African Americans, those from English-speaking 
Caribbean countries, and those from Haiti. Their approach successfully identified 
key differences between groups in terms of how curable colorectal cancer was 
perceived, how it was could be prevented, and where they would prefer to access 
information. As a final example of qualitative studies with sub-group comparisons, 
Paul, Ross, Bryant, Hill, Bonevski et al., (2010) compared smokers of high and low 
socio-economic statuses using focus groups. Key differences were identified in 
terms of social context, thus informing future anti-smoking campaigns. 
 
2.2:  The target group and how they were approached 
 Participants who participated in the qualitative study were initially participants 
enrolled onto the PRINCE Secondary trial. Therefore, information has been 
provided on the trial initially, in order to provide the necessary context. 
 
2.2.1:  The PRINCE Secondary trial  
The PRINCE Secondary trial is an RCT testing the clinical and cost 
effectiveness of a new approach of CBT in patients living with a diagnosis of PPS. 
Participants were either allocated to receive CBT with Standard Medical Care, or 
Standard Medical Care only. Due to pre-existing CBT trials with Chronic Fatigue 
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Syndrome patients (White, Goldsmith, Johnson, Potts, Walwyn et al., 2011), and 
dissociative seizures (Goldstein et al., 2010), patients presenting these particular 
syndromes/symptoms only were excluded from the trial and therefore the qualitative 
study.   
Patients were recruited into the PRINCE Secondary trial following their 
attendance at secondary care clinics at Guy’s and St Thomas’ Hospital and King’s 
College Hospital.  Patients included within the trial had received at least one 
diagnosis from the following syndromes or individual symptoms: fibromyalgia or 
chronic widespread pain, non-cardiac chest pain, functional neurological symptoms, 
functional gastrointestinal symptoms including IBS and functional dyspepsia, and 
functional respiratory symptoms including dysfunctional breathing and chronic 
cough. Patients were only recruited into the trial if they had received confirmation of 
their diagnosis following diagnostic tests during a consultation with either a 
Consultant, a Specialist Registrar (SpR), or a Nurse Specialist.  Patients with co-
morbid conditions were not necessarily excluded from the trial, as long as these 
associated symptoms were either in remission or were considered less debilitating 
than relevant PPS. Other inclusion criteria for the PRINCE Secondary trial were 
those aged 18-70, a Work and Social Adjustment Scale (WSAS) score of a 
minimum of 10 indicating at least a moderate level of functional impairment (Mundt, 
Isaacs, Shear & Greist, 2002), and an ability to read and write in English. Exclusion 
criteria included alcohol and drug dependency, a daily intake of 10mg or more of 
Benzodiazepines, and being considered at imminent risk of self-harm.  
 
2.2.2:  Target group and setting:  the qualitative study 
Ethical approval for the qualitative study was obtained through the 
Camberwell and St Giles Ethics Committee (see Appendix II). This was conducted 
as information relating to the qualitative study was included as part of the 
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submission of an ethical amendment for the PRINCE Secondary trial. Within the 
amended protocol (see Appendix III), it was clearly stated that participants may be 
approached to conduct an ad hoc qualitative interview. Once ethical approval was 
officially granted by the Committee, the approval letter and all developed documents 
including the updated PRINCE Secondary protocol were forwarded to all relevant 
Research and Development (R&D) departments within NHS trusts actively referring 
patients for the PRINCE Secondary trial (Appendix IV). Individual documents for the 
qualitative study included the participant information sheet (Appendix V), consent 
form (Appendix VI), topic guide (Appendix VII) and the debrief sheet (Appendix VIII). 
This was to ensure that all participating hospitals were aware that their registered 
patients may also be approached for the qualitative study following their enrolment 
onto the trial. Integrated Research Application System (IRAS) forms for PRINCE 
Secondary were also updated to include the qualitative study (Appendix IX).  No trial 
participants were approached for the qualitative study until R&D departments had 
acknowledged and approved the new and amended documents. 
Trial participants were not considered contactable unless they had provided 
their own consent to be contacted for future research. This was optional when 
providing their consent to participate within the trial. Participants who answered in 
the affirmative to be contacted were documented at the point of enrolment as 
approachable for the qualitative study.  
 
2.2.3:  Sampling strategy  
In order for both white British and BME participants to be equally represented 
within the qualitative study, a non-probability quota sampling strategy was selected. 
Purposive sampling was also employed within the BME and white British groups, 
with the aim to achieve a representative mix of different PPS and gender. Within the 
BME group, an attempt was also made to achieve a mix of ethnic identities. The 
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sample was limited to those who had provided their consent to be contacted for 
future research, and then to those who eventually returned their consent form. 
 
2.2.4:  Sample size 
Guy’s and St. Thomas’ Charity (who funded the PRINCE Secondary trial and 
had invested interest in this qualitative research conducted), were keen for this 
qualitative research to consist of as many interviews with participants as feasibly 
possible. However, it was decided that recruitment should be ceased once 30 
interviews were completed (15 white British and 15 BME). This was for two reasons. 
Firstly, this sample size was large enough to have accommodated a reasonable mix 
of PPS type and gender, as well as a mix of ethnic identities within the BME group, 
which would have been more difficult to achieve within a smaller sample size. 
Secondly, and most importantly however, data saturation had already been 
achieved within each group by this point. 
 
2.2.5:  Definition of BME  
BME was defined within this study as any participants who did not classify 
themselves as white British, i.e. did not identify as white English, Welsh or Scottish. 
While the Institute of Race Relations (2017) defines BME as “the terminology 
normally used in the UK to describe people of non-white descent”, white British was 
separated from other white groups within this study due to the potential cultural 
differences. To support this point, a study by Koutrelakos (2013) identified key 
differences between specific white groups (including Jewish, Armenian and Greek), 
and other white groups (including white European and pan-ethnic), particularly in 
terms of the strengths of their religious beliefs and ethnic identity. In addition to this, 
the Office for National Statistics lists ‘white British’ as separate from ‘white Other’, in 
recognition of ethnic differences (Office for National Statistics, 2016).  
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For all participants participating in the trial that had confirmed their willingness 
to be contacted for further research (as captured within their consent form), 
information regarding participants’ ethnic identity was accessed through the 
demographic forms completed at baseline. This information on participants was 
stored alongside contact details, PPS type and gender within a password-protected 
spreadsheet accessible only to the researcher.  
 
2.2.6:  Process of recruitment  
Due to the qualitative researcher being blinded to which treatment arm 
participants were allocated to within the PRINCE Secondary trial, participants were 
not approached until 20 weeks after trial enrolment. This was to ensure that the 
qualitative interviews did not clash with scheduled CBT sessions. Due to blinding, it 
is not known exactly how many qualitative participants received the CBT prior to 
their interview, but it was expected that a significant number of participants would 
have received the CBT. In an attempt to reduce any effect that this may have had 
upon responses, and to reduce the risk of un-blinding, participants were informed 
prior to the interview that the interviewer was blinded to their group allocation and 
therefore any CBT received as part of the trial should not be discussed.  
Participants were contacted personally by the researcher via their previously 
stated preferred method of contact (telephone, text or email), where the qualitative 
study was briefly explained and interest was gauged. Those who expressed an 
interest were sent the detailed information sheet and consent form either via email 
or in the post. The information sheet explained the aims and objectives of the study, 
the potential benefits and drawbacks of taking part, and what their data would be 
used for. In addition, the information sheet informed participants that their 
participation within the study would remain confidential, and that they would remain 
anonymous throughout the analysis and write-up stage, with no quotes being 
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directly attributed to them. Participants were also informed of their right to refuse to 
answer questions if they did not feel comfortable answering, and were told of their 
right to stop the interview at any point and withdraw from the study. The information 
sheet also informed participants of the intention to audio-record the interview and 
that the purpose of this was that their interview could be listened to again by the 
researcher, transcribed and analysed. Participants were also reassured that 
interview recordings would be stored securely on password-protected computers at 
King’s College London. These interviews would therefore only be accessible to 
researchers involved in the study. Prospective participants were also informed of 
the intention to publish this qualitative research within a peer-reviewed journal. 
Once participants were provided with the information sheet and consent form, they 
were advised to consider participation in the study for at least 48 hours. 
Once signed consent forms were returned, participants were contacted by the 
researcher in order to arrange a suitable date and time for the interview. They were 
firstly invited to come for a face-to-face interview at King’s College London. Face-to-
face interviews were originally selected as it allows for a richer understanding of the 
participants and their responses, through the observation of body language and 
even verbal cues (Opdenakker, 2006; Willig & Stainton-Rogers, 2008).  However, 
telephone interviews were also permitted following the requests of participants 
themselves. This was generally found to be more suitable for logistical reasons, and 
due to the debilitating nature of participants’ symptoms. Telephone interviews were 
considered as a suitable alternative to face-to-face, due to their ability to capture 
data simultaneously with hard-to-reach populations (Opdenakker, 2006). This 
flexibility regarding how the data was captured was considered necessary in this 
case and arguably helped to obtain the required number of participants within the 
available timeframe. The researcher covered any travel expenses incurred as a 
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result of the interview, and all telephone calls were made by the researcher in order 
to avoid any cost to the participants. 
 
2.3:  Data collection method:  Semi-structured (qualitative) interviews 
The individual topics that were to be covered within the interviews were 
deliberated and finalised well in advance. From here, the shape of the topic guide 
was considered as well as the individual questions. In order to deploy good practice, 
interview questions were open-ended and non-leading, thereby allowing the 
participant to lead the discussion themselves to a certain extent (Jacob & 
Furgerson, 2012).  
 
2.3.1:  The topic guide 
The topic guide (see Appendix VII) was designed to ensure that participants 
were presented with easier questions near the beginning, followed by more 
challenging questions later on. This was to enable participants to develop a rapport 
with the interviewer, and grow in confidence when answering the questions (Jacob 
& Furgerson, 2012). At the start of the topic guide, there was an introduction, where 
participants were reminded of the information provided within the information sheet. 
In particular this referred to what the interview would aim to cover, the intention to 
audio-record the interview for transcription and analysis purposes only, and the 
participant’s right to stop the interview or withdraw themselves from the research 
either during the interview or up to a certain date afterwards. The main body of the 
interview however consisted of four sub-sections: 1) their family and cultural/ ethnic 
background, 2) their PPS, 3) their experiences in accessing both primary and 
secondary healthcare for these symptoms, and 4) their daily life with the symptoms, 
particularly their work and social life. Examples of questions eventually included 
within the topic guide, were as follows:  
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“Can you tell me a bit about your cultural background?”   
“Can you tell me about your symptoms? Type of symptom, frequency etc.” 
“Can you tell me about when you first went to seek medical advice for your 
symptoms?” 
“How has your social life changed since you developed your symptoms? (If 
yes) how does this make you feel?” 
Questions included within the main sections were not necessarily discussed in 
the order of the questions presented within the topic guide. If certain topics were 
raised spontaneously, it was prioritised by the researcher for interviews to flow as 
naturally as possible. At the end of the interview, participants were invited to add 
any further commentary, or ask any questions regarding the study. Following the 
completion of interviews, each participant was provided with a debrief sheet and a 
copy of their signed consent form, which reminded them of how data would be 
stored, as well as the next steps in terms of the research study. Participants were 
also informed of their right to request a copy of the findings, and were also provided 
with the contact details of the researcher in case they had any questions or 
concerns in relation to the study.  
 
2.4:  The researcher 
As a member of the PRINCE Secondary trial team, I was fortunate in that I 
already had access to the personal details of potential participants for the qualitative 
research, and following ethical approval of the study, I was able to directly contact 
prospective participants immediately. Having played a fundamental role in the 
recruitment of patients for the trial, in some cases I had already been formally 
introduced to potential qualitative participants within the hospital setting, which may 
have provided an advantage in that it would likely have instilled an element of 
authenticity and trust. However, as I already had an awareness of patient’s 
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experience of PPS following previous discussions with patients, the likelihood of 
researcher bias was recognised to be high. Therefore, as the qualitative researcher 
and interviewer I understood the importance of detaching oneself from previous 
information in order to adopt an objective stance (Norris, 1997). This was to ensure 
that identified themes were not influenced by information external to the data 
provided within this qualitative research. Furthermore, in order to ensure that data 
collection and analysis process demonstrated rigour, it was important to approach 
the interviews systematically and reflexively.  With this in mind, if another researcher 
were to have conducted the study, similar themes and conclusions in theory would 
have been reached (Mays & Pope, 1995).  
 
2.5:  Ethical considerations 
Guidelines were followed in order to obtain ethical approval from the 
Camberwell and St Giles Ethics Committee. In order to conduct this appropriately, 
the Informed Consent sheet was detailed and ensured to cover all necessary 
information. In particular it included information on the aims of the research, and 
their right to avoid specific questions and to stop the interview and/or withdraw. 
Whilst this information was first presented within the informed consent sheet, these 
main points were also re-iterated at the start of the interview.  Within the informed 
consent sheet, participants were provided with the contact details of the primary 
researcher and their supervisor. Participants were also informed within the informed 
consent sheet that participant data would remain confidential and anonymous. This 
was also re-iterated within the introduction of the interview, where they were 
informed that rather than refer to participants by name, anonymity would be 
protected by the utilisation of a Personal Identification Number (PIN). For ease, the 
same PINs used within the trial for each participant were adopted.   
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It was acknowledged that participants may become distressed while being 
interviewed, due to them discussing their potentially debilitating PPS. In order to 
effectively manage this, as mentioned previously, participants were informed of their 
right to stop the interview, or withdraw themselves. Within the information sheet, 
participants were also informed that should they become distressed during the 
interview, they should seek help for this from their GP or from another qualified 
healthcare professional. The decision to allow for telephone interviews to be 
conducted as an alternative to face-to-face interviews was also partly ethically 
driven. Not only were participants given the option to travel to King’s College 
London for the interview should they wish to leave the house for the day, if 
symptoms were severe they could do the interview from the comfort of their own 
home. 
In order to ensure that patients’ confidentiality and anonymity was honoured, 
interviews were recorded either face-to-face in a quiet room on University grounds, 
if the patient had opted to conduct their interview face-to-face, or they were 
conducted again in a private room over the telephone. In addition, only a password 
protected device was used to audio-record the interviews, and once interviews were 
completed they were immediately downloaded onto a secure server at King’s 
College London. Interviews were not kept on the device, in case the device was 
mislaid at any point. Once completed, transcripts were encrypted, before being 
saved securely on the server. The researcher did not inform anyone of the 
password for these interviews, due to the potential breach of patient confidentiality 
that this could have caused. In a further attempt to protect patient confidentiality, as 
interviews were typed up they were referred to by their PINs only rather than any 
other information that could potentially identify them. 
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2.6:  Transcripts 
Audio-recordings of all interviews were transcribed word-for-word, in order to 
recreate the interview on paper. This meant that any further vocal sounds such as 
‘erm’, and any half-finished words or sentences were included within the transcript. 
In order to help with the analysis, all interviews were listened to again and written up 
personally by the researcher. In order to ensure that transcripts were as accurate to 
the spoken interview as possible, they were typed up as soon as possible following 
the completion of each interview. This helped with the contextual understanding of 
the interviews, which would likely have been lost to a certain degree should there 
have been a long delay. Following the completion of transcripts, they were re-read 
whilst listening to the audio-recording once again, to ensure that participants were 
not misrepresented within their transcripts. 
 
2.7:  Data analysis 
2.7.1:  Thematic analysis and the rationale for use 
As the research aims were descriptive and exploratory in nature, interviews 
were analysed using an inductive style of the thematic analysis technique. Using an 
inductive approach allowed for themes to be devised from the data produced, rather 
than from the individual questions covered which expose the pre-conceived 
perceptions of the researcher (Willig & Stainton-Rogers, 2008). This type of 
qualitative analysis technique is perhaps the most frequently used technique within 
qualitative research, and is suitable for the analysis of descriptive data as well as 
interpretative data (Braun & Clarke, 2014). Thematic analysis is well established as 
a methodology, and has been successfully used in somewhat similar studies, 
including studies relating to Health Services Research (Golenko, Pager & Holden, 
2012), patients’ perceptions of nursing staff (Stewart, Burrow, Duckworth, Dhillon, 
 76 
 
Fife et al., 2014), and patient experiences of living with illness, focusing on their 
beliefs with regards to their illness and treatment (Pouli, Das Nair, Lincoln & Walsh, 
2014). The process of thematic analysis has been successfully broken down into six 
steps by Braun and Clarke (2006). All six of these individual steps were carefully 
followed here in order to successfully and competently execute the thematic 
analysis:  
1. Making sure to become more familiar with the data – listening, 
transcribing and reading the data produced 
2. Identifying an initial set of codes 
3. Identifying the themes 
4. Reviewing the themes 
5. Defining and naming the themes 
6. Producing a report - final analysis and write-up 
 
2.7.2:  A framework analysis method and the rationale for use 
In order to identify any qualitative differences between self-identified white 
British and BME groups, an adapted version of the framework analysis method was 
employed. This type of method has been described as a “systematic and flexible 
approach to analysing qualitative data”, and it is most frequently used in conjunction 
with semi-structured interviews and thematic analysis (Gale, Heath, Cameron, 
Rashid & Redwood, 2013). Gale et al., (2013) identified several steps to follow in 
order to ensure correct employment of the method, the first few stages of which 
closely coincide with the stages initially outlined by Braun and Clarke (2006):  
1) Transcription  
2) Familiarisation with the interviews 
3) Coding 
4) Developing a functioning analytical framework 
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5) Effectively applying the analytical framework 
6) Entering the data into the framework matrix produced 
7) Interpreting the data 
All qualitative data was analysed together before the identification of key 
differences between white British and BME participants, with the interview 
transcripts coded on an ongoing basis after the completion of each interview. With 
the traditional framework analysis method, data is organised into a spreadsheet 
Matrix (also known as Charting), with individual codes organised into columns and 
with participants in individual rows. However, within this study the researcher colour-
coded the transcripts of white British and BME participants (purple for white British, 
red for BME), prior to developing the analytical framework. Items of data labelled 
with a specific code (with the participants’ PIN number and PPS type also linked) 
were grouped together onto individual Word documents, with each separate Word 
document representing a different code. From here, a functioning analytical 
framework was created as the codes (Word documents) were easily grouped 
together (i.e. categorised). The use of colour coding white British and BME data 
meant that when reviewing the data overall in order to identify differences between 
the white British and BME groups, it was clear where both the similarities and 
differences were in terms of participants’ responses. In summary, all identified steps 
of thematic analysis were employed, but these were integrated with steps 1-5, and 7 
of the framework analysis method. The data was not however entered into a 
traditional framework matrix (step 6) as defined by Gale et al., (2013). 
Thematic analysis and framework analysis methods have previously been 
used in together where researchers were interested in both the similarities and 
differences between distinct groups. For example, Tonkin-Crine, Yardley, Coenen, 
Fernandez-Vandellos, Krawczyk et al., (2011) conducted a qualitative study 
exploring patients’ views of different interventions used within primary care for an 
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acute cough. The study was conducted over six European countries, and 
researchers were interested to see whether there were any differences between 
countries. Following translation into English where necessary and the application of 
thematic analysis, the framework analysis method was successfully able to identify 
differences in patient views across the different countries.  
 
 
2.8:   The Importance of reflexivity 
 
It is important to consider the potential impact of being an active researcher on 
the trial, and how it may have affected qualitative recruitment, data collection and 
interpretation of the research findings. In terms of recruitment in particular, due to 
the researcher having had previous contact with participants through the trial, 
participants may have felt obliged to consent to being contacted for future research. 
It is also possible that having already had professional contact with participants, 
past interactions may influence who eventually participates within the qualitative 
study. However, it could also be affected by the researcher feeling that certain trial 
participants may be more suitable for qualitative interviews and/or be more insightful 
than others. This would mean that certain participants who may be keen to be 
interviewed stand less chance of participating than others. Previous knowledge of 
participants may also lead the researcher to sub-consciously phrase questions in a 
certain way, which may lead participants to disclose certain information rather than 
other information. In addition, the researcher’s interpretation of the qualitative data 
collected may also be skewed by previous knowledge or experience of participants. 
An example of this could be the expectation that if trial participants demonstrate low 
self-efficacy in terms of completing questionnaires on time, they may also report 
their PPS having a greater effect upon their ability to engage in daily activities. 
In order to ensure that the data is honest and upstanding, it is the researcher’s 
duty to reflect on these potential factors, and ensure that any existing 
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preconceptions or biases that may have been internalised are not expressed at the 
recruitment stage, at the point of interview, or while analysing the data. In order to 
effectively action the reflexive approach, the researcher is required to at least 
consider and be mindful of the different ways that preconceptions or bias may creep 
in and influence research findings (as described above).  Other ways of how 
research findings could be affected are through preconceptions or biases relating to 
a participant’s gender, age group, ethnic group, religious beliefs, political beliefs, 
sexuality and/or educational level. The researcher should always adopt a reflexive 
stance towards data collection and analysis to ensure that biases are not reflected 
at any point during the research process. 
 
 
CHAPTER 3:  RESULTS 
3.1:     Introduction to results 
This section demonstrates the process, as well as the findings from the 30 
qualitative interviews. Between May 2016 and May 2017, a total of 154 trial 
participants (both white British and BME) were identified as being eligible for 
contact, i.e. had provided their permission to be approached regarding future 
research. In total, 65 of these were invited to participate within the study on the 
rolling basis, either by telephone, text or email. Of those that were approached, 26 
(40.0%) did not respond to their initial invitation, and 4 (6.2%) did not return their 
consent form by post after giving their verbal consent. Out of the five who provided 
reasons for their refusal to participate, four expressed a lack of interest in the study, 
and one disclosed a recent family bereavement. Out of the 65 trial participants 
contacted, 30 (46.2%) went on to participate in the study. Recruitment was ceased 
once it was perceived that a good mix of PPS type and gender had been included, 
and that data saturation had been achieved within both the white British and BME 
groups. Interviews ranged in length from 32 minutes and 49 seconds, to 80 minutes 
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and 27 seconds, with an average interview length of 57 minutes and 18 seconds. 
BME interviews were slightly longer on average than white British, averaging at 59 
minutes and 44 seconds, compared with 54 minutes and 48 seconds. Please see 
Appendix X for the full interview schedule. 
While all qualitative interviews were analysed by the main researcher, in 
order to improve inter-coder reliability and minimise any risk of researcher bias, a 
second qualitative research analyst was introduced to manually code four of the 
interview transcripts independently. Two of these transcripts were of interviews with 
white British participants, and two were of interviews with BME participants. 
Independent coding of the transcripts was later followed by a one-hour debrief 
session between both analysts, during which initial codes and labelling were 
discussed at length, as well as the general findings from interviews so far. Following 
the debrief session some codes were re-labelled in order to reflect the qualitative 
interpretations of both analysts. 
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3.2:    Descriptive information  
Five key themes were identified by the end of the analysis process, which 
were further broken down into 15 sub-themes. Please see Figure 2A1 below.  
 
Figure 2A1.  Themes and sub-themes 
 
Differences between the white British and BME group have been 
acknowledged and highlighted within the results section below. In order to elaborate 
and help illustrate identified themes and sub-themes, participant verbatims have 
been selected and included as appropriate. In order to protect participant identity as 
promised, participants have been referred to by PIN allocated, as well as their PPS 
1. Beliefs surrounding the symptoms 
1.1:  Uncertainty regarding what can trigger symptoms 
1.2:  The potential impact of trauma 
1.3:  Uncertainty regarding the future 
1.4:  The role of religious beliefs 
2. Putting on a strong face 
2.1:  Trying to remain positive 
2.2:  Keeping the symptoms to oneself 
3. A need for social support 
3.1:  The role of family 
3.2:  Attitudes of non-family members 
4. Quality of life has been stripped away 
4.1:  The physicality of symptoms 
4.2:  Impact of symptoms on day-to-day life 
4.3:  Impact of symptoms on psychological well-
being 
5. Inconsistency within the NHS 
5.1:  NHS staff can be really supportive 
5.2:  NHS staff are not always understanding 
5.3:  Long delays are common in healthcare 
5.4:  A mixed treatment approach is better 
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type. For a full breakdown of identified codes as well as participant responses, 
please see Appendix XI. 
 Of the BME group, 11 participants were female and four were male. Six 
were currently living with their partner or spouse and children; four were living alone; 
two were living with a partner; one was living within the family home; one was living 
with a sibling, and one was sharing a room within sheltered accommodation. Nine 
participants completed their interviews over the telephone and six face-to-face, as 
requested. Table 2A1 provides more information on participant gender, PPS type 
and ethnic identity. 
Table 2A1. Black and Minority Ethnic participants 
Black and Minority Ethnic (BME) 
Participant 
No. 
Gender Persistent physical symptom Ethnic group 
P02002 Female Fibromyalgia White British and Sri Lankan 
P02018 Female Fibromyalgia White Italian 
P02021 Female Fibromyalgia White British and Indian 
P02029 Female Fibromyalgia White Irish 
P02152 Female Fibromyalgia Hispanic (Colombian) 
P01019 Female Functional neurological symptoms Black African Caribbean 
(Jamaican and Bajan) 
P01033 Female Non-cardiac chest pain Indian 
P01052 Female Functional neurological symptoms Iranian 
P01053 Male Non-cardiac chest pain Black African Caribbean 
(Jamaican) 
P01061 Male Dysfunctional breathing 
(Respiratory) 
White Irish 
P01079 Female Functional belching 
(Gastroenterology) 
Black African  
(Sierra Leone) 
P02008 Female Fibromyalgia White British and Canadian 
P02034 Female Fibromyalgia White Irish 
P01149 Male Irritable Bowel Syndrome White Portuguese 
P02195 Male Abdominal pain and fatigue Kurdish 
  
 Of the 15 white British participants, the largest group (seven) lived alone; 
three lived with family members; two lived with partners; two lived in a flat-share, 
and one did not disclose this information. Of these participants, 12 completed their 
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interview over the telephone and three completed them face-to-face, as requested. 
Table 2A2 provides more information on participant gender and PPS type. 
Table 2A2. White British participants  
White British 
Participant No. Gender Persistent physical symptom 
P01001 Female  Functional neurological symptoms 
P01009 Female Functional neurological symptoms 
P01044 Female Fibromyalgia Syndrome 
P01094 Female Irritable Bowel Syndrome (IBS) 
P01117 Female Irritable Bowel Syndrome (IBS) 
P01135 Male Irritable Bowel Syndrome (IBS) 
P01138 Female Chronic Cough 
P02031 Female Fibromyalgia Syndrome  
P02032 Female  Fibromyalgia Syndrome 
P02038 Female Fibromyalgia Syndrome 
P02040 Male Fibromyalgia Syndrome 
P02010 Female Fibromyalgia Syndrome 
P01172 Female Chronic cough 
P02170 Female  Abdominal pain and burning (Gastrointestinal) 
P01058 Female Functional neurological symptoms 
 
3.3:    Themes and sub-themes 
Theme 1:  Beliefs surrounding the symptoms 
Within this theme, participants discussed their beliefs surrounding the cause and 
outlook of their symptoms. Within the first sub-theme, participants discussed their 
uncertainty regarding their symptoms. Within the second sub-theme however, many 
also disclosed their experiences of a physical or emotional trauma, demonstrating 
their beliefs that this may have been a contributor to their symptoms. Within the third 
sub-theme, participants discussed uncertainty regarding a potential cure for their 
symptoms. The final sub-theme acknowledged the religious beliefs of participants. 
Although religion was not linked as a cause of symptoms, some did express 
managing to find comfort through their religious beliefs. 
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Sub-theme 1.1:  Uncertainty regarding what can trigger symptoms  
 
White British and BME participants’ responses were similar in terms of the amount 
of confusion expressed regarding what may have caused their symptoms. Within 
both groups, many participants claimed to be uncertain about what had caused or 
triggered their symptoms in the first place, and claimed at this point to have no 
particular beliefs or suspicions about what the causes or triggers may have been. 
“From what I can gather, as far as I can remember, it’s not something that 
my family had, so I don’t know if it’s hereditary or not. Erm, I’m, apart from 
about the thing in early 2000s, there’s not much stress I’ve had in my life you 
know. I don’t know, to be honest with you” (P02040, white British, 
Fibromyalgia). 
In a few cases, participants stressed that symptoms would tend to flare up in the 
absence of there being any warning, which made them even harder to control or 
manage. 
“… It comes on. I mean I could go to bed OK, get up in the morning and 
can’t move. It’s just a thing that just happens, and I don’t know why it 
happens” (P02032, white British, Fibromyalgia). 
Sub-theme 1.2:   The potential impact of trauma 
Another similarity between the white British and BME participants was that many 
participants from both groups had a history of trauma. Past physical traumas 
included injuries, medical procedures, physical abuse, illnesses or infections, and/or 
road accidents. In the vast majority of cases across both groups, participants had 
linked these experiences with their current symptoms, suggesting that they could 
have been a causal factor.  
“I assume that it happened when I fell out of my nan’s loft, but I am not so 
sure, erm, the thing with my neck. It may have happened when I had a car 
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crash I suppose, because I had two in the space of a year. I had one in the 
beginning of the year and one at the end of the year... Then obviously when 
the physio did the traction thing it, it could have affected it there” (P01009, 
white British, Functional Neurological Symptoms). 
In terms of emotional trauma, both white British and BME participants reported 
experiences of bereavement, physical/verbal and sexual abuse, mental illness, poor 
relationships with family, and political/religious conflict. In cases of emotional trauma 
however, it was somewhat less common for the trauma to be linked with their 
symptoms, with many disclosing emotionally traumatic experiences independently. 
“When we were in Iran we had to say we were Muslim. We can’t obviously 
say we’re Atheist because it has an execution penalty for that... We had to 
flee Iran a couple of times and finally to England in 2002... I was growing up 
and I could see things and I could realise that, you know, also my father, he 
was an Atheist. My uncle who died in battle in Iran against the regime, he 
was also an Atheist” (P01052, BME, Functional Neurological Symptoms). 
Interestingly, a significant proportion of those who disclosed either physical or 
emotional traumas had also expressed uncertainty regarding what may have 
triggered symptoms. This suggests that they may have had an idea that trauma 
contributed to the onset of their symptoms, but did not feel certain of this and were 
open-minded to the idea of there may being other contributing factors. A minority of 
white British and BME participants recognised that stress caused by either work or 
life events had likely acted as a trigger or contributed towards their symptoms. 
“When I think about my background, I think about my, I think about 
[inaudible] with me, it increase the symptoms as well. When I’m worried as 
well, yeah because it’s definitely worrying me a lot, and it’s worry a lot that 
causes it” (P01079, BME, Functional belching). 
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Sub-theme 1.3:   Uncertainty regarding the future 
White British participants were more likely to report having initially had a positive 
outlook regarding their symptoms, expecting that something could be done to either 
significantly reduce their symptoms or cure them completely. 
 “I think at the start I expected a quick cure, a simple change in something 
and it would be fine, and then maybe just one follow-up just to say 
“Everything’s fine. We don’t need to see you anymore”. Yeah, they were my 
expectations” (P01135, white British, Irritable Bowel Syndrome). 
BME participants were more likely to report struggling to accept their symptoms as 
they were.  
“… Though I know there is no cure, though I have been to various hospitals 
and seeing various people, and I’ve been to pain management group 
meetings and workshops and in hospital stay to learn how to manage the 
pain, I still have not accepted it. I still cannot believe that there is absolutely 
nothing to bring the pain down to a more acceptable level. That is what I 
cannot accept” (P02018, BME, Fibromyalgia). 
While BME participants were more likely to express hope that they would see an 
improvement one day, or that a cure would be discovered at some point in the 
future due to likely improvements in treatments available, they were also more likely 
to express worry about how it may affect their long-term future.  
“I just think like, I’ve just turned 30, um, and we’re talking about having 
children and doing all these things like really great normal things, and in the 
back of my mind I’m like, “Shit, how am I going to have children with this? 
Like, I’m already in pain, I’m barely struggling to like get myself going and 
then I want to add like more stress and just, like just, natural drama into the 
mix?  I just find like the prospect of having children very overwhelming. I 
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don’t, yeah I don’t know what my body’s going to do…” (P02002, BME, 
Fibromyalgia).  
Sub-theme 1.4:  The role of religious beliefs 
A difference between the white British and BME participants was that BME were 
much more likely to have been raised to be religious, or at least had a religious 
influence upon their life, which also impacted upon their personal values. They were 
also more likely to discuss having spiritual leanings, taking a particular interest in 
alternative teachings, spiritual healing and meditation.   
“When I was living in Colombia, when I was small, I used to go to the church 
every week anyway. I grew up in a very believing family anyway, that you 
always had to put God first and pray to God to help you to go through things 
in life, and as soon as you put God in your mind, that’s your primer thing 
anyway. You always believe in, in that” (P02152, BME, Fibromyalgia). 
While neither BME nor white British participants linked religion as a causal factor for 
symptoms, BME participants did more commonly describe how they had sought 
comfort through their religious beliefs, e.g. through praying to God for pain relief or 
for the strength to continue. 
“Sometimes I think, you know, sometimes just with every step I take, you 
know God will help me get through this, you know, if something happens... 
God will help me. My father, after he helped me, I just pray” (P01033, BME, 
Non-cardiac chest pain). 
 
Theme 2:   Putting on a strong face 
Within this theme, participants discussed how they did not want it to appear as 
though the symptoms were taking over their lives and bringing them down. Within 
the second sub- theme, participants described their need to demonstrate this strong 
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façade to others, by keeping their symptoms private and not openly discussing them 
at every opportunity. 
Sub-theme 2.1:   Trying to remain positive  
Although fairly common amongst both groups, the white British participants were 
more likely to express defiance towards their symptoms as well as determination 
that their symptoms would not take over their life, particularly in terms of their daily 
activities. Instead, they discussed making a strong effort to carry on with their day 
regardless of symptoms, in an attempt to continue to lead as normal a life as 
possible.  
“... There is that element that in comes in, but I get over it. I don’t let it affect 
what I do, so yeah on a daily basis it’s there all the time, calmer when I’m 
quiet, erm, so, but I just tend to get on with stuff, and just, not ruling my life” 
(P01001, white British, Functional Neurological Symptoms). 
White British participants also more commonly stressed that even though their 
symptoms were debilitating, they had managed to gain some perspective, 
acknowledging that their current health and future outlook could be much worse. 
This approach had gone some way towards helping these participants to 
psychologically cope with their own symptoms.  
“It’s not the worst thing it could be kind of thing, you know it could be really, 
really bad, like I could have cancer or leukaemia or something, or something 
really bad. You know that’s what I’ve been telling myself all the way through” 
(P01009, white British, Functional Neurological Symptoms). 
While a number of white British and BME participants emphasised the importance of 
feeling and appearing ‘normal’ (i.e. not living with PPS), it was more common for 
BME participants to express how this had negatively affected them. 
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“... I just try to do the best that I can do with it, and be really positive about it, 
although it like totally gets me down that I’m not a normal person…” 
(P02002, BME, Fibromyalgia). 
Sub-theme 2.2:   Keeping the symptoms to oneself 
A similarity between white British and BME participants was that they both 
commonly expressed the importance of keeping symptoms private and to 
themselves so as not to have a negative effect on those around them, particularly 
as there was nothing that others could do to help. 
“I’m the sort of person who keeps things to myself, I think, yeah, if 
something’s not quite right. I don’t go around telling the whole world, you 
know... I don’t know, it’s just my personality I think. When I was at work, I 
used to go into work feeling like pain and it was awful some days, but you 
know, just get on with it. There’s not much people can do is there really 
when you’re in that situation. They’ve all got busy jobs, and you’ve just got to 
get on with life really” (P02170, white British, Abdominal pain and burning).  
 
Theme 3:   A need for social support 
This theme demonstrates the importance of a good social support network. Within 
the first sub-theme, participants discussed the nature of their relationships with their 
family, with those who had good relationships more supported and understood by 
family members. Within the second sub-theme, participants discussed non-family 
members such as friends, who often were less understanding.  
Sub-theme 3.1:   The role of family 
Around half of all participants reported having a close and healthy emotional 
relationship with their family or significant others overall, seeing or speaking with 
them on a regular basis.  A difference between the white British and BME 
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participants however was that BME participants were generally polarised in terms of 
their relationship with family. BME participants were much more likely to report 
ongoing family problems, disclosing a wide range of ongoing issues, including 
tension and stress relating to family illness, trauma, rebellion, recent separation and 
even rejection. This meant that their support network was likely to be affected. 
“...I don’t have any contact with [older brother], so he doesn’t bother to 
phone me, or, you know, ring me. Never wants to know how I’m living here. 
He knows I’m on my own and got lots of health problems, because he’s 
very angry because I married against my family, and since then he doesn’t 
want to make any contact, or any relationship with me... Sometimes this 
makes me a bit upset, from time to time, and on the top, you know, when I 
got domestic violence, I was more upset because, you know because of 
that person, I didn’t listen to my family and then this happened, you know, it 
was really, you know, hard for me” (P01033, BME, Non-cardiac chest pain). 
Other BME participants however had chosen to openly discuss their symptoms and 
their impact with family, which meant that they could deal with the symptoms closely 
together.  
“...Yes [wife and son] are upset about it, obviously yes they are upset about 
it, especially my wife...obviously it does have an impact on all of them 
because there are times where I’m in great pain. If we want to go and have a 
day out, you know, and I’m, you know, and I’m walking and I’m suddenly 
losing my, you know, if I walk a little bit, about 10, 15 minutes I get, I get 
very, I get tired and sore, and you just, you can’t because you’ve got pain all 
over your body sometimes...  I don’t think they’re happy with it, you know, 
they don’t like it” (P02195, BME, Abdominal pain and fatigue). 
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Sub-theme 3.2:   Attitudes of non-family members 
Another similarity between the white British and BME participants was that while 
many participants felt that they received good support overall from others around 
them, it was common for participants to report that their symptoms had been poorly 
understood by others, which triggered feelings of frustration.  
“… Everyone at work knows I’ve got IBS because if they’re handing out 
cake, I can’t have it, and they’re like ‘Oh are you on a diet? Why are you on 
a diet? You’re thin enough’. It’s like, ‘well do you think that I don’t want to eat 
the cake?’ And I think that’s the problem, everyone thinks you’re making it 
up because it’s fashionable” (P01094, white British, Irritable Bowel 
Syndrome). 
A few participants, from both the white British and BME group, stated that many of 
their relationships, particularly friendships or relationships with employers, had 
broken down since the onset of the symptoms, due to a poor understanding from 
others of how the symptoms had impacted upon their life.  
“I’ve lost 99% of my friends, I’ve only got about three real friends now. I don’t 
hardly see anybody anymore, because 99% I’ll have to cancel any meetings, 
any leisure, any outings, because at the last minute I could not go, and they 
did not think that it was all due to my not being well, because looking at me, 
it doesn’t show that I’m in pain” (P02018, BME, Fibromyalgia). 
 
Theme 4:   Quality of life has been stripped away 
Within this theme, participants discussed the impact that symptoms had had upon 
their day-to-day lives. Within the first sub-theme, participants provided a physical 
description of their symptoms. In the second sub-theme, participants discussed how 
physical limitations had brought about big compromises in terms of social life and 
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working life. The final sub-theme addresses the impact that the onset of symptoms 
had had upon psychological well-being. 
Sub-theme 4:1:  The physicality of symptoms 
A similarity between white British and BME participants was the description they 
gave of their symptoms. It was particularly common for participants from both 
groups to report pain and IBS symptoms, regardless of their main presenting PPS. It 
was also common for both white British and BME participants to experience 
extreme fatigue and poor sleep.    
“Pain exhausts you, physically exhausts you, erm, but when I say really tired 
I mean I really cannot stand up anymore. I cannot even erm, wash, brush my 
teeth. That’s how exhausted I become” (P02018, BME, Fibromyalgia). 
A difference between white British and BME participants was that BME participants 
were more likely to report living with multiple PPS, and/or co-morbid medically 
explained conditions, meaning that their health problems were generally more 
complex and likely to be more difficult to treat.  
“... You get dizzy spells, I’ve passed out a couple of times, you know, pains 
in your chest, you know, where at some point you think you’re going to have 
a heart attack, you know, so it’s a combination of a lot of things. It really 
depends how far I let my shortness of breath, I try to contain it, I don’t get 
those sort of things but if I’ve got a long flight of stairs or I try to rush for 
something then I’ll end up getting it, like dizzy spells, numbness, you know 
where you’re tingling in your hands and pains in your chest so you really 
have to say, ‘oh it’s a bad day’” (P01061, BME, Dysfunctional breathing). 
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Sub-theme 4.2:   Impact of symptoms on day-to-day life 
A similarity between both white British and BME participants was that they 
described previously having led fast paced, busy and independent lives, meaning 
that they had a certain perception and expectation of themselves.  
“I think, I’m such an extrovert as well, sort of loud character, and I feel I’ve 
always been, I’m always meant to be like, especially my family like, you 
know the one that holds it together, and the one that’s the middle child, like 
I’m meant to be the strong one, like the only one that’s like left for University 
or gone travelling, or you know, stuff like that…” (P01094, white British, 
Irritable Bowel Syndrome). 
A further similarity between white British and BME participants was in terms of how 
their hobbies were affected. Many from both groups discussed having previously 
indulged in active interests, including various types of sporting activities, gardening, 
dancing, travelling, or going out to the theatre or to eat. However, the onset of PPS 
had forced them to make major life changes, such as adopting certain relaxation 
techniques and pacing in order to cope.  
“I just go at my own pace, I don’t get myself concerned about rushing 
because I’m not going to get myself sick, to a point where I collapse which I 
have done in the past” (P01061, BME, Dysfunctional breathing). 
The onset of symptoms meant that they could no longer indulge in their previous 
interests as frequently, and in some cases they had had to give up their hobbies 
altogether. 
“Before I got sick, there was nothing that I liked more than going out to eat, 
or cooking. I love cooking, baking, it was such a passion, I really enjoyed it, 
and it just felt like that got stripped away, and I wasn’t able to enjoy those 
things anymore...” (P01094, white British, Irritable Bowel Syndrome). 
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Both white British and BME participants discussed how PPS had negatively 
impacted upon their working life. However, there was a difference between the 
groups in terms of their response:  while white British participants were more likely 
to report making adaptations at work, either by changing their role or responsibilities 
or by reducing their hours, BME participants were more likely to report retiring from 
work altogether. 
“I used to do voluntary work and I had to give up because I was making such 
a mess of it, and they thought I was just totally stupid, and I’d go in another 
day and I seemed to be doing OK”. (P02034, BME, Fibromyalgia). 
Another similarity between white British and BME participants was that PPS had 
had a big impact upon their social life, stopping them partaking in social activities 
that they used to enjoy, such as going to parties, clubs, restaurants, cinema, or 
going round to friends’ houses. 
“[What] I used to do is play darts, and things were, and I was working, so 
things went from erm, from those groups I’d be doing things all the time. 
Now, sometimes I don’t see another person in days. Erm I can’t think about, 
oh I love, used to love dancing, going to clubs. I go to parties now, on the 
odd occasion, and just have to sit there, because I can’t do it” (P01044, 
white British, Fibromyalgia). 
Several participants, both white British and BME, described experiencing a reduced 
tolerance of others since the onset of symptoms, which had led them to avoid 
certain characters. 
“There are certain friends that are not in my life now, but when I first had 
[fibromyalgia] I was really, really bad and didn’t know how to deal with it, 
erm, so like I [had friends] before I tolerated, I couldn’t anymore. I couldn’t 
bear to be in their company because they were really full on, really hyper, er, 
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kind of really highly strung people, whereas before I would be quite tolerant. 
Now I find that my tolerance levels of those sorts of people around me are 
just non-existent really, so I kind of again tend to withdraw” (P02010, white 
British, Fibromyalgia). 
In a few cases, participants reported how they felt they regularly let people down by 
either cancelling their plans with them entirely, or by inconveniencing them if/when 
they did attend (e.g. by making them feel obliged to make special allowances). 
These experiences tended to deter them from attending these types of social 
events. 
“I won’t go to a dinner party because I don’t want to put too much stress on 
the host having to make a separate meal, so I’ll just never go to people’s 
houses having meals or buffets, I’ll just completely avoid it...” (P01094, white 
British, Irritable Bowel Syndrome). 
Sub-theme 4.3:   Impact of symptoms on psychological well-being 
A difference between the two groups was that BME participants were much more 
likely to report feeling emotionally frustrated by living with symptoms in the absence 
of a clear diagnosis. This was due to not being able to explain their symptoms to 
others, and due to the lack of uncertainty regarding their health.  
“... I went home with the medication but I’m still having pains. So obviously, 
well I think they miss something, so I kept on going back, to get to the 
emergency, and they kept on saying everything’s alright, all the bloods, 
ECG… it’s OK… so what’s the pain then, what is it? And nobody, up to this 
day I still don’t know why I’m having the pain”. (P01053, BME, Non-cardiac 
chest pain) 
A similarity between white British and BME participants however was that many 
from both groups reported experiencing low mood and depression since they had 
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had their symptoms, due to the frustration they experienced as direct result of the 
symptoms, as well as the direct impact and stress that symptoms had had upon 
them and their lives. 
“It affects you big time, because you know what I mean, er in my brain I’m 
still 21 and I don’t want to be turning into an old man already because I’m 
only 52, so you do get upset mentally, because you don’t want to be that 
way. You want to be running down the road or whatever, chasing after a girl 
if you’re lucky enough but er, and if not you want to feel young and this does 
upset you very, very much mentally” (P01061, BME, Dysfunctional 
breathing). 
A further difference between the white British and BME participants was that white 
British participants were much more likely to express feeling sad that their 
symptoms had left them feeling as though they could no longer keep up, which led 
to them feeling as though they were getting left behind.  
“...When I do go out, I walk very slow because I am in a lot of pain, and I go 
out, everybody has to slow down for me. Or they carry on walking and then 
they’ll wait for me, and it makes me feel horrendous. That’s, that’s one more 
thing that I can’t do that I used to be able to. It’s one thing trying to keep up 
with the conversation with people, you know, I just, they yell back at me 
sometimes ‘Oh yeah such and such and such and such’, yeah it makes me 
feel terrible...” (P01044, white British, Fibromyalgia). 
A few others, mostly BME, also expressed feelings of anxiety, which had come on 
as a direct result of their symptoms. These feelings of anxiety were exacerbated by 
the fear that these symptoms may actually be an indication of a more life-
threatening health problem. 
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“It makes me feel that I’m… going to die. I’m on edge; I’ve always got my 
phone next to me. I’m always on edge on my arse, thinking that something 
could happen...I think the doctors said that I’ve got social anxiety, because 
that’s how it’s made me” (P01053, BME, Non-cardiac chest pain). 
Another difference between the groups was that BME participants were more likely 
to report being able to hide or manage their negative emotions. White British 
participants however reported not feeling in control of their emotional response to 
symptoms, frequently describing feelings of upset, anger or worry.  
“I think if I talk when I’m upset I can actually be quite emotional, to the point 
that it takes me a lot to cry. It could be the embarrassment, because as soon 
as people see you’re upset, they’re automatically going to ask you ‘Are you 
OK?’ and that’s the question that you dread, because you know that you’re 
going to ball up and cry afterwards, and the fact is nothing’s wrong. I’m not 
depressed because my dad’s died or you know, my cat got run over. I’m just 
depressed because I’ve got this” (P02031, white British, Fibromyalgia). 
 
Theme 5:  Inconsistency within the NHS 
This theme highlights the inconsistency of participants’ experiences with the NHS. 
The first sub-theme demonstrates that many participants had had a positive 
experience at some point during their medical journey. However, the second sub-
theme refers to participants’ experiences of also being dissatisfied at some point 
with the knowledge and attitudes of healthcare professionals. The third sub-theme 
refers to how participants felt the process was often too slow or interrupted, and the 
final sub-theme indicates participants’ attitudes towards the treatment approach 
taken, as well as what they would have expected. 
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Sub-theme 5.1:  NHS staff can be really supportive 
A difference observed between the groups was that white British participants 
generally reported a more positive experience of NHS healthcare than BME 
participants. Many told stories that revealed positive experiences of the NHS at 
some point in their journey, including them finding NHS staff to be very caring, with 
a genuine motivation to help them understand their symptoms and manage them in 
an appropriate way.  
“They’ve always been great. [The Consultant] has always tried. He’s tried so 
many different things throughout the years. I mean we were on first name 
terms. I had his secretary’s phone number so if I ever had a really bad time, I 
could ring through and arrange to see him. They’re really supportive” 
(P01117, white British, Irritable Bowel Syndrome). 
Despite white British participants having more positive experiences with the NHS 
overall, BME participants more commonly reported having had positive experiences 
with their GP, describing them as very thorough and instrumental in getting them 
referred quickly to specialists for appropriate help as quickly as possible.   
“I mean 95% of it I would say is my GP because, I have to see him every two 
weeks anyway, and he’s always very, he always wants to make sure, you 
know, is everything OK. And also your mental (health), and whatever, and so 
at some point, I’ve been very short of breath the last couple of weeks, and 
then he’ll push me in to the specialist and the specialist will take it from 
there. And then from there they’ve put me to this, and so, I’d say my GP 
would be 95% the person that has pushed me in the right direction. I feel I’ve 
been pushed in the right direction” (P01061, BME, Dysfunctional breathing). 
 
In a very small minority of cases, participants also acknowledged the current 
pressure that the NHS in general is under. Amongst this group, there was the 
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general belief that NHS staff were doing the best that they could under very difficult 
circumstances. 
“I would say it was, it was excellent. Absolutely. I have huge respect for 
[NHS hospital] as a hospital. I know the NHS is getting a slamming at the 
moment, but we all know it isn’t the NHS’s fault. But you know, like I’ve been 
down to my local hospital this morning for something else and you know, it is 
just amazing how it works and the care that one gets” (P01138, white British, 
Chronic cough). 
Sub-theme 5.2:  NHS staff are not always understanding 
A similarity between groups was that the majority of both white British and BME 
participants had felt let down or abandoned with their questions unanswered at 
some point during the medical process, either in primary care or secondary care. 
This meant that they were unsure of what to do or where to go next in order to get 
further help.  
“... Well the bottom line, they did send me for a few tests, but obviously there 
was no change... I have to say [healthcare] was poor, because I was 
discharged with a serious condition. Most importantly, I cannot go to work in 
this condition. It is life changing, and so the fact that a life changing condition 
is able to lead to the medical specialists discharging me, I cannot be 
satisfied with that, or believe that it was an acceptable effort. It will never be 
an acceptable effort as long as I am left with this condition for life” (P01149, 
BME, Irritable Bowel Syndrome). 
Around half of participants expressed frustration at the lack of understanding that 
healthcare professionals, including GPs, had demonstrated towards them, as well 
as their failure to action appropriately. In the majority of these cases this was in the 
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context of healthcare professionals doubting the authenticity of symptoms, or not 
demonstrating enough understanding. 
“... Every time I’ve gone to the GP, I’ve gone to one in Sheffield as well 
forgot about that, and it was just like, ‘well you know you have a problem 
with lactose’, the end. And it’s like, “I already know that!”... The impression I 
got from doctors was that I was just like being a silly girl” (P01094, white 
British, Irritable Bowel Syndrome). 
BME participants were more likely to report that healthcare professionals, including 
therapists, had not always delivered an appropriate level of care towards them, 
which had left them feeling despondent. While some of these participants described 
not receiving the reassurance that they required, in other cases participants 
reported feeling that these professionals were simply going through the motions of 
doing a job, and had failed to listen intently or even demonstrate empathy towards 
them.  
“I’ve seen so many therapists, the physiotherapists, they understand, try 
their very best to understand the problem that you’ve having, but there is the 
other one that, they say yes, but they are always with their mouth and also 
with their head, but you can see that in their eyes that it’s completely 
somewhere else. They’re not really listening to you properly. It’s like looking 
at my mum who’s got dementia. I speak to her, she’s looking at me, but her 
eyes are gazing through me, if you know what I mean. She’s looking at me 
but not really seeing me, and that’s the feeling that I get from some of the 
people that I’ve seen and talked to” (P02018, BME, Fibromyalgia). 
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Sub-theme 5.3:  Long delays are common in healthcare 
A similarity between white British and BME participants was that the majority of 
each group had reported the general medical process to be too slow. In many 
cases, this was due to delays in primary care.  
“... First of all with the GP it’s really hard to get an appointment and they say 
the first clinic in the morning you have to phone, therefore you have to wait a 
really long time and then you wait, wait, wait, and then they then come back 
and ‘we’ll see what we can do’. Then after that went back again, because 
literally, I went to sleep, and you know when you literally have to move your 
whole body because if you move, you get a popping, kind of, and that was 
happening a lot. So I went back, got told the same thing. They said “Yeah 
you probably slept wrong”. Still no scans, nothing and no referral” (P01019, 
BME, Functional Neurological Symptoms). 
Around a third of participants - both white British and BME participants - commented 
that they had struggled to make an appointment with their GP. Often this was 
because the surgery was struggling in terms of capacity. In other cases, participants 
reported that they had a preferred GP to see and therefore found that they had to 
wait to see them.  
“My GP practice is rather overloaded with, and trying to get in to see any 
GP, let alone my own, it’s like trying to make an appointment with God. 
Some days you could be lucky, and other days, forget it. They have so many 
locums that I’m lucky if I see the same GP twice. So, like in, I don’t really like 
to discuss it with people that don’t really know me”. (P02038, white British, 
Fibromyalgia). 
Another similarity between white British and BME participants is that around half of 
both groups disclosed having been misdiagnosed at some point by a healthcare 
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professional. This only acted to further delay the process of receiving their diagnosis 
of PPS. 
“I think at the beginning they thought I was just like making it up, erm, and 
they thought I was just being trendy until I was admitted to hospital, and 
because of the pain they thought I had appendicitis, then Crohn’s. For about 
two weeks I had Crohn’s disease and I thought that was the worst thing that 
could ever happen” (P01094, white British, Irritable Bowel Syndrome). 
A further participant stated: 
 “What happened was, when I went to [hospital name], they actually did a 
video link between them and [hospital name], and that’s when [Hospital 
name] rang me and told me it was cancerous, and then clearly when 
Professor [name] looked at the tests, when they did the endoscopy, he found 
out that it wasn’t, so when I went to see him, he told me, you know, the good 
news. So that was a bit off-putting” (P02170, white British, Chronic cough). 
While more frequently white British participants described a sense of disconnect 
within the NHS due to their confusing experiences of healthcare, a similarity 
between the white British and BME participants was that many had had to take 
matters into their own hands and chase up their GP or the hospital department in 
order to avoid any further delays.  
“Apparently I fell off, fell through a load of cracks. I think the secretary didn’t 
like me, erm, and made sure I didn’t get the follow-up appointments, so my 
daughter had to turn around and start nagging this secretary and I got one” 
(P02038, white British, Fibromyalgia). 
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Sub-theme 5.4:  A mixed treatment approach is better 
Another similarity between white British and BME participants was that the majority 
from each group had described how healthcare professionals had chosen to 
prescribe them with medication in order to treat their symptoms. This was not 
desirable, due to reports of the medications not being effective, being addictive and 
having side-effects, such as on general alertness. Some also criticised healthcare 
professionals for being quick to prescribe anti-depressants, rather than them 
investigate their symptoms more thoroughly.  
“...[GPs] seemed sympathetic, but they didn’t really seem to know an awful 
lot about what to do or, that they were quick to dish out antidepressants 
which I found didn’t help me at all” (P02010, white British, Fibromyalgia). 
However, a similarity between both white British and BME participants was that the 
majority for both were either offered or received other medical interventions later on. 
These included physiotherapy, specialised pain management courses, pain 
injections and even psychological therapy. A difference between the two groups 
however was that BME participants were slightly more in favour of holistic 
treatments, and would have liked to have received more complementary treatment. 
“They should, if, they should first find out what the problem, the root of the 
problem, and they should provide erm, services, like, if it is counselling you 
need, if it is activities, whatever, to help us because they can treat like 
Austria. They are really good with erm, people like us, people in general, 
they care about their society, they provide services. For example, they sent 
patients or clients to have activities to help rebuild their lives, to rebuild their 
confidence, their self-esteem, so they can tackle the stress. They can tackle 
all this anxiety, and for them to go back to work...” (P01052, BME, Functional 
Neurological Symptoms). 
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3.4.  Summary of key differences 
Please find below a summary table of the differences between white British and 
BME participants, as observed within this study. 
Table 2A3.  Key differences between white British and BME participant responses 
 
Key differences 
Theme 1:   
Beliefs 
surrounding the 
symptoms 
 White British initially had a more positive outlook than 
BME 
 BME struggled more to accept PPS and their impact 
 Still holding out for a cure 
 More concern for the future 
 BME had a greater religious influence 
 More likely to seek comfort through religious beliefs 
Theme 2:   
Putting on a 
strong face 
 White British more defiant and determined that symptoms 
would not control their lives 
 White British often perceive that their health could be 
worse 
 BME more affected by not feeling like a “normal” person 
Theme 3:   
A need for 
social support 
 BME polarised in their relationships with family 
 More unresolved family conflicts 
Theme 4:   
Quality of life 
has been 
stripped away 
 BME more likely to have multiple PPS/ co-morbid 
conditions 
 BME more likely to retire from work than white British, 
who were more likely to adapt their working life instead 
 BME more frustrated by living without a diagnosis 
 White British more likely to feel sad that they could no 
longer go at the same pace as those around them 
 BME more likely to report anxiety regarding their 
symptoms, assuming them to be a symptom of 
something else 
 BME felt more in control of emotions than white British 
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Theme 5:   
Inconsistency 
within the NHS 
 White British had more positive experiences of NHS 
healthcare overall 
 BME reported more positive experiences with their 
GP 
 BME more likely to report an inappropriate level of care 
by healthcare professionals, due to lack of reassurance 
or empathy 
 BME more in favour of holistic therapies than white 
British 
 
 
4.    Discussion 
4.1.   Addressing the aims 
Although the themes and sub-themes were identified following inductive 
analysis of the qualitative data, they have successfully addressed the aims. 
Discussion of the findings in relation to the aims and the significance of these 
findings within a wider context have been explored in detail below.  As the data for 
white British and BME participants were analysed collectively, the findings will be 
discussed in similar fashion, with identified differences between white British and 
BME participants addressed and discussed wherever appropriate. 
 
4.2.   Discussion of the findings based on the identified themes 
The first theme, entitled “Beliefs surrounding the symptoms”, described the 
beliefs that participants disclosed regarding their symptoms. Within this theme, 
participants referred specifically to uncertainty regarding the potential cause of their 
PPS, and their uncertainty regarding their future, which can largely be explained 
using the IPQ concepts (Weinman et al., 1996).  Within the first sub-theme of 
Theme 1, “Uncertainty regarding what can trigger symptoms”, participants 
discussed their confusion surrounding what may have possibly caused or triggered 
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their symptoms, with many reporting no particular beliefs or suspicions. This sub-
theme identifies closely with the ‘Causes’ subcomponent of the IPQ, as well as the 
‘Curability/Controllability’ subcomponent. A second sub-theme, “Uncertainty 
regarding the future”, where participants were unsure of what the future held for 
them, overlaps with both the ‘Curability/Controllability’ and ‘Consequences’ 
subcomponents. Based on this, when considering the findings from a previous 
review (Broadbent et al., 2015), it is reasonable to conclude that the IPQ can 
adequately account for the cognitive representations of PPS, and therefore may be 
used to predict the longer term health-related outcomes. As a preventative 
measure, knowledge of the cognitive processes could be used to guide healthcare 
professionals towards what information to cover within their future consultations with 
PPS patients.  
Within this study, BME participants were more hopeful for a cure, but also 
expressed more worry for the future. The potential implications of this are that any 
feelings of psychological distress and anxiety surrounding symptoms are likely to be 
more prolonged amongst the BME population, which in itself contributes to the 
longevity and severity of symptoms (Kenny, 2004; Price & Okai, 2016). Previous 
RCTs conducted with chronic pain and fibromyalgia patients have demonstrated 
ACT to significantly reduce anxiety, depression and symptom severity, as well as 
increase self-efficacy, mental agility and functioning (Veehof et al., 2011; Wicksell et 
al., 2013). ACT may therefore be of benefit to the population included within this 
study, particularly BME patients. However, larger and more robust studies 
conducted with PPS populations are required before concluding whether ACT is 
effective enough to be included as a recommended therapy within clinical guidelines 
and training. 
Within a separate sub-theme, entitled “The role of religious beliefs”, BME 
participants were more likely to report having strong religious beliefs, and although 
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they did not realise these beliefs as being in any way linked with the cause of their 
symptoms, they were more likely to take comfort in them, in that they had faith that 
their symptoms would be relieved, or that they would be given the strength to 
continue through God. This finding is supportive of previous studies comparing BME 
groups with both white British and American groups, which demonstrated certain 
ethnic minority groups to have stronger religious beliefs (Nandi & Platt, 2014; Njoku 
et al., 2005). Evidence suggests that religious and spiritual beliefs can boost health 
outcomes (Chida et al., 2009; Cotton et al., 2005; Park et al., 2017). However, 
despite this, BME groups have been shown to experience poorer physical and 
mental health (Missine & Bracke, 2012; Office for National Statistics, 2013; 
Parliamentary Office for Science and Technology; Stevenson & Rao, 2014).  While 
the reasons for this are somewhat unclear, there is some evidence that certain BME 
populations are less likely to disclose mental health problems to healthcare 
professionals, due to their religious beliefs. Semi-structured interviews with 26 Black 
Africans of faith reported that poor mental health was perceived by the church to be 
a sign of “weakness” and a “moral failing”, due to the expectation that they should 
be “spiritually strong”. These interviews also revealed that the first port of call 
following onset of mental illness was the church, where a spiritual approach would 
be taken rather than they be advised to seek out professional help (Mantovani, 
Pizzolati & Edge, 2017). A review by Lauber and Rössler (2006) also reported the 
negative influence of religious beliefs upon mental health stigma and disclosure 
amongst the Asian community. Within this research study, it could therefore be 
interpreted that BME participants felt more uncomfortable disclosing psychological 
distress, and therefore reported feeling more in control of their emotions than white 
British participants, particularly when considering that BME participants experienced 
more health co-morbidities, as well as more concern for the future. However, this 
theory is in no way conclusive and needs to be explored further. 
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Within the second theme, ‘Putting on a strong face’, white British participants 
generally reported greater psychological resilience following symptom onset than 
the BME group. For the first sub-theme, entitled ‘Trying to remain positive’, white 
British participants expressed a determination that their symptoms were not going to 
completely take over their life, and also actively attempted to reduce the perceived 
seriousness of their situation by comparing PPS with more serious health 
conditions, such as leukaemia. The reason for white British participants 
demonstrating a greater acceptance of PPS within this study could be explained by 
research in the USA that demonstrated non-white groups to be more likely to adopt 
avoidant coping strategies when exposed to stressful events, such as denial (Lam & 
Zane, 2004; Lee & Mason, 2014; Njoku et al., 2005). Once again, the findings 
suggest that striving to improve patients’ psychological flexibility, mental agility and 
self-efficacy may be beneficial, and may be achievable through the use of ACT. 
However, the findings from previous evidence, as well as this current study, should 
be viewed with caution, due to the employment of small sample sizes within the 
studies, but also due to the possible danger of research having misinterpreted BME 
coping styles. 
A further theme, ‘A need for social support’, emphasised again the 
importance of a strong and positive social support network, thus supporting previous 
research studies that have reported the benefits of this upon physical and mental 
health outcomes (Carpenter et al., 2010; Shier et al., 2013). Poor quality 
relationships during adulthood have been linked to increased somatisation (Liu et 
al., 2011), or the adoption of the ‘sick’ role (Adshead & Guthrie, 2015). Within this 
study, white British participants were more consistently reported to have close and 
supportive relationships within their family network. While many BME participants 
also reported this, as a whole the BME group was polarised as many reported 
ongoing family conflicts. A lack of support within the family network could also be 
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further compounded by increased risk of discrimination or lack of support within the 
wider community (Das-Munshi et al., 2010). A tentative explanation for BME 
participants reporting less consistently supportive relationships with family members 
could be history of insecure attachment, which has been found to be more common 
amongst certain BME populations (Bakermans-Kranenburg, van IJzendoom & 
Kroonenberg, 2005; Malda & Mesman, 2017). The study by Bakermans-Kranenburg 
et al., (2005) for example compared African and white children’s scores on the 
Attachment-Q sort, and reported African children’s mean scores to be significantly 
lower than those of white children, with maternal sensitivity the greatest predictor of 
attachment quality. Taylor et al., (2012) linked insecure attachment directly with an 
increased prevalence of PPS. However, the relationship between insecure 
attachment and PPS, particularly amongst BME populations, needs further 
clarification and supportive evidence.  
Another theory for why BME groups may have reported more ongoing family 
conflicts within this study could be down to BME patients feeling the need to adapt 
their social environment in order to accommodate their physical needs. Lam and 
Zane (2004) argued that certain BME populations were more likely to try to adjust 
themselves in order to to fit better with their current environment, in comparison with 
the white American population who were more likely to manipulate their 
environment to accommodate their own needs. Based on this argument, it may be 
that BME patients struggle to adapt within their current social environment following 
the onset of symptoms, due to the tension it would create (Bailey & Dua, 1999; 
Rothbaum et al., 1982).   
Another reason for ongoing family conflicts may be due to the strain that is 
placed upon family members, including significant others. While relationships with 
partners were not discussed as such within the topic guide for this study, and 
therefore not greatly acknowledged within the findings in their own right, evidence 
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for their strain has been provided by Arnold et al., (2008), who found that 
fibromyalgia significantly impacted upon romantic relationships due to the additional 
pressure on partners to financially support them and run the home, as well as the 
loss of physical intimacy. These findings are supported by another study with IBS 
patients, which also showed that perceived burden on partners was positively 
correlated with the level of physical disability, suggesting a definite impact on the 
relationship on behalf of the partner (Wong et al., 2011). 
Regardless of the potential reasons for reduced social support, all PPS 
patients require access to a positive social support network in order to boost their 
physical and mental health outcomes (Carpenter et al., 2010; Shier et al., 2013). It 
is therefore important to ensure that all patients with PPS have access. In cases 
where patients appear to be socially isolated, it may be useful for example for 
healthcare professionals to discuss the benefits of social support and even provide 
access to local support groups.  
The need for participants to adapt following the onset of symptoms was 
evident once again within the fourth theme, where participants discussed their 
experiences of living with the symptoms day-to-day. Physical symptoms more often 
than not were described as painful, but other common symptoms included IBS, 
fatigue and difficulty sleeping. Due to the similar descriptions given of symptoms 
across both white British and BME groups, it would indicate that a simple trans-
diagnostic approach may be suitable for application for patients with different types 
of PPS. That being said, BME participants within this study reported more complex 
symptoms, due to the existence of co-morbid conditions alongside symptoms. BME 
participants were also more likely to report multiple PPS. These findings lend some 
support to the review by Rahim-Williams et al., (2012), who stated that African 
Americans within the USA demonstrated a much lower threshold to their PPS, and 
were more likely to report them. This may also why BME participants within this 
 111 
 
study generally expressed lower resilience towards their symptoms (Bailey & Dua, 
1999; Lee & Mason, 2014; Njoku et al., 2005; Rothbaum et al., 1982). Nevertheless, 
greater complexity of symptoms amongst BME patients, places them at risk of a 
poorer prognosis in comparison to white British patients (Rosendal et al., 2017). 
Based on these findings, clinical guidelines for treatment should acknowledge the 
additional complexities of treating BME patients, meaning that current clinical 
guidelines may need to be further reviewed. 
Within a further sub-theme, entitled ‘Impact of symptoms on day-to-day life’, 
daily functioning for white British and BME participants alike were shown to be 
affected, with significant negative effects reported in terms of both their working life 
and social life, as well as their ability to regularly engage in their hobbies. These 
findings are therefore consistent with those of Lidén et al., (2015) study, where 
individuals with PPS symptoms reported their overwhelming impact upon daily 
functioning. This therefore supports previous research that has demonstrated PPS 
to have a major impact upon psychosocial functioning (Arnold et al., 2008; Lidén et 
al., 2015).  Within the study by Arnold et al., (2008), participants discussed how their 
symptoms had forced them to change their day job or adapt their current role in 
order to accommodate their needs. BME participants within the current study 
however were more likely to report redundancy, or retirement from work altogether 
due to their ill health. This again could be explained by avoidant coping behaviours 
(Bailey & Dua, 1999; Lam & Zane, 2004; Lee & Mason, 2014; Njoku et al., 2005; 
Rothbaum et al., 1982), as well as increased adherence to the sick role (Adshead & 
Guthrie, 2015). CBT has been shown to be effective in helping individuals to 
manage their PPS, in order to improve their quality of life and reduce work-related 
disability (Richmond et al., 2015).  Furthermore, a previous RCT by Reme et al., 
(2015) demonstrated a significant improvement in terms of ability to engage at work, 
following the provision of CBT. The benefits following treatment were still 
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maintained at 18 months, demonstrating a long-term and perhaps even permanent 
change. Based on the findings from this study, and from previous research, CBT 
should be considered in cases where patients with PPS are keen to return to work.  
A further sub-theme, entitled ‘Impact of symptoms on psychological well-
being’, described the psychological and emotional impact of the symptoms on 
participants. More than half of all participants within this study stated that they 
experienced low mood and/or depression, alongside their physical symptoms. 
Several other participants also expressed feelings of anxiety, although this was 
presented less often within the interviews. The prevalence of low mood supports the 
findings from Burton et al., (2011), who reported within their case control study that 
depression and anxiety was significantly more prevalent in patients with PPS seen 
in primary care. It also acts as further support for Henningsen et al’s (2003) meta-
analysis that revealed the prevalence of anxiety and depression to be even more 
prevalent in patients living with PPS, than in healthy patients and those with 
medically explained conditions.   
Many participants described their feelings of emotional frustration, borne out 
of them living without a medical diagnosis, or the absence of an explanation for their 
symptoms. This also made it difficult for them to explain their symptoms to others, 
and validate their related behaviours. For a few, the additional worry and stress 
brought about by the absence of diagnosis put a further strain on their general 
sense of well-being, including their physical symptoms. The findings from this study 
are therefore consistent with those from previous studies (Aamland et al., 2013; 
Nettleton et al., 2004; Nettleton, 2006). Nettleton (2006) in particular implicated the 
impact that the absence of diagnosis had upon psychological health, due to the 
uncertainty relating to the symptoms themselves, and the assumption that 
symptoms may be psychological. Interestingly within this study, white British 
participants were much more likely to report ongoing feelings of sadness that they 
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were unable to continue with the lifestyle that they had become accustomed to as a 
result of their symptoms. In addition, white British participants were also more likely 
to report feeling as though they were not in control of their negative emotions, which 
they described as a mix of anger, shame, upset, worry and embarrassment. This 
somewhat contradicts previous research findings, which had presented BME 
patients to generally exhibit higher rates of mental health problems than white 
British patients (Missine & Bracke, 2012; Office for National Statistics, 2013; 
Parliamentary Office for Science and Technology, 2007; Stevenson & Rao, 2014), 
including higher rates of suicide (Mental Health Foundation, 2017). The reasons for 
this are unclear. However, as stated previously, BME populations living with mental 
health problems are less likely to report them and seek out professional help, due to 
cultural barriers including linguistic differences and poor awareness of the NHS 
healthcare system (Bristow et al., 2011). To support this further, higher suicide rates 
are known to exist amongst Asian women and higher alcoholism and depression 
amongst the white Irish population (Mental Health Foundation, 2017). A study 
conducted with Asian women in comparison with white British women has indicated 
that mental illness perceptions are likely to differ, and that Asian women are less 
likely to refer themselves for available treatments (Taylor et al., 2013). This is not 
surprising, given recent reports that current programmes are still perceived to be 
lacking in cultural awareness and sensitivity (Karasz, Gany, Escobar, Flores, 
Prasad et al., 2016). Regardless of ethnic differences in terms of reporting mental 
illness, this study and previous research suggests that all patients with PPS are 
likely to be at high risk of depression, sadness and anxiety (Aamland et al., 2013; 
Burton et al., Henningsen et al., 2003; Nettleton et al., 2004; Royal College of 
Psychiatrists, 2017), even more so than patients living with recognised medical 
conditions (Henningsen et al., 2003). This again suggests that the uncertainty and 
confusion surrounding symptoms is a likely contributor to poor psychological well-
being.  
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As low mood and anxiety is evidently linked with the uncertainty and lack of 
understanding of symptoms, patients should receive psychoeducation in order to 
alleviate any potential doubts or confusions surrounding the nature of PPS. This 
point has already been published within recent guidelines for healthcare 
commissioners (Joint Commissioning Panel for Mental Health, 2017). However, to 
elaborate on this further, they should ensure to focus on the prevalence of 
symptoms in order to reassure patients that they are not alone. Secondly, they 
should aim to discuss potential predisposing, precipitating and maintaining factors of 
symptoms, in order to help patients understand how they may be unintentionally 
exacerbating symptoms. By explaining these points in a simplistic way, patients will 
then be able to relay this information on to others. Psychoeducation in this context 
should also include briefing on CBT-based principles, in order to describe the nature 
of the relationship between thoughts, feelings and health-related behaviours. At this 
time, healthcare professionals should also explain the benefits of CBT and its 
effectiveness in treating anxiety and depression and perceived symptom severity 
(Marks et al., 2014; Goldstein et al., 2010; Moss-Morris et al., 2010). ACT, which 
may also be effective in treating anxiety, depression and symptom severity, as well 
as boosting self-efficacy and mental agility (Veehof et al., 2011; Wicksell et al., 
2013), should also be further reviewed as a potential therapy to include specifically 
within future commissioner guidelines (Joint Commissioning Panel for Mental 
Health, 2017). 
 The final theme identified within the data referred to patients reported 
experiences of NHS healthcare for their PPS. The first sub-theme, entitled “NHS 
staff can be really supportive”, exemplifies how both white British and BME 
participants commonly reported having had a positive experience of the NHS at 
some point during their healthcare journey, due to NHS staff demonstrating genuine 
care and concern, as well as being quick to act in order to ensure they received the 
 115 
 
help that they needed. However, within the second sub-theme, “NHS staff are not 
always understanding”, the majority of participants disclosed that at some point 
along the way they did not feel their symptoms had been taken seriously enough. 
This was expressed in two very distinct ways. Firstly, at least half of both white 
British and BME participants reported feeling a sense of abandonment and 
confusion regarding what they should do next following their consultation. Secondly, 
many participants felt that healthcare professionals were initially doubtful of 
symptoms and were dismissive. Some participants also reported poor treatment 
from specialists and other healthcare professionals, such as physiotherapists. Many 
stated that they did not feel they had been treated as an individual, and did not feel 
in any way reassured following consultations. These findings strongly support those 
of previous studies that have demonstrated healthcare professionals to exacerbate 
symptoms, particularly through the delivery of both unhelpful and inconsistent 
information (Page & Wessely, 2003; Price & Okai, 2016). As poor treatment by 
healthcare professionals was more commonly reported amongst BME participants, 
it once again lends support to the argument that there is still low cultural sensitivity 
within clinical guidelines (Karasz et al., 2016). 
The next sub-theme, entitled “Long delays are common in healthcare” 
referred to the length of the medical process, which was considered by participants 
within this study to be too long. The reasons for this included the GP taking too long 
to refer, as well the length of time it takes to see a GP. In addition, a number of 
participants also reported being misdiagnosed with an organic condition, such as 
Crohn’s disease, which supports the assertion that healthcare professionals favour 
providing patients with a medically explained diagnosis where considered possible 
(Nimnuan et al., 2000). The implications of this were that a diagnosis of PPS took 
longer than anticipated, as patients already believed themselves to have a ‘real’ 
diagnosis. Delays were also caused by occasional mix-ups within the NHS, e.g. 
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between hospital departments, which was more commonly reported by white British 
participants. These long delays prompted many to follow-up with either their GPs or 
the hospitals they were seen in, in order to ensure that referrals to specialists or for 
aftercare were not lost. The findings from this study also revealed that patients were 
often prescribed medications for their symptoms first, which they were dissatisfied 
with due to the potential side effects and addictiveness of the medications. In 
addition to this, it also reinforced patients’ beliefs that healthcare professionals 
consider PPS to be ‘all in the mind’ (Nettleton et al., 2004). This finding suggests 
that in cases where healthcare professionals are unsure of the best treatment, they 
may choose to resort to the biomedical model of medicine. This is consistent with 
previous studies conducted with healthcare professionals that have demonstrated 
poor awareness of how to effectively treat PPS (Carson et al., 2004; Maatz et al, 
2016; Salmon, 2007; Wainwright et al., 2016; Wileman et al., 2002; Yon et al., 
2015).  Junior doctors within the UK recently disclosed a lack of self-confidence in 
identifying and effectively treating PPS, which by their own admission even led them 
to even avoid patients altogether. As this discomfort in treating PPS is likely 
exacerbated by the negativity of more senior healthcare professionals (Maatz et al., 
2016; Warner et al., 2017), it is important that this is overcome. By educating 
healthcare professionals on the nature of PPS, it will help them to identify symptoms 
quickly, and therefore treat or refer patients on more promptly. Yon et al. (2017), 
who distributed online questionnaires to training programme directors, reported an 
inadequate level of training for junior doctors, despite their recommendation of three 
hours every year. Workshops with a multidisciplinary team including junior doctors 
themselves led to several recommendations. Firstly, it was recommended that real 
examples be included and discussed within the programme, as well as role play and 
videos. As discussed earlier, while this may indicate for healthcare professionals 
what other professionals consider good and bad consultations, it does not take into 
account what patients themselves consider to be satisfactory and helpful. 
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Regardless of dissatisfaction with being prescribed medications and feeling 
dissatisfied with the care they received, many participants did disclose also having 
received or been referred for a wider range of treatments later on, including non-
pharmacological treatments such as physiotherapy, injections, psychological 
therapies such as CBT and counselling, and even pain management courses. BME 
participants within this study were particularly likely to favour these holistic 
approaches. This type of flexibility in terms of treatment approach indicates that 
despite reported shortcomings in terms of NHS treatment, healthcare professionals 
are adhering to a biopsychosocial approach, rather than a biomedical approach. 
Based on the findings from this study, it may be that quicker access to holistic 
therapies would be of benefit, particularly for BME patients.  
 
4.3. Limitations 
There were several limitations for this study. Firstly, participants were 
recruited through a Cognitive Behaviour Therapy trial for patients with PPS. 
Participants taking part in the trial and in this qualitative study were likely to be 
particularly motivated, as well as open-minded when it came to seeking out and 
accepting professional help for their symptoms hence this was unlikely to be a 
representative sample. There are likely to be many patients living with PPS who are 
much harder to reach and therefore engage with and treat, due to their failure to 
attend hospital appointments. This is likely to be particularly relevant in the case of 
BME patients who were not born in the UK, who are considered more likely to 
struggle with language and specific terms, less likely to know what to expect from 
healthcare professionals, and less aware of what medical and psychological 
treatments are available through the NHS. Further research is required in order to 
understand how these particularly hard-to-reach groups could successfully be 
accessed and treated within the NHS. 
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Another limitation of recruiting from a trial was that some participants would 
most likely have received the CBT, whereas other participants would not have. Due 
to blinding, it is difficult to reflect on the extent to which this would have impacted 
upon the findings in practice, due to the unknown numbers within each group. 
However, it is likely that those who received CBT as part of the trial reported more 
positive experiences of healthcare overall. While attempts were made at the 
beginning to reduce the potential impact of this, such as requesting that participants 
refrain from discussing their experiences of CBT as part of the trial and informing 
them that the researcher was blinded to their group allocation, it is still likely that 
reflections of healthcare were affected which needs to be taken into account. 
Another limitation was that the qualitative researcher was also employed on 
the CBT trial, which may have biased the overall results. Qualitative participants 
would have already been familiar with the interviewer, and therefore it is possible 
that participants may have felt obliged to provide desirable responses or may have 
withheld negative feedback, particularly when discussing their experiences of NHS 
healthcare, perhaps due to fears that feedback could be disclosed to their 
consultant. Participant responses may also have been affected due to their 
awareness of the researchers’ own ethnic background. This may have led 
participants to expect the researcher to make judgements based on their answers, 
which again may have deterred them from being completely honest in their 
responses. On a reflective note, while attempts were made to avoid this by being as 
professional as possible, it is still possible that the researcher could have interpreted 
participants’ responses slightly differently based on their previous knowledge and 
experience of participants whilst working on the trial. It is also possible that the 
researcher’s own experiences of using NHS healthcare may have influenced their 
own interpretation of the overall findings.  
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The third limitation is that for this qualitative study all non-white British 
participants were grouped together as ‘BME’. While this was conducted due to the 
unfeasibility of conducting the number of interviews required to confidently compare 
between individual ethnic groups, there are inevitably cultural differences between 
groups that were not acknowledged within this study. Due to the practical limitations 
of time and resource, in order to tailor future healthcare more closely, similar 
research should aim to gain an understanding of the cultural differences between 
different ethnic groups. The findings from this prospective research can be built 
upon the findings from this qualitative study. 
Another limitation is that all participants, both white British and BME, were 
originally recruited through London-based hospitals. As the main focus was on the 
experiences of BME participants, it is important to note that London as a city is 
ethnically diverse, particularly within the boroughs of Lambeth and Southwark where 
Guy’s and St. Thomas and King’s College Hospital are based. This would indicate 
that the experiences of the BME participants within this study may not be 
representative of BME populations across the UK. This is likely to be particularly 
true in cases where BME patients are located in predominantly white British areas 
elsewhere. In the case of this study, it was not feasible to conduct interviews with 
BME participants based in other parts of the UK. However, it should certainly be a 
consideration for any future studies that are conducted with BME participants. 
The final limitation is related to sampling. A flexible quota sampling method 
was used, as well as a purposive sampling method in order to obtain a mix of PPS 
and gender. Therefore, some participants were approached before others in order 
to try and achieve this. In addition, the researcher also attempted to recruit BME 
participants from a range of ethnic backgrounds, as well as obtain a representative 
mix of male and female participants. This meant that not all participants were 
granted the opportunity to participate within the study, especially towards the end of 
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recruitment where participants were approached on an individual basis. Participants 
were also largely self-selecting, in that many who were initially approached did not 
respond to their invitation. Several others declined participation, or could not be 
contacted. However, as the prospective participants were already taking part in the 
trial, it was anticipated that some would not have time to participate, or would not be 
open to engaging in further research when asked, despite providing their consent to 
be contacted. 
 
4.4. Recommendations for future practice 
The first recommendation would be for healthcare professionals to ensure to 
deliver patients with psychoeducation within their consultations where possible, in 
order to inform patients and caregivers and help them to psychologically adjust 
(Stafford & Colom, 2013).  Previous evidence, including meta-analyses, has already 
demonstrated that psychoeducation is effective in reducing both feelings of 
depression and anxiety (Donker et al., 2009). In addition to this, it has also been 
shown to have some effect in reducing the severity of symptoms (Chen et al., 2013; 
Luciano et al., 2011). Furthermore, psychoeducation can be delivered successfully 
to patients living with long-term conditions in a number of different formats, which 
include paper-based documents, via the internet or social media, and face-to-face 
(Oncology Nursing Society, 2016). In the case of PPS, psychoeducation should 
endeavour to cover how ‘normal’ PPS are within primary and secondary care. 
Within this study, the word ‘normal’ was expressed many times within the 
interviews, suggesting that normalisation of symptoms is important for people living 
with PPS, supportive of an earlier study (Dowrick et al., 2004). Based on the 
findings from this research and further recommendations outlined by Dowrick et al. 
(2004), psychoeducation should endeavour to express the close relationship 
between psychological factors and physical symptoms in order to provide any 
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necessary reassurance for patients that their symptoms are not a sign of a serious 
medical condition.  
In order to help patients manage their PPS and reduce the impact they have 
on day-to-day functioning, healthcare professionals should consider referring 
patients for evidence-based psychological therapies. CBT has already been shown 
to be effective in helping those with chronic health conditions engage at work (Reme 
et al., 2015). As suggested within this study, this may be particularly relevant for 
BME patients, who appeared more likely than white British to retire from work. 
However, there are further factors to consider. Unemployment rates for the BME 
population as a whole are already much higher than for the white population, 
estimated at 7.8% and 4.0% respectively (Brown, 2017). In addition, BME 
individuals educated even to degree-level are still reported to earn significantly less 
(23.1%) than the white population, and despite being over-represented within the 
healthcare sector for example, the BME population is generally under-represented 
at the higher level positions (Equality and Human Rights Commission, 2017; 
Gateshead Council, 2016). This could provide further insight as to why some BME 
participants may be more likely to retire from work altogether following the onset of 
PPS. It highlights potentially further challenges for healthcare professionals, 
including CBT therapists, which need to be addressed. 
Acceptance and Commitment Therapy (ACT), a new therapeutic approach 
that integrates behaviour change with acceptance (BABCP, 2017), may be an 
effective therapy for those who are struggling to come to terms with PPS and their 
impact on their lives. As previously stated, this is due to its potential ability to 
alleviate anxious or depressive feelings, improve patients’ self-efficacy, increase 
patients’ mental flexibility and enable patients to come to terms with and accept their 
health conditions (McCracken & Gutierrez-Martinez, 2011; Veehof et al., 2011; 
Wicksell et al., 2012; Wicksell, Kemani, Jensen, Kosek, Kadetoff et al, 2013). Within 
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the context of this study, mental flexibility could potentially also help patients to 
come to terms with the possibility of their symptoms being permanent, and help 
them to come to terms with any physical limitations. However, further robust studies 
with the PPS population are necessary to establish the effectiveness of ACT, and 
whether it should be included alongside CBT and psychoeducation as a 
recommended treatment within clinical guidelines. 
As a final recommendation, it is important to ensure that all patients have 
access to social support. Based on the findings of this study, some patients, 
particularly BME, may be at risk of social isolation due to having more frequent 
family conflicts. It is therefore imperative that healthcare professionals delve deeper 
within consultations in order to understand the scale and quality of their patients’ 
support network. If social support is not a prominent feature of patients’ lives, 
healthcare professionals should consider referring their patients to local support 
groups for ongoing support and social networking. 
 
4.5. Recommendations for future research 
The findings from this study have demonstrated key differences between 
white British and BME participants, which should be further explored. Future 
research should be conducted with individual ethnic groups, due to likely differences 
between them which have not been explored here. A qualitative approach similar to 
the one used within this study, would provide greater insight into the day-to-day 
lives, cultural factors, and experiences and expectations of NHS healthcare 
between individual ethnic groups. This would inform how to deliver a more tailored 
and culturally sensitive approach, so that BME patients may receive treatment as 
early as possible. 
Qualitative research should also be conducted with both healthcare 
professionals and BME patients in future, in order to understand how effective 
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current recommended multidisciplinary treatment, as recommended published by 
the Joint Commissioning Panel for Mental Health in 2017, actually is in treating 
PPS. While it is commendable that the importance of educating healthcare 
professionals on PPS is being taken much more seriously than previously, and that 
a multidisciplinary approach is being recommended, current training courses and 
guidelines have been designed by healthcare professionals, with no direct input 
from patients who live with PPS  themselves. The potential result of this is that not 
all patients will likely receive what they themselves believe to be the most 
appropriate course of treatment for symptoms. Healthcare professionals and 
patients collaborating in the design of any future training and written guidelines will 
help to ensure that patients receive the best possible healthcare and outcomes, and 
that healthcare professionals feel confident when treating their patients. 
Despite the usefulness of qualitative research, it should also be noted that 
qualitative research as a whole is limited in that it is generally subjective, based on 
the answers of a small sample size. This means that the research findings produced 
whilst using this methodology cannot realistically be generalised to the PPS 
population. Therefore, future amendments to clinical guidelines and training cannot 
be implemented based on the results from this study alone. Qualitative research 
studies such as this are valuable in that they can produce rich and detailed 
descriptive and exploratory data, clearly highlighting the key issues. Based on the 
qualitative research findings, larger scale studies with greater scientific rigour (such 
as RCTs) can then be used to produce more robust evidence that clinical guidelines 
and training for healthcare professionals should be amended. 
 
4.6. Researcher reflections on the research process 
The idea to conduct this particular study came about following news that 
Guy’s and St. Thomas’ Charity, who had funded the PRINCE Secondary trial, were 
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also very interested in further research with BME patients living with PPS. As I had 
already developed a personal interest in conducting research with marginalised 
groups, including BME, it seemed to me like a great opportunity. I was also pleased 
that I was able to invest so much time in a project that not only I found interesting, 
but also those around me. Further to that, I knew I was carrying out research that 
potentially could lead to a review of the quality of healthcare not only for BME 
patients, but all patients with PPS.  
The fact that I was able to contact participants directly through the trial did 
make recruitment easier, in that I already did not have to worry about participants 
not having PPS. In addition, there was no risk of my recruitment clashing with that of 
the trial. Having said that, I still found recruitment to be very challenging, as 
understandably many that I contacted were dubious regarding speaking so candidly 
about their lives with PPS, particularly their experiences of primary and secondary 
healthcare which were not always that positive. In total, recruiting and carrying out 
all 30 interviews took me approximately a year to complete, due to a number of 
prospective participants either turning down the opportunity to take part, or not 
responding to their invitation at all which I sometimes found quite soul destroying. At 
one particularly low point, it really felt like I was never going to finish the number of 
interviews I needed! Of course, this was not helped by having to conduct 30 
interviews alone, with 15 in each group. Ideally, I would have conducted a slightly 
smaller number, taking into consideration my workload for the DPsych and my full-
time placement. During the more difficult times, it was challenging for me to remain 
focused on the end goal and I found myself having to take steps back from the 
study now and again in order to refresh myself, before returning to it. Luckily, I had 
opted to transcribe my interviews and code them on an ongoing basis, rather than 
save them until the end of data collection. This really helped me to be organised, 
particularly when it came to analysing the data, as I already found that I had ideas of 
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what my main findings were, and what my themes could be. Once I had coded all 
my interviews, and extracted relevant verbatims from the transcriptions, the first 
draft of my themes and categories seemed to come together for me fairly quickly. At 
the end of the analysis process, I found that I had five main themes with 15 sub-
themes in total with clear differences between white British and BME responses. All 
in all, I found that being organised with this project really did help everything to 
come together on time. I did worry at one point that my findings may have been 
influenced by my understanding of previous research findings, or even what I had 
expected to find. However, having read back through my transcripts I am confident 
that only the information shared through the interviews was reported following the 
analysis. 
For me personally, the best part of this project was being able to conduct the 
interviews myself, for two distinct reasons.  Firstly, while I have previously worked 
as a qualitative researcher in the past, I have had very little opportunity to exercise 
these learned skills in recent years and I found this a great opportunity to do that. 
Secondly, I enjoyed talking to the individuals themselves on a one-to-one basis, 
which I felt they enjoyed too due to them being so open during our discussion. One 
patient even referred to their interview as “therapeutic”. Once all participants had 
had made the decision to take part, they chose to be very open and honest about 
how the symptoms had impacted on their lives and what they felt about the quality 
of healthcare that they had received, which I found to be very insightful. None of the 
participants interviewed chose to stop the interview or withdraw their data from the 
study, which was naturally a relief for me, but I also found it very telling as it showed 
to me how serious participants were about the project being undertaken. Many 
participants emphasised at the end of their interviews how important they felt a 
research study like this was for them, which I found extremely motivating as it 
reinforced my own feelings that my research project could make a positive 
 126 
 
difference, particularly for those with PPS within the BME population. I also really 
felt like that I had gained from carrying out all the interviews and transcribing them 
myself, as it taught me so much about the day-to-day experiences of living with 
PPS, and opened my eyes to some of the difficulties experienced amongst the BME 
group. Perhaps prior to these interviews, I was not fully prepared for what I heard, 
as there is only so much that can be learned beforehand by reading through 
previous studies.  
I opted originally to conduct qualitative interviews using the thematic analysis 
technique, for two main reasons. Firstly, I felt there was already enough evidence 
out there to rule out using a Grounded Theory approach. Secondly, while 
Interpretative Phenomenological Analysis (IPA) is often used for studies focusing on 
experiences, they are generally very time consuming exercises, and therefore only 
around ten interviews would be conducted for a thesis of this size. However, this 
was not suitable for this study, as I had hoped to capture a range of PPS, and also 
compare between white British and BME participants. While it should be 
remembered that this is a qualitative study rather than quantitative, by being able to 
interview more people, I was comfortably able to reach data saturation with a mix of 
participants within the white British and BME group, and enable a large number of 
participants to tell their story. 
In terms of my least favourite elements of conducting this study, I have two. 
The first was doing the transcriptions straight after completing the interviews, which 
took a very long time especially there were so many interviews. Each interview took 
practically a whole working day to finish transcribing. My second least favourite part 
of conducting this qualitative study was the recruitment. For reasons I touched on 
previously, I found the whole recruitment process to be gruelling and frustrating. At 
times I also felt restricted in that I was limited to contacting people who were already 
part of the trial. If I was to possibly conduct this research again, I would have 
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contacted individuals through secondary care clinics and perhaps existing national 
patient organisations, the latter of which would have enabled me to collect a more 
representative data sample by interviewing BME patients based also outside of the 
ethnically diverse city of London. As stated within the limitations above, there is the 
possibility that the experience for BME patients living with PPS can differ, 
depending on where they are living. This would be another interesting avenue to 
venture down, and one that I definitely would not rule out doing myself in the future.  
Further to this, I would also like to explore and compare specific ethnic groups, in 
order to obtain a greater understanding of the differences between different BME 
populations. 
Since the data and findings from this study were written up, I am happy to 
say that I have already had the opportunity to disseminate my research findings to a 
wide and influential audience. On 1st June 2017, I presented this study at a seminar 
meeting held within the School of Health Sciences (SHS) at City, University of 
London. As this was the first opportunity I had had to present the study I was fairly 
nervous about how it would be received, but the feedback was generally very 
positive. One week later on 8th June, I also gave a poster presentation of this study 
at the annual SHS Doctoral Conference, again held at City, University of London, 
which also had a positive outcome. Since finishing the study, I have also had the 
opportunity to disseminate my research externally. On Thursday 22nd June, I gave a 
fifteen minute presentation on the research process of this study and its key findings 
at a stakeholder meeting organised and held at the South London and Maudsley 
Hospital. This meeting was attended by CCG leads, charity staff, healthcare 
professionals and academics, who generally expressed interest and enthusiasm for 
the study and its findings. Finally, I also presented this study as part of a symposium 
for the UK Society for Behavioural Medicine (UKSBM) conference, held in 
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December 2017. Over the next few months, I hope to continue to disseminate these 
research findings and will seek out appropriate opportunities to do so. 
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APPENDIX I  
Supervision plan:  Research thesis 
 
Supervisee: ___Katie Watts______________ 
Supervisor: ___Dr. Triece Turnbull___________ 
 
 
 
Research Area of work (*outside of normal work) Supporting 
evidence 
Changes 
Research 
thesis 
Setting:  Patients living with Persistent 
Physical Symptoms (Medically Unexplained 
Symptoms) currently taking part in the 
PRINCE Secondary Cognitive Behaviour 
Therapy trial (originally recruited through 
the Guy’s and St. Thomas NHS Trust, and 
the King’s College Hospital NHS Trust) 
 
Description:   
30 qualitative semi-structured interviews 
with patients living with persistent physical 
symptoms (15 White British participants, 15 
Black and Minority Ethnic participants). The 
aims are to: 
1) To understand BME experiences of 
living with persistent physical 
symptoms 
2) Understand their experiences of 
accessing and receiving health 
care 
3) Understand the role and influence 
of cultural factors.  
1-hour Interviews are to be conducted 
either on the telephone or in person, 
dependent upon participant preference.  
Interviews will be transcribed and then 
analysed inductively, using Thematic 
Analysis. In order to identify how BME 
experiences may differ from White British, a 
framework analysis method will be 
employed. 
Thesis  of 
30,000 words 
(evidence of 
ethical 
approval in 
appendices) 
 
 
N/A 
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APPENDIX V 
 
 
 
 
PARTICIPANT INFORMATION SHEET 
 
Exploring the Role of Culture on the Experience and Perception of 
Healthcare and Daily Life in Patients with  
PPS 
 
 
You are being invited to take part in a research study. It is important 
therefore that you understand why the research is being done and what it will 
involve, before you decide whether or not to participate. Please take your 
time to read the following information carefully. We are happy to answer any 
questions that you may have about the study. 
 
1. What is the purpose of the study? 
We are undertaking a study to understand experiences of living with PPS, 
such as fibromyalgia, chronic pain, irritable bowel syndrome, respiratory 
symptoms (e.g. breathlessness), and neurological symptoms (e.g. tingling, 
abnormal movements or dizziness). This will be done through an interview 
with a researcher asking about your experience of symptoms in relation to 
healthcare services, personal beliefs, culture and daily life. The aim of the 
study is to gain a deeper understanding of the symptoms and how culture 
may have an impact upon symptoms. 
 
Invitation to participate 
You are being invited because we are aware that you are currently living with 
at least one type of PPS and are already participating/have participated in the 
PRINCE Secondary trial. In addition, you have given us permission to 
contact you about further research studies.  
 
Do I have to take part? 
No, your participation is completely voluntary. You are free to opt out of the 
study at any point without having to provide any reason to the researcher. 
There are no penalties for deciding to withdraw from the study. 
 
What will happen to me if I take part? 
A researcher will arrange to discuss the study at a time convenient for you. 
During this meeting, the researcher will explain the study procedure and 
answer any questions you may have about the study. You will be asked to 
complete a short demographics questionnaire and sign a consent form. The 
researcher will then interview you about your experiences of PPS. The 
interview should last no longer than one hour. You do not have to answer any 
questions you do not want to, and you are free to stop the interview at any 
point. The interview will be audio-recorded so that the researcher doing the 
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interview has a good record of your conversation so that they can listen to it 
afterwards and transcribe (type out) the interview. The interview audio-
recording will be deleted after transcription. Audio-recording and 
transcribing the interview will help researchers to look for similar themes 
expressed by those taking part in the study. You will not be identified by any 
accounts or verbatim taken from your interview.  
 
What are the possible benefits of taking part? 
By taking part you will help us understand the role of culture on the 
experience and accessibility of healthcare services and daily living in those 
with PPS. This will hopefully help in the development of effective treatments 
to help people with these symptoms. The interview will provide you with the 
opportunity to talk about your own experiences, which you may find 
therapeutic 
 
What are the possible disadvantages and risks of taking part? 
There are no foreseeable risks greater than typical everyday life associated 
with taking part in this study. However, sometimes people find talking about 
personal experiences upsetting. If, as a result of taking part in this study, you 
become concerned about your feelings you can talk to your GP or another 
healthcare professional.  
  
Will my taking part in this study be kept confidential?                                         
All information which is collected about you during the course of the research 
will be deemed as strictly confidential. All data collected will be stored on 
password-locked computer files, and any paperwork will be stored securely in 
locked cabinets within King’s College London.  
The researchers who contact you will need to keep your contact details at 
King’s College London research sites only for the purposes of contacting you 
to arrange a meeting with you. This information will be securely stored and 
destroyed after the study. You will be allocated a participant code that will be 
used instead of your name on the transcribed interview and demographics 
questionnaire. This is to preserve your anonymity. This code will be used in 
any reference to the study, including publications. Participant codes will be 
stored on a password-locked computer, which will be only accessible to the 
researchers involved in this study. The audio-recordings of the interview will 
be deleted once they have been transcribed to preserve your anonymity. Any 
names given during the interview will be anonymised when the interviews 
are transcribed in order to preserve your anonymity and theirs. 
 
If during the study the researcher becomes concerned about your well-being 
or about the implications of what you tell them regarding someone else’s 
well-being, we would need to inform your GP or other health professionals. 
We would, of course, discuss this with you.  
 
What happens to the results of the research study?                                
We may wish to publish the findings of the research in scientific journals and 
we hope to present these findings at future meetings. In addition, we will talk 
to service providers about the findings of our research. If you would like a 
copy of the published findings, we can provide this at the end of the study.  
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Withdrawal from the study 
Taking part in this study is entirely voluntary. You can withdraw from the 
study at any time without giving a reason and without this affecting your 
care.  
 
Who is organising and funding the research? 
The study is being funded by the Guy’s and St Thomas’ Charity, and 
organised by researchers at King's College London and the South London 
and Maudsley NHS Foundation Trust.   
 
Who has reviewed the study? 
Ethics approval has been granted by the London - Camberwell and St Giles 
Research Ethics Committee.  
 
Contact for further information? 
If you wish to discuss the study in greater detail, please contact the main 
researcher: 
 
Researcher: Katie Watts 
Dept. of Psychological Medicine 
London SE5 8AFTel: 020 7848 0950 
Email: katiewatts1@nhs.net 
 
 
 
Thank you for reading this information sheet and for considering taking part 
in this study. If you decide to participate you will be provided with a copy of 
this information sheet. 
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APPENDIX VI 
 
 
 
 
CONSENT FORM FOR PARTICIPANTS 
 
Title of study: Exploring the Role of Culture on the Experience and 
Perception of Healthcare and Daily Life in Patients with PPS 
 
Research Ethics Ref:____________   Participant code: _________ 
 
 
Thank you for considering participating in this research. The researcher must 
explain the study to you before you agree to take part. Please ask the 
researcher if you have any questions arising from the Participant Information 
Sheet before you decide to join. You will be given a copy of this Consent Form 
to keep. 
 
 
Please tick or initial each box 
 
Mandatory 
 
 
I confirm that l understand that by ticking/initialing each box that 
l am consenting to that part of the study. I understand that it will 
be assumed that any blank boxes mean that l do not give consent 
for that part of the study. I understand that by not giving consent 
to any one part of the study could mean that l am considered 
ineligible for the study. 
 
I confirm that l have read and understood the Participant 
Information Sheet dated 20-01-2016 (version 1) for the above 
study and have had the opportunity to ask questions. 
 
I understand that my participation is voluntary and that l am free 
to withdraw at any time without giving any reason, and without 
my medical care or legal rights being affected. Furthermore, l 
understand that l will be able to withdraw my data from the study 
up until the time of transcription or a date specified by the 
researcher. 
 
I give permission for a researcher to contact me by 
phone/text/email (please circle your preference) for the purposes 
of arranging a suitable date and time for interview. 
 
Please tick or 
initial 
 175 
 
I consent to the processing of my personal information for the 
purposes explained to me. I understand that such information will be 
handled in accordance with the terms of the UK Data Protection Act 
1998. 
 
I consent to my interview being audio-recorded and transcribed. I 
understand that this will be done to help the researcher analyse the 
data more effectively, and that only the researchers will have access 
to this data.  
 
I understand that my confidentiality and anonymity will be 
maintained throughout, and that it will not be possible to identify me 
in any future publications. I understand that my identity will also not 
be revealed within the transcript. 
 
 
I agree to take part in the above study. 
 
 
Optional 
 
I give permission to be contacted in the future by King’s College 
London researchers who would like to invite me to participate in 
future research. 
 
 
Participant name (please print): ______________________________ 
 
 
Date (DD/MM/YYYY): _____________Signature: ________________  
 
 
I confirm that l have explained the study to _________________ 
(name of participant) and have answered any questions honestly and 
fully. 
 
 
Researcher name (please print): ______________________________ 
 
Date (DD/MM/YYYY): _____________ Signature: _______________ 
 
 
1 copy of participant and 1 copy for study file. 
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APPENDIX VII 
 
Exploring the Role of Culture on the Experience and 
Perception of Healthcare and Daily Life in Patients with 
PPS 
 
Qualitative Topic Guide 
 
 
Introduction 
 Thank you for agreeing to take part in this interview. 
 I am a Research Worker /City University student working at King’s 
College London. 
 I am interviewing people with PPS to understand their experience of 
symptoms, healthcare and the role of culture within these.  
 The interview will be no longer than 1 hour in length. 
 With your permission, I would like to audio-record our interview today. 
This is for analysis and transcription purposes only.  
 I will keep your information anonymous and confidential at all times. 
Your real name won’t be used when l transcribe the interview. 
 As a reminder, you do not have to answer any question you do not want 
to just say and we can move onto the next question. You have the right to 
stop the interview at any point and withdraw from the research.  
 Any questions before we start? 
 
Section A.  
Firstly l would like to ask you some personal questions about yourself and 
family. 
 Can you tell me about your family? 
o Can you tell me about who you live with? (if not covered) 
 Would you mind telling me what role your faith or spirituality plays in 
your life?  
 Can you tell me about a bit about your cultural background? 
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Section B.  
Now l would like to ask you some questions about your PPS.  
 Can you tell me about your symptoms? Type of symptom, frequency etc. 
 When did you first experience these? 
 Can you tell me whether you notice any other physical changes in your 
body when you experience your symptoms?  (Prompt: before, during, 
after the symptoms) 
o If yes, could you please tell me more about them? 
 When you notice your symptoms how do they make you feel emotionally? 
 Can you tell me more about your feelings when you experience the 
symptoms? (Ask if specific feelings not mentioned) 
o Why do you think you feel this way?  
o How would you recognise you are feeling X?  
o How do you think your family would realise you are feeling X? 
o How would other people realise you are feeling X? (friends, 
strangers) 
o Could you tell me whether you feel in control of your emotions? 
Why do you think this is? 
 When you experience your symptoms what do you do? Why? (Prompt: 
Are you able to find comfort in your faith or beliefs when dealing with 
your symptoms?) 
 How long have you had your symptoms?  
 What do you think caused your symptoms? In what way do you think 
cultural factors impact on your symptoms if any (Prompt: Place of 
worship, friends, family)  
 
Section C.  
Now l would like to ask you some questions about your experiences accessing 
and using healthcare. 
 Can you tell me about when you first went to seek medical advice for your 
symptoms? (Prompts: What happened, referral process) 
 How did this make you feel?  
 How did you find the process of referral to your consultant? 
 Can you tell me about any advice or treatment you have been given? 
 Can you tell me your thoughts and expectations about your treatment? 
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 What are your thoughts on the standard of care that you received through 
the NHS?  
 Are there any recommendations you would make for future care and 
treatment?  
 
Section D.  
This is the last section of the interview. I am going to ask some questions 
about your everyday life. 
 Can you tell me about your everyday life before the symptoms? 
 Can you tell me about your everyday life since the symptoms? (Prompts: 
work life, caring responsibilities) 
 How has your social life changed since you developed your symptoms? If 
yes, how does this make you feel? (Prompt:  Can you tell me more about 
your feelings? (If they don’t label them easily) ) 
 Is there anything else that has changed in your social life? (Prompt: 
activities, relationships with others, working life) 
 How do you express your emotions to people close to you? 
Prompts:  
o Why do you think this is?  
o Has it always been like this for you? (If not, explore why) 
o What about other people like colleagues or friends?  
 How have your family/friends responded to your 
symptoms? (If not covered in previous section) 
 
Closing and Ending 
That’s the end of my questions. Thank you very much for sharing your 
thoughts and experiences with me today.  What you have told me will really 
help us to understand patients’ experiences of PPS.  
 Are there any final comments you would like to make? 
 Is there anything you would like to ask me? 
 
End of interview
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APPENDIX VIII 
 
 
 
 
Debrief Sheet 
 
Exploring the Role of Culture on the Experience and Perception of 
Healthcare and Daily Life in Patients with 
PPS 
 
 
Thank you once again for participating in this study. Your time and your 
comments are greatly appreciated. As a reminder, your interview will be 
stored in a secured location at King’s College London, and only the 
researchers will have access to it. 
 
 
What happens now? 
Your interview will be transcribed by the researcher, before being analysed. 
However, only the themes identified will be talked about – it will not be 
possible to identify you directly. 
 
 
What will happen to the themes? 
The researcher may eventually publish the completed study in an academic 
journal. A summary of the results will be made available to you if you would 
like them. 
 
 
Contact for further information? 
If you wish to discuss the study in greater detail, please contact: 
 
Researcher: Katie Watts 
Dept. of Psychological Medicine 
London SE5 8AF 
Tel: 020 7848 0950 
Email: Katie.Watts@kcl.ac.uk 
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APPENDIX X 
 
Exact Interview Schedule 
 
PIN Group Telephone/ 
Face-to-
face 
First 
contact 
Second 
contact 
Third 
contact 
Date of 
interview 
P02029 BME Telephone 22/04/2016   04/05/2016 
P02008 BME Face-to-face 22/04/2016   05/05/2016 
P01001 White 
British 
Face-to-face 22/04/2016   06/05/2016 
P01009 White 
British 
Telephone 22/04/2016   10/05/2016 
P02018 BME Telephone 22/04/2016   11/05/2016 
P01019 BME Face-to-face 10/05/2016 23/05/2016  24/05/2016 
P02010 White 
British 
Telephone 22/04/2016 18/05/2016  26/05/2016 
P02021 BME Telephone 26/04/2016 26/05/2016  27/05/2016 
P02002 BME Face-to-face 22/04/2016 18/05/2016  03/06/2016 
P02034 BME Telephone 08/06/2016   17/06/2016 
P02031 White 
British 
Telephone 25/04/2016 16/05/2016  29/06/2016 
P01044 White 
British 
Telephone 10/06/2016   30/06/2016 
P02032 White 
British 
Telephone 10/06/2016   01/07/2016 
P02038 White 
British 
Telephone 08/06/2016 24/06/2016 08/07.2016 15/07/2016 
P01033 BME Telephone 27/04/2016 03/06/2016 10/06/2016 15/07/2016 
P01061 BME Face-to-face 15/07/2016   29/07/2016 
P02040 White 
British 
Telephone 08/06/2016 24/06/2016  03/08/2016 
P01052 BME Face-to-face 08/07/2016 02/09/2016  09/09/2016 
P01053 BME Face-to-face 08/07/2016 05/09/2016  28/09/2016 
P01079 BME Telephone 02/09/2016   07/10/2016 
P01135 White 
British 
Telephone 15/12/2017 03/01/2017  13/01/2017 
P01117 White 
British 
Telephone 09/12/2016   15/01/2017 
P01138 White 
British 
Telephone 15/12/2016 19/01/2016  20/01/2017 
P02152 BME Telephone 16/02/2017   03/03/2017 
P01094 White 
British 
Telephone 01/03/2017   09/03/2017 
P01172 White 
British 
Telephone 17/03/2017   03/04/2017 
P02170 White 
British 
Face-to-face 17/03/2017   07/04/2017 
P01149 BME Telephone 20/04/2017   28/04/2017 
P01058 White 
British 
Face-to-face 20/04/2017   05/05/2017 
P02195 BME Telephone 18/05/2017   26/05/2017 
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APPENDIX XI 
Thesis:  Codes list 
 
Purple = White British responses 
Red = BME responses 
 
Beliefs surrounding the symptoms 
– Uncertainty regarding what can trigger symptoms 
o Uncertainty around the cause 
(P02040)(P02038)(P01044)(P01138)(P02031)(P01172)(P0217
0) (P01058) 
(P01019)(P01033)(P01053)(P01061)(P01079)(P02034)(P0200
2) (P01149) 
o No warning for symptoms 
(P02032)(P01094) 
(P02008)(P01053)(P01061)(P02002) 
– The potential impact of trauma 
o History of physical trauma 
(P02038)(P02010)(P01009)(P01001)(P02031)(P01094) 
(P01019) 
(P01033)(P01079)(P02018)(P02021)(P02029)(P02195) 
o History of emotional trauma 
(P02040)(P02010)(P01001)(P02032)(P01117)(P01138) 
(P01019)(P01033)(P01052)(P01053)(P01061)(P01079) 
o Stress is a trigger  
(P01117)(P02170) 
(P01052)(P01079)(P02029) 
 
– Uncertainty regarding the future 
o Initial expectations for a cure/help to reduce symptoms 
(P01001)(P01135)(P01138)(P01172)(P02170)(P01058) 
(P02034)(P02021)(P02029) 
o Hope for the future  
(P02040)(P01009)(P01138)(P01094) 
(P02008)(p02002)(P02018) 
o Worry for the future  
(P02031)(P01094) 
(P01053)(P02034)(P02002) 
o Struggling to accept symptoms  
(P02010)(P01009)(P01172)(P01058) 
(P02008)(P02034)(P02018)(P02029)(P02152)(P02195) 
(P01149) 
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o Acceptance of the new life and symptoms  
(P01001)(P01117)(P01138) 
(P02008)(P02034) 
 
 
– The role of religious beliefs 
o Raised in a religious family  
(P01044)(P01138)(P01172)(P01058) 
(P02008)(P01033)(P01052)(P01053)(P01061)(P01079)(P0203
4)(P02018)(P02029)(P02152)(P02195)(P01149) 
o No strong religious influence 
(P02040)(P02010)(P02038)(P01009)(P01001)(P02032)(P0111
7) (P01135)(P02031)(P01094)(P02170) 
(P01019) (P01052)(p01053)(P02002)(P02021) 
o Spiritual leanings  
(P02010)(P01138)(P02031)(P01058) 
(P02008)(P01019)(P01052)(P02021)(P02029)(P01149) 
o No spiritual leanings  
(P02032)(P01117)(P01094) 
(P01053)(P02002)(P02021)(P02195) 
o Supportive role of religion/ faith on symptoms  
(P01044) 
(P01033)(P01079)(P02018)(P02029)(P02152) 
o Religion is not a cause of symptoms 
(P01033)(P01053)(P01061)(P02002)(P02195)(P01149) 
 
 
Putting on a strong face 
 
– Trying to remain positive 
o Defiance of symptoms 
(P02040)(P02010)(P02038)(P01009)(P01001)(P01044)(P0113
8) (P02031)(P02170)(P01058) 
(P02008)(P01019)(P01061)(P02002)(P02021)(P02029)(P0219
5) 
o My situation could be worse 
(P01001)(P01009)(P01044)(P01138)(P01172) 
(P02029)(P02021) 
o A desire to be ‘normal’  
(P02010)(P01044)(P01094)(P02170) 
(P02002)(P02018)(P02021)(P02029)(P02152)(P01149) 
 
– Keeping the symptoms to oneself 
o The need to keep private about symptoms 
(P02038)(P01009)(P01044)(P02032)(P01117)(P01135)(P0203
1) (P02170) 
(P02008)(P01019)(P01052)(P01053)(P01061)(P01079)(P0203
4) (P02021)(P02029)(P02152) 
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A need for social support 
– The role of family 
o Close to family 
(P01009)(P01001)(P02032)(P01117)(P01094)(P01172) 
(P02170)(P01058)  
(P02008)(P01019)(P01061)(p02021)(P02152)(P02195) 
o Family and close friends recognise and understand symptoms 
(P02040)(P02010)(P02038)(P01001)(P01044)(P01117) 
(P01135)(P01172)(P01058) 
(P02008)(P01019)(P01052)(P02034)(P02002)(P02018) 
(P02021)(P02029)(P02152)(P02195)(P01149) 
o Family conflict 
(P01044)(P01038)(P02031)(P02170) 
(P02008)(P01019)(P01033)(P01052)(P01053)(P01061) 
(P02034)(P02002)(P02029)(P01149) 
o Openness with family and close friends  
(P01009)(P01117)(P01058) 
(P02008)(P01033)(P02002)(P02018)(P02021)(P02195) 
(P01149) 
o Lack of openness with family  
(P02170) 
(P01052)(P01053)(P01061)(P01079)(P02034)(P02195) 
o Ill family culture  
(P01009)(P01172) 
(P01019)(P01079)(P02034)(P02002)(P02021)(P01149) 
o Romantic relationships  
(P01044)(P02031)(P01094) 
(P01061) 
 
– Attitudes of non-family members 
o Poor understanding from non-family members 
(P02040)(P02010)(P01044)(P02031)(P01094) 
(P02008)(p01052)(P01053)(p02002)(P02034)(P02018) 
(P01149) 
o Lack of support from non-family members 
(P02010)(P02038)(P01001)(P01138)(P02031) 
(P01053)(P02152) 
o Good support from non-family members 
(P01001)(P01044)(P02032)(P01117)(P01138)(P01094) 
(P02170)(P01058) 
(P02008)(P01019)(P01052)(P01061)(P02002)(P02195) 
 
Quality of life has been stripped away 
 The physicality of symptoms 
o Painful symptoms 
(P02040)(P02010)(P02038)(P01009)(P02032)(P01117) 
(P02031)(P01094)(P01058) 
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(P02008)(P01019)(P01033)(P01052)(P01053)(P02002) 
(P02018)(P02021)(P02029)(P02152)(P02195) 
o IBS symptoms  
(P02010)(P01044)(P01117)(P01135)(P01094)  
(P02008)(P01052)(P01079)(P02195)(P01149) 
o Fatigue  
(P02040)(P02010)(P02031)(P01044)(P02031)  
(P02018)(P02029) (P02152)(P02195) 
o Poor sleep 
(P02040)(P02010)(P01001)(P02031) 
(P02008)(P01019)(P01053)(P02034) 
o Multiple symptoms  
(P02010)(P02040)(P01001)(P01058) 
(P01053)(P01061)(P02034)(P02002)(P02018)(P02029) 
(P02152)(P02195) 
o Comorbidity with organic medical conditions makes it worse 
(P01117)(P02031)(P02032) 
(P01033)(P01053)(P01061)(P01079)(P02034)(P02002) 
(P02018)(P02152)(P02195) 
 
– The impact of symptoms on day-to-day life 
o Busy life pre-symptoms 
(P02040)(P02010)(P02038)(P01009)(P01001)(P01044) 
(P01117)(P01135)(P02031)(P01172)(P02170)(P01058) 
(P02008)(P01019)(P01052)(P01053)(P01061)(P02034) 
(P02002) (P02018)(P02021)(P02029)(P02152)(P02195) 
(P01149) 
o Negative impact on social life 
(P02040)(P02010)(P02038)(P01009)(P01044)(P02032) 
(P01117)(P01135)(P02031)(P01094)(P01172)(P01058) 
(P02008)(P01019)(P01033)(P01053)(P01061)(P02034) 
(P02002)(P02018)(P02021)(P02152)(P02195)(P01149) 
o Social withdrawal with symptoms 
(P02040)(P02010)(P02038)(P01044)(P02032)(P01117) 
(P02031)(P01094)(P01058) 
(P01019)(P01033)(P01053)(P02034)(P02018)(P02029) 
(P02152)(P01149) 
o Reduced tolerance for other people 
(P02010)(P01001)(P02032)(P01058) 
(P02002)(P02018)(P02021)(P02029)(P02152) 
o Previously ambitious and independent 
(P01001)(P01135)(P01138)(P02038)(P01094)(P01058) 
(P01061)(P02002)(P02152)(P02008)(P01019)(P02195) 
o Impact on hobbies 
(P02038)(P01001)(P02010)(P01044)(P02032)(P01117) 
(P01094)(P01172) 
(P01019)(P01052)(P01053)(P01061)(P02034)(P02021) 
(P02029)(P02195)(P01149) 
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o Adopting new activities to control symptoms 
(P02010)(P02040)(P02038)(P01044)(P02032)(P01117) 
(P01094) (P01138)(P02031)(P02032)(P01172)(P02170) 
(P02008)(P01019)(P01033)(P01052)(P01053)(P01061) 
(P01079)(P02034)(P02002)(P02021)(P02029)(P02195) 
(P01149) 
o Needing to take care of oneself 
(P01094)(P02010)(P02040)(P02031)(P01009)(P02038) 
o (P01044) (P01138)(P02031)(P01172)(P01058)(P02170) 
(P01061)(P02002)(P02034)(P02002)(P02018)(P02008) 
(P01019)(P01052)(P02029)(P02152)(P02195) 
o Had to completely give up work  
(P01009)(P02032)(P01058) 
(P01033)(P01053)(P01061)(P02034)(P02018)(P02152) 
(P01149) 
o Had to adapt working life  
(P02040)(P01044)(P01138)(P02031)(P01044) 
(P02008)(P01052)(P02002)(P02021)(P02029)(P02195) 
o Work is challenging 
(P02040)(P02010)(P01009)(P02031)(P01094) 
(P01052)(P02195) 
 
– The impact of symptoms on psychological well-being 
o Frustration of living without an clear diagnosis 
(P01009)(P01117)(P01135)(P02031)(P01058) 
o (P01019)(P01052)(P01053)(P01079)(P02018)(P02021) 
o (P02029)(P02152)(P02195)(P01149) 
o Frustration of living with symptoms 
(P02010)(P01044)(P01117)(P01135)(P02031)(P01094) 
o (P01058) 
(P02008)(P02034)(P02018)(P02029)(P02152)(P02195) 
(P01149) 
o Feeling left behind  
(P02010)(P01009)(P01044)(P02031)(P01094) 
(P02034) 
o Low mood and depression 
(P02010)(P01001)(P01044)(P02032)(P02031)(P01094) 
(P02170)(P01058) 
(P02008)(P01019)(P01033)(P01053)(P01061)(P01079) 
(P02152)(P02195) 
o Anxiety  
(P02031)(P01094) 
(P01052)(P01053)(P01079)(P01149) 
o Feelings of embarrassment or shame 
(P01172)(P01094) 
(P02029)(P01079) 
o Not in control of emotions 
(P02010)(P01001)(P01044)(P02032)(P01117)(P01135) 
o (P02031)(P01094)(P01058) 
(P01019)(P01033)(P01079)(P02018)(P02152)(P01149) 
 192 
 
 
o In control of emotions  
(P02040)(P02038)(P01001) 
(P02008)(P01052)(P01061)(P02034)(P02002)(P02021) 
(P02029)(P02195) 
 
 
Inconsistency within the NHS 
 
– NHS staff can be really supportive 
o NHS did their best for me 
(P02010)(P02038)(P01009)(P01001)(P01044)(P02032) 
(P01138)(P02031)(P01172)(P02170) 
(P01061)(P02034)(P02002)(p02018) (P02029)(P02152) 
o GP is helpful  
(P01009)(P01138) 
(P01061)(P02034)(P02002)(P02018)(P02152) 
o Referral process was quick and straightforward 
(P01009)(P01001)(P02031)(P01172)(P02170) 
(P01052)(P01061) (P02002)(P02018)(P02021)(P02152) 
 
– NHS staff are not always understanding 
o Feeling abandoned by health professionals 
(P02040)(P02010)(P01117)(P01135)(P02032)(P02031) 
(P01094)(P01172)(P01058) 
(P02008)(P01019)(P01033)(P01052)(P01053)(P01079) 
(P02034) (P02002)(P02021)(P02029)(P02195)(P01149) 
o Lack of understanding of GPs/ health professionals 
(P02040)(P02010)(P02038)(P01009)(P02032)(P01094) 
o (P01058) 
(P02008)(P01019)(P01053)(P01079)(P02034)(P02018) 
(P02021) (P02029)(P02195)(P01149) 
o Needing more understanding and help from healthcare 
professionals (P02010)(P01094)(P01058) 
(P02008)(P01053)(P02034)(p02002)(P02018)(P02021) 
(P02029)(P02195)(P01149) 
o Unprofessional medical approach by GPs 
(P02010)(P01009)(P01135)(P01138)(P01094)  
(P01052)(P02018)(P01149) 
o Unprofessional medical approach by specialists and other 
health professionals 
(P02010)(P01135)(P02170)(P01058) 
(P01019)(P01053)(P02002)(P02018)(P02195)(P01149) 
 
– Long delays are common in healthcare 
o Medical process too slow 
(P02040)(P02010)(P02038)(P01009)(P01001)(P01135) 
(P01094)(P02170)(P01058) 
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(P02008)(P01019)(P01052)(P01053)(P02034)(P02002) 
(P02018)(P02029)(P01149) 
o Hard to see the same GP 
(P02040)(P02038)(P01117)(P01094)(P01172) 
(P02008)(P01033)(P02002)(P02029)(P02152) 
o Misdiagnosis from GPs/specialists 
(P02040)(P02010)(P02032)(P01117)(P01138)(P02031) 
(P01094) (P02170)(P01058) 
(P02008)(P01019)(P01053)(P01079)(P02018)(P02029) 
(P02195) 
o Disconnect within the NHS 
(P02010)(P01001)(P01044)(P01094)(P02170)(P01058) 
(P01079)(P02002)(P02195) 
Having to take the lead with health professionals 
(P02010)(P02038)(P01135)(P01138)(P01058) 
(P02008)(P01052)(P01053)(P02002)(P02195)(P01149) 
 
– A mixed method approach is better 
o Prescribed medication 
(P02040)(P02010)(P02038)(P01001)(P01044)(P02032) 
(P01117) (P01138)(P02031)(P01172)(P02170) 
(P02008)(P01019)(P01053)(P01079)(P02034)(P02002) 
(P02018)(P02021)(P02029)(P02152) 
o Alternative treatments and advice 
(P01009)(P01001)(P02032)(P01135)(P01138)(P01094) 
(P02170) 
(P02008)(P01019)(P01052)(P01053)(P01061)(P02002) 
(P02018)(P02021)(P02029)(P01149) 
o Health professionals should be more open to holistic 
approaches  
(P01001)(P01135)(P02031) 
(P02008)(P01019)(P01052)(P01079)(P02029) 
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SYSTEMATIC REVIEW:  2B 
 
The effectiveness of mindfulness-based 
cognitive therapy (MBCT) in treating PPS: 
A systematic review 
 
 
 
 
 
 
 
 
 
 
Word count:  6420  
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2B.1:    INTRODUCTION 
 
2B.1.1:  Rationale 
PPS, also known as MUS, Body Distress Syndrome, and Functional 
Symptoms, are a collection of syndromes or symptoms that appear to be absent of 
a clear medical diagnosis (Marks & Hunter, 2015). Very common examples of PPS 
include fibromyalgia, CFS, IBS, and chronic pain. PPS are frequently seen within 
primary and secondary care (Nimnuan, 2001; Steinbrecher, Koerber, Frieser & 
Hiller, 2011), and are estimated to account for over £3 billion per year in healthcare 
costs alone (Bermingham, Cohen, Hague & Parsonage, 2010).  CBT, a 
psychological therapy that focuses specifically on the relationship between 
thoughts, feelings and behaviours, has already been shown to be an effective 
treatment for PPS (Menon, Rajan, Kuppili & Sarker, 2017), and due to its existing 
evidence base, is listed as a standard psychological treatment (Joint 
Commissioning Panel for Mental Health, 2017). However, there is also a growing 
evidence base for mindfulness-based interventions (MBIs). Based on Buddhist 
principles where individuals are taught to focus on the present moment and 
approach daily stressors differently (Mental Health Foundation, 2017), mindfulness 
has been successfully adapted for use within the Western world. Mindfulness-based 
stress reduction (MBSR), originally developed in order to treat chronic pain (Kabat-
Zinn, 1982), has been shown to benefit a wide range of mental and physical health 
problems (Grossman, Nieman, Schmidt & Walach, 2004; Johansson, Bjuhr & 
Rönnbäck, 2011; Witek-Janusek, Albuquerque, Chroniak, Chroniak, Durazo-Arvizu 
et al., 2008).   
MBSR was originally combined with CBT in order to reduce the risk of 
relapse in depression (Teasdale, Segal, Williams, Ridgway, Soulsby et al., 2000). 
So far, reviews of the existing evidence have concluded that MBCT may be as 
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effective in treating PPS as MBSR, with both more effective than less specific MBIs 
(Lakhan & Schofield, 2013). Systematic reviews on MBIs in general have indicated 
that MBCT may reduce symptom severity, reduce depression and anxiety, and 
improve quality of life for those with PPS (Aucoin, Lalonde-Parsi & Cooley, 2014; 
Hilton, Hempel, Ewing, Apaydin, Xenakis et al., 2017; Lakhan & Schofield, 2013). 
However these findings were not conclusive, due to the limited number of MBCT 
studies included within each review, particularly RCTs (Aucoin et al., 2014; Hilton et 
al., 2017; Lakhan & Schofield, 2013). The reviews also criticised the existing studies 
for their high risk of bias, or unclear risk due to inadequate reporting (Aucoin et al., 
2014; Hilton et al., 2017).  
Evidence for the effectiveness of MBCT in treating CFS is particularly weak. 
Rimes and Wingrove (2013) conducted a single pilot study for patients with CFS (as 
included within the review by Lakhan & Schofield, 2013), which reported a reduction 
in symptom severity, level of impairment and depressive symptoms. A further 
exploratory uncontrolled study has suggested MBIs may reduce symptom severity, 
improve physical functioning, and reduce levels of depression and anxiety in those 
with CFS (Suraway, Roberts & Silver, 2005). However, exploratory and pilot studies 
do not possess the scientific rigour needed for conclusive evidence.   
This systematic review proposes to re-examine the effectiveness of MBCT in 
selected PPS. Similarly to the MBI review by Lakhan and Schofield (2013), this 
review will focus upon IBS, fibromyalgia and CFS, with the expectation that more 
robust and high quality MBCT studies with these PPS populations would have been 
conducted since. Medically unexplained chronic pain will also be included within the 
review, due to its prevalence and overlap with fibromyalgia. Studies that have 
included the above PPS within an RCT will also be considered for inclusion. A 
greater understanding of the effectiveness of MBCT within the PPS population will 
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help to inform healthcare professionals of the most appropriate treatment for PPS, 
which has the potential to improve healthcare outcomes for patients. 
 
2B.1.2:  Review questions 
This review will examine the quality of the evidence for MBCT as an effective 
treatment for PPS. It will review the findings and take a systematic approach 
towards reviewing the methodological approaches taken. The aims of this review 
are therefore to: 
1) Understand the effectiveness of MBCT in reducing symptom severity, 
relieving depression and anxiety, and improving quality of life, in patients 
with IBS, chronic pain, fibromyalgia and CFS. 
2) Assess the quality of the RCTs in order to understand whether there is now 
conclusive evidence that MBCT can be an effective treatment for PPS. 
Unlike previous reviews that have focused only on specific Symptom Severity or 
Quality of Life measures, this review will be more inclusive. Symptom Severity will 
therefore also encompass other symptom severity measures (such as symptom 
intensity and frequency). Quality of Life will also include measures of general health, 
impairment, disability, functioning, interference, impact, life satisfaction and 
participants’ impression of change. 
 
 
2B.2:     METHOD 
 
2B.2.1:  Search strategy 
A systematic approach was taken in order to look for appropriate research 
studies. Between 20th July and 8th August 2017, a thorough search was conducted 
within the following electronic databases: Ovid Full Text, PsycArticles, PsycInfo, 
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Embase, Medline, CINAHL, Cochrane Central Register of Controlled Trials 
(CCRCT), PubMed, ScienceDirect, Scopus and Web of Science. The following 
search terms were employed within the databases in order to generate results: 
1) "mindfulness" or "mindfulness-based" or "mindfulness-based cognitive 
therapy" or "MBCT" or "mind-body"   
2) AND "somatization" or "somatic" or "somatoform" or "medically unexplained 
symptoms" or "MUS" or "functional symptoms" or "unexplained symptoms" 
or “unexplained pain” or “chronic pain” or “idiopathic pain” or “functional pain” 
or "fibromyalgia" or "irritable bowel syndrome" or "IBS" or "CFS" or "chronic 
fatigue syndrome" 
3) AND "randomized" or "randomised" or "RCT" or "randomised controlled" or 
"randomized controlled" or "randomly allocated" or "randomly assigned" 
Reference lists of previous systematic reviews were also searched through in order 
to ensure that an inclusive review of MBCT was achieved (Aucoin et al., 2014; 
Hilton et al., 2017; Lakhan & Schofield, 2013). For a more detailed breakdown of the 
search strategy for each database, please see Appendix II. 
 
2B.2.2:   Selection criteria 
All studies eligible for inclusion conducted an MBCT intervention for patients 
with either fibromyalgia, chronic pain, IBS or CFS. In order to qualify as MBCT and 
be included within the review, at least one session of mindfulness meditation in 
collaboration with CBT needed to be delivered in any format (i.e. face-to-face, by 
telephone or online). Only RCT study designs were eligible, and therefore all 
included studies contained either a control or delayed treatment group, or a 
comparison therapy group. Comparison therapy groups could be either drug 
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therapy, or any psychological therapy excluding mindfulness and/or CBT. All studies 
were conducted with adults (aged 18 and over), and published in English. Studies 
that employed participants with a diagnosed medical condition, such as arthritis or 
irritable bowel disease (IBD) were excluded, as were non-specific MBI studies or 
MBSR studies. Outcomes were reviewed and then extracted from each study, 
including symptom severity (including pain intensity and frequency), anxiety and 
depression, and quality of life (including general health, functioning, disability, 
impairment, impact and interference). Studies containing at least both baseline and 
post-intervention data were included, so that the impact of the interventions could 
be assessed. Follow-up data was extracted only if available, in order to provide 
further insight into the effectiveness of MBCT. Only studies using validated scales, 
or scales that had been successfully employed within previous studies with 
acceptable Cronbach’s α were included. There were no limitations on the years of 
publishing, although due to MBCT being relatively recent, it was anticipated that 
studies would have been conducted within the last ten years.  
 
2B.2.3:   Process of reviewing data 
The PRISMA 2009 Flow Diagram was followed in order to identify eligible 
trials for inclusion (Moher, Liberati, Tetzlaff, Altman & Prisma Group, 2009). The 
search terms were entered into each database in order to generate results. 
Following this, all identified duplicates were removed. Titles of all results were 
screened, as well as the abstracts of potentially relevant studies. Full text articles 
were then accessed where titles and abstracts suggested potential inclusion within 
the review, or where it was not clear from the abstract whether the study may be 
eligible for inclusion. These full text articles were then read through in order to check 
eligibility. Single study selection was employed. 
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2B.2.4:   Cochrane Risk of Bias Tool 
The Cochrane Risk of Bias Tool was designed in order to identify the risk of 
bias within randomised controlled trials (Higgins, Altman, Gøtszche, Jüni, Moher et 
al., 2011), and has been frequently employed to assess bias risk in systematic 
reviews  (Aucoin et al., 2014; Krogsbøll, Jørgensen, Larsen & Gøtzsche, 2012). It 
assesses the level of bias across several areas, including 1) Selection Bias: 
Random sequence generation and Allocation concealment; 2) Reporting Bias: 
Selective reporting; 3) Attrition bias (incomplete outcome data); 4) Performance 
bias: Blinding (participants and personnel); 5) Detection bias (outcome 
assessment); 6) Any other sources of bias. For each criteria outlined above, studies 
were awarded High Risk, Low Risk, or Unclear ratings. Based on this information, 
studies were then given an overall rating. In cases where studies were deemed to 
be not at high risk or low risk, they were awarded a Moderate rating. Please see 
Appendix III for a breakdown of study assessment. Single coding of the risk of bias 
was used. 
 
2B.3:   RESULTS 
The search strategy led to the identification of 2324 titles. 338 duplicates 
were initially removed and the remaining records were reviewed. The remaining 
abstracts were read through, and the full text for potentially relevant studies was 
obtained (n=65). The majority of these were also excluded due to their focus on 
MBSR or non-specific MBI, or because they were not RCTs. Ten studies were 
included within the final analysis. Please see below for a flow diagram of the study 
selection process, using the Prisma 2009 template (Figure 2B1). 
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Figure 2B1. Flow diagram of study selection 
 
As a guide for data extraction, the Prisma 2009 Checklist was consulted. 
The Prisma 2009 checklist, or Prisma Statement, was originally designed to try and 
improve the quality of systematic reviews by providing detailed guidance of what 
information to include (Moher et al., 2009). With regards to data extraction, the 
checklist provided clear instruction to extract and report data on participants, 
interventions, comparisons, outcomes and study design. The checklist also 
indicated to report on study size and the lengths of follow-up times, as well as effect 
sizes and confidence intervals. While data extraction within this review was guided 
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(n = 55) 
Not MBCT:  26 
Not an RCT:  21 
Abstract only:  6 
Protocol only:  2 
 
 
Full text articles 
included in analysis  
(n = 10) 
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by the Prisma 2009 Checklist, it was also reliant upon the objectives of the study, 
i.e. to investigate the effects of MBCT upon symptom severity, anxiety and 
depression, and quality of life. Data within included studies that did not address 
these objectives were not extracted and therefore are not discussed within this 
review. 
 
2B.3.1:   Study characteristics 
Of the ten studies included, four were on chronic pain (Day, Thorn, Ward, 
Rubin, Hickman et al., 2014; de Jong, Peeters, Gard, Ashih, Doorley et al., 2017; 
Dowd, Hogan, McGuire, Davis, Sarma et al., 2015; Zgierska, Burzinski, Cox, Kloke, 
Stegner et al., 2016), one on fibromyalgia (Parra-Delgado, Latorre-Postigo, 2013), 
three on IBS (Asadollahi, Mehrabi, Neshatdoost, Kalantari, Afshar et al., 2014; 
Ljótsson, Falk, Vesterlund, Hedman, Lindfors et al., 2010; Ljótsson, Hedman, 
Andersson, Hesser, Lindfors et al., 2011), one on CFS (Rimes & Wingrove, 2013), 
and one on multiple PPS where fatigue, gastrointestinal symptoms and back pain 
were included (van Ravesteijn, Lucassen, Bor, van Wheel & Speckens, 2013). All 
studies were published between 2010 and 2017. The majority of these (70%) were 
conducted in Europe, with two from the Netherlands, two from Sweden (Ljotsson et 
al., 2011; Ljotsson et al., 2010), one from Spain (Parra-Delgado & Latorre-Postigo, 
2013), one from the UK (Rimes & Wingrove, 2013) and one from Ireland (Dowd et 
al., 2015). Two were conducted in the USA (Day et al., 2014; Zgierska et al., 2016), 
and one in Iran (Asadollahi et al., 2014). 
Studies employed a mix of comparison groups. The majority (60%) had a 
control, wait-list control, usual care or delayed treatment (DT) group (Asadollahi et 
al., 2014; Day et al., 2014; de Jong et al., 2017; Parra-Delgado & Latorre-Postigo, 
2014; Rimes & Wingrove, 2013; Zgierska et al., 2016). Of the remaining studies, 
comparison therapy groups were Stress Management (Ljotsson et al., 2011), 
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Enhanced Usual Care (Van Ravesteijn et al., 2013), Pain Management 
Psychoeducation (Dowd et al., 2015), and an online discussion forum (Ljotsson et 
al., 2010). Five studies (50%) included eight weekly 2-2.5 hour-long group sessions 
of MBCT face-to-face within a clinical setting (Day et al., 2014; de Jong et al., 2017; 
Rimes & Wingrove, 2013; van Ravesteijn et al., 2013; Zgierska et al., 2016). Parra-
Delgado and Latorre-Postigo (2013) delivered eight 2.5 hour sessions over a three 
month period. Asadollahi et al., (2014) did not provide detailed information regarding 
how MBCT was delivered. All five studies that tested face-to-face MBCT employed 
a qualified mindfulness teacher (de Jong et al., 2017; Rimes & Wingrove, 2013; 
Parra-Delgado & Latorre-Postigo, 2013; van Ravesteijn et al., 2013; Zgierska et al., 
2016).  For each of these, participants were provided with homework exercises 
(such as meditation) to complete in between sessions.   
Three studies delivered MBCT using an online or computerised programme 
which participants worked through remotely (Dowd et al., 2015; Ljotsson et al., 
2011; Ljotsson et al., 2010). Dowd et al., (2015) delivered twelve 20-minute MBCT 
sessions in audio-visual format, which were delivered twice-weekly over a six-week 
period. Participants were kept alert to the next session’s availability via email (Dowd 
et al., 2015). The other two studies delivered online MBCT over ten weeks and 
provided participants with access to a closed online discussion forum, as well as 
online therapists who could provide feedback and support (Ljotsson et al., 2011; 
Ljotsson et al., 2010). Online MBCT programmes were based on previously tested 
approaches (Dowd et al., 2015, Ljotsson et al., 2011; Ljotsson et al., 2010). 
Eight out of ten studies included follow-up analyses. The length of follow-ups 
for studies were two months (Asadollahi et al., 2014; Rimes & Wingrove, 2013), 
three months (Ljøtsson et al., 2010; Parra-Delgado & Latorre-Postigo, 2013), six 
months (Dowd et al., 2015; Ljøtsson et al., 2011; Zgierska et al., 2016), and nine 
 206 
 
months (van Ravesteijn et al., 2013). Day et al., (2013) and de Jong et al., (2017) 
did not follow-up after post-intervention analyses. 
The total number of participants included within all studies was 718 (mean = 
71.8; SD = 57.2). The majority of studies however included much smaller samples 
than the mean, with six studies (60%) randomising less than 25 participants into 
each group (Asadollahi et al., 2014; Day et al., 2014; de Jong et al., 2017; Parra-
Delgado & Latorre-Postigo, 2013; Rimes & Wingrove, 2013; Zgierska et al., 2016).  
The remaining RCTs included between 98 and 61 participants to receive MBCT, 
with similar numbers reported within the control groups (Dowd et al., 2015; Ljotsson 
et al., 2010; Ljotsson et al., 2011; van Ravesteijn et al., 2013). Five studies (50%) 
included information on power analysis calculations in order to justify sample size. 
However, two of these studies reported not achieving their target (de Jong et al., 
2017; Ljotsson et al., 2011). One study justified its small sample size, stating that 
this was anticipated due to it being a pilot study (Day et al., 2014). The four 
remaining studies provided no justification for sample size (Asadollahi et al., 2014; 
Parra-Delgado & Latorre-Postigo, 2013; Rimes & Wingrove, 2013; Zgierska et al., 
2016). 
The majority of studies (80%) provided descriptive statistics on gender and 
age. These studies demonstrated that the vast majority of participants were female, 
with the percentage ranging from 75-100% across studies (mean = 84.6; SD = 9.8). 
The mean ages of participants ranged from 34.6 to 52.9 years (mean = 44.0; SD = 
7.1). Seven studies (70%) reported on calculations of potential differences between 
groups at baseline, and in five studies no significant differences were found in terms 
of baseline data or demographics. Four studies (40%) reported significant 
differences in baseline data (Asadollahi et al., 2014; Parra-Delgado & Latorre-
Postigo, 2013; Rimes and Wingrove, 2013, Zgierska et al., 2016). However, only 
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two studies controlled for these differences (Parra-Delgado & Latorre-Postigo, 2013; 
Rimes and Wingrove, 2013).  
Validated and/or previously tested self-report measures were employed for 
all studies, and where Cronbach’s α were reported these were either acceptable or 
good. Two studies employed online symptom diaries in order to monitor symptom 
severity, such as the Gastrointestinal (GI) diary (Ljotsson et al., 2011) and the online 
headache diary (Day et al., 2014), both of which were based on diaries tested within 
previous studies. Please see Appendix IV for the Data Extraction table, where 
individual outcome measures for each study are reported. 
 
2B.3.2:  Assessment of bias risk 
Most studies (90%) provided information on the method used to randomly 
allocate participants. Only one study did not provide this information (Asadollahi et 
al., 2014). Most of these studies (70%) demonstrated that random allocation 
outcomes were not foreseeable to participants prior to their enrolment (Dowd et al, 
2015; Ljotsson et al., 2011; Ljotsson et al., 2010; Parra-Delgado & Latorre-Postigo, 
2013; Rimes & Wingrove, 2013; van Ravesteijn et al., 2013, Zgierska et al., 2016). 
For the remaining studies, whether allocations were foreseeable prior to enrolment 
was unclear.  With regards to performance bias, only one study somewhat blinded 
participants to their treatment group by not disclosing the differences between 
treatments (Ljotsson et al., 2011). Three studies claimed that they did not, or that it 
was not possible to blind participants or research staff (Day et al., 2013; Dowd et al., 
2015; Zgierska et al., 2016). For the remaining studies however, not enough 
information was provided to make a judgement. Regarding detection bias, only two 
studies indicated that outcome assessors were not blinded to the participant 
treatment group (Day et al., 2014; Zgierska et al., 2016). 
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In the vast majority of studies (80%), an informative level of information 
regarding attrition rates was provided. Of the two studies that did not, one did not 
provide reasons for withdrawals or how any missing data would be handled (Parra-
Delgado & Latorre-Postigo, 2013). The other study did not provide reasons for two 
withdrawals, and two further participants were not acknowledged (Asadollahi et al., 
2014). Generally, withdrawal rates were low, with the majority reporting rates 
between 5.4% and 21.6% at the point of follow-up. Only two studies reported 
notably high attrition rates of 33.3% (Day et al., 2014) and 59.7% (Dowd et al., 
2015). In four studies (40%), Intention-To-Treat (ITT) analysis was performed 
(Dowd et al., 2015; Ljotsson et al., 2011; Parra-Delgado & Latorre-Postigo, 2013; 
Zgierska et al., 2016), and in three of these, only ITT analysis was reported 
(Ljotsson et al., 2011; Parra-Delgado & Latorre-Postigo, 2013; Zgierska et al., 
2016), indicative of selective outcome reporting. Parra-Delgado and Latorre-Postigo 
(2013) also biased the findings of their research by only providing a breakdown of 
what was statistically significant, omitting other information on between-group effect 
sizes, intra-group changes and changes in outcomes. 
In terms of recruitment bias, a few studies employed self-referral methods, 
meaning that participants were not officially confirmed to have PPS by a healthcare 
professional (Dowd et al., 2015; Ljotsson et al., 2011; Ljotsson et al., 2010).  Rimes 
and Wingrove (2013) requested therapists to recruit CFS patients into the study, 
which introduced bias in two ways. Firstly, participants may have been more 
receptive to therapy than the average CFS patient, had a positive experience of 
therapy, or known what the results of the study were likely to show. Secondly, if 
participants were known to therapists it is possible they would have felt pressure to 
participate.  
Overall, the risk of bias within the ten included studies was reasonable. Five 
studies (50%) were judged to be at low risk of bias overall (de Jong et al., 2017; 
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Ljotsson et al., 2011; Ljotsson et al., 2010; Rimes & Wingrove, 2013; van Ravesteijn 
et al., 2013), and four (40%) at moderate risk (Day et al., 2014; Dowd et al., 2015; 
Parra-Delgado & Latorre-Postigo, 2013; Zgierska et al., 2016). For the remaining 
study, the risk of bias was unclear due to an inadequate level of reporting 
(Asadollahi et al., 2014). 
 
2B.3.3:  Results of individual studies 
Due to the heterogeneity of the studies in terms of PPS type, study size and 
the various measures employed within individual studies, particularly for the quality 
of life assessment, it was considered that it would not be appropriate to perform a 
meta-analysis. The findings of individual studies have been discussed below, 
categorised under ‘Symptom Severity’, ‘Anxiety’ and ‘Depression’ which will be 
examined as two separate constructs, and ‘Quality of Life’. The results have also 
been documented separately by PPS type. For most studies, significance levels and 
effect sizes were reported.  
 
Symptom severity 
IBS 
The three studies reporting upon the effect of MBCT upon symptom severity 
provided mixed results. Two studies reported significant improvements upon IBS 
severity following MBCT in comparison with the control group, with moderate to 
large effect sizes (Ljotsson et al., 2010; Ljotsson et al., 2011).  Ljotsson et al., 
(2011) reported particularly significant effects upon bloating (d=0.94, 95%, CI: 0.46, 
1.41, P<0.001) and primary symptoms (d=0.83, 95%, CI: 0.36, 1.29, P<0.001).  
Both of these studies also reported similar findings at follow-up, indicating a long-
term improvement.  However, Asadollahi et al., (2014) reported only a non-
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significant improvement post-intervention (d=0.28, P=0.07), with any improvement 
lost at follow-up (d=0.03, P=0.58). 
Chronic pain and fibromyalgia 
Findings for chronic pain and fibromyalgia were also mixed. Of the five 
available studies, only two reported any significant within-groups effects post-
intervention upon pain reduction, intensity and frequency, with medium to large 
effect sizes (Day et al., 2014; Parra-Delgado & Latorre-Postigo, 2013). Only small 
within-group effect sizes were reported post-intervention for cervical pain (d=0.31, 
95%, CI: -0.42, 1.02), and no effect was observed at all for dorsal, right arm, left 
arm, or right leg pain (Parra-Delgado & Latorre-Postigo, 2013). Following between-
groups analysis, only two out of four studies reported medium-to-large effect sizes 
for MBCT (Day et al., 2014; Zgierska et al., 2016), and only for one of these studies 
was the difference between groups significant (Zgierska et al., 2016).  The two 
remaining studies reporting on pain severity showed no improvement post-
intervention (de Jong et al., 2017; Dowd et al., 2015).  
Three studies provided some evidence for the long-term benefit of MBCT for 
pain severity (Dowd et al., 2015; Parra-Delgado & Latorre-Postigo, 2013; Zgierska 
et al., 2016), with either greater significance or slightly larger effect sizes within 
groups reported in comparison with post-intervention (Dowd et al., 2015; Parra-
Delgado & Latorre-Postigo, 2013). Only one study reported a significant 
improvement and large effect size between groups at follow-up (d=0.86, 95%, CI: 
0.2, 1.9; P=0.045) (Zgierska et al., 2016). 
CFS and PPS (mixed) 
For the remaining two studies, reductions were observed in terms of 
symptom severity. van Ravesteijn et al., (2013) reported a significant reduction in 
symptoms within the MBCT group post-intervention (d=-1.61, 95%, CI: -2.50, -0.71, 
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P<0.05). Between-groups analysis also demonstrated significant reductions in 
fatigue (P=0.014) (Rimes & Wingrove, 2013), and physical symptoms in general 
with a large negative effect size (d=-1.17, 95%, CI: -2.57, 0.23) (van Ravesteijn et 
al., 2013).  Reductions in symptom severity were also evident within both studies at 
follow-up. van Ravesteijn et al., (2013) reported a significant within-groups effects of 
MBCT on symptoms at follow-up (d=-1.44, 95%, CI: -2.60, -0.28, P<0.05), and both 
studies reported either significant between-group effects (P=0.01) (Rimes & 
Wingrove, 2013), or small to moderate negative effect sizes between groups (d=-
0.40, 95%, CI: -1.99, 1.20) (van Ravesteijn et al., 2013). 
 
Anxiety 
IBS 
All three studies reported reductions in anxiety following MBCT. Within-
groups analysis demonstrated significant reductions in anxiety, with effect sizes 
ranging from d=0.33 (Ljotsson et al., 2011) to d=0.64 (Ljotsson et al., 2010). 
However, of the two studies reporting between-groups effects, only Ljotsson et al., 
(2010) reported a significant benefit of MBCT. While Ljotsson et al., (2011) did 
report a small to moderate effect size between groups post-intervention (d=0.33, 
95%, CI: 0.04, 0.62) using the Visceral Sensitivity Index, this was not reported as 
significant. Furthermore, between-groups analysis using the anxiety scale of the 
HADS demonstrated no effect (d=0.04, 95%, CI: -0.25, 0.32). 
Follow-up analyses provide weak evidence that MBCT may have a long-
term positive effect upon anxiety. Significant small to moderate effect sizes within 
groups were reported within two studies (Asadollahi et al., 2014; Ljotsson et al., 
2011), and a further reduction in health anxiety was noted at follow-up within the 
remaining study, although this did not quite reach significance level (P=0.06) 
(Ljotsson et al., 2010). Between-group analyses demonstrated there to be no long-
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term benefit of MBCT in comparison with Stress Management (d=0.14, 95%, CI: -
0.16, 0.44, P=0.647) (Ljotsson et al., 2011). 
Chronic pain and fibromyalgia 
Only two out of five studies reported on the effects of MBCT upon anxiety 
(de Jong et al., 2017; Dowd et al., 2015), with the former reporting on the effects of 
MBCT on both anxiety and depression combined. For both of these studies, within-
groups analyses demonstrated only a small to moderate and non-significant effect 
of MBCT post-intervention. Between groups analysis also demonstrated a non-
significant effect of MBCT post-intervention, with a reported effect size of d=-0.10 
(Dowd et al., 2015).  Follow-up analyses also indicated no long-term benefit of 
MBCT upon anxiety either within the MBCT group (d=-0.12, P>0.05) or between 
groups (d=-0.10, P>0.05) (Dowd et al., 2015). Day et al., (2013) and de Jong et al., 
(2017) did not conduct follow-up analyses.  
CFS and PPS (mixed) 
The two remaining studies provided little evidence for the effect of MBCT on 
anxiety (Rimes & Wingrove, 2013; van Ravesteijn et al., 2013). A significant 
reduction in anxiety was only reported within the MBCT group for one study (van 
Ravesteijn et al., 2013), and for both studies between-groups analyses 
demonstrated non-significant effects post-intervention. Follow-up analyses within 
the MBCT groups provided mixed results, with one study demonstrating a continued 
significant reduction in terms of physical symptoms within (van Ravesteijn et al., 
2013), and the other reporting a continued non-significant reduction in anxiety 
(Rimes & Wingrove, 2013). Between-group analyses for both studies however 
demonstrated MBCT to have a non-significant benefit at follow-up.   
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Depression 
IBS 
Mixed results were also reported for the effects of MBCT upon depression. 
Two out of three studies reported significant reductions in depressive symptoms 
within the MBCT group post-intervention (Asadollahi et al., 2014; Ljotsson et al., 
2011), with a small to moderate effect size of d=0.41 reported (Asadollahi et al., 
2014). While one study reported a significant difference between groups with a 
small to moderate effect size (d=0.43, 95%, CI: 0.00, 0.86, P<0.05) (Ljotsson et al., 
2010), the other study reporting between-groups effects found no benefit of MBCT 
at all (d=0.01, 95%, CI: -0.28, 0.29) (Ljotsson et al., 2011). The follow-up within-
groups analyses demonstrate a possible long-term benefit of MBCT upon 
depression (Asadollahi et al., 2014; Ljotsson et al., 2011). However only one study 
reported their findings as significant (Ljotsson et al., 2011), and available between-
groups analyses at follow-up demonstrated no benefit for MBCT (d=0.08, 95%, CI: 
0.22, 0.38, P=0.817) (Ljotsson et al., 2011). 
Chronic pain and fibromyalgia 
Only two studies reported on the effects of MBCT upon depression alone, 
which produced mixed results. Parra-Delgado and Latorre-Postigo (2013) reported 
a significant reduction in depressive symptoms with a large effect size post-
intervention (d=0.82, 95%, CI: 0.06, 1.55, P<0.001). de Jong et al., (2017)  reported 
a significant improvement for the MBCT group amongst the Per-Protocol sample 
(P=0.04), but not the ITT sample (P=0.26). Between-groups analysis for the two 
studies also produced mixed results, with one study demonstrating a significant 
difference post-intervention (Parra-Delgado & Latorre-Postigo, 2013), and the other 
reporting no difference amongst either the Per-Protocol sample (P=0.23) or the ITT 
sample (P=0.48).  Parra-Delgado and Latorre-Postigo (2013) reported a continued 
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significant improvement at follow-up both within the MBCT group (d=0.86, 95%, CI: 
0.09, 1.59, P<0.001), and in comparison with the control group (P=0.006). 
CFS and PPS (mixed) 
There was some evidence of short-term benefit of MBCT within the two 
remaining studies. A reduction in depressive symptoms was reported within the 
MBCT group (van Ravesteijn et al., 2013), and for MBCT in comparison with the 
control group (P=0.038) (Rimes & Wingrove, 2013).  Within-groups and between-
groups analyses did not produce any significant results at follow-up, although there 
was reported to be a small reduction in depressive symptoms amongst the MBCT 
groups (Rimes & Wingrove, 2013; van Ravesteijn et al., 2013). 
 
Quality of life 
IBS 
Only two studies reported on quality of life. However in both cases there was 
evidence that MBCT could have a positive effect. Moderate to large between-groups 
effect sizes were reported, ranging from d=0.47 on the Sheehan Disability Scale, to 
d=0.93 on the IBS-QOL scale (Ljotsson et al., 2010). Ljotsson et al., (2011) also 
reported moderate between-group effects for MBCT in comparison with the Stress 
Management group (d=0.51, 95%, CI: 0.23, 0.80).  Follow-up analyses for both 
studies demonstrated between-groups effects to remain significant at follow-up, 
however the benefit of MBCT over comparison therapies was reported to reduce 
over time (d=0.31, 95%, CI:0.01, 0.61, P<0.001) (Ljotsson et al., 2011). 
Chronic pain and fibromyalgia 
The five studies focused on chronic pain and fibromyalgia provided evidence 
of improvement upon quality of life following MBCT. Within-groups analyses 
demonstrated MBCT to significantly reduce pain interference (BPI) (d=-0.76, 
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P<0.0001) and improve Satisfaction with Life (d=0.90, P<0.0001) (Dowd et al., 
2015). Improvements in mental health (d=0.57, P=0.003) and Vitality (d=0.50, 
P=0.017) were also shown, following analyses of the ITT sample (de Jong et al., 
2017). Parra-Delgado and Latorre-Postigo (2013) also reported significant within-
group effects upon fibromyalgia impact post-intervention, following use of the FIQ 
scale (d=1.13, 95%, CI: 0.33, 1.87, P<0.001).   
Between-groups analyses provided less consistent findings. While Dowd et 
al., (2015) reported no difference in terms of pain interference (d=0.04, P>0.05), 
significant differences with small to moderate between-group effect sizes were 
reported for Satisfaction with Life (d=0.59, P<0.05), ability to manage emotions as 
measured through the PGIC scale (d=0.46, P=0.011), ability to deal with stressful 
events (d=0.62, P=0.001), and ability to enjoy pleasant events (d=0.41, P=0.025). 
While significant between-group effects with moderate to large effect sizes were 
also reported for Mental Health and Vitality amongst both the ITT and Per-Protocol 
samples (de Jong et al., 2017), in another study between-groups effects were only 
significant when compared with the Completer Sample (d=-1.29, P<0.01), and not 
the ITT sample (Day et al., 2014). No significant differences were found between 
groups for Physical Functioning, Role Limitations (Physical), Role Limitations 
(Emotional), Social Functioning, Pain or General Health. No significant 
improvements were observed within the other studies (Day et al., 2014; Parra-
Delgado & Latorre-Postigo, 2013; Zgierska et al., 2016). 
Follow-up analyses provided some evidence for the long-term effects of 
MBCT. Small to moderate effect sizes were reported for ability to manage emotions 
(d=0.36, P=0.039) and deal with stressful situations (d=0.36, P=0.044), although 
there was no significant effect upon ability to enjoy pleasant events (P=0.631) 
(Dowd et al., (2015). Two further studies provided evidence for a long-term effect 
upon quality of life. Parra-Delgado and Latorre-Postigo (2013) reported significant 
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within-group effects for MBCT (d=0.94, 95%, CI: 0.17, 1.67, P<0.001), whereas 
Zgierska et al., (2016) reported a large but non-significant effect size when 
comparing MBCT with Usual Care (d=0.68, 95%, CI: -1.0, 14.0, P=0.209).  
CFS and PPS (mixed) 
The two remaining studies again demonstrated mixed evidence for the 
benefit of MBCT. van Ravesteijn et al., (2013) demonstrated significant within-
groups effects when using the Physical Role sub-scale and the Visual Analogue 
Scale (EuroQoL) post-intervention. However, between-groups analyses 
demonstrated the benefit to be non-significant on the Visual Analogue Scale 
(P>0.05). Rimes and Wingrove (2013) reported a significant between-groups effect 
of MBCT upon work and social adjustment (WSAS) post-intervention (P=0.04), 
although reported a non-significant effect of MBCT upon Physical Functioning 
(P=0.124) (Rimes & Wingrove, 2013).  Follow-up within-groups analyses 
demonstrated significant long-term improvements in terms of Physical Functioning, 
Physical Role, Bodily Pain, and General Health (van Ravesteijn et al., 2013). Long-
term within-group effects were also evident within the CFS study, although 
significance was only reported when comparing the two and six-month follow-up 
data for the MBCT group (P=0.004). Non-significant findings were reported for 
Physical Functioning at follow-up (P=0.345), and a comparison of pre-treatment and 
six-month follow-up data also produced non-significant results (P=0.051) (Rimes & 
Wingrove, 2013).  
 
2B.4:   Discussion 
This review of ten RCTs had two main aims: 1) To understand whether 
MBCT can effectively reduce symptom severity, reduce anxiety and depression, and 
improve quality of life in individuals with PPS; 2) Understand the quality of the 
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existing RCTs within this area, in order to assess the validity and reliability of the 
evidence. Due to variations across studies in terms of PPS type, the control group 
interventions, and the various measures employed by studies, it was not considered 
appropriate to conduct a meta-analysis.  
The findings did generally show that MBCT is be effective in reducing 
symptom severity in IBS (Ljotsson et al., 2011; Ljotsson et al., 2010), CFS (Rimes & 
Wingrove, 2013), and in a mix of PPS (van Ravesteijn et al., 2013), which supports 
the findings of previous reviews (Aucoin et al., 2014; Hilton et al., 2017; Lakhan & 
Schofield, 2013).  Chronic pain and fibromyalgia studies also demonstrated MBCT 
to reduce pain severity, intensity and frequency (Day et al., 2014; Parra-Delgado & 
Latorre-Postigo, 2013; Zgierska et al., 2016), although with varying levels of 
success. Only one IBS study did not demonstrate a long-term reduction in symptom 
severity following MBCT (Asadollahi et al., 2014). However, it is difficult to ascertain 
the possible reasons for this, due to limited information available for this study. 
In terms of alleviating anxiety, these studies suggest that there is some 
evidence that MBCT may slightly or moderately reduce anxiety for those with IBS 
(Ljotsson et al., 2010; Ljotsson et al., 2011). van Ravesteijn et al. (2013) 
demonstrated that MBCT may reduce anxiety in those with multiple PPS. It does not 
appear that MBCT has much effect in reducing anxiety in those with chronic pain 
and/or fibromyalgia or CFS. However, further studies are required, due to only two 
chronic pain studies reporting effects on anxiety within this review (de Jong et al., 
2015; Dowd et al., 2015), and only one CFS study (Rimes & Wingrove). In terms of 
depression, MBCT was shown to be effective for IBS (Asadollahi et al., 2014; 
Ljotsson et al., 2011; Ljotsson et al., 2010), and CFS short-term (Rimes & 
Wingrove, 2013). However, this was not reported for multiple PPS (van Ravesteijn 
et al., 2013). In terms of chronic pain, while de Jong et al., (2017) reported weak 
evidence for MBCT treating depressive symptoms, it was only following analysis of 
 218 
 
the Per-Protocol sample, which is unlikely to be representative due to these 
participants potentially being more motivated and open to MBCT. 
The strongest evidence came following the review of MBCT and its effects 
upon quality of life, as significant improvements were reported in those with IBS 
(Ljotsson et al., 2011; Ljotsson et al., 2010), CFS (Rimes & Wingrove, 2013), 
chronic pain (Day et al., 2014; Dowd et al., 2015), fibromyalgia (Parra-Delgado & 
Latorre-Postigo, 2013), and in multiple PPS types (van Ravesteijn et al., 2013). 
These findings support those of previous MBI reviews for functional bowel 
disorders, chronic pain and PPS in general (Hilton et al., 2017; Lakhan & Schofield, 
2013). However, the findings for MBCT within this review are more defined due to 
MBCT being examined separately from other MBIs. 
 
2B.4.1:  Limitations 
There were a number of limitations within this review. The first limitation is 
the lack of studies that employed a robust sample size, increasing the risk of error. 
In addition, four studies were pilots rather than full RCTs. While it was not a 
limitation that could be controlled due to the lack of studies, it does compromise the 
quality of the evidence. Furthermore, there are high percentages of female 
participants, which limits the generalisability of the findings to the whole population. 
While PPS is generally more common in females, future studies are required to 
employ a higher proportion of male participants in order to be representative.  
Another limitation of this review was the heterogeneity across included studies. 
While heterogeneity was already inevitable due to the variations across PPS types, 
there were differences in terms of follow-up length, comparison group, how the 
MBCT intervention was delivered (e.g. face-to-face or online), and which outcome 
measures were employed. 
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Other limitations were related to bias. At the study selection stage, there was 
a moderate risk of publication bias. While attempts to avoid this were originally 
made by conducting a wide search through multiple databases and looking through 
any existing grey literature for further RCTs, attempts to contact authors in order to 
obtain access to further unpublished work were not undertaken which needs to be 
taken into consideration. Secondly, only single study selection was used due to time 
constraints and limited resource. Double study selection would have been more 
suitable due to the increased probability that only studies matching the defined 
inclusion criteria were actually included. A further limitation relates to the coding of 
the level of risk within studies. While the review did include a higher than anticipated 
number of ‘Low risk’ studies, only single coding of the risk of bias within selected 
studies was employed. This somewhat compromises the reliability that a fair risk of 
bias (e.g. Low or High) was attributed to each study. Double coding would have 
increased the probability that studies within the review had been interpreted 
correctly, and judged fairly.   
Other limitations, noted when conducting the risk of bias assessment, were 
that there was a lack of blinding across all included studies. While it is 
acknowledged that the blinding of participants, research staff and even outcome 
assessors may not always be practical, it can still compromise the integrity of 
research. Furthermore, studies generally employed self-report measures in order to 
capture data, which compromises the quality of data quality due to participant 
subjectivity and memory. On a final note, many studies employed self-referral 
methods, which meant that participants were not medically confirmed to have met 
the criteria for PPS.  
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2B.4.2:  Conclusions 
 
It can be concluded following this review that MBCT is likely to have at least 
a small positive effect in treating symptom severity, anxiety and depression, and in 
improving quality of life for patients living with PPS. This indicates therefore that the 
evidence-base for MBCT as a treatment for PPS has been strengthened, having 
positive implications for future healthcare. The implications of this are that MBCT 
may be helpful as an alternative treatment to CBT and other MBIs in the future. We 
can also conclude however that more RCTs with larger sample sizes are required, 
and that conclusive evidence for the effectiveness of MBCT in treating PPS has not 
yet been produced. More low-risk and representative studies with robust sample 
sizes are required, particularly for CFS, which continues to be under-researched 
despite promising findings from the existing pilot study. 
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APPENDIX I  
 
Supervision Plan:  Systematic review 
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Research Area of work 
(*outside of 
normal work) 
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evidence 
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Systematic 
review 
Psychological 
factors associated 
with BME patients 
with MUS 
Systematic review 
(6000 words) 
Changed to: 
Systematic 
review relating to 
the FODMAP 
diet. 
Changed to: 
The effectiveness 
of mindfulness-
based cognitive 
therapy in treating 
Persistent 
Physical 
symptoms 
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APPENDIX II 
 
Search strategy 
 
Date of 
search 
Database Dates 
included in 
search 
Search terms No. of 
result
s 
22nd– 24th 
July 2017 
 
Ovid  
(Ovid Full 
Text, 
PsycARTICL
ES Full Text, 
PsycINFO, 
Embase, 
Ovid 
MEDLINE) 
 
All "mindfulness" or 
"mindfulness-based" or 
"mindfulness-based 
cognitive therapy" or 
"MBCT" or "mind-body" 
AND 
"somatization" or 
"somatic" or 
"somatoform" or 
"medically unexplained 
symptoms" or "MUS" or 
"functional symptoms" or 
"unexplained symptoms" 
or "unexplained pain" or 
"chronic pain" or 
"idiopathic pain" or 
"functional pain" or 
"fibromyalgia" or "irritable 
bowel syndrome" or "IBS" 
or "CFS" or "chronic 
fatigue syndrome" 
AND 
"randomized" or 
"randomised" or "RCT" or 
"randomised controlled" 
or "randomized 
controlled" or "randomly 
allocated" or "randomly 
assigned" 
Limits:  Full Text 
1,186 
 
 
27th – 28th 
July 2017 
Cochrane 
Central 
Register of 
Controlled 
Trials 
(CCRCT) 
All "mindfulness" or 
"mindfulness-based" or 
"mindfulness-based 
cognitive therapy" or 
"MBCT" or "mind-body" 
AND 
"somatization" or 
"somatic" or 
"somatoform" or 
"medically unexplained 
symptoms" or "MUS" or 
"functional symptoms" or 
"unexplained symptoms" 
or "unexplained pain" or 
"chronic pain" or 
"idiopathic pain" or 
"functional pain" or 
217 
 229 
 
"fibromyalgia" or "irritable 
bowel syndrome" or "IBS" 
or "CFS" or "chronic 
fatigue syndrome" 
AND 
"randomized" or 
"randomised" or "RCT" or 
"randomised controlled" 
or "randomized 
controlled" or "randomly 
allocated" or "randomly 
assigned" 
31st July 
2017 
CINHAL 
 
All "mindfulness" or 
"mindfulness-based" or 
"mindfulness-based 
cognitive therapy" or 
"MBCT" or "mind-body" 
AND 
"somatization" or 
"somatic" or 
"somatoform" or 
"medically unexplained 
symptoms" or "MUS" or 
"functional symptoms" or 
"unexplained symptoms" 
or "unexplained pain" or 
"chronic pain" or 
"idiopathic pain" or 
"functional pain" or 
"fibromyalgia" or "irritable 
bowel syndrome" or "IBS" 
or "CFS" or "chronic 
fatigue syndrome" 
AND 
"randomized" or 
"randomised" or "RCT" or 
"randomised controlled" 
or "randomized 
controlled" or "randomly 
allocated" or "randomly 
assigned" 
79 
2nd August 
2017 
PubMed 
 
All "mindfulness" or 
"mindfulness-based" or 
"mindfulness-based 
cognitive therapy" or 
"MBCT" or "mind-body" 
AND 
"somatization" or 
"somatic" or 
"somatoform" or 
"medically unexplained 
symptoms" or "MUS" or 
"functional symptoms" or 
"unexplained symptoms" 
or "unexplained pain" or 
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"chronic pain" or 
"idiopathic pain" or 
"functional pain" or 
"fibromyalgia" or "irritable 
bowel syndrome" or "IBS" 
or "CFS" or "chronic 
fatigue syndrome" 
AND 
"randomized" or 
"randomised" or "RCT" or 
"randomised controlled" 
or "randomized 
controlled" or "randomly 
allocated" or "randomly 
assigned" 
6th August 
2017 
ScienceDirec
t 
 
All "mindfulness" or 
"mindfulness-based" or 
"mindfulness-based 
cognitive therapy" or 
"MBCT" or "mind-body" 
AND 
"somatization" or 
"somatic" or 
"somatoform" or 
"medically unexplained 
symptoms" or "MUS" or 
"functional symptoms" or 
"unexplained symptoms" 
or "unexplained pain" or 
"chronic pain" or 
"idiopathic pain" or 
"functional pain" or 
"fibromyalgia" or "irritable 
bowel syndrome" or "IBS" 
or "CFS" or "chronic 
fatigue syndrome" 
AND 
"randomized" or 
"randomised" or "RCT" or 
"randomised controlled" 
or "randomized 
controlled" or "randomly 
allocated" or "randomly 
assigned" 
74  
7th August 
2017 
Scopus All "mindfulness" or 
"mindfulness-based" or 
"mindfulness-based 
cognitive therapy" or 
"MBCT" or "mind-body" 
AND 
"somatization" or 
"somatic" or 
"somatoform" or 
"medically unexplained 
symptoms" or "MUS" or 
14 
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"functional symptoms" or 
"unexplained symptoms" 
or "unexplained pain" or 
"chronic pain" or 
"idiopathic pain" or 
"functional pain" or 
"fibromyalgia" or "irritable 
bowel syndrome" or "IBS" 
or "CFS" or "chronic 
fatigue syndrome" 
AND 
"randomized" or 
"randomised" or "RCT" or 
"randomised controlled" 
or "randomized 
controlled" or "randomly 
allocated" or "randomly 
assigned" 
8th August 
2017 
Web of 
Science 
All "mindfulness" or 
"mindfulness-based" or 
"mindfulness-based 
cognitive therapy" or 
"MBCT" or "mind-body" 
AND 
"somatization" or 
"somatic" or 
"somatoform" or 
"medically unexplained 
symptoms" or "MUS" or 
"functional symptoms" or 
"unexplained symptoms" 
or "unexplained pain" or 
"chronic pain" or 
"idiopathic pain" or 
"functional pain" or 
"fibromyalgia" or "irritable 
bowel syndrome" or "IBS" 
or "CFS" or "chronic 
fatigue syndrome" 
AND 
"randomized" or 
"randomised" or "RCT" or 
"randomised controlled" 
or "randomized 
controlled" or "randomly 
allocated" or "randomly 
assigned" 
529 
Total (databases) 2319 
1st-8th 
August 
2017 
Other 
sources  
All 5 
Total (All sources) 2324 
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APPENDIX III 
 
Bias risk for included RCTS 
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APPENDIX IV 
 
Data extraction table 
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2C.1:    A qualitative investigation into the experiences of 
genital herpes: Navigating the road back to 
psychosocial recovery 
Katie Watts, Triece Turnbull, Paula Corcoran 
 
ABSTRACT 
Objectives: Genital herpes is a stigmatised and incurable sexually transmitted 
infection that has a negative effect upon people’s psychological and emotional well-
being. It is important for diagnosed individuals to receive information and support. 
However, it is unclear what resources are currently made available in practice within 
the United Kingdom (UK) and how frequently these are accessed. 
Methods: Semi-structured interviews were conducted to investigate people’s 
experiences of being diagnosed and living with genital herpes. Participants also 
discussed what resources were made or not made available, and what they felt 
would have been helpful. Data was analysed inductively using thematic analysis. 
Results: Results identified three key themes: “The stigma is far worse than the 
disease”; “I’ve been diagnosed: now what?” and “You’ve got a community”. Four 
sub-themes were established. Participants reported similar accounts, with no clear 
differences between age and gender. 
Conclusions: Genital herpes patients in the UK were dissatisfied with the quality of 
care received from healthcare professionals, particularly due to the lack of 
understanding and emotional support. Healthcare professionals should consider 
quick referral to the Herpes Virus Association to ensure patients receive good 
advice and support quickly. Future research should aim to identify ways of reducing 
genital herpes stigma. 
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INTRODUCTION 
Genital herpes is a common and incurable sexually transmitted infection (STI). It is 
caused by a virus that affects up to 70% of the population. Despite having few 
long-term medical implications, it is stigmatised and has been found to have a 
significant impact upon psychological and emotional well-being,,. Common 
reactions following diagnosis include fear of rejection, anger, low mood and 
shame, with the impact particularly severe in newly diagnosed patients. While 
negative responses following diagnosis are usually transient, feelings of 
undesirability and the fear of disclosure and transmission to others can be 
prolonged due to rumination6,7,8. Individuals with genital herpes are therefore in 
need of psychological and emotional support at the point of diagnosis9.  
The psychosocial impact of genital herpes stigma has been shown to be alleviated 
by social support8. Social support is therefore important in determining patients’ 
quality of life following diagnosis9. The delivery of adequate support therefore 
promotes psychological and emotional well-being in genital herpes patients8. In the 
UK, people with suspected genital herpes can visit their General Practitioner or a 
Genito-Urinary Medicine (GUM) clinic, who can provide informational support and 
free and confidential testing. All NHS staff are required by statute and case law to 
“provide a service of no less a quality than that to be expected, based on the skills, 
responsibilities, and range of activities within their particular trade or profession”. 
In addition, the Sexually Transmitted Infection Foundation course is available for all 
relevant healthcare professionals, in order to ensure they receive basic sexual 
health training. Satisfactory consultations with healthcare professionals are 
important for ensuring that patients attend follow-up appointments, and receive 
necessary aftercare. Nevertheless, bureaucracy and recent cuts in NHS funding 
mean that health professionals struggle to deliver consistent good quality care,. 
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Patients therefore may not always receive the information and support they require, 
and the resources provided for patients in practice are unknown. 
The Herpes Virus Association (HVA) provides useful and up-to-date advice on 
genital herpes, and can provide access to counselling and support groups6. 
Information and support may also be sought out online7,8, due to the removal of 
geographic restrictions and the anonymity provided9. Currently, there are a 
number of official websites delivering information and advice for genital herpes, 
including Bupa, the NHS and the Terrence Higgins Trust,,. Unregulated 
communal websites such as ‘H-ype’ have also been set up to enable people with 
genital herpes to socially interact and support one another7.  
Reducing stigma has already been identified as a priority for improving sexual 
health in England, and a study conducted in the United States of America (USA) 
found that the provisions of antiviral medication, written information and other 
resources lessen the psychological impact of a genital herpes diagnosis. More 
research is needed in England in order to understand what would be beneficial for 
people with the condition, and identify whether any further support or understanding 
is required. Therefore, the aims of this research are to:  
 Understand patients’ experience of diagnosis in the UK 
 Understand what resources are provided at the point of diagnosis by 
healthcare professionals, and following diagnosis 
 Understand what is needed for people with genital herpes to adapt following 
their diagnosis 
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METHOD 
Design 
Due to the sensitive nature of the study semi-structured telephone interviews were 
used to explore people’s experiences of being diagnosed with genital herpes in the 
UK; what resources were provided, and what they would have preferred. 
Participants 
Participants were recruited through the genital herpes support website ‘H-ype’. 
Membership of the website was considered confirmation of their diagnosis. Six 
women and three men participated, aged between 29 and 55 years (mean = 45.56, 
SD = 7.68). Four were diagnosed between 2011 and 2016, four between 2004 and 
2016, and one prior to 2004. Eight were originally diagnosed in the UK, and one in 
Canada. Six participants were single and three were in relationships. 
Materials 
Participants were initially provided with an information sheet to read, and a consent 
form. The interview guide included open-ended questions asking participants about 
when they were diagnosed and what emotions they experienced, and whether they 
actively sought support. This was followed with more specific questions regarding 
the resources that were actually available, as well as what they would have 
preferred in order to adapt to living with genital herpes. The role of websites, 
including H-ype, was explored within this context and following the interview, 
participants were provided with a debrief detailing the purpose of the study. 
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Procedure 
Ethics was sought and granted by the Department of Psychology at City University, 
London. Approval was then granted from H-ype’s head administrator in order to 
recruit participants through the website. An advertisement was placed within the H-
ype forum and volunteers contacted the researcher directly. They were sent an 
information sheet with more detailed information regarding the study, as well as an 
informed consent sheet.  Participants were assured anonymity and informed of their 
right to withdraw. Following the interview, participants were provided with a debrief 
of the study. 
Analysis 
Participant interviews were transcribed and an inductive approach to analysis was 
chosen to ensure themes were reflective of the actual data produced rather than the 
discussion guide, in order to minimise bias risk. Following transcription and 
familiarisation with the data, initial codes were produced, before being grouped into 
initial themes, and potential sub-themes. These themes were further refined. 
 
RESULTS 
Three key themes were identified following analysis, with four additional sub-
themes. The themes highlighted the impact of diagnosis upon participants as well 
as the ongoing issues experienced by participants and how they felt they may be 
resolved. They also discussed how they managed to navigate their way back to 
psychosocial recovery. 
 
Theme 1:  “The stigma is far worse than the disease” 
This first theme refers to both the impact and long-term effect of genital herpes 
diagnosis. Participants described the powerful impact that their diagnosis had had 
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upon their psychological and physical well-being, their feelings of sexual desirability, 
and even their sense of social belonging. Stigma was highlighted as the root cause 
of these negative feelings. 
Sub-theme 1:  The world is no longer my oyster 
Participants felt that due to the stigma surrounding their diagnosis, their options 
were now much more limited, particularly in terms of sexual relationships as they 
would always have to explain their condition to new partners going forward. 
“... Before you kind of think that you’re young, free and single, you know the 
world is your oyster. All of a sudden you think “oh gosh, I’ve got, I’ve got, I’m 
going to have a lot to explain to people or any potential partner going 
forward”. (Felicity, 38 years). 
Participants also described their feelings of shame following diagnosis, as well as 
the initial shock of finding out that they had such a stigmatised condition. Their fears 
of being judged by others led them to keep their diagnosis to themselves, which led 
them feel as though they were completely on their own with their diagnosis. 
“I just felt completely on my own and you just feel as though you can’t share 
with somebody, because you’re going to be judged”. (Jackie, 50 years). 
Subtheme 2:  The media says, “It’s better than having herpes!” 
Participants felt that the media was the main driving force behind the genital herpes 
stigma. The use of genital herpes jokes in films and television programmes was 
described to have had a significant negative impact upon their feelings, leading 
them to feel somewhat discriminated against. 
“I don’t think they should be allowed basically to er, put it in films or make it 
the butt of anybody’s jokes, or, you know, it’s people, it’s not, it’s not a 
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laughing matter...It was a comedy [television programme], you know, and I’m 
watching it and it comes out with “It’s better than having herpes”, you know 
and I just stopped laughing at that point, and my blood ran cold”. (Kate, 49 
years). 
In the same way that the media was felt to exacerbate genital herpes stigma, it was 
also felt that the media could also help to successfully overturn it by educating 
people and reducing the levels of fear. This could be done through placing particular 
emphasis on genital herpes being really just a cold sore, and not worthy of that level 
of stigmatisation. 
“...I think the best thing that could be done is a type of campaign, whereby 
people stop stigmatising herpes so much, because it is just a cold sore, erm, 
but it’s got this label now of something to be really scared of and people are 
erm, really afraid of it”.(Michaela, 29 years). 
 
Theme 2:  I’ve been diagnosed, now what? 
Within the second theme, participants described how disillusioned they felt following 
diagnosis, and criticised the clinical approach taken by healthcare professionals 
when what they needed was emotional support, as well as factual information and 
practical advice. This negatively impacted upon their doctor-patient relationships as 
well as their psychological well-being at that time, as they did not know where else 
to turn. 
Subtheme 1:  “I’ve just sort of suffered in silence” 
Participants stressed the importance of not being cast aside by the healthcare 
profession following diagnosis. Many described how they had initially suffered and 
felt alone, and would have benefitted strongly from professional support at the point 
of diagnosis. 
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“... I’ve never been back to the GP. I’ve never had any antivirals or anything 
like that. I’ve just sort of suffered in silence to be honest. I think if I’d been 
offered some sort of support when I’d been diagnosed, it might have been 
different...” (Jackie, 50 years). 
While very general information on genital herpes was sometimes provided, 
participants were angry at the lack of empathy shown, and were particularly 
frustrated at health professionals’ inability to recognise the social aspects of having 
an STI. 
“I’ve gotten myself upset a few times when I’ve been talking about it, and 
[the GP] just seem to kind of refer to “Do you want some antidepressants? 
Do you need treatment from a depression point of view?” They can’t quite 
grasp that I’m not depressed, I’m just trying to work my way around the, the 
social aspect of having an STI...” (Michaela, 29 years). 
Subtheme 2:  “Put me in touch with the HVA” 
Participants generally only became aware of available resources once they had 
sought out help for themselves. Through seeking out their own resources, most 
participants had become aware of the HVA and reported that they had found them 
helpful in providing them with useful advice and support. It was felt that HVA referral 
would have been particularly useful immediately following diagnosis. 
“I think they [should have] put me in touch with the HVA immediately, as 
soon as the diagnosis came through. I think the GUM clinic should have 
taken that step and made sure that you had all the, the information and all 
the emotional support that you would need right at the beginning”. (Michaela, 
29 years). 
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In some cases, participants also felt that in order to avoid feeling utterly alone at the 
time they were diagnosed, they would have benefitted from counselling from 
someone with knowledge of genital herpes, which the HVA can also provide. 
“... Earlier reference to people like the HVA, in the first instance... They do 
have the counsellors that can give you help and guidance, erm, I know I 
came away from the clinic on first diagnosis and you just feel utterly alone 
with it...” (Sam, 48 years). 
 
Theme 3:  “You’ve got a community”  
Within this third and final theme, participants discussed their need to depend upon 
others and share experiences, which was eventually achieved through the H-ype 
website. This helped participants to somewhat normalise the condition. The process 
of communicating with others was a major step towards their psychosocial recovery, 
in that it helped them to no longer feel like a ‘leper’. Most importantly, it also brought 
them back from the brink of social isolation, by making them feel like part of a 
community once again. 
“I find that H-ype has been beneficial from sharing the experiences with 
other people, and not feeling like so much of a leper because you’ve, you’ve 
got a community...”(Michaela, 29 years). 
Sharing experiences through H-ype not only helped participants to support one 
another, it also led to the formation of genuine friendships, particularly for those in 
the South East and London where most members were located. Having this close 
contact opened the doors to a new social life, leading them to enjoy new social 
experiences that they would not have necessarily gotten to do otherwise.   
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“... It actually gave me a social life and it gave me a social life with other 
single people. I’ve made some incredibly good friends. I’ve been off and 
done things that I’d never have done otherwise, I’ve visited all sorts of places 
in the UK I’d never been before, um and I actually ended up with a social life 
that was the envy of my teenage children...” (Fran, 55 years). 
 
Key messages 
 Participants are dissatisfied with their quality of healthcare following 
diagnosis. 
 Healthcare professionals should consider signposting newly diagnosed 
and/or particularly distressed patients to the HVA, who can also provide 
counselling. 
 Action is required to reduce stigmatisation of genital herpes, e.g. through a 
media-led campaign to reduce the level of fear and misunderstanding. 
 Unregulated online support websites such as H-ype play an important role in 
psychosocial recovery through the sharing of experiences and forming of 
close friendships with other site users. 
 
DISCUSSION 
The aims were to understand the experience of diagnosis of genital herpes, what 
resources were made available to patients to help them manage the condition, and 
what patients felt they needed in order to psychosocially recover. Participants 
described the feelings of shock and devastation they experienced at the point of 
diagnosis with genital herpes,,. In addition, they emphasised how their diagnosis 
had left them in particular need of psychological and emotional support9. Despite 
this, participants disclosed feeling disillusioned by the lack of support and empathy 
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provided by healthcare professionals. As discussed earlier, good communication 
between healthcare professionals and patients is fundamental for ensuring that 
patients receive help. Participants within this study were particularly dissatisfied 
with the clinical approach taken by healthcare professionals, and their lack of 
understanding surrounding the stigma and psychosocial implications,,6,7. This 
demonstrates that the psychosocial needs and expectations of genital herpes 
patients are not currently being met, which is in breach of regulations. 
As with previous research, the findings from this study have demonstrated the 
importance of social support for psychosocial recovery following diagnosis9. The H-
ype website enabled participants to share their experiences, which enabled them to 
feel ‘normal’ and part of a community again. This supports previous research 
highlighting the potential benefits of online support for stigmatised conditions8. 
Nevertheless, as H-ype is unregulated this website should not be officially 
recommended at the point of diagnosis. Participants also emphasised the important 
role of the HVA, and that they would have appreciated quick referral by healthcare 
professionals. Routine signposting to the HVA will ensure patients receive 
information and support at the earliest opportunity, where they can also be referred 
for counselling or support groups if necessary6. In order to ensure that healthcare 
professionals are aware of the HVA, the Sexually Transmitted Infection Foundation 
course run by BASHH should ensure to cover basic information on the HVA and 
suggest referral to there to be part of routine treatment. 
Participants raised the importance of reducing stigma generated through the media, 
and suggested that this could be achieved through a media-led campaign. While the 
Department of Health’s (2013) framework for improving sexual health in England 
has highlighted reducing stigma as a priority, the framework did not state what 
this would entail, and did not focus specifically on genital herpes. This may be due 
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to the high percentage of the population affected by the virus, and the lack of 
serious long-term health implications. While it is right that the Department of Health 
continue to prioritise funding for serious health conditions, the impact of genital 
herpes diagnosis should not be ignored due to the effect upon psychological and 
emotional well-being.  
In conclusion, healthcare professionals should ensure to understand the 
psychosocial implications of genital herpes, and signposting to the HVA at the 
earliest available opportunity should be considered for all newly diagnosed patients. 
Future research should investigate the most effective strategies to reduce the 
stigma. 
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2C.2:    The effectiveness of mindfulness-based cognitive 
therapy (MBCT) in treating PPS:  A systematic review 
 
ABSTRACT 
Persistent Physical Symptoms (PPS) are common and place a significant strain on 
patients and healthcare services. While mindfulness-based interventions (MBIs) and 
Cognitive Behaviour Therapy (CBT) have been shown to be effective in treating 
patients with PPS, evidence for mindfulness-based cognitive therapy (MBCT) is 
weak due to a limited number of high-quality randomised controlled trials (RCTs) 
within previous reviews. This review aimed to re-examine the effectiveness of 
MBCT in reducing symptom severity, reducing anxiety and depression, and in 
improving quality of life. On completion of the search, 10 RCTs met the inclusion 
criteria and study quality was assessed using the Cochrane Risk of Bias tool. 
Results demonstrated MBCT to significantly reduce symptom severity and improve 
quality of life across multiple PPS. MBCT was shown to somewhat reduce anxiety 
and depression for IBS and CFS, but not chronic pain. This review includes more 
low-risk studies than previous reviews, therefore strengthening the evidence base 
for MBCT. However, there are still very few RCTs with large and representative 
sample sizes. Larger RCTs are required in order to provide conclusive evidence of 
the effectiveness of MBCT for PPS. 
Key words Persistent Physical Symptoms; Mindfulness-Based Cognitive Therapy; 
Randomised Controlled Trials; Symptom Severity; Anxiety and Depression; Quality 
of Life 
 
INTRODUCTION 
Persistent Physical Symptoms (PPS), also known as Medically Unexplained 
Symptoms (MUS), are symptoms that exist in the absence of a medical diagnosis 
(Marks and Hunter 2015). Common examples include fibromyalgia, Chronic Fatigue 
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Syndrome (CFS), Irritable Bowel Syndrome (IBS), and chronic pain. PPS are 
commonly seen in primary and secondary care (Nimnuan 2001; Steinbrecher et al. 
2011), and account for over £3 billion per year in healthcare costs (Bermingham et 
al. 2010). Cognitive Behaviour Therapy (CBT), a psychological therapy that focuses 
on the relationship between thoughts, feelings and behaviours, has already been 
established as an effective treatment for PPS (Menon et al. 2017), and is a standard 
psychological treatment for patients with PPS within the United Kingdom (UK) (Joint 
Commissioning Panel for Mental Health 2017). There is also evidence for the 
effectiveness of mindfulness-based interventions (MBIs). Mindfulness, based on 
Buddhist principles, has been successfully adapted for the Western world, 
promoting constant awareness and acceptance (Mental Health Foundation 2017). 
Mindfulness-based stress reduction (MBSR) was originally developed to treat 
chronic pain (Kabat-Zinn 1982), and has since been shown to benefit a range of 
mental and physical conditions (Grossman et al. 2004; Johansson et al. 2011; 
Witek-Janusek et al. 2008).   
MBSR was originally combined with CBT to reduce risk of depression relapse 
(Teasdale et al. 2000). Previous reviews have concluded MBCT to be as effective in 
treating PPS as MBSR and more effective than non-specific MBIs in reducing 
symptom severity, depression and anxiety, and improving quality of life (Aucoin et 
al. 2014; Hilton et al. 2017; Lakhan and Schofield 2013). However, findings are 
inconclusive due to the limited number of MBCT studies within each review, and 
particularly RCTs (Aucoin et al. 2014; Hilton et al. 2017; Lakhan and Schofield 
2013), as well as high or unclear bias risk (Aucoin et al. 2014; Hilton et al. 2017). 
Evidence for the effectiveness of MBCT for CFS is particularly weak, with only a 
single pilot study included within previous reviews (Lakhan and Schofield 2013; 
Rimes and Wingrove 2013). While suggestive of effectiveness of MBCT in reducing 
symptom severity, level of impairment and depressive symptoms (Rimes and 
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Wingrove 2013), pilot studies do not possess the scientific rigour required to provide 
conclusive evidence. 
Understanding the effectiveness of MBCT within the PPS population will help inform 
healthcare professionals of appropriate and beneficial treatments for PPS. This 
systematic review examines the effectiveness of MBCT alone in selected PPS. 
Similarly to a previous systematic review and meta-analysis (Lakhan and Schofield 
2013), this review focused on IBS, fibromyalgia and CFS, with the expectation that 
more robust and high quality MBCT studies would have been conducted. Medically 
unexplained chronic pain was also included, due to its prevalence and overlap with 
fibromyalgia. This review had two aims: 
1) To understand the effectiveness of MBCT in reducing symptom severity, 
reducing depression and anxiety, and improving quality of life 
2) To assess the quality of current RCTs in order to understand the validity and 
reliability of the evidence 
Unlike previous reviews that included only Symptom Severity or Quality of Life 
measures, this review will attempt to capture a better understanding by adopting an 
inclusive approach. Measures of symptom intensity and frequency were included for 
Symptom Severity. Measures of general health, impairment, disability, functioning, 
interference, impact, life satisfaction and participants’ impression of change were 
included to assess Quality of Life. 
 
 
 
 
 
 
 
 257 
 
METHOD 
 
Search strategy 
A search was conducted within the following electronic databases in order to identify 
studies: Ovid Full Text, PsycArticles, PsycInfo, Embase, Medline, CINAHL, 
Cochrane Central Register of Controlled Trials (CCRCT), PubMed, ScienceDirect, 
Scopus and Web of Science. Search terms were as follows: 1) "mindfulness" or 
"mindfulness-based" or "mindfulness-based cognitive therapy" or "MBCT" or "mind-
body"; 2) "somatization" or "somatic" or "somatoform" or "medically unexplained 
symptoms" or "MUS" or "functional symptoms" or "unexplained symptoms" or 
“unexplained pain” or “chronic pain” or “idiopathic pain” or “functional pain” or 
"fibromyalgia" or “CFS” or "chronic fatigue syndrome" or “IBS” or “Irritable Bowel 
Syndrome”; 3) "randomized" or "randomised" or "RCT" or "randomised controlled" 
or "randomized controlled" or "randomly allocated" or "randomly assigned".  
Reference lists of previous reviews were also scanned (Aucoin et al. 2014; Hilton et 
al. 2017; Lakhan and Schofield 2013). In order to reduce risk of publication bias, 
grey literature was also reviewed.  
  
Study selection 
Eligible studies tested an MBCT intervention for patients with either fibromyalgia, 
chronic pain, IBS or CFS. Studies also included either a control or alternative 
therapy group, such as drug therapy or psychological therapy excluding mindfulness 
and CBT. In order to qualify as MBCT, at least one session of mindfulness is 
required in collaboration with CBT. Further inclusion criteria included randomised 
controlled trials (RCTs) only, adults over 18, and studies published in English. 
Exclusion criteria included diagnosed medical conditions such as arthritis or irritable 
bowel disease (IBD), non-specific MBI and MBSR studies, and any non-RCT 
 258 
 
studies. Outcomes were reviewed and extracted from each study, including those 
measuring symptom severity, anxiety and depression, and quality of life. The 
PRISMA 2009 Flow Diagram was followed to identify eligible trials for inclusion 
(Moher et al. 2009). Search terms were entered into each database in order to 
generate results, and duplicates were removed. Titles and abstracts of results were 
screened. For relevant or unclear articles, full text articles were accessed where 
possible to confirm eligibility.  
 
Quality Assessment 
The Cochrane Risk of Bias Tool was employed in order to assess risk of bias and 
quality of studies (Higgins et al. 2011). This tool has been successfully applied 
within systematic reviews within the area of PPS (Aucoin et al. 2014; Krogsbøll et al. 
2012). It assesses the likelihood of risk in terms of random sequence and allocation, 
concealment, reporting, attrition, blinding and detection. For each, studies were 
marked as High, Low, or Unclear, prior to an overall risk rating. Where studies were 
in between, they were awarded an overall Moderate rating. Single coding of risk of 
bias was employed. 
 
Data Extraction 
General data was initially extracted on study authors, year, location and setting. 
Further data extracted included the type of PPS, sample size, participant age and 
gender, control group type, measures used and general findings. 
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Data Analysis 
Due to the clear heterogeneity of measures used across included studies, a meta-
analysis was not performed. Narrative synthesis was therefore conducted 
throughout the review.  
 
RESULTS 
The search for articles led to the identification of 2324 titles. 338 duplicates were 
initially removed and the remaining abstracts were read. Full text for potentially 
relevant studies were sought (n=65). The majority were excluded for the following 
reasons: 1) MBSR on non-specific MBI rather than MBCT (n=26), 2) not RCT study 
design (n=21), 3) abstracts only (n=6); 4) protocol only (n=2). Ten studies were 
included within the final review. Single study selection was employed for this review. 
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Figure I. Flow diagram of study selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching  
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Additional records identified 
through other sources  
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Full text articles 
assessed for eligibility  
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Full text articles 
excluded with 
reasons  
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Not MBCT:  26 
Not an RCT:  21 
Abstract only:  6 
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Full text articles 
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      Table I. Data extraction table 
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Study characteristics are listed within Table I. Four studies were on chronic 
pain (Day et al. 2014; de Jong et al. 2017; Dowd et al. 2015; Zgierska et al. 2016) 
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and one on fibromyalgia (Parra-Delgado and Latorre-Postigo 2013), three on IBS 
(Asadollahi et al. 2014; Ljótsson et al. 2010; Ljótsson et al. 2011), one on CFS 
(Rimes and Wingrove 2013), and one on multiple PPS where fatigue, 
gastrointestinal symptoms and back pain were included (van Ravesteijn et al., 
2013). All studies were published between 2010 and 2017, and the majority (70%) 
were conducted in Europe. Of these, two were conducted in the Netherlands, two in 
Sweden (Ljotsson et al. 2011; Ljotsson et al. 2010), one in Spain (Parra-Delgado 
and Latorre-Postigo 2013), one in the UK (Rimes and Wingrove 2013) and one in 
Ireland (Dowd et al. 2015). Two were conducted in the USA (Day et al. 2014; 
Zgierska et al. 2016), and one in Iran (Asadollahi et al. 2014).   
The majority (60%) of studies employed a control, wait-list control, usual 
care or delayed treatment (DT) group (Asadollahi et al. 2014; Day et al. 2014; de 
Jong et al. 2017; Parra-Delgado and Latorre-Postigo 2014; Rimes and Wingrove 
2013; Zgierska et al. 2016). Comparison therapy groups included Stress 
Management (Ljotsson et al. 2011), Enhanced Usual Care (van Ravesteijn et al. 
2013), Pain Management Psychoeducation (Dowd et al. 2015), and an online 
discussion forum (Ljotsson et al. 2010). Five studies (50%) included eight weekly 2-
2.5 hour-long group sessions of MBCT face-to-face within a clinical setting 
(Asadollahi et al. 2014; Day et al. 2014; de Jong et al. 2017; Rimes and Wingrove 
2013; van Ravesteijn et al. 2013; Zgierska et al. 2016). Parra-Delgado and Latorre-
Postigo (2013) delivered eight MBCT sessions over three months. Asadollahi et al. 
(2014) did not provide information regarding how the MBCT was delivered. Five 
studies (71.4% of all face-to-face MBCT studies) employed a qualified mindfulness 
teacher (de Jong et al. 2017; Rimes & Wingrove 2013; Parra-Delgado and Latorre-
Postigo 2013; van Ravesteijn et al. 2013; Zgierska et al. 2016), and all of these 
provided participants with homework exercises in between sessions, such as 
meditation.   
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Three studies delivered MBCT using an online or computerised programme 
(Dowd et al. 2015; Ljotsson et al. 2011; Ljotsson et al. 2010). Dowd et al. (2015) 
delivered 12 20-minute MBCT sessions in audio-visual format, which were delivered 
twice-weekly over six weeks. Participants were alerted to the next session’s 
availability via email (Dowd et al. 2015). The other two studies delivered online 
MBCT over ten weeks and provided participants with access to a closed online 
discussion forum, as well as online therapists for feedback and support (Ljotsson et 
al. 2011; Ljotsson et al. 2010). Online MBCT programmes were based on previously 
tested approaches (Dowd et al. 2015, Ljotsson et al. 2011; Ljotsson et al. 2010). 
Eight out of ten studies included follow-up analyses. The length of follow-ups 
were two months (Asadollahi et al. 2014; Rimes and Wingrove 2013), three months 
(Ljøtsson et al. 2010; Parra-Delgado and Latorre-Postigo 2013), six months (Dowd 
et al. 2015; Ljøtsson et al. 2011; Zgierska et al. 2016), and nine months (van 
Ravesteijn et al. 2013). Two studies did not follow up after post-intervention (Day et 
al. 2013; de Jong et al. 2017). 
The total number of participants for all studies was 718 (mean = 71.8; SD = 
57.2). Most studies (70%) however randomised less than 25 participants into each 
group (Asadollahi et al. 2014; Day et al. 2014; de Jong et al. 2017; Parra-Delgado 
and Latorre-Postigo 2013; Rimes and Wingrove 2013; Zgierska et al. 2016).  
Remaining RCTs included between 98 and 61 participants to receive MBCT, with 
similar numbers reported within the control groups (Dowd et al. 2015; Ljotsson et al. 
2010; Ljotsson et al. 2011; van Ravesteijn et al. 2013). Five studies (50%) provided 
information on power analysis calculations, but did not achieve their target (de Jong 
et al. 2017; Ljotsson et al. 2011). One further study attempted to justify a small 
sample size, re-affirming its pilot status (Day et al. 2014). Four studies provided no 
justification for sample size (Asadollahi et al. 2014; Parra-Delgado and Latorre- 
Postigo 2013; Rimes and Wingrove 2013; Zgierska et al. 2016). 
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The majority of studies (80%) provided descriptive statistics on gender and 
age. The majority of participants were female, with percentages ranging from 75-
100% (mean = 84.6%; SD = 9.8). Mean ages of participants ranged from 34.6 to 
52.9 years (mean = 44.0; SD = 7.1). Seven studies (70%) reported calculations of 
potential differences between groups at baseline, and in five studies no significant 
differences were reported in terms of baseline data or demographics. Four studies 
(40%) reported significant differences at baseline on outcome measures (Asadollahi 
et al. 2014; Parra-Delgado and Latorre-Postigo 2013; Rimes and Wingrove 2013, 
Zgierska et al. 2016). Two studies controlled for these (Parra-Delgado and Latorre-
Postigo 2013; Rimes and Wingrove 2013). Validated self-report measures were 
employed for all studies and Cronbach’s α where reported were acceptable or good. 
Two studies employed validated online symptom diaries to monitor symptom 
severity (Day et al. 2014; Ljotsson et al. 2011). 
Most (90%) provided information on the random allocation of participants, 
with only one study not providing information (Asadollahi et al. 2014). The majority 
(70%) demonstrated random allocation outcomes were unforeseeable to 
participants prior to enrolment (Dowd et al. 2015; Ljotsson et al. 2011; Ljotsson et 
al. 2010; Parra-Delgado and Latorre-Postigo 2013; Rimes and Wingrove 2013; van 
Ravesteijn et al. 2013, Zgierska et al. 2016), with the remainder providing 
insufficient information. With regards to performance bias, only one study blinded 
participants to treatment through non-disclosure of the differences between groups 
(Ljotsson et al. 2011). Three studies did not blind participants or staff (Day et al. 
2013; Dowd et al. 2015; Zgierska et al. 2016), and the remainder did not provide 
enough information. Only two studies indicated that outcome assessors were un-
blinded to the participant allocation (Day et al. 2014; Zgierska et al. 2016). 
Most studies (80%) provided an informative level of information regarding 
attrition rates. One study did not provide reasons for withdrawals or how missing 
data would be handled (Parra-Delgado and Latorre-Postigo 2013), and another did 
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not provide sufficient information (Asadollahi et al. 2014). Withdrawal rates were 
low, with the majority reporting rates between 5.4% and 21.6% at follow-up. Two 
studies reported high attrition rates of 33.3% (Day et al. 2014) and 59.7% (Dowd et 
al. 2015). In four studies (40%), Intention-To-Treat (ITT) analysis was performed 
(Dowd et al. 2015; Ljotsson et al. 2011; Parra-Delgado & Latorre-Postigo 2013; 
Zgierska et al. 2016). In three of these, only ITT analysis was reported (Ljotsson et 
al. 2011; Parra-Delgado and Latorre-Postigo 2013; Zgierska et al. 2016), indicative 
of selective outcome reporting. Parra-Delgado and Latorre-Postigo (2013) only 
provided a breakdown of statistically significant findings, omitting information on 
between-group effect sizes, intra-group changes and changes in outcomes. 
Several studies (30%) employed self-referral methods, and so participants 
were not medically confirmed as having PPS (Dowd et al. 2015; Ljotsson et al. 
2011; Ljotsson et al. 2010). One study employed therapists to recruit CFS patients 
into the study, therefore introducing recruitment bias as participants were likely to be 
partial to therapy and expect positive outcomes for MBCT (Rimes and Wingrove 
2013).  
Overall, the risk of bias within the ten included studies was reasonable (see 
Appendix I). Five studies (50%) were judged overall to be at low risk (de Jong et al. 
2017; Ljotsson et al. 2011; Ljotsson et al. 2010; Rimes and Wingrove 2013; van 
Ravesteijn et al. 2013), and four (40%) at moderate risk (Day et al. 2014; Dowd et 
al. 2015; Parra-Delgado and Latorre-Postigo 2013; Zgierska et al. 2016). For the 
remaining study, the risk of bias was unclear due to inadequate level of reporting 
(Asadollahi et al. 2014).  
The findings for ‘Symptom Severity’, ‘Anxiety’, ‘Depression’ and ‘Quality of 
Life’ have been documented separately by PPS type. All studies used self-report 
measures, apart from two studies which also employed online diaries. In the 
majority of studies, significance levels and effect sizes were reported.  
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Symptom severity 
Ljotsson et al. (2010) reported MBCT to have a large between groups effect 
upon IBS severity (d=1.21, 95% CI: 0.73, 1.66, P<0.001), particularly for bloating 
(d=0.94, 95%, CI: 0.46, 1.41, P<0.001) and primary symptoms (d=0.83, 95%, CI: 
0.36, 1.29, P<0.001). Medium to large effect sizes were also reported for flatulence 
(d=0.66, 95%, CI: 0.19, 1.12, P<0.01) and constipation (d=0.76, 95%, CI: 0.26, 
1.27), although the latter was not significant. Small comparative effect sizes were 
also reported for diarrhoea (d=0.32, 95% CI: 0.15, 0.79, P<0.001) and belching 
(d=0.20, 95%, CI: 0.34, 0.74), but again was not significant. Follow-up analysis did 
not report a significant change in GSRS-IBS score, demonstrating reductions in 
symptom severity were maintained. Ljotsson et al. (2011) indicated a smaller, but 
still significant improvement of MBCT over Stress Management, with a small to 
moderate effect size (d=0.38, 95%, CI: 0.09, 0.67, P<0.001), which was repeated 
six-month follow-up (d=0.44, 95%, CI: 0.14, 0.75, P<0.001), demonstrating a long-
term benefit of MBCT. Asadollahi et al. (2014) reported a non-significant 
improvement in terms of symptom severity (d=0.28, P=0.07), but this was not 
maintained (d=0.03, P=0.58). 
Dowd et al. (2015) reported following ITT analysis that there was no 
reduction in Pain Intensity within the MBCT group, although Pain Right Now was 
found to reduce over time (P=0.02). Between-groups analysis however did not 
report a significant difference between MBCT and the Pain Management Psycho-
Education group.  Day et al. (2014) reported following ITT analysis that headache 
frequency was reduced for the MBCT intervention and control group (d = -0.64; 
P=0.001), but MBCT had no benefit over the control (P=0.900). Within-groups 
analysis of the completer sample demonstrated significant negative effects, 
indicative of reduced peak intensity (d=-0.68, P = 0.001), average intensity (d = -
0.63; P=0.003), and frequency (d=-0.73, P = 0.001). Between-groups analysis also 
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demonstrated a large negative effect size favouring the MBCT group (d=-0.80, 
P>0.05), although this was not significant. de Jong et al. (2017) demonstrated a 
slight reduction in pain intensity for MBCT through mean scores (6.1 at baseline, 
reduced to 5.6), but this was not significant post-intervention (P=0.77). Similar 
findings were reported within the per-control sample, with the small reduction of 
MBCT mean scores (6.0 at baseline, reduced to 5.5), but the difference between 
groups was not significant (P=0.83).  Parra-Delgado and Latorre-Postigo (2013) 
reported lumbar pain as significantly reduced post-intervention for the MBCT group 
(d=0.62, 95%, CI: -0.12, 1.34, P<0.05). Some improvement was also observed with 
small effect sizes for cervical pain post-intervention (d=0.31, 95%, CI: -0.42, 1.02) 
and at follow-up (d=0.34, 95%, CI: -0.38, 1.06). A small effect was also reported for 
left leg pain at follow-up (d=0.22, 95%, CI: -0.50, 0.94). No effect was observed for 
dorsal, right arm, left arm, or right leg pain. Differences between groups for all pain 
points were all non-significant. Zgierska et al. (2016) reported chronic back pain 
intensity as significantly reduced following MBCT, in comparison with the Usual 
Care control post-intervention (d=0.69, 95%, CI: 0.01, 1.7). A bigger between-
groups effect size and a significant difference was also reported between baseline 
scores and six-month follow-up scores (d=0.86, 95%, CI: 0.2, 1.9; P=0.045). 
Rimes and Wingrove (2013) reported a significant benefit of MBCT in 
reducing fatigue post-intervention (P=0.014) and at follow-up (P=0.033). When 
comparing with pre-treatment scores, this reduction in symptom severity was 
maintained at the six-month follow-up (P=0.01). van Ravesteijn et al. (2013) 
reported a significant reduction in physical symptoms following MBCT post-
intervention (d=-1.61, 95%, CI: -2.50, -0.71, P<0.05) and at follow-up (d=-1.44, 
95%, CI: -2.60, -0.28, P<0.05). In comparison, the EUC group showed a significant 
improvement at follow-up only (d=-1.24, 95%, CI: -2.37, -0.11, P<0.05). Between-
groups analysis demonstrated a very large negative effect post-intervention in 
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favour of MBCT (d=-1.17, 95%, CI: -2.57, 0.23) with a small to moderate negative 
effect at follow-up (d=-0.40, 95%, CI: -1.99, 1.20), although this was not significant. 
 
Anxiety 
Ljotsson et al. (2010) reported a significant benefit of MBCT over the online 
discussion group control condition (d=0.64, 95%, CI: 0.20, 1.07, P<0.001). Although 
non-significant (P=0.06), follow-up analyses of the MBCT group at three months 
showed that levels of health anxiety had continued to reduce. Ljotsson et al. (2011) 
demonstrated through the Visceral Sensitivity Index (VSI) scale significant 
reductions in anxiety following MBCT (P<0.001), which appeared more efficacious 
than the Stress Management control group post intervention (d=0.33, 95%, CI: 0.04, 
0.62), and significantly more at follow-up (d=0.37, 95%, CI: 0.06, 0.005, P=0.005). 
On the anxiety subscale of the HADS however, both groups demonstrated 
significant reduction of anxiety (P<0.001) with little difference between groups post-
intervention (d=0.04, 95%, CI: -0.25, 0.32) and at follow-up (d=0.14, 95%, CI: -0.16, 
0.44, P=0.647). Asadollahi et al. (2014) reported small-moderate reductions in 
anxiety within the MBCT group post-intervention (d=0.45, P=0.01), and at follow-up 
(d=0.33, P=0.04), but there was little difference between groups. Dowd et al. (2015), 
who reported anxiety and depression within the same analyses, demonstrated a 
small-medium but non-significant effect of MBCT post intervention (d=-0.39, 
P>0.05), which was reduced at follow-up (d=-0.12, P>0.05). Between-groups 
analysis also demonstrated negligible effect sizes post-intervention (d=-0.10, 
P>0.05) and at follow-up (d=-0.03, P>0.05). de Jong et al. (2015) demonstrated 
within the ITT sample, a small non-significant reduction in anxiety within the MBCT 
group through mean scores reported. A small but non-significant reduction was also 
observed within the MBCT group following Per-Protocol analysis. The difference 
between groups was also shown to be non-significant following ITT and Per-
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Protocol analysis, with P=0.14 and P=0.10 respectively. The two remaining studies 
for chronic pain and fibromyalgia did not measure anxiety (Day et al. 2014; Parra-
Delgado and Latorre-Postigo 2013). 
Rimes and Wingrove (2013) reported a slight reduction in anxiety post-
intervention amongst the MBCT group, which was maintained at follow-up. A non-
significant reduction in anxiety was reported between pre-intervention and six-month 
follow-up (P=0.206), and between-analysis demonstrated a non-significant benefit 
of MBCT post-intervention (P=0.173) and at follow-up (P=0.296). van Ravesteijn et 
al. (2013) reported a significant reduction within the MBCT group post-intervention, 
and at follow-up (P<0.05). However, between-groups analysis demonstrated a non-
significant difference between MBCT and EUC groups post-intervention and at 
follow-up (P>0.05).  
 
Depression 
Ljotsson et al. (2010) reported a non-significant improvement in depressive 
symptoms post-intervention (P>0.05), but between-groups analysis demonstrated a 
significant improvement for the MBCT group (d=0.43, 95%, CI: 0.00, 0.86, P<0.05). 
Ljotsson et al. (2011) reported a significant improvement following MBCT, which 
was maintained at follow-up (P<0.001). Between-groups analysis however showed 
no benefit of MBCT at all post-intervention (d=0.01, 95%, CI: -0.28, 0.29) or at 
follow-up (d=0.08, 95%, CI: 0.22, 0.38, P=0.817). Asadollahi et al. (2014) reported a 
significant benefit of MBCT post-intervention (d=0.41, P=0.02). A small effect size 
for MBCT was also observed at follow-up, although not significant (d=0.23, P=0.10). 
Between-groups analyses were not reported, but no significant changes were 
observed within the control group. 
de Jong et al. (2017) reported a significant benefit of MBCT over the control 
group within the Per-Protocol sample (P=0.04), but not following ITT group analysis 
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(P=0.26). Between-groups analysis reported no difference post-intervention when 
analysing either the ITT sample (P=0.48) or Per-Protocol sample (P=0.23). Parra-
Delgado and Latorre-Postigo (2013) reported a significant reduction of depressive 
symptoms following MBCT (d=0.82, 95%, CI: 0.06, 1.55, P<0.001) which was 
maintained at follow-up (d=0.86, 95%, CI: 0.09, 1.59, P<0.001). Between-groups 
analysis also showed a significant benefit of MBCT post-intervention (P<0.001) and 
at follow-up (P=0.006). The two remaining studies for chronic pain did not measure 
depression (Day et al. 2014; Zgierska et al. 2016). 
Rimes and Wingrove (2013) reported a significant reduction of depressive 
symptoms in those with CFS following MBCT, in comparison with wait-list control 
(P=0.038). However, this was not sustained (P=0.153) with non-significant 
reductions also reported between two and six-month follow-ups (P=0.069), and pre-
treatment and six-month follow-up (P=0.051). van Ravesteijn et al. (2013) reported 
following within-groups analysis a slight reduction of depressive symptoms for the 
MBCT group post intervention and at nine-month follow-up, but at neither point was 
this significant (P>0.05). A significant improvement was noted however within the 
EUC group at the nine-month follow-up (P<0.05). 
 
Quality of life 
Ljotsson et al. (2010) reported a significant improvement in IBS-QOL scores within 
the MBCT group at follow-up (P<0.05), which was also significantly greater than the 
control group (d=0.93, 95%, CI: 0.47, 1.36, P<0.001). A small to moderate between-
groups effect was also demonstrated on the Sheehan Disability Scales (d=0.47, 
95%, CI: 0.04, 0.90, P<0.001).  Ljotsson et al. (2011) also reported a substantial 
improvement in quality of life in comparison with the Stress Management group,  
with moderate effect size post-intervention (d=0.51, 95%, CI: 0.23, 0.80). While the 
difference between groups remained significant at follow-up, the effect size was 
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reduced (d=0.31, 95%, CI: 0.01, 0.61, P<0.001), due to an improvement in quality of 
life reported within the Stress Management group.  Asadollahi et al. (2014) did not 
use any Quality of Life measure within their study. 
Dowd et al. (2015) demonstrated a significant reduction in pain interference 
(BPI) within the MBCT group (d=-0.76, P<0.001). However, there was little 
difference between MBCT and the Pain Management Psycho-Education group 
(d=0.04, P>0.05). The Satisfaction with Life scale demonstrated a significant 
improvement amongst the MBCT group post-intervention (d=0.90, P<0.0001), which 
was also significantly better than the control group (d=0.59, P<0.05). The PGIC also 
demonstrated the MBCT group to be significantly more able to manage their 
emotions than the control group post-intervention (d=0.46, P=0.011), deal with 
stressful situations (d=0.62, P=0.001) and enjoy pleasant events (d=0.41, P=0.025). 
While ability to manage emotions (d=0.36, P=0.039) and deal with stressful 
situations (d=0.36, P=0.044) remained significantly improved, it was not for their 
ability to enjoy pleasant events (P=0.631). Day et al. (2014) reported a large 
between-groups effect in favour of MBCT within the completer sample (d=-1.29, 
P<0.01), but this was not significant following ITT analysis (P=0.07).  de Jong et al. 
(2017) analysed all sub-scales of the SF-36 separately, and reported significant 
within-group differences with moderate effect sizes for Mental Health (d=0.57, 
P=0.003) and Vitality (d=0.50, P=0.017), following analysis of the ITT sample. 
Significant differences were also reported between groups for Mental Health 
(P=0.031) and Vitality (P=0.006), indicating little change within the Delayed 
Treatment group. Analysis of the Per-Protocol sample also revealed significant 
improvements within the MBCT group for Mental Health (d=0.83, P=0.002) and 
Vitality (d=0.68, P=0.016), with significant differences between groups for Mental 
Health (P=0.013) and Vitality (P=0.005).  No significant differences were found for 
Physical Functioning, Role Limitations (Physical), Role Limitations (Emotional), 
Social Functioning, Pain or General Health. Parra-Delgado and Latorre-Postigo 
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(2013) reported a significant reduction in fibromyalgia impact (FIQ) within the MBCT 
group post-intervention (d=1.13, 95%, CI: 0.33, 1.87, P<0.001), which was 
maintained at follow-up (d=0.94, 95%, CI: 0.17, 1.67, P<0.001), but this was not 
found between groups post-intervention (P=0.43). However, the difference between 
groups was close to significance at follow-up (P=0.12) following an increase in FIQ 
score within the Delayed Treatment group at follow-up (d=-0.48).  Zgierska et al. 
(2016) reported little difference in terms of physical functioning between the MBCT 
group and control group post-intervention (d=0.15, 95%, CI: -5.5, 9.3). MBCT was 
shown to be very effective over time (d=0.68, 95%, CI: -1.0, 14.0), although this was 
not significant in comparison with the control group (P=0.209). 
Rimes and Wingrove (2013) reported a significant difference in work and 
social adjustment (WSAS) between groups post-intervention (P=0.04). A notable 
difference was still present at follow-up, but it did not remain significant (P=0.054). 
However, a significant reduction was observed within the MBCT group between two 
and six months (P=0.004). Improvement within the MBCT group was demonstrated 
at six-month follow-up, but this was non-significant (P=0.051). An increase in 
Physical Functioning was observed, although between-groups analysis showed no 
significant difference between groups post-intervention (P=0.124) or at follow-up 
(P=0.345). van Ravesteijn et al. (2013) demonstrated a significant benefit of MBCT 
through the Visual Analogue Scale (EuroQoL) at post-intervention and follow-up 
(P<0.05), but between-groups analysis showed MBCT scores to be non-significant 
in comparison with the EUC group (P>0.05). In terms of Physical Functioning, 
significant improvements were observed following MBCT were demonstrated for the 
Physical Role subscale post-intervention, and at the nine-month follow-up for 
Physical Functioning, Physical Role, Bodily Pain, and General Health (all reported 
at P<0.05 level). In comparison, the EUC group only demonstrated an improvement 
within Physical Role at the nine-month follow-up (P<0.05). For Mental Functioning, 
significant differences within the MBCT group were reported on most sub-scales at 
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post-intervention and at follow-up, including Mental Functioning, Vitality, Social 
Functioning and Emotional Role sub-scales (all reported at P<0.05). No significant 
change was reported for Mental Health. In comparison, the EUC group 
demonstrated significant improvement at follow-up on all Mental Functioning sub-
scales (P<0.05). 
 
DISCUSSION 
This review showed MBCT is effective in reducing symptom severity in IBS 
(Ljotsson et al. 2011; Ljotsson et al. 2010), CFS (Rimes and Wingrove, 2013), and 
in a mix of PPS (van Ravesteijn et al. 2013), supporting the findings of previous 
reviews (Aucoin et al. 2014; Hilton et al. 2017; Lakhan and Schofield 2013).  Pain 
severity, intensity and frequency was also reduced following MBCT (Day et al. 2014; 
Parra-Delgado and Latorre-Postigo 2013; Zgierska et al. 2016), with varying 
success. One IBS study reported MBCT to have no effect upon symptom severity 
(Asadollahi et al. 2014), although potential reasons for this are unclear due to 
limited information available. 
In terms of alleviating anxiety, this review suggests that MBCT may slightly 
or moderately reduce anxiety for those with IBS (Ljotsson et al. 2010; Ljotsson et al. 
2011), and CFS post-intervention (Rimes and Wingrove 2013). van Ravesteijn et al. 
(2013) also reported MBCT to successfully reduce anxiety in those with multiple 
PPS. However, MBCT generally did not reduce anxiety in the two chronic pain 
studies that reported on anxiety. Further studies are required, due to only two 
chronic pain studies reporting the effects on anxiety within this review. In terms of 
depression, again this review demonstrates some evidence for the benefits of 
MBCT amongst the IBS population (Asadollahi et al. 2014; Ljotsson et al. 2011; 
Ljotsson et al. 2010), as well as CFS short-term (Rimes and Wingrove 2013). 
Nevertheless, this was not reported within all studies (van Ravesteijn et al. 2013). 
 275 
 
While de Jong et al. (2017) reported weak evidence for MBCT treating depressive 
symptoms long-term, it was only following analysis of the Per-Protocol sample, 
therefore is unlikely to be reliable. 
MBCT was reported to improve quality of life, with significant improvements 
were reported for IBS (Ljotsson et al. 2011; Ljotsson et al. 2010), CFS (Rimes and 
Wingrove 2013), chronic pain (Day et al. 2014; Dowd et al. 2015), fibromyalgia 
(Parra-Delgado and Latorre-Postigo 2013), and multiple PPS (van Ravesteijn et al. 
2013). These findings support those of previous MBI reviews for functional bowel 
disorders, chronic pain and PPS in general (Hilton et al. 2017; Lakhan and Schofield 
2013). However, the findings for MBCT within this review are tailored specifically to 
MBCT. 
The review has a number of limitations to address. Firstly, there was a 
moderate risk of publication bias due to authors not being contacted about any 
unpublished work. Secondly, only single study selection and single coding of bias 
risk was employed. Thirdly, small sample sizes were included within the majority of 
studies, with four studies identifying as pilots. While this could not be controlled due 
to lack of availability, it compromises the quality of the evidence.  Other limitations 
were the over-representation of female participants limiting the generalisability of 
the findings, and the heterogeneity of studies. While heterogeneity was already 
inevitable due to variations across PPS, there were also variations in terms of the 
length of follow-ups, control group intervention, how the MBCT intervention was 
delivered and in the outcome measures employed. Regarding bias, there was a lack 
of blinding across studies. While it is acknowledged that blinding may not always be 
feasible, it compromises research integrity. Several studies also used self-referral 
which suggests that included participants may not have met criteria for PPS. Finally, 
all studies employed self-report measures in order to capture the majority of the 
data, which compromises data quality due to reliance on participants’ subjectivity 
and memory. Nevertheless, this review did include a higher than anticipated number 
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of ‘Low risk’ studies indicating the evidence-base for MBCT as a treatment for PPS 
is strengthened, which has positive implications for future healthcare.  
In conclusion, MBCT is likely to have at least a small positive effect in 
treating symptom severity, anxiety and depression, and quality of life in patients with 
PPS. The implications of this are that MBCT may be suitable for use as an 
alternative treatment to CBT and other MBIs. Due to limitations within current 
studies as discussed, conclusive evidence for the effectiveness of MBCT in treating 
PPS is not yet available. Low-risk RCTs with large sample sizes are required, 
particularly for CFS for which there is currently still only one pilot RCT despite its 
promising results.   
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APPENDIX I 
 
Bias risk for included randomised controlled trials 
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2C.3:  Event Review:  To the DHP for giving me this 
opportunity: Diolch yn fawr iawn! 
Katie Watts 
 
It was my big chance to share my research with like-minded health psychologists at 
my home from home, Cardiff.  I was never going to turn this opportunity down! 
When I received an email from the 
Division of Health Psychology (DHP) 
back in April to confirm my research 
abstract had been accepted for an 
oral presentation, I was naturally 
delighted, and even more so when I 
received notification that my bursary 
application had been successful too! 
Being half-Welsh, many school 
holidays were spent around Cardiff, 
so returning was like going home. 
However, this time I was there in a 
professional capacity, presenting my 
own research and representing not 
only myself but City University 
London.  
 I was due to present on 
Thursday 7th September at 11.10am, 
Caernarfon Suite. Peak-time in the 
biggest room! While keen to 
disseminate my research findings in 
the interest of developing my career 
as a Health Psychologist, I am still 
prone (at the age of 32) to nerves and 
self-doubt. On this occasion, the 
somewhat familiar feelings of anxiety 
were further compounded for two 
reasons. Firstly, it was my first 
presentation at the DHP annual 
conference so I did not know what to 
expect. Secondly, I was heading in to 
present a somewhat controversial 
topic, entitled: ‘“I have genital herpes. 
Now what do I do?” Navigating the 
road back to psychosocial recovery’. 
This study was my MSc Health 
Psychology dissertation where I 
conducted nine telephone interviews 
with individuals living with genital 
herpes, in order to explore their 
experiences of diagnosis and 
perceived information and support 
requirements following diagnosis. 
With a stigmatised subject, I had 
many thoughts running through my 
head: “what is the response going to 
be?” and “Would people want to hear 
about this study?” as well as the 
generic concerns of someone 
presenting their work for the first time. 
The day of the presentation 
arrived. I remember little of talking 
through my PowerPoint slides that I 
had vehemently rehearsed, but I do 
remember a sense of pride as I 
addressed the audience. I also 
remember how engaged the audience 
appeared to be with the topic, and 
being congratulated at the end of the 
presentation, and feeling a euphoric 
surge of relief as I sat down to enjoy 
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the rest of the presentations. What I 
have learned from this experience is 
not to fear the unknown. Now that I 
have given an oral presentation at the 
DHP annual conference, I can 
remember this and compare my fears 
with the actual lived experience. I am 
still buzzing that I got to present my 
own work on a national stage to 
established health psychologists. I 
also feel proud that I had successfully 
juggled delivering a presentation at a 
national conference with the demands 
of finishing doctorate and working full-
time. I remember thinking to myself on 
the train back to London that if I can 
deliver something good under 
pressure, then there is nothing to fear 
in the future! 
The social side of the 
conference was great too. I attended 
the full three days and the conference 
dinner, so was able to make the most 
of it. I would strongly recommend 
anyone attending in future to also 
attend the conference dinner as it 
helps to further break down barriers. 
Being a City University student and 
employed by King’s College London, I 
had already bumped into many 
familiar faces, but I ended up meeting 
many more at the conference dinner! 
Overall, the conference 
provided me with a great overview of 
the possibilities of Health Psychology. 
Being able to meet psychologists from 
across the United Kingdom (and even 
beyond) inspired me as a trainee in 
terms of future career steps. I also 
feel it has increased the chance of 
opportunities, in two distinct ways. 
Firstly, it helps you to present your 
own research interests, should 
anyone be seeking a future 
collaborator. Secondly, you build on 
relationships at the conference, many 
of whom you may wish to contact in 
the future.   
In conclusion, attending the 
DHP conference is great from a 
career and social perspective. I would 
strongly encourage anyone thinking of 
attending in future to go. Being able to 
present one’s own work enables you 
to work on your presenting skills, 
especially as a trainee, but there is so 
much more to be gained. To anyone 
thinking of attending in the future, I 
would just say: don’t turn it down! 
 
Katie Watts, 
Trainee Health Psychologist 
City, University of London 
Email:  Katie.Watts.1@city.ac.uk 
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3A:   Consultancy:  Health Status Assessment Project 
 
3A.1:    What is consultancy? 
Consultancy is defined as “providing a professional or technical service to 
benefit a specific client (i.e. a third party), where a fee-for-service or equivalent 
relationship exists…” (Shugan, 2004).  To explain further, consultants use their 
expertise within a certain area of interest in order to deliver informed and objective 
advice, identify ways of overcome any outstanding problems, and enhance the 
performance of their client’s organisation (Management Consultancy Association, 
2016).   
In order to ensure client satisfaction, the consultant is required to deliver a 
strong performance that goes beyond technical ability. It is also important for 
consultants to recognise unspoken expectations of their client, which may be both 
personal and professional (Bergholz, 1999; Chelliah & Davis, 2011). Examples of 
expectations that go beyond contractual obligations may include free advice, a 
personable and fun working partnership, and additional time to listen to needs or 
concerns (Chelliah & Davis, 2011).  It is therefore important to manage these 
expectations effectively in a way that ensures the client is satisfied (Bergholz, 1999). 
While there are clear advantages for clients in that they can improve their service by 
employing a consultant with specialist knowledge, there are also advantages for 
consultants. This includes being able to expand their knowledge, gain experience in 
managing client expectations, and build new working relationships.    
This report covers my own experience of consultancy. In order to conduct, 
evaluate and reflect upon my experience, I will be considering each of the Seven 
C’s, within the C’s framework (Cope, 2000). This framework includes the following:  
Client – understanding the client, the project and their objectives; Clarify – 
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understanding what the consultant requires; Create – using techniques to ‘create’ a 
solution to the identified problem (e.g. by conducting research); Change – 
understanding current factors that may be preventing or leading to change, and 
implementing the solution to overcome that; Confirm – measuring the extent that the 
intervention has made a difference; Continuing – ensuring that any change is long-
term; Closing – close the working relationship with the client with a review of what 
the consultant and the client has learned from the project, as well as any future work 
required.  
 
3A.2:   Assessment of requests for consultancy, planning consultancy, and 
establishing and maintaining working relationships with clients 
I first became aware of my client shortly after posting a message on social 
media enquiring about any potential consultancy opportunities. An associate got in 
touch with me after they had previously conducted research for the Tuke Institute, 
confirming that the Chairman was keen for further assistance. I promptly sent an 
email to them, and received a reply suggesting we hold a Skype meeting to discuss 
his requirements and my availability.  Prior to our first Skype meeting, I conducted 
my own research into the background of the Tuke Institute and previous research 
projects. From this, I discovered that the client is a qualified psychiatrist, 
immunologist, and patient-advocate, and that the Tuke Institute is a non-profit 
organisation set up with the aim of improving and adapting health services. This is 
to ensure that patient-centred healthcare is delivered in the most effective way to 
meet the requirements of chronically unwell patients. In their own words, the 
Institute aims to “translate the reality of illness into health-effective medical practice, 
an approach that integrates all the domains of medicine (prevention, diagnosis, 
treatment, and rehabilitation); all the professional domains within clinical medicine 
(nursing, physical, mental, and social medicine); and welcomes contributions from 
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diverse traditions of medicine” (Tuke Institute, 2016).  I found it admirable that the 
Tuke Institute had been set up without the aim of financial gain, and morally I 
considered them an attractive client to work with. 
My first Skype session with the client took place on 29th June 2016. I 
understood that the overall aim of this project, entitled ‘Health Service Assessment’, 
was eventually to introduce a new mobile app for patients living with long-term 
conditions, which could then eventually be integrated within the NHS. However, my 
personal involvement would be to conduct the necessary background research and 
build a business case for the app. Having read what I had regarding the previous 
work of the Tuke Institute, I was initially concerned that I would not be experienced 
enough to perform to the level that they were likely accustomed to. However, 
following personal introductions, I relaxed as the client quickly demonstrated an 
intuitive understanding of my personal capabilities and strengths, including project 
management and qualitative research skills. As the Tuke Institute is a non-profit 
organisation, it was confirmed during the initial call that any consultancy would be 
voluntary.  
Our second meeting took place on 15th July, and involved a more in-depth 
discussion of the individual project tasks and responsibilities. We jointly discussed a 
step-by-step process of what was required, and divided the consultancy into three 
distinct parts – the Scientific Perspective, Patient Perspective and Business 
perspective. Following this meeting and being aware of what the aims and 
objectives were, I composed a draft version of the contract and sent it to the client 
for comments. Following a revision of the completion dates, the contract was 
officially signed on 20th July (see Appendix II). Within the contract, each individual 
part was given a deadline for completion which was 31st August; 31st October, and 
31st December, which I proposed in order to ensure the consultancy was completed 
on schedule. We agreed for Skype meetings to be arranged on an ad hoc basis, 
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and for minutes from each Skype meeting to be typed up immediately after each 
meeting and stored electronically within the Podio platform. Tasks and any written 
documents would also be reviewed on an ongoing basis. Details of the individual 
tasks within each section are documented in detail below. 
It became apparent within our second meeting, that the Process 
Consultation Model by Schein (1990) was the most appropriate model for this 
project due to the collaborative nature of the work itself. The Process Consultation 
model presents that the client and consultant work as a team in order to answer any 
questions and identify solutions. In the case of this project, neither the client nor 
myself were sure at the beginning of the current app market and how this and 
discussions with patients may eventually affect the business case, so it was a 
journey of discovery for both the client and consultant.   
 
3A.3:   Conducting consultancy and monitoring its implementation 
3A.3.1:  Conducting research from a scientific perspective 
This part of the consultancy was to gain an initial understanding of what 
software was already in existence. This involved conducting a manual search within 
the Apple store to identify apps for those living with long-term conditions, such as 
HIV, diabetes, depression, schizophrenia, chronic pain and cancer. Due to the large 
volume of apps available, a purposive mixed sample of 24 apps were selected and 
downloaded onto a smartphone. Each app was then reviewed individually in terms 
of its usability, user interface, its interaction of software with healthcare 
professionals (i.e. do they have access to data and are patients able to provide 
feedback), its advertising, the type of programming modules and packages used, its 
size and cost to download, the measures of health used and aspects of health 
covered. For the latter, apps were referenced against the International Classification 
of Functioning, Disability and Health (ICF) checklist (World Health Organization, 
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2003), to investigate whether apps had incorporated each of the following:  
impairments of body functions; impairments of body structures; activity limitations 
and participation restriction; environmental factors, and other contextual information. 
The ICF is the World Health Organization’s (WHO) framework for health, designed 
to provide a more realistic measure of health and disability (WHO, 2016). Ratings 
already provided by current users were also reviewed. Based on all this information, 
the apps were finally given an independent rating of zero to five stars. All 
information on the individual apps was organised and stored online within the Podio 
website, to allow for the client to review the information on an ongoing basis. This 
in-depth analysis provided a good understanding of competitor apps, particularly 
their strengths and limitations. Overall, it was concluded that the quality of existing 
health apps was poor, particularly as almost all failed to include key parts of the ICF 
checklist. Furthermore, it was observed that the more advanced health apps 
generally incurred a considerable cost to the patient. Therefore, we were able to 
conclude from this review that there was a market gap. A separate report was later 
written on request to clearly highlight the extent to which the ICF is covered (see 
Appendix III). The agreed deadline of 31st August for Scientific Perspective was 
generally met, which enabled a smooth transition into the second part of the 
consultancy. The only exception was the ICF report, which was completed in 
December 2016 as an additional task.  
 
3A.3.2:  Conducting research from a patient sperspective 
Now that we understood the market, we had a better understanding of what to 
potentially include in discussions with patients; to understand what the main 
problems are for patients living with the different conditions, and their preferences 
when monitoring their health through a mobile app. In order to gather information to 
help create the vignettes, and due to my previous qualitative experience, it was 
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agreed that qualitative telephone interviews should be conducted with individuals 
living with long-term conditions. In order to prepare, I composed a topic guide, which 
was later revised following feedback from the client (see Appendix IV for the revised 
version). Following an advertisement on social media asking for participants, six 
interviews were eventually conducted with individuals living with various conditions, 
including fibromyalgia, chronic migraine, Type-2 diabetes, ulcerative colitis, 
hypothyroidism and CFS. During the interviews, they were asked about their 
condition, their symptoms and associated problems, their relationship with 
healthcare professionals, and their current use of health-related mobile apps. This 
included the strengths and weaknesses of those apps, what they would ideally like 
to be able to log into a health app, how they would like to enter the information (e.g. 
in either a 5-point or a 10-point scale to indicate mood), and how they would like 
information to be displayed. Notes were made during the interviews and interviews 
were listened to again, rather than being analysed in full due to time and resource 
restrictions. The insight created from the interviews provided me with the 
information to create three vignettes in detail (see Appendix V).  These vignettes 
were written, reviewed by the client, and then revised to prepare for one to be 
eventually included as part of a pitch presentation. The deadline of 31st October for 
the Patient Perspective was adhered to. However, vignettes continued to be 
adapted while the final part was under way.  
 
3A.3.3:  Conducting research from a business perspective; preparing a business 
case 
The final part of the consultancy required the composition of a business case 
for the provision of the app. Prior to writing the business case, entitled ‘Health 
Status Assessment Project: Business Perspective’ (see Appendix VI), I conducted 
my own research to understand exactly what should be included, as this was 
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unfamiliar territory to me. I used the guide provided by Workfront, Inc. (2016).  The 
following information was therefore included within the document:  An Executive 
Summary; Finance; Introduction and Overview; Business Objectives; Benefits and 
limitations; Option Identification Selection; Outline Plan; Market Assessment; Risk 
Assessment; Project Approach. Three further headings were also included within 
the Business Case document – Scope, Impact and Interdependencies, Purchasing 
Strategy; and Recommendations. However, following discussion regarding the 
content, it was agreed that this additional information would later be provided by the 
client.   
Within Introduction and Overview, information was included on how effective 
or ineffective services are in terms of managing health and cost; how much service 
usage is a result of long-term conditions; how integrated services may be effective 
in reducing service-usage and cost; what is needed for effective integrated services, 
and how the introduction of this app might reduce financial and social costs. The 
Finance section included an example of how the overall cost may be calculated 
using a whole-cost framework, while the Outline Plan included a Gantt chart of a 
provisional timeline for 2017. This required consideration of the different stages 
likely to occur following on from this project, including legal procedures, research 
and development, product development, manufacturing, acquiring of the necessary 
licences and personnel, marketing and the app’s launch. The Market Assessment 
included a thorough consideration of the political, economic, sociological, technical, 
legal and environmental factors involved – otherwise known as a PESTLE analysis 
(PESTLE Analysis, 2016).  Risk Assessment included not only the risks of 
introducing the mobile app, but also led to a consideration of what opportunities may 
emerge from knowing this in advance and what plans should be put in place to 
ensure that any dangers are avoided. The final task of the project was to conduct 
further research, and report back to the client how to produce a successful 
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promotional video. This information was delivered via Skype. In order to keep it 
concise, I discussed the five-step outline provided by Ruffell (2016).  I also referred 
to useful hints and tips provided by Stockman (2011).   
As within the contract, the final part of the consultancy was completed by 
31st December 2016. The final discussion, which was held on 28th December, 
included a final revision of all tasks within the contract, to ensure that I had met all 
contractual obligations.  
 
3A.4:  Evaluating the impact of consultancy 
While it was not originally agreed within the contract, I proposed that the 
mobile app be evaluated in the future on a short-term and long-term basis following 
successful launch, using the RE-AIM evaluation model by Glasgow, Vogt and Boles 
(1999).  Originally designed to evaluate the impact of health promotion interviews on 
public health, this model can also be consulted in advance to encourage careful 
planning and consideration of key aspects, such as the app’s external validity 
(Glasgow et al., 1999). The framework has been demonstrated to be effective and is 
used on a frequent basis (King, Glasgow & Leeman-Castillo, 2010). Within this 
context, I suggested that the framework could be used to evaluate each of the 
following: how many of the target population have become aware of and have 
downloaded the app at three months, and at the one year mark (Reach); how 
effective the app is at integrating health services and managing patient health 
(Effectiveness); how many General Practitioners/nurses encourage patients and 
use the app within their practices, and how many NHS surgeries have accepted the 
app as part of general practice (Adoption); how consistently the app is used, what 
costs have been incurred or saved, and what adaptations have had to be made. 
This can refer to adaptations to the app itself, as well as adaptations within general 
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healthcare practice (Implementation); and to what degree the app has been 
accepted and integrated for long-term use (Maintenance). 
The client was asked to complete a qualitative evaluation form, in order to 
provide detailed written feedback (please see Appendix VII). This information 
assisted me with my reflexive analysis of consultancy.  
 
3A.5:    A reflexive approach 
Generally, I enjoyed the consultancy experience, especially the opportunity 
of working with my client as I found them to be very personable, inspiring and 
understanding. We had a collaborative working partnership which enabled the client 
and I to share individual skills in order to obtain what was needed. My skills primarily 
related to conducting research and conducting qualitative interviews, writing and 
drawing on elements of Health Psychology where required, such as the RE-AIM 
evaluation model (Glasgow et al., 1999). 
At this stage in my career, I was glad that I had the opportunity to utilise the 
Process Consultation model of consultancy.  I felt that this worked well for this 
particular project, and I doubt I would have felt confident enough to adopt the Expert 
model, where the client is understood to be the expert but have little involvement 
within the consultancy process, or the Doctor-Patient model where I would have 
been identified as the expert looking to find ways of identifying solutions (Schein, 
1990). While I fear the Expert model may have encouraged me to act less often on 
initiative, the expectations incurred by the Doctor-Patient model I expect would have 
been too high, given that I still feel I need time and space to grow and develop my 
client managing skills.  The need to develop these skills was also evident from the 
client feedback, which identified that improvements could still be made in terms of 
contract setting, writing business cases, taking the lead during meetings, and 
 297 
 
adapting to clients’ use of different technologies. All of this constructive feedback 
and suggestions for future training I took on board. I considered it very useful at this 
point in my career as in the future I acknowledge that I am likely to come across 
demanding clients who expect these consultancy skills to be already established. 
Despite the positive experience overall, I admit that I found the demands of 
this project to be very high. Whilst I still managed to meet deadlines as 
acknowledged within the feedback, I often struggled due to the volume of work. I 
even started to worry that the consultancy could start to impede on other work or 
University related demands, particularly as some tasks demanded quick adaptation 
and the learning of new skills, such as working with new online platforms (e.g. 
Podio). At first, the Podio interface frustrated me greatly and I felt that it slowed me 
down, leading to the investment of more time than initially anticipated. Some 
required tasks were also completely new to me. For example, I had to write a 
Business Case, where I needed to act on my own initiative and conduct further 
research to fully understand what was required. Referring to the Locus of Control 
theory, which suggests that individuals can either attribute internal factors or 
external factors (Rotter, 1954), I came to the conclusion that I would hold myself 
responsible for my own learning and successful completion of tasks, rather than 
attribute it to any external factors such as workload. This led to the dedication of 
additional time and prioritisation of work in order to overcome these challenges. I 
also conducted further research and individual tasks where necessary to further 
help with my development. An example of this is that prior to writing the Business 
Case, I wrote a brief two-page guide of what was necessary to include, before 
writing it out in full. This task was a helpful exercise for me as I anticipate 
undertaking further consultancy projects in future. That said, I also found at times 
that I had to discourage my client from trying to introduce new tasks, which would 
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have led to the failure of meeting agreed deadlines. Judging from the feedback, I 
believe that I managed this well. 
Overall, the consultancy has enhanced feelings of self-efficacy (Bandura, 
1977), in terms of project management.  However, the constructive feedback has 
opened my eyes and made me very aware of what to consider, and what I need to 
improve on. While I very much approached the consultancy project as a great 
opportunity on this occasion, I would not accept a project of this magnitude in future 
without agreed payment cited within the contract due to the volume of work 
involved. Now that I am aware of how demanding consultancy can be, I will ensure 
that there is an agreed payment stated within the contract and that all tasks are 
realistically viable within a certain timeframe.  
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APPENDIX I 
Supervision Plan:  Consultancy 
 
Supervisee: ___Katie Watts____________________ 
Supervisor: ___Dr. Triece Turnbull______________ 
Consultancy Area of work 
(*outside of 
normal work) 
Supporting 
evidence 
Changes 
Case study A systematic 
review on 
stress 
management, 
to be 
conducted for 
an externally-
based client 
(no further 
details 
available) 
Case study 
report (3000 
words)  
Evaluation form 
completed by 
client 
Workplace 
evaluation form 
 
Changed to: 
Setting:   The Tuke Institute 
(Dr Rupert Whitaker – 
Chairman) 
Description:   
A 3-part project for Dr. Rupert 
Whitaker, to understand the 
need for a mobile application 
to help with the management 
of long-term conditions. 
1) Scientific perspective:  
Review of existing 
health-related software 
2) Patient perspective:  To 
create some skeleton 
vignettes of patients 
who will use the mobile 
app, following 
interviews with people 
living with long-term 
conditions 
3) Business perspective:  
To write a business 
case on the 
effectiveness of health 
services, current costs 
of managing health 
conditions, 
demonstrate how a 
mobile app could 
reduce overall costs.  
Also, provide 
information on how to 
develop promotional 
material, e.g. videos. 
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APPENDIX III 
 
International Classification of Functioning, Disability and Health 
(ICF), and a review of health-related mobile applications 
 
The ICF 
The ICF is the framework employed by the World Health Organisation (WHO) to 
measure health and disability at both population and clinical level. It is an approach 
that was officially endorsed in 2001 by all 191 WHO member states (WHO 2016). 
 The introduction of the ICF led to a shift in the way that ‘health’ was generally 
conceptualised. While previously understood to mean a lack of pathological illness, 
there is encouragement to focus on a wide range of factors which may directly or 
indirectly impact upon health.  As well as any perceived changes within body 
structures, the ICF also places emphasis upon the body’s functionality, a person’s 
ability to participate and engage in various activities, and the impact of any 
environmental factors. The latter may include for example support and relationships, 
the attitudes of health professionals, and any health or legal services. In addition, 
there is still further scope to document further variables which may play a role in 
determining one’s state of health (Kostanjsek, 2011).   
To date, the ICF has been used in wide variety of health-related contexts, including 
for large population studies - such as the World Health Survey (2003), and to aid in 
the development of disability survey modules & questions for the EUROSTAT 
Survey Module on ‘Disability and Social Integration’ (WHS-Collaborating Group, 
2003). Examples of how the ICF may be used at clinical level include the ICF being 
used to appropriately assess a patient’s personal needs, planning the best health 
and social care solutions for them, and monitoring and measuring the impact of 
interventions.   
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Mobile applications within healthcare 
Mobile applications for smartphones are now frequently used within the field of 
healthcare. A systematic review conducted four years ago concluded that apps are 
frequently used amongst both health professionals and patients, and have the 
potential to play significant roles in both educating and helping patients so that they 
can effectively manage their own health, as well as enable health professionals to 
monitor patients away from a clinical setting (Mosa, Yoo & Sheets, 2012).Since 
2012, a number of new health-related mobile applications have been produced. 
However, the provision of health-related mobile applications is often unregulated, 
which raises grave concerns regarding their suitability for use (Boulos, Brewer, 
Karimkhani, Buller & Dellavalle, 2014).  It also suggests that the applications 
themselves may not follow the ICF framework. 
Review of new mobile applications for healthcare 
In order to investigate the suitability of mobile applications for healthcare, the Tuke 
Institute conducted a search for mobile applications currently available for 
download. Due to the very high volume of health-related applications available, a 
sample of 24 applications were downloaded to review. The applications were 
targeted towards those living with a range of long-term physical and mental health 
conditions, including HIV (2), chronic pain (3), cancer (3), diabetes (2), mental 
health disorders including depression, anxiety and schizophrenia (9). The remainder 
of the reviewed applications were designed for a range of disorders (5).  Of these, 
four applications, entitled ‘Medocity MD’, ‘Anxiety Psychopharmacology’, 
‘Schizophrenia Psychopharmacology’  and ‘Hearing Voices Version 1.4’ were 
intended for health professionals, rather than patients.  
All mobile applications were independently rated from 0 to 5 stars in terms of their 
features, usability and interface, and were also individually assessed alongside the 
ICF Checklist, Version 2.1a (WHO 2003). While the quality of the mobiles 
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applications within this sample was extremely varied, overall it was clear that mobile 
applications currently available do not demonstrate a clear understanding of the 
guidelines as set out by the ICF.  While approximately half of these mobile 
applications failed to address the potential impact of health conditions upon body 
functionality (ICF codes B1-B8) and the individual’s ability to engage and participate 
in activities separately (ICF codes D1-D9), approximately two thirds overlooked the 
potential impact of any environmental factors (ICF codes E1-E5) and any further 
contextual information (ICF 4.1 and 4.2). Out of all 24 applications, only one 
application entitled Beyou+ for HIV broadly appeared to cover all ICF categories. 
However, this application was only awarded 3 stars out of 5 due to other factors 
(e.g. overuse of text throughout, and a long introductory video).  
Measures used within applications and evidence of effectiveness 
Please note:  Eleven of the twenty four mobile applications did not take any clear 
measures for health monitoring, as they had been designed to provide basic 
information, or provide links to sources. Therefore, feedback on measures used 
within applications is only based on 13 applications. ‘Health Mapper Version 1.3.0’ 
monitored the extent of how symptoms were affecting an individual, using a three 
point scale:  None, Some, A Lot, whereas ‘iCancerHealth Version 1.6.4 / MedoCity 
MD: Healthcare and cancer management’ used a four-point verbal rating scale 
(VRS) to measure symptom severity:  No Issue, Minor, Moderate, and Severe. In 
addition, ‘Anxiety Psychopharmacology’ used the Generalised Anxiety Disorder 
scale (GAD-7) which monitors the frequency of anxiety over a two-week period. This 
particular standardised questionnaire uses seven statements, which are rated on a 
four-point scale:  Not At All, Several Days, More Than Half the Days, and Nearly 
Every Day (Spitzer, Kroenke, Williams & Lowe, 2006). The Patient Health 
Questionnaire (PHQ-9), employed within the ‘Start’ application for Depression, uses 
the same measure points - also over the past two weeks (Kroenke, Spitzer & 
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Williams, 2001). While the latter in particular is a frequently used questionnaire, a 
previous review has reported that smaller scales such as this (with two, three or 
even four points of measurement), are not robust in terms of their validity, 
discriminating power and reliability (Preston and Colman, 2000), which suggests 
that these chosen measures are unlikely to be the most effective. However, there is 
some supportive evidence behind other measures used within applications. ‘My 
Pain Diary: Chronic Pain and Symptoms Version 3.5.8’ and ‘Chronic Pain Tracker 
Lite Version 3.8.3’, both monitored symptom severity (e.g. pain) through scores 
ranging from 0 (no pain) to 10 (very severe pain) - known as the Numeric Rating 
Scale (NRS). The Abnormal Involuntary Movement Scale (AIMS), used within the 
‘Schizophrenia Pharmacology’ application, used a five-point scale to rate movement 
from None to Severe (Lane, Glazer, Hansen, Berman & Kramer, 1985).  This 11-
point scale and five-point scale respectively, have been demonstrated as popular - 
particularly the 11-point scale, as well as effective, and are still widely used 
(Bourdel, Alves, Pickering, Ramilo, Roman & Canis, 2015; Preston and Colman, 
2000).   
Two mobile applications allowed individuals to log their mood through the selection 
of certain such, as Bad, Happy, Relaxed, as in the case of Pacifica - used to 
measure anxiety, stress and depression. iCancerHealth Version 1.6.4 enables the 
user to select words such as Happy, Angry, Hopeful, Sad, Scared and Frustrated. 
 However in both these cases, it is unclear how the application proposes to clearly 
monitor the patient’s health over time. Within Pain Diary and Community Version 
3.5.6, a measurement of mood is taken over a scale of five facial expressions - 
however, this is only becomes available to the user following an additional payment. 
In two additional cases, mobile applications tracked physiological readings, such as 
HbA1c in the case of my Sugr Diabetes Diary Version 3.22.0, or CD4/viral count in 
the case of HIVPlus Treatment Guide, which enables patients to track these 
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readings over time.  However, these particular applications were generally focused 
on physiological health only.   
Interaction of patient and health professional through mobile applications 
Generally there was very little interaction between patients and health professionals 
through the mobile applications reviewed. In total 16 out of 24 did not offer any 
interaction between both parties. However, in four of these cases - iTriage-Health, 
Doctor, Symptoms Version 5.30, Your.md, Talklife Version 5.1.3 and Beyou+, 
information and/or links were given providing access to health professionals.  The 
remaining mobile applications that did provide a level of interaction, provided the 
option to produce weekly or monthly reports that could be either exported as a PDF 
file and sent via email, or produced and downloaded to show to health professionals 
during consultations. However, in most cases it was only possible to produce 
reports through upgrading the applications and paying an additional fee for them. 
Only the iCancerHealth Version 1.6.4 (for patients) / Medocity MD: Healthcare and 
cancer management Version 1.4.2 (for health professionals) appear to interact 
together and enable the patient to provide health professionals with real-time 
access to their following information:  private messages, medical summaries, health 
alerts, captured vital readings, calendar, custom resources, medications and 
nutrition.  Overall, it is clear from the review of applications that sharing information 
between patients and health professionals in real-time is not common. In addition, 
the ability to share health information through reports is generally is not a cost-
effective option on behalf of the patient. 
So how would a new mobile application help patients and healthcare 
professionals to manage health effectively? 
The mobile application does not view patient health as one-dimensional.  As 
demonstrated within the ICF, health can be far more complex, with a range of 
factors affecting patient’s general well-being. These factors can also impact on each 
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other, and therefore should also be addressed in order to provide patients with the 
best opportunity for complete recovery. 
Example:  Janice 
Janice is a married 52 year old, living with type-2 diabetes.  As well as the structural 
problem of the pancreas not providing insulin to control her blood sugar (S550), it 
has also incurred other problems in her life, including pain in the joints (B2/b28016), 
poor quality of vision (B2/b21029), inability to regulate her emotions (B1/b1521) and 
an inability to control her fat metabolism (B5/b5403), the latter two of which have led 
to a strained relationship with her husband (D7/d7701). She is also struggling to 
manage multiple tasks (including work) and look after her health properly 
(D5/d5708). Not being able to multitask and look after herself properly (particularly 
her poor eyesight) threatens to impact on her ability to work and thus earn her own 
money (D8/d8700).  The diagram below shows in more detail how the different 
factors within Janice’s life - physical, mental and social, are likely to impact on one 
other.  
 
By Janice entering this information into a mobile application (e.g. her pain 
symptoms and their severity, her moods, how she rates her relationships, her 
number of hours worked/ tasks completed), her GPs/nurse will be able to look at 
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produced reports from the mobile application which have highlighted trends 
between the flagged ICF codes. From here, GPs/nurses will have a better 
understanding of how much Janice’s life has been affected by her type-2 diabetes, 
and will be able to refer her to the appropriate healthcare professionals (e.g. an 
occupational therapist for problems related to work, a clinical psychologist for her 
depression).   By treating the individual elements in this way, Janice is likely to 
stand a better chance of getting well and staying well. This will also reduce the 
pressure on her GP/nurse, as they can then focus purely on medical matters only 
(e.g. Janice’s blood sugar levels) and ensuring that it stays within acceptable limits. 
What will happen with the data? 
As well as the data being produced for the GP/nurse, Janice’s data would be 
anonymised with permission and then combined with the data from other patients 
living with type-2 diabetes also using the mobile application.  The data collected 
over time from a database of patients living with type-2 diabetes will demonstrate 
any general changes in patient health over time following administration of the 
mobile application, and thus will eventually provide robust evidence of the 
application’s performance and effectiveness in managing patient health. 
Conclusion 
Overall, this review indicates an unmet need for a mobile application which not only 
is considered user-friendly, but also aims to address all key areas as indicated 
within the ICF checklist, with the ability to share health-related information between 
patients and health professionals without an incurred cost. Measures used within 
applications to monitor patient health should evidently be reliable, robust, 
ecologically valid and straightforward to use.  The Tuke Institute therefore proposes 
to produce a mobile application tailored to individual patients that follows the ICF 
guidelines using evidence-based measurements, to ensure that the application 
enables patients to accurately track their overall health through the application. The 
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patient would then easily be able to share this information with their GP/nurse.  
Once the application is successfully in place, we predict that the strain upon the 
NHS will be reduced as there will be less demand for regular face-to-face 
consultations. 
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APPENDIX IV 
Mobile applications for chronic health 
conditions 
Discussion guide - Revised 
 
Introduction 
 Thank you for your interest in taking part in this interview. 
 I am a doctoral student in Health Sciences at City University, conducting some 
research on behalf of the Tuke Institute, which is an independent  organisation 
aiming to create make health services work better for people who are ill 
 I am asking questions of people with chronic health conditions around their use 
of health-related apps. It takes about 30 minutes. 
 Is this something you’d be willing to help out with? 
 Do you have a health condition? (check inclusion criteria) 
 (If yes to health condition) What we are looking to understand is: 
1. Your experience of using mobile apps – particularly healthcare apps 
2. Understand about any apps you are using to help monitor your 
health, and what you like/ don’t like about the app 
3. What features you consider necessary/ unnecessary, in order to 
monitor your own health in a way that’s most helpful to you 
4. What other features you consider necessary/ unnecessary for mobile 
apps in general 
 I would like to audio-record our interview today. This is so that we can analyse 
your interview, and use the information you give us to help us build an 
description of what a typical person might want from their health app 
 I will keep your information confidential and anonymous, and you can skip any 
question you don’t want to answer or just finish the discussion whenever you 
want  
 Do you have any questions at this point? 
Section A:  Chronic condition 
 Would you mind telling us a little bit about you: your age, and what you do for a 
living, if anything? 
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 You have also indicated that you are living with a chronic health condition. 
Would you mind disclosing which condition you are currently living with? 
o When did you first get diagnosed with this condition? 
 What types of symptoms do you tend to get with your condition? 
 What problems did it cause you at first (search: physical, mental, social)? 
 What problems does it cause you now? 
 How do you monitor the changes over time? 
o How does monitoring the problems you have over time, help you to 
manage your own health? 
 How many times roughly over the last six months have you visited a healthcare 
professional (e.g. nurse/ GP/ Specialist, Physiotherapist, CBT therapist/ 
Counsellor) in order to review your condition? 
o (For each mentioned) Would it help to see them more or less often? 
Please explain. 
Section B:  Current usage of mobile applications (including healthcare) 
I would now like to ask you some questions about your use of mobile apps. 
 First of all, do you have a smartphone that you use regularly?  
o iPhone/iPad or Android? 
 (If yes to owning smartphone) How often do you use the apps on it, per day/per 
week? 
 Have you downloaded any mobile applications to keep track of your own health? 
o Which mobile applications for tracking your health have you 
downloaded? 
o How do they help you do what you want to do? 
 Is there one or two apps that you like to use to monitor your health? Which 
ones? 
o How often do you use this app/these apps? 
 What do you like about this app? 
 What do you not like about this app? 
 To what extent do you find the app helpful to you in terms of 
tracking your health? 
Section C:  Expectations for an effective mobile application 
I would now like to get your opinion on more specific features for tracking health. 
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 If you think back to how you track the effects that your health condition has on 
your physical, mental and social life, what would you ideally like an app to do in 
order to allow you to track your health in a way that’s really useful to you? 
(Probe on physical/psychological/social health and life) 
 When you want to tell the app how your health is, how do you like best to do 
that? (Wait for spontaneous responses, then probe) 
 How would you prefer to see your health tracking information displayed for you? 
(Wait for spontaneous responses, then probe) 
 Would you like/ not like to be able to share your health information through your 
smartphone with your GP/Consultant/other health professional? 
o (If yes) How would that help you? 
o How do you think that would help your health professional? 
o What else do you feel the app would need in order for you to use the 
mobile app in this way (if anything)? 
Section D:  Other mobile application features 
We understand that there are other features within apps that may/ may not also be 
important, so we would like to get your opinion on some we have thought of. 
 Would you like/ not like to be able to use the app to message or speak to others 
living with the same condition? Why? 
 What would you like to see first as you open up the app?  
o What would you like to see after that?  
o What would you not want to see? 
 What are your thoughts on other features (if not already discussed): 
o Font size 
o Colour 
o Language used 
o Size of the app 
o Use of different types of media (e.g. videos/ podcasts) 
 What are your thoughts regarding confidentiality/ security/ privacy (if not already 
discussed)? 
 If you had to pay for an app to be able to use it, what would you consider to be 
an acceptable cost (either one-off, or monthly/ annually)? 
 Anything else that is important re mobile apps that we haven’t already 
discussed? 
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Section E:  General healthcare 
I just want to ask a few final questions relating to healthcare in general.  
 How do you find accessing your healthcare? 
 How would you say communication is (of your health condition) between you 
and health professional(s)? 
 When you discuss your health with health professionals, what aspects of your 
health do they tend to cover? (Wait for spontaneous responses) 
o (e.g. your moods, social support, sex life, your job, housing situation etc.) 
 To what extent is this/are these discussed? Any actions taken by 
your health professional? 
Thank you for your time today. We hope to be able to use this information to get a 
better idea of what health app users really want from their apps, so that we can 
hopefully move forward with this in the future. You’ve been very helpful. 
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APPENDIX V 
 
Vignettes 
 
Vignette 1:  Janice 
Janice is a 52 year old lady who runs her own PA and transcription company. She is 
married to Bill, aged 56, and is currently living with Type 2 diabetes. Her main 
symptoms are poor eyesight, being overweight, having pain in her joints, poor sleep 
and depression. If her blood sugar goes too high or too low, she can start to feel 
dizzy. She currently tries to manage her blood sugar by injecting a daily dose of 
insulin, and by eating three regular meals a day.  She also tries to walk as much as 
she can in order to keep her weight down. She used to enjoy swimming, but her 
weight gain means that she now feels too embarrassed to go swimming. However, 
she struggles to walk long distances because of the pain in her joints, and struggles 
to eat a healthy, balanced diet due to having a sweet tooth. 
Day to day, Janice struggles to complete multiple tasks around the home and for 
work, and finds it difficult to plan her duties around her meal times and her 
injections. As she is self-conscious about having diabetes due to her perceived 
stigma of the condition and having to inject insulin, she always ensures that she is in 
a position to take her insulin on time. This sometimes means that she has avoids 
taking part in any social activities or communal activities that she is invited to. Being 
self-employed, she finds it perhaps easier to work around her injections and eating 
times. However, she still finds work difficult to manage as she feels that deadlines 
always have to take priority. She also worries that her eyesight may one day 
deteriorate so much that she can no longer work and be self-sufficient. 
As well as the above, Janice struggles to sleep through the night, and often feels 
quite fatigued. She also has a diagnosis of depression, which is likely to be linked 
with her poor sleep. She feels that her low moods are exacerbated by her weight 
gain and its impact on her relationship with her husband Bill, who is not only 
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resentful of how her regular eating patterns and injections have impacted on his life, 
but also does not understand the serious implications of diabetes. As a habitual 
drinker, he often encourages Janice to drink with him, which she feels compelled to 
do, despite its impact upon her blood sugar levels. Bill also struggles with her 
depression, and does not understand why she feels so low. Janice’s relationships 
with wider family have also been affected, as she has gradually withdrawn from 
many of them, as she does not want to discuss her diabetes, her low moods or how 
things are between her and her husband. 
She describes her current relationship with her GP as OK, but she has chosen not 
to see him lately as she is worried he may try to refer her for psychological help. 
Instead, she sends monthly blood sugar readings to the diabetes clinic, who then 
pass on this information to the GP. The diabetes clinic and her GP are therefore 
completely unaware of how Janice is, other than how stable her blood sugar 
readings are. 
Several months after the introduction of the mobile app, Janice is feeling much 
better. The app has enabled her to easily enter, and then effectively monitor over 
weeks and months her own blood sugar readings, her sleep and her exercise 
patterns, her relationships and her moods. This has highlighted to her the extent of 
her own problems, as she has finally realised how much of an impact her diabetes 
was having on her life. With all the information from the app being available to her 
GP in real time, the GP has also been able to identify the key problems for Janice 
and has a much better understanding of his patient. In addition, he has been able to 
get Janice the extra help that she needs by raising his concerns within 
multidisciplinary clinics and getting the appropriate health professionals involved in 
her care. Although Janice was not keen at first, after recognising the extent of her 
low moods through the app, she is now having sessions with a psychologist in order 
to treat her depression. Since she has started attending, she has noticed that she is 
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sleeping a bit better, which means that on a day to day basis, she feels much 
brighter and alert and able to focus on whatever she needs to get done that day.  
Her GP, having noticed that Janice’s relationship with her husband appeared 
strained, invited Janice and her husband in for a GP appointment where he was 
able to provide Bill with more information on diabetes and its implications. He was 
also able to discuss the effects of an unhealthy diet, as well as alcohol. Since then, 
Bill has been much more understanding about how Janice feels, and the importance 
of her having a healthy balanced diet. He has also actively reduced his own alcohol 
intake, which means that Janice has also been drinking less regularly. She has 
since noticed that she has lost a little bit of weight. All in all, Janice and Bill’s 
relationship is much improved, and they are both feeling happier at home. They 
have also started to see her brother’s family once a week, and speak to friends 
more regularly on the phone. Janice does not feel that she needs to see her GP 
regularly, but feels satisfied that her problems are being dealt with in the most 
effective way.  In addition, her GP is under less strain, as his primary focus now is 
monitoring her blood glucose levels, now that he knows she is doing well. 
 
Vignette 2:  Laura 
Laura is 26, and lives with her partner Stuart, aged 28, and their two young children. 
She works as an office manager, but is currently on maternity leave.  Laura has 
been living with fibromyalgia for about 9 years now, and was diagnosed 5 years 
ago. Her main physical problems are widespread pain and stiffness, fatigue and 
IBS, although she also has problems with her memory and concentration and rarely 
gets a good night’s sleep.  She is also depressed, and finds her condition hard to 
deal on a daily basis because there is no particular treatment for her.  To try and 
ease the pain she has, she just takes painkillers and tries to stay upbeat, particularly 
when around her children. She also runs a fibromyalgia support group to try and 
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help others living with it, which she finds very rewarding. However, fibromyalgia is 
affecting her own life more than she would like to admit. 
When Laura’s symptoms are really bad, she struggles to get out of bed and do 
simple things, like wash and dress herself. She knows that she has to do these 
things in order to care for her children when her partner is at work, so she tries to 
pace herself, but finds it hard - particularly on bad days. On these days, she cannot 
do things by herself, such as lift things, or walk to the shops with the baby buggy, 
because it can leave her feeling wiped out and in pain.  This puts more pressure on 
Stuart, as he worries a lot about her when he’s at work and often comes home to 
find that he has to do most of the chores. He has noticed lately that Laura puts 
much less effort into her appearance now, and they rarely make love because she 
is either in pain or too tired for it. Laura feels frustrated as she thinks that Stuart just 
does not understand fibromyalgia or how she is feeling. This is all starting to put a 
big strain on their relationship. 
Laura feels quite lonely, as she does not have the energy to see friends or other 
members of her family. She even feels that she has lost some of her friends 
recently, because she has had to cancel so many plans with them due to her not 
feeling well enough. The few friends she has left, she hardly ever speaks to them on 
the phone because she thinks they will probably ask her about how she is or how 
things are with Stuart, which she doesn’t want to talk about. She avoids talking to 
her dad on the phone as he does not really understand fibromyalgia, and has said 
before that the condition must be “all in her head”, which really upset her. 
Laura does not have a great relationship with her GP, as she gets annoyed with him 
trying to brush her off with different pills all the time to try and manage her pain. He 
does not question how things are, except for how much pain she’s in and whether or 
not she feels suicidal at the moment. She always says no because of her children, 
so her GP never asks any more questions about her feelings. However, at the 
moment she feels like she is barely holding things together, and dreads how things 
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will be when she has to go back to work. Before she left to have her baby, her 
employer would give her a hard time whenever she needed to call in sick, which is 
quite often. She worries that she will end up losing her job when she goes back, and 
that Laura and Stewart won’t have enough money to live on. 
Feeling desperate, Laura decides to look online to see what new options there are, 
and noticed that some GP surgeries are now offering patients the chance to use an 
app so that they and their GP can monitor their health better. She thinks this might 
be good for her, and calls her GP surgery who say that they are also trying out the 
app and that she should speak to the nurse who can give her more information and 
help her get set up. She makes an appointment with the nurse, who tells her that 
she can get the app herself by downloading it from the app store. The nurse then 
gives her some instructions of how to use the app and what it can do.  When Laura 
gets home, she downloads the app and is asked straight away by it what her main 
health problem is. She speaks into it and says ‘fibromyalgia’, and after that she is 
able to enter what her main symptoms are, when she has them, how she’s feeling, 
as well as how relationships are and her social life. She finds being able to speak 
into the app handy, as typing can trigger pain in her fingers. She also likes the fact 
that she can just pick up her phone anytime, anywhere, and discreetly enter this 
information at any time. She likes the idea that after a couple of weeks, she can see 
herself how much the fibromyalgia is really affecting her, and then share this 
information with the nurse by downloading reports from the last week or month. 
One month later. Laura comes back to see the nurse, who then looks at all the 
trends in her information. The nurse talks to her about how the symptoms are 
affecting her life, and asks her what she would like to change. They then put 
together a plan over the next six months, which includes treatment for people with 
fibromyalgia and their partners run by a nurse and a psychologist. This is to help 
Laura manage her symptoms, and to help Stuart understand the condition better. 
Laura is also invited to see the psychologist on her own, to talk about her 
 324 
 
symptoms, the strains on her relationships, her feelings of depression, and for tips 
on how to improve her sleep. The nurse also makes an appointment for her with an 
occupational therapist, which helps Laura prepare to go back to work. 
After six months, Laura is feeling better, which she can see through the app itself. 
She is now on a lower dose of antidepressant and is now back at work after her 
maternity leave. Her return to work was not as difficult as she thought it might be, as 
she felt better prepared after seeing the occupational therapist. Things between her 
and Stuart are gradually improving, as he now understands fibromyalgia and how 
hard it has been for her to manage. As Laura is feeling happier in herself, she is 
starting to take more pride in how she looks, and her sex life with Stuart is starting 
to improve. She has also started to build on friendships with colleagues, and feels 
like she now has some sort of social life. She still struggles to see others outside of 
work, but this is more due to her lack of time. Her relationship with her dad is also 
improving, and she now tries to call him once a week to talk. She often talks about 
the app with him.  As well as the app improving her own life, Laura is proudly letting 
her own anonymised data be used to show how well the app is helping GPs/nurses 
to manage their patients’ health. 
 
Vignette 3:  Paul 
Paul is 36, and is married with three young daughters. He was told he has ulcerative 
colitis two years ago. He gets bad stomach pain, diarrhoea, and cramping, and 
since his diagnosis, he has also been diagnosed with depression and anxiety, as he 
worries a lot that he could have bowel cancer. He is also often very tired during the 
day as he often lies awake until the early hours worrying about this.  The 
medications he was told to take by the gastroenterologist for his stomach often 
make him feel drowsy, so he does not always take them as regularly as he should. 
He finds that the only way he can control his symptoms a bit is by avoiding some of 
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his favourite foods and by not doing too much, although as someone who used to 
love spicy food and used to be out and about all the time, this does get him down a 
lot. 
Since having his diagnosis, he has found that his life has changed in many ways. 
He used to have a busy office job with a long commute, but this was becoming too 
much for him and was making his symptoms worse. For the last 18 months, he has 
been working locally as a park ranger doing 20 hours a week. While he knows that 
this is better for his health at the moment, he feels guilty because his wife has since 
had to start working full time in order to make sure they have enough money to get 
by. He feels that his wife may resent him for this, as she now has to juggle her full 
time job with caring for their three children, as well as look after him when he is 
unwell. While his wife is sympathetic to how she thinks he must be feeling, she gets 
frustrated that he won’t talk to her about it and spends so much time on his own in 
the computer room. His inability to open up to her is putting a strain on them as a 
couple. Paul’s relationship with his children is becoming distant as well, as he does 
not feel he can take them out anymore because of his embarrassing symptoms. He 
also wants to protect them from his low moods. Overall he feels that he is failing his 
children, but they are too young to understand why their dad spends less time with 
them than he used to, which is making them upset.  
Paul’s social life has also changed since he was told he had ulcerative colitis. He 
often used to go out on Friday nights with his friends to the pub for a pint and then a 
curry. He cannot drink beer anymore or eat curry because this affects his stomach 
too much, and so he does not go out with them on Friday nights anymore. He is too 
embarrassed to talk about the symptoms he has with these friends, which has 
meant that they did not understand why he would suddenly keep turning down 
invitations to come out.  Paul has since lost touch with most of the people he used 
to see locally. He still speaks to his mum on the phone, but does not go to see her 
as it is a long drive away and he worries about what he would do if he suddenly 
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needed the toilet in the middle of the journey.  He does find talking to his mum 
upsetting though, as his mum now knows about his health problems as his wife told 
her all about them. His mum just wants him to talk to her about it and whenever they 
speak, she asks about it but he just tells her everything is fine. He does this 
because he does not want to hurt her, but he hates lying to her.  
One day, Paul’s wife sits him down and tells him just how much of a strain this is 
putting on the whole family and how unhappy she is. She finally convinces him to go 
to see his GP that week, and offers to go with him so that they can do something 
about it. While they are in the waiting room at the surgery, they notice a flyer for a 
new app that has been designed for people with long-term health problems.  Paul 
has always been interested in technology, and when they are with the GP they ask 
him about it. The GP explains that they could use it to monitor different aspects of 
health and share the information with the surgery. He tells Paul to look for the app 
on Google Play, download it and then make an appointment with the nurse at the 
surgery, who would tell him how it works. The following week, they come back to 
see the nurse, who tells him that he can either speak or type information into the 
app about his symptoms and how severe they are, his weight, possible triggers - 
including food and drink and activities, his moods, how he feels his relationships 
are, whether or not he has made it into work or had to call in sick. She tells him he 
can also set medication reminders, to help him take his medication on time. She 
tells him that he can enter all of this information in for a month, then download 
everything he has entered in over that past month into a report and come back to 
see her with it. Feeling intrigued and encouraged by his wife, he gives it a go. 
One month later, Paul returns with his report. From this, the nurse was able to see 
that his depression and anxiety was having a big effect on him in different areas of 
his life.  Paul was sent to a clinical psychologist, who talked to him about his 
feelings of depression and anxiety. She also gave him a sleep chart, and taught him 
some meditation techniques to cope in times he felt most stressed.  Going with his 
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wife to see the psychologist helped, as they were able to deal with his problems as 
a couple.  He was also made an appointment with a Health Psychologist, who 
talked to him about why he was not taking his medication as he was supposed to, 
and helped him to understand the importance of managing his Ulcerative Colitis. 
She also talked to him about healthy food options, and gave him tips on foods to 
avoid.  Paul was also referred for relationship counselling so that he could work on 
mending his relationship, and also to an occupational therapist, who talked to him 
about how to manage his work life with his condition. 
Six months on, Paul is feeling much better in himself. He is sleeping better, and 
feels less anxious about things, which seems to have helped him with his symptoms 
as well. He has come to terms with the fact that final tests have already ruled out 
bowel cancer, but understands that he needs to look after himself, even if this does 
mean cutting out certain foods and beer.  His relationship with his wife has improved 
as they have gone through this journey together, and their sex life is better than it 
was a few months ago too. He now speaks to his mum and tells her the truth about 
how he is, and as he now has more control over his symptoms, he has told her that 
he hopes to come and visit her one weekend with the children. As he is feeling 
better, he also plans to get back in touch with some of his old friends, and suggest 
going for a non-alcoholic drink instead. When he is at home, he is now helping out 
more and spending more time with his children, either watching TV or playing 
games.  All in all, he feels much happier in his life, and thankful that the app has 
been such a big help to him and his family. 
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APPENDIX VI 
Health Status Assessment Project 
Business Perspective 
 
Executive summary 
There is evidence that the National Health Service (NHS) is currently unable to 
perform to the level required, particularly for patients with long-term conditions who 
are dissatisfied with the care and support they received. However, the demand for 
improvements within NHS healthcare is not being matched by an increasing 
provision of NHS healthcare funding, which looks set to continue. For patients to 
have the best outcomes possible, it is important that as well as physical health, 
other factors are taken into account, e.g. mental health, relationships with partners, 
friends and family, work and financial security, and environmental conditions. 
Currently, however, is difficult for GPs/nurses to gather this level of information, due 
to time constraints. The implications of this are that patients will continue to have 
poor health outcomes. Our recommendation is to introduce a new mobile 
application, which enables patients to enter data on health-related factors, as 
outlined above. This information can be integrated within the app and downloaded 
or shared in a report for health professionals (e.g. GPs), who will be able to view 
how factors are impacting upon one another, and their patient’s health. Outstanding 
problems will be flagged within multidisciplinary teams, with patients directed 
towards the appropriate professionals in order to ensure they receive the help they 
need. Not only would this improve health outcomes for patients, it would also help 
healthcare professionals to ensure that their patients receive the care they need in 
order to get well and stay well. 
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Finance 
Whole costs analysis / Cost Benefits Analysis 
A whole cost analysis enables us to fully understand the true total costs and 
benefits of a particular intervention or programme, in order to work out the true 
value of an intervention or scheme. While it can be understood to be purely in 
financial terms when comparing costs with benefits, in this case the benefits can be 
in terms of patient health. Currently, there is no such tool which accounts for the 
benefits of patient health against financial cost.  However, dividing the costs by the 
benefits shown in patient health, will likely demonstrate a more accurate return of 
investment (Mind Tools Ltd, 2016). To demonstrate how a whole costs analysis 
would work in this case, the mobile app would provide output data for analysis at 
baseline and then again later (e.g. six months after the launch of the mobile 
application). The data from the two time points may then be compared, as explained 
below. 
Example of how whole costs analysis / cost benefit analysis could work in 
healthcare 
1. At baseline, we can assume baseline healthcare costs to be at 100%. 
However, patients may only be on average at 25% of their optimal health.   
2. In order to improve patient health, there requires further financial investment 
in order to address psychological and social factors (which also are likely to 
be impacting on a patient’s health). This may elevate the financial cost up to 
150% (i.e. 50% more per patient). However, patient health may increase to 
75%, thus demonstrating health to be at 300% (if assuming their health to be 
at 100% at baseline of what was possible with previous resources available). 
Return of investment could then be calculated by dividing cost of 150%, by 300%. 
 This therefore calculates a return of investment of 50%, showing that the mobile 
application overall will be beneficial. 
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Introduction and overview 
The National Health Service (NHS), founded in 1948, aims to provide free 
healthcare for all UK residents. Currently there is a population of 64.6 million in the 
UK, and 54.3 million in England (NHS Choices, 2016). The NHS has been 
favourably compared with the health systems of other nations (including the USA, 
New Zealand, Canada, Australia, Norway, Sweden, France, Germany, the 
Netherlands and Switzerland), ranking first in terms of patient-centred care, effective 
and safety care, coordinated services and cost-related problems. It has also been 
ranked second for equity.  
On the surface, the NHS also appears cost-effective with only 9.78% spent per GDP 
in 2015, in comparison with the USA’s expenditure of almost 17% (NHS 
Confederation, 2016).  However, in comparison with other nations, the NHS is faring 
relatively poorly, in terms of long-term patient outcomes. Within a recent patient 
survey, only 56% of patients reported that they had felt involved in their own 
healthcare decisions, only 70 per cent felt that health professionals had listened to 
them, and only 65% of patients rating mental health services awarded it a 7 out of 
10 or above. In addition, only 67.4% gave a high rating for their GP out-of-hours 
service (NHS England, 2016). Patients with long-term conditions are particularly 
badly affected. Following a survey with cancer patients, only 63% reported that they 
felt they were adequately supported by local health services in order to manage 
their condition effectively, only 54% felt they were properly informed of what to 
expect from treatment, and only 52% had identified a member of staff that they felt 
they could discuss their concerns with. Following treatment, only 45% of patients 
reported that they felt that health services had continued to support them where 
necessary, e.g. through community nursing and informing them of important 
matters, e.g. which benefits they are eligible to claim (Quality Health Limited, 2016).  
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Not only is it important to manage long-term conditions from a moral perspective, it 
makes sense to effectively manage long-term conditions from a financial 
perspective.  Long-term conditions currently account for approximately 55% of GP 
appointments, 68% of outpatient appointments and 77% of in-patient stays, and 
make up an estimated 70% of NHS expenditure in England (House of Commons 
Health Committee, 2014). The British Medical Association (BMA, 2016) grimly 
estimates that there will be up to a £30 billion a year deficit up until 2020/2021 
between what patients require and what resources are actually available.  The 
demand for improvement of NHS healthcare in order to improve patient outcomes is 
not being matched with an increasing provision of NHS funding (House of 
Commons Health Committee, 2014). Therefore, quality of care is unlikely to improve 
unless there are fundamental changes in the way that healthcare is managed. 
In order to improve patient health, health-care services need to focus not only on 
physical health, but also additional factors. This includes mental health conditions, 
which often precede or follow physical health conditions (Prince, Patel, Saxena, 
Maj, Maselko, Phillips et al., 2007).  A failure to address existing mental health 
issues can increase the risk of those living with long-term physical health conditions 
(The King’s Fund; Centre for Mental Health, 2012).  To further the argument of not 
why health should not only be considered only in its physical form, a national debate 
involving 175 events across the UK with 7,250 people, demonstrated that health is 
also influenced by relationships with partners, friends and family, satisfaction and 
security in terms of work and finance, and present and future environmental 
conditions (Office for National Statistics, 2011). This validates the utilisation of the 
Integrated Classification of Funding Disability and Health (ICF) as a measure of 
well-being within the UK, as it successfully integrates these factors (World Health 
Organization, 2016). 
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Cummings, O’Donohue and Cummings (2009) argued that a poor understanding of 
economics and a failure to integrate behavioural interventions as a legitimate 
standard of healthcare, rather than psychosocial care, provides an explanation for 
why many patients may continue to experience poor health.  However, while a 
multidisciplinary approach (combined health and social care) is likely to improve 
patient care, it does not necessarily overcome the challenge of balancing demands 
for healthcare with available funding. One potential option is to integrate technology, 
to make integrated healthcare simpler. Increasingly mobile applications are being 
used within the field of healthcare, and a systematic review in 2015 of 24 trials 
concluded that mobile applications are well received by those using smartphones. 
The review also concluded that mobile applications are somewhat effective in the 
delivery of health interventions (Payne, Lister, West & Bernhardt, 2015), which 
indicates that it is safe to take the next step and integrate mobile applications into 
the NHS.  
In order for patient well-being to be appropriately addressed within an application, 
the Tuke Institute proposes that the International Classification of Funding Disability 
and Health (ICF), as outlined by the World Health Organization (WHO 2016), should 
be incorporated successfully within a mobile application to optimise its efficacy in 
managing patient health. 
Business objectives 
What is the goal of this project? 
The primary long-term goal is to successfully improve patient health outcomes, 
particularly in patients living with long-term conditions.  A secondary goal is to 
effectively reduce NHS healthcare costs. 
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What is needed to achieve this? 
This project proposes to introduce a new mobile application that patients will be able 
to use and enter all their own health-related data into. This information will be 
integrated, and patients will be able to share the information with their GP/nurse 
who will analyse it. From here, the GP/nurse will be able to identify the main 
problems of that patient, and be able to refer them to the appropriate healthcare 
professionals, e.g. physiotherapists, psychologists, occupational therapists, or social 
workers.  
How will the project support business strategy? 
The mobile application will make it easier for GPs/nurses to identify the main 
problems of the patient, and then refer patients to healthcare professionals who will 
focus specifically on those key problems.  By targeting problems that may be 
contributing to health, patients are likely to have improved health outcomes and 
fewer NHS appointments in the future. Fewer appointments, hospital in-stays and 
medications mean that potentially there would be significant reduction in terms of 
NHS cost for these patients. 
Benefits and limitations 
The potential benefits that this project could bring are as follows: 
 Allowing patients to have ownership over their own healthcare, by allowing 
them to observe their own healthcare trends over weeks/ months. This will 
enable them to feel as though they are taking ownership of their own health. 
 By enabling patients to share health-related information discreetly with their 
GP/nurse - either by downloading a health report to show or by sharing data 
in real time 
 GP/nurse will be able to observe which factors may be impacting upon their 
health, and will be able to address them more effectively, e.g. by referring to 
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a clinical psychologist (if patient is demonstrating signs of poor mental 
health), to an occupational therapist if they are struggling at work, or a to a 
physiotherapist if they are unable physically function. 
If patient health is managed more effectively, this should reduce the number of 
appointments made, due to improved patient health outcomes.  
GPs will be able to identify problems and refer the patient to the appropriate health 
professionals, which should reduce the stress placed on them as they only need to 
focus themselves on managing the physical symptoms or biomarkers (e.g. blood 
sugar or in the case of diabetes).  
The potential limitations are as follows: 
 The mobile application may not be easy for all to use at first, and training is 
likely to be required for staff and potentially patients as well. 
 The mobile application will need to be regularly maintained - particularly as 
so many could potentially use the mobile application. 
 The mobile application is intended to be free for patients to use. This means 
that it will incur an NHS charge. However, the money saved in terms of NHS 
appointments is anticipated to far outweigh the cost of the mobile 
application. 
 Not all patients with long-term conditions are familiar with smartphones and 
mobile applications, and these patients could potentially be accidentally 
discriminated against. 
Option identification and selection 
1. To introduce a new mobile application for patients to use, in order to track 
their own health, and show to GP/nurse who will assess the data and then 
refer patients on any necessary healthcare professionals. 
2. To continue as normal without the introduction of a mobile application. 
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The mobile application option has been selected, as smartphones are now regularly 
used, as are mobile applications, and previous data has shown that they can work 
well within healthcare. 
Scope, impact and interdependencies 
[To be completed by Dr Whitaker, as agreed] 
Outline plan 
Here is an approximate timeline of the project from January 2017.  
 
Dr Rupert Whitaker will be the primary contact, and will be responsible for the 
smooth running of the project. He will be in regular contact with skilled engineers/ 
designers who will help with the development of the mobile application itself and 
testing. 
Market Assessment 
In order to conduct a thorough market assessment, a PESTLE analysis has been 
used. 
Political factors 
 Not all NHS patients are currently smartphone or mobile application users, 
which may introduce inequality within the NHS population. 
 The uncertainty of the longevity of NHS as it stands, means that there is the 
mobile application may not be available long-term.  This would mean that 
there would be no funding for the maintenance of the mobile application. 
 This could potentially lead to a cost for the patients. 
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Economic factors 
 Potential loss of funding from the sponsor/NHS. This would potentially mean 
that patients would have to pay for the mobile application themselves to be 
able to use it. 
Sociological factors 
 Not all NHS patients will regularly use smartphones or mobile applications, 
and therefore may be unlikely to use mobile applications.  Some 
populations, e.g. the elderly, may be particularly hard to reach. 
 There may be ethical concerns regarding the sharing (particularly in real-
time) of patient information through an application. 
 It may be challenging for NHS patients to buy into the idea of using a mobile 
application to empower them in terms of managing their own health, before 
sharing the information with healthcare professionals. 
 May be difficult to monitor how accurate the data is that patients 
enter into the application (particularly if they are embarrassed about 
relationships, working life, etc.) 
Technological factors  
 Rival mobile applications could be introduced, or existing mobile applications 
could be adapted, leading to reduced uptake of the application and a 
reduction in market share. 
 As it is a complicated mobile application, designed to manage the complexity 
of patient health, the application is likely to be very challenging to design and 
manufacture.  Constant maintenance is required, particularly in the early 
stages, in order to optimise the usability of the application. 
 There is the risk of mobile applications operated within the NHS being 
victimised by cyber criminals, which means that confidential patient health 
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data could be leaked. Therefore, the application needs to be extremely 
secure with data encrypted 
Legal factors 
 As the mobile application is looking to be used with the NHS, and handle 
patient health data, there will be legal implications with regards to the patient 
data and insurance. 
Environmental factors 
 The mobile application could be blamed for patients not attending face-to-
face appointments with GPs/nurses when necessary, as patients may feel 
that appointments are not required as well. This could create tension.  
 Uncertainty regarding what would happen should patients lose or damage 
their smartphone - will they be able to access their previous data on a new 
phone? 
Review of existing mobile applications 
In order to investigate the suitability of mobile applications for healthcare, the Tuke 
Institute conducted a search for mobile applications currently available for 
download. 24 were reviewed, and all were individually assessed alongside the ICF 
Checklist, Version 2.1a (WHO 2003). Overall it was clear that mobile applications 
currently available do not demonstrate a clear understanding of guidelines to 
effectively managing patient health, as set out by the ICF.  Out of all 24 applications, 
only one entitled Beyou+ for HIV broadly appeared to cover all ICF categories. 
Further to this, eleven of the twenty four mobile applications assessed did not use 
any measures at all for health monitoring, as they had only been designed to 
provide basic information, or provide links to sources.  Generally there was little 
interaction between patients and health professionals through mobile applications, 
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and in cases where patients were able to download and send their health data, it 
was not free for patients.  
Qualitative interviews 
Six qualitative interviews were also conducted independently by the Tuke Institute, 
with patients living with fibromyalgia, type-2 diabetes, chronic migraine, ulcerative 
colitis, hypothyroidism and chronic fatigue syndrome (CFS). Patients were 
questioned on how they currently used mobile applications to monitor health (if at 
all), and how they would prefer to enter health-related information and have it 
displayed. They were also questioned on their preferences in terms of what the 
application would allow them to do, and how to communicate their information to the 
GP/nurse. These interviews allowed for vignettes to be created, to demonstrate in 
advance how the mobile application may work for a patient, and what benefits they 
would likely experience. 
Risk Assessment  
What are the risks? 
The biggest risk is the risk of the mobile application being hacked and patient data 
being leaked. 
What are the consequences of a risk happening? 
Leaked patient data would mean that sensitive information would be available within 
the public domain. 
What opportunities may emerge? 
Identifying potential risk earlier means that there is the opportunity to design and 
create a safe and secure mobile application, which cyber criminals are unable to 
hack into. 
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What plans are in place to manage the risk? 
Highly qualified engineers would be employed in order to ensure that all sensitive 
data is encrypted and secure. 
Project Approach 
Dr Rupert Whitaker, Chairman of the Tuke Institute, will be the main contact for this 
project. He will liaise with the appropriate legal representatives, contractors and 
engineers in order to develop the mobile application, and prepare it for launch. 
Purchasing Strategy 
[To be completed by Dr Whitaker as agreed] 
Recommendations 
[To be completed by Dr Whitaker as agreed] 
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3B:    Behaviour Change Intervention: 
Cognitive Behaviour Therapy Leaflet for Fibromyalgia 
 
3B.1.    What are Behaviour Change Interventions (BCIs) and why are they 
necessary? 
Behaviour Change Interventions (BCIs) are designed as a way to encourage 
individuals or groups to alter their behaviour patterns in order to improve their health 
(Michie, van Stralen & West, 2011). BCIs may be used within the context of multiple 
health behaviours, including reducing alcohol consumption (Michie, Whittington, 
Hamoudi, Zarnani, Tober & et al., 2012), smoking cessation (Bartlett, Sheeran & 
Hawley, 2014) and increasing physical activity (Foster, Hillsdon, Thorogood, Kaur & 
Wedatilake, 2005), and can be executed at individual, community and policy level 
(National Institute for Health and Care Excellence, 2017).   
The Behaviour Change Wheel, designed by Michie et al., (2011) following 
their review of nineteen behaviour change frameworks, is comprised of three levels. 
At the core lies the COM-B model, which states that in order to ensure an 
intervention can be effective, the target subject or group must be ‘Capable’ at a 
psychological and physical level of making behaviour changes, must have the 
‘Opportunity’, and must have the ‘Motivation’. At the next level, the wheel embodies 
nine separate Behaviour Change Techniques (BCTs) including Training, Education 
and Enablement. These can be selected based on what may be considered the 
most effective approach for the target audience. The outer level of the wheel 
contains seven distinct policy categories including Guidelines, Legislation and 
Communication/Marketing, thus demonstrating the various ways that BCTs can be 
disseminated to a wider group.  Altogether, the Behaviour Change Wheel provides a 
useful guide of what to consider when designing interventions, including the 
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identification of any potential facilitators and barriers, whilst highlighting the range of 
techniques available (Smits, McCutchan, Wood, Edwards, Lewis et al., 2016). 
 
3B.2:   Designing and implementing interventions to change health-related 
behaviours 
Fibromyalgia is a long-term condition primarily characterised by widespread 
pain and fatigue. Other symptoms may include IBS, stiffness in the muscles, 
headaches, disturbed sleep and brain fog (NHS Choices, 2016). Although not 
widely known, it is thought to be a common ailment affecting as many as much as 
5% of the population. The causes for fibromyalgia are unclear, but triggers are 
thought to be viral infections, operations, and traumatic physical and/or emotional 
life events (Arthritis Research UK, 2016). 
There is currently no cure for fibromyalgia, and current treatments such as 
painkillers, anti-depressants, sleeping tablets, muscle relaxants, antipsychotics and 
anticonvulsants (NHS Choices, 2016), are often not effective due to the complexity 
of the symptoms. These medications often also have side-effects (Hawkins, 2013). 
Evidence suggests that non-pharmacological treatments, such as CBT, can be 
effective in helping fibromyalgia patients to manage their own symptoms. A 
systematic review by Bernardy, Klose, Busch, Choy and Hauser (2013) of 23 RCTs 
reported a definite improvement in terms of symptom severity, mood and functioning 
following CBT treatment for fibromyalgia. However, face-to-face CBT generally has 
a considerable drop-out rate of 26.2%, mostly attributed to the type of environment 
and the number of CBT sessions (Fernandez, Salem, Swift & Ramtahel, 2015). This 
would suggest face-to-face CBT may not always be suitable. Written self-help has 
been shown to be just as effective (Anderson, Lewis, Araya, Elgie, Harrison et al., 
2005; Perkins, Murphy, Schmidt & Williams, 2006), and in 2010 Fibromyalgia Action 
UK (FMA UK) produced a comprehensive booklet on how to manage the symptoms 
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(Fibromyalgia Action UK, 2016). According to guidelines set by NICE (2012), 
treatment needs to be accessible and tailored in order to be effective. As 
fibromyalgia often causes brain fog and memory problems (NHS Choices, 2016), it 
is feasible that a detailed booklet would contain too much information, and succinct 
leaflets may be more suitable. However, the usability of a leaflet needs to be 
investigated further. 
The initial idea for this intervention was to provide fibromyalgia sufferers with 
just enough information to improve their health literacy and increase self-efficacy by 
empowering them to manage their own symptoms (Bandura, 1977). Self-efficacy 
has been demonstrated to be a good indicator of behaviour change (Bandura & 
Adams, 1977). A recent meta-analysis of 204 studies demonstrated self-efficacy to 
have a moderate effect size overall on behavioural intention, and at least a small to 
moderate effect size on actual behaviour change (Sheeran, Maki, Montanaro, 
Avishai-Yitshak & Bryan, 2016). A successful leaflet intervention delivered on a 
wider scale could eventually lead to positive financial implications for the NHS, due 
to a reduction in the number of consultations with GPs and referrals to secondary 
care. Currently, it is estimated that the annual cost of PPS including fibromyalgia 
exceeds £3 billion (Chitnis, Dowrick, Byng, Turner & Shiers, 2011). 
Due to the existing evidence base for CBT I developed a CBT leaflet and 
tested it with a small sample of the fibromyalgia population over several weeks. In 
order to help produce the leaflet, a recent booklet currently being tested with 
patients as part of the PRINCE Cognitive Behaviour Therapy trial (a clinical trial for 
patients living with PPS, of which I am currently a member of the research team for), 
was modified and adapted into a concise leaflet format. The primary outcome was 
work and social functioning, and secondary outcomes were symptom severity and 
mood (depression and anxiety). In order to achieve this, instructions were provided 
on how to increase physical activity, improve sleep hygiene, and improve eating and 
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breathing behaviours. All of these have been shown within previous studies to have 
a direct effect on functioning, symptom severity and mood. Busch, Schachter, 
Overend, Peloso and Barber (2008) for example conducted a systematic review 
investigating the effects of exercise on physical functioning and symptoms in those 
with fibromyalgia. A meta-analysis of six studies provided good evidence that 
moderate exercise improves functioning and overall well-being. Another study by El-
Salhy, Lillebø, Reinemo, Salmelid and Hausken (2010) which introduced a health 
programme consisting of exercise, eating behaviours and reassurance for IBS 
sufferers, reported significant long-term improvements in symptom severity and 
quality of life. Busch, Magerl, Kem, Haas, Hajak et al., (2012) also demonstrated 
significant improvements in pain threshold and mood following deep and slow 
breathing (DSB) intervention for chronic pain syndrome, while Martinez, Miró, 
Sánchez, Diaz-Piedra, Cáliz et al., (2014) reported sleep hygiene treatment to 
significantly improve quality of sleep. Although these behaviours were not measured 
directly within this intervention, the impact of the behaviour changes was observed 
through changes to work and social functioning, symptom severity and mood.  
As well as the behaviour changes and information on the CBT model, this 
leaflet employed established BCTs such as Training, to provide information and tips 
on how to make these behaviour changes. Secondly, the leaflet employed 
Education by providing factual information on fibromyalgia, including the types of 
symptoms experienced and its prevalence, in order to increase their understanding 
of the condition. Finally, the leaflet used Enablement by providing information on 
where to seek out further information and/or support (Michie et al., 2011). Previous 
interventions using these BCTs provide evidence of their effectiveness in reducing 
symptom severity and disability. Cedraschi, Desmoules, Rapiti, Baumgartner, 
Cohen et al., (2004) for example, conducted an RCT to demonstrate the efficacy of 
an educational six-week self-management programme for fibromyalgia. Outcomes 
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at six months were significantly more positive in terms of functioning and quality of 
life for those receiving the treatment. In addition, a past review of various coping 
skills training for fibromyalgia, including relaxation techniques, pacing and physical 
activity, has demonstrated training to be effective in reducing symptom severity and 
disability (Sandstrom & Keefe, 1998). 
For a clear explanation of the intervention including outputs, outcomes and 
eventual impact of the CBT-based intervention, please see the logic model below. 
 
Figure 3B1. Logic model for CBT-based leaflet for fibromyalgia 
 
An evaluation model for health promotion was considered and followed 
when designing this intervention. ‘An Outcome Model for Health Promotion’ by 
Nutbeam (1998), stressed the importance of improving and measuring ‘Health and 
Social Outcomes’ – such as day-to-day functioning, symptom severity and mood. 
‘Intermediate Health Outcomes’ (e.g. healthy lifestyle changes) were covered 
through the introduction of various symptom management techniques including 
physical activity, improved sleep hygiene and improved eating and breathing 
behaviours. As stated previously, their effects upon work and social functioning, 
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symptom severity and mood were monitored. ‘Health Promotion Outcomes’ 
including health literacy was targeted through the provision of factual information 
about fibromyalgia and the introduction of the CBT model. Finally, ‘Health Promotion 
Actions’ was also covered through the introduction of the CBT model and the 
introduced behaviour changes.  
 
3B.3.  Providing expert opinion and advice based on the existing evidence, 
and directing the implementation of the intervention 
My initial action was to contact the Director of the organisation Fibromyalgia 
Awareness UK, to discuss potentially producing the leaflet for individuals living with 
fibromyalgia based on the existing evidence for CBT and behaviour changes using 
BCTs, and to also conduct a brief needs assessment. It was agreed that this CBT-
based leaflet with recommended behaviour changes was suitable and that there 
was a need for this type of intervention, particularly for newly diagnosed patients. I 
was then granted permission via email to attend their support groups and invite their 
members to participate within this leaflet intervention. 
Following the production of all necessary written materials including the 
Information Sheet (Appendix II), Consent form (Appendix III), Debrief sheet 
(Appendix IV) and the leaflet  itself (Appendix V), the documents were checked by 
my workplace supervisor before being submitted within my study application to the 
King’s College London Ethics Committee. Within my application, I stated that I 
would be assessing the impact of the leaflet using standardised questionnaires only 
including the PHQ-9 (Kroenke & Spitzer, 2002), PHQ-15 (Kroenke, Spitzer & 
Williams, 2002), WSAS (Mundt, Marks, Shear & Greist, 2002) and the GAD-7 
(Spitzer, Kroenke, Williams & Löwe, 2006). Please see Appendices VI to IX for 
these questionnaires. Permission was also sought from the corresponding author to 
use the WSAS, and evidence of this was provided. The full application was 
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submitted on Friday 28th October, and a letter of approval was received on Friday 
25th November. At this point I got back in contact with the Director of Fibromyalgia 
Awareness UK, who put me in contact with the support group leaders for Wickford 
Essex and Ealing.  
I attended the Dulwich support group on Tuesday 17th January. Following a 
brief introduction of my job role and my academic background, I discussed the 
purpose of testing this leaflet and provided information on the leaflet itself. In 
general, this involved discussing the use of health psychology principles, such as 
BCTs, and the importance of behaviour change and how these could impact upon 
health. In order to illustrate this further, the CBT model was introduced within this 
context. It was also important to establish within the first meeting the level of interest 
and perceived relevance to support group members, and address any queries. 
Those who expressed interest were provided with prepared packs of information, 
containing a short instruction page, an information sheet, a consent form, the leaflet 
itself, the baseline questionnaire set and two prepaid envelopes so that the consent 
form and questionnaires could be posted back separately. While it was 
acknowledged that postal response rates were likely to be poor and that completing 
forms during the support groups would have ensured a higher response rate, this 
could not be conducted, for two reasons. Firstly, they would have been unable to 
read the information sheet and consent form thoroughly before agreeing to 
participate, and secondly, reading and completing the forms would have been too 
disruptive for the meeting. Prospective participants were instructed that in order to 
take part, they should complete the consent form and questionnaires and return 
them separately, before reading the leaflet and following it for one month. Eight out 
of ten support group members present expressed interest and took home the initial 
pack. The same process was repeated on Thursday 26th January at the Wickford 
 355 
 
Essex support group, where again eight support group members took away the 
information.  
Despite the initial interest, only 50% across both groups eventually returned 
these consent forms and questionnaires even following a text reminder, with four 
returned from the Dulwich group and four from the Wickford group. On Friday 17th 
February, I attended the Ealing support group for the first time. Eight names were 
taken, but the return rate was particularly poor with only two completed consent 
forms and questionnaires returned. On Wednesday 22nd February and Thursday 
23rd February, I attended the Dulwich and Wickford groups for the second and final 
time and provided follow-up packs including the questionnaires, an evaluation form 
and the debrief sheet.  
 
3B.4. Communicating the processes and outcomes of interventions  
During the follow-up support group meetings, participants openly discussed 
the impact of the CBT leaflet, as well as whether they had found it easy to follow. I 
invited those who did not complete the questionnaires to also take away an 
evaluation form with a prepaid envelope in order to maximise feedback on the 
leaflet. However, these additional evaluation forms were not returned. On Friday 
17th March, due to cancellation of the Ealing support group, I contacted the two 
active participants, and posted follow-up packs to their home addresses. Of the ten 
participants in total who sent back their consent forms and baseline questionnaires, 
only seven (70%) also returned their follow-up questionnaires. In the few cases 
where there was little to no feedback on the leaflet itself within evaluation forms, 
following permission via text I gained additional feedback over the phone. Six 
evaluation forms were eventually completed.  
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Scores from questionnaires were totalled for each person per questionnaire 
and entered into an Excel spreadsheet (see Table 3B1). Total scores for each 
questionnaire were then averaged by the total number of returned questionnaires, 
using formulas to calculate average scores for both the pre and post-leaflet 
questionnaires.  
 
Table 3B1. Pre and post-intervention scores 
 
 
For all questionnaires, higher scores indicated a greater level of impairment. 
A comparison of pre and post-leaflet average scores demonstrated very little 
change in terms of functional impairment and depression, and a slight worsening in 
symptom severity with an average increase in score of 0.6. However, there was a 
modest reduction in anxiety of 0.8 points (out of a maximum score of 21), 
suggesting a slight positive effect upon participants’ psychological well-being. 
Anxiety reduction has actually been demonstrated to reduce perceptions of pain and 
the severity of IBS (Fond, Loundou, Hamdani, Boukouaci, Dargal et al., 2014; 
Jensen, Petzke, Carville, Fransson, Marcus et al., 2010).   
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As only six evaluation forms were completed and posted back, it was 
somewhat difficult to fully evaluate the participants’ perception of the leaflet. 
However, this was anticipated to some extent and so only written qualitative and 
verbal feedback was sought. Please see Appendix X for the evaluation feedback. 
Both written and verbal comments indicated that the CBT leaflet was easy to follow, 
and relevant to them. Within the follow-up support group meetings, a few stated that 
they had been introduced to some of this information previously, but for them it had 
acted as a useful refresher, even if they felt they were unable to physically attempt 
all of the behaviour changes. However, the feedback indicated that more 
information should have been included than what could realistically be provided 
within the leaflet. More specific comments were that the list of fibromyalgia 
symptoms was not extensive enough; that there were not enough examples of how 
CBT works to improve the management of symptoms, and that there should have 
been an additional section on financial benefits and further help currently available, 
including eligibility for a Freedom Pass, a Blue Badge, and Dial-A-Ride. Although 
not mentioned specifically within the feedback, during the groups there were 
frequent discussions relating to the FODMAP diet, which is designed to help treat 
IBS by eliminating certain foods from their diet. As this approach has already been 
demonstrated as effective in symptom management (Roest, Dobbs, Chapman, 
Batman, O’Brien et al., 2013), in hindsight the leaflet could have contained 
information on this. 
 
3B.5. Promoting psychological principles, providing psychological advice to 
aid policy decision making, and disseminating psychological knowledge to 
address current issues 
Although the findings provide some evidence of the efficacy of the leaflet, it 
cannot be considered conclusive due to the low number of responses. Should this 
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intervention be repeated, it will need to be conducted across a larger number of 
support groups in order to obtain a robust sample of the fibromyalgia population. In 
addition, there should also be the inclusion of a control group for comparison 
(Steckler & McLeroy, 2008). Ideally, a RCT research design would be employed, 
due to this design’s ability to eliminate potential biases (Akobeng, 2005).  
Furthermore, while it was only possible to assess the impact of the CBT leaflet in 
this case, should the leaflet be trialled on a larger scale, participant health outcomes 
should be assessed over a longer duration, e.g. at six and twelve months, which 
would measure its true effectiveness as an intervention for fibromyalgia. The 
intervention would also ideally be thoroughly evaluated, using one of the established 
models used within health psychology (Glasgow, Vogt & Boles, 1999; Nutbeam, 
1998). It was not practical to evaluate on this occasion due to time constrictions and 
anticipated high drop-out rates over a longer duration (Parker & Dewey, 2000). An 
evaluation of the intervention in the future will determine whether the intervention is 
accessible to the target group, as well as effective. It will also demonstrate whether 
the intervention is easy to adopt, and easy to implement and maintain, e.g. within 
psychological services (Glasgow et al., 1999). The findings from the evaluation, if 
positive, should be widely disseminated in order to promote the use of CBT-based 
leaflets with integrated behaviour changes using BCTs, in order to treat 
fibromyalgia. The findings can also be used to influence and advise future policy 
decision making when it comes to future implementation of treatment within 
psychological services. 
The experience of designing the leaflet and attending support groups has 
been a big learning curve, as it has alerted me to the challenges of conducting 
research with this population. While the majority of those spoken to within the 
groups were willing to participate, it was difficult to maintain engagement or monitor 
the extent to which they were following the leaflet in between groups. This is true 
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even for those who completed and posted back the forms. While my experience of 
this intervention has enabled me to sympathise with fibromyalgia patients, I also 
empathised towards CBT therapists helping to treat fibromyalgia patients. 
Regardless of this, I thoroughly enjoyed the experience of being welcomed into the 
support groups and listening in on meetings. This experience was particularly 
invaluable in terms of gaining insight into the real issues affecting fibromyalgia 
patients.  
 
3B.6. Contributing towards the evolution of ethical and professional 
standards in health and applied psychology 
Based on experiences of this intervention, fibromyalgia patients should have 
the right to play an active role in the design and development of any future 
fibromyalgia interventions (e.g. leaflets and booklets). This would ensure that the 
issues most important to fibromyalgia patients themselves are included, rather than 
just the issues that health professionals consider the most important. This would 
mean that interventions are more tailored towards this population, and are more 
likely to be accepted amongst the fibromyalgia community.  
  
 360 
 
REFERENCES 
 
Akobeng, A.K. (2005). Understanding randomised controlled trials. Archives of 
Disease in Childhood, 90(8), 840-844. 
Anderson, L., Lewis, G., Araya, R., Elgie, R., Harrison, G., Proudfoot, J., Schmidt, 
U., Sharp, D., Weightman, A. & Williams, C. (2005). Self-help books for depression: 
how can practitioners and patients make the right choice? British Journal of General 
Practice, 55, 387-392.  
Arthritis Research UK. (2016). What causes fibromyalgia? 
Retrieved from: http://www.arthritisresearchuk.org/arthritis-
information/conditions/fibromyalgia/causes.aspx 
Bandura, A. (1977). Self-efficacy: toward a unifying theory of behavioural 
change. Psychological Review, 84(2), 191. 
Bandura, A. & Adams, N.E. (1977). Analysis of self-efficacy theory of behavioral 
change. Cognitive Therapy and Research, 1(4), 287-310. 
Bartlett, Y.K., Sheeran, P. & Hawley, M.S. (2014). Effective behaviour change 
techniques in smoking cessation interventions for people with chronic obstructive 
pulmonary disease: A meta-analysis. British Journal of Health Psychology, 19(1), 
181–203. http://doi.org/10.1111/bjhp.12071 
Bernardy, K., Klose, P., Busch, A.J., Choy, E.H., & Häuser, W. (2013). Cognitive 
behavioural therapies for fibromyalgia. The Cochrane Database of Systematic 
Reviews, (9), CD009796. 
Busch, V., Magerl, W., Kern, U., Haas, J., Hajak, G. & Eichhammer, P. (2012). The 
effect of deep and slow breathing on pain perception, autonomic activity, and mood 
processing - an experimental study. Pain Medicine, 13(2), 215-228. 
 361 
 
Busch, A.J., Schachter, C.L., Overend, T.J., Peloso, P.M. & Barber, K.A. (2008). 
Exercise for fibromyalgia: a systematic review. The Journal of Rheumatology, 35(6), 
1130-1144. 
Cedraschi, C., Desmoules, J., Rapiti, E., Baumgartner, E., Cohen, P., Finckh, A., 
Allaz, A.F., & Vischer, T.L. (2004). Fibromyalgia: a randomised, controlled trial of a 
treatment programme based on self management. Annals of the Rheumatic 
Diseases, 63(3), 290-296. 
Chitnis, A., Dowrick, C., Byng, R., Turner, P. & Shiers, D. (2014). Guidance for 
health professionals on medically unexplained symptoms (MUS) - 2011. Royal 
College of General Practitioners and Royal College of Psychiatrists.  
Retrieved from 
http://www.rcpsych.ac.uk/pdf/CHECKED%20MUS%20Guidance_A4_4pp _6.pdf 
El-Salhy, M., Lillebø, E., Reinemo, A., Salmelid, L. & Hausken, T. (2010). Effects of 
a health program comprising reassurance, diet management, probiotics 
administration and regular exercise on symptoms and quality of life in patients with 
irritable bowel syndrome. Gastroenterology Insights, 2(1), 6. 
Fernandez, E., Salem, D., Swift, J.K., & Ramtahal, N. (2015). Meta-analysis of 
dropout from cognitive behavioral therapy: Magnitude, timing, and moderators. 
Journal of Consulting and Clinical Psychology, 83(6), 1108-1122. 
Fibromyalgia Action UK. (2010). Patient Booklet. 
Retrieved from:  http://www.fmauk.org/information-packs-mainmenu-58/booklet-
mainmenu-135/490-patient-booklet 
 
 
 362 
 
Fond, G., Loundou, A., Hamdani, N., Boukouaci, W., Dargel, A., Oliveira, J., Roger, 
M., Tamouza, R., Leboyer, M. & Boyer, L. (2014). Anxiety and depression 
comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-
analysis. European Archives of Psychiatry and Clinical Neuroscience, 264(8), 651-
660. 
Foster, C., Hillsdon, M., Thorogood, M., Kaur, A. & Wedatilake, T. (2005). 
Interventions for promoting physical activity. Cochrane Database of Systematic 
Reviews. Issue 1. Art. No.: CD003180. DOI: 10.1002/14651858.CD003180.pub2 
Glasgow, R.E., Vogt, T.M. & Boles, S.M. (1999). Evaluating the public health impact 
of health promotion interventions: the RE-AIM framework. American Journal of 
Public Health, 89(9), 1322-1327. 
Hawkins, R.A. (2013). Fibromyalgia:  A Clinical Update. The Journal of the 
American Osteopathic Association, 113, 680-689. 
Jensen, K.B., Petzke, F., Carville, S., Fransson, P., Marcus, H., Williams, S.C., 
Choy, E., Mainguy, Y., Gracely, R., Ingvar, M. & Kosek, E. (2010). Anxiety and 
depressive symptoms in fibromyalgia are related to poor perception of health but not 
to pain sensitivity or cerebral processing of pain. Arthritis & Rheumatism, 62(11), 
3488-3495. 
Kroenke, K. & Spitzer, R.L. (2002). The PHQ-9: a new depression diagnostic and 
severity measure. Psychiatric Annals, 32(9), 509-515. 
Kroenke, K., Spitzer, R.L. & Williams, J.B. (2002). The PHQ-15: validity of a new 
measure for evaluating the severity of somatic symptoms. Psychosomatic 
Medicine, 64(2), 258-266. 
 
 363 
 
Mahvi-Shirazi, M., Fathi-Ashtiani, A., Rasoolzade-Tabatabaei, S.-K. & Amini, M. 
(2012). Irritable bowel syndrome treatment: cognitive behavioral therapy versus 
medical treatment. Archives of Medical Science, 8(1), 123–129. 
http://doi.org/10.5114/aoms.2012.27292 
Martinez, M.P., Miró, E., Sánchez, A.I., Diaz-Piedra, C., Cáliz, R., Vlaeyan, J.W.S., 
& Buela-Casal, G. (2014). Cognitive-behavioral therapy for insomnia and sleep 
hygiene in fibromyalgia: a randomized controlled trial. Journal of Behavioral 
Medicine, 37(4), 683-697. 
Michie, S., van Stralen, M.M., & West, R. (2011). The behaviour change wheel: A 
new method for characterising and designing behaviour change interventions. 
Implementation Science: IS, 6, 42. http://doi.org/10.1186/1748-5908-6-42 
Michie, S., Whittington, C., Hamoudi, Z., Zarnani, F., Tober, G. & West, R. (2012). 
Identification of behaviour change techniques to reduce excessive alcohol 
consumption. Addiction, 107(8), 1431-1440. 
Mundt, J.C., Marks, I.M., Shear, M.K. & Greist, J.M. (2002). The Work and Social 
Adjustment Scale: a simple measure of impairment in functioning. The British 
Journal of Psychiatry, 180(5), 461-464. 
National Institute for Health and Care Excellence. (2017). 3 Recommendations. 
Behaviour Change: General Approaches.  
Retrieved from:https://www.nice.org.uk/guidance/ph6/chapter/3-Recommendations 
National Health Services (NHS) Choices. (2016). Symptoms of fibromyalgia. 
Retrieved from:  http://www.nhs.uk/Conditions/Fibromyalgia/Pages/Symptoms.aspx 
 
 364 
 
National Institute for Health and Care Excellence. (2012). Patient experience in 
adult NHS services: improving the experience of care for people using adult NHS 
services. 
Retrieved from: https://www.nice.org.uk/guidance/cg138/chapter/1-guidance 
Nutbeam, D. (1998). Evaluating health promotion—progress, problems and 
solutions. Health Promotion International, 13(1), 27-44. 
Parker, C.J., Dewey, M.E. & Total Study Group. (2000). Assessing research 
outcomes by postal questionnaire with telephone follow-up. International Journal of 
Epidemiology, 29(6), 1065-1069. 
Perkins, S.J., Murphy, R., Schmidt, U. & Williams, C. (2006) Self-help and guided 
self-help for eating disorders. Cochrane Database of Systematic Reviews, 19(3), 
CD004191. 
Roest, R.D., Dobbs, B.R., Chapman, B.A., Batman, B., O'brien, L.A., Leeper, J.A., 
Hebblethwaite, C.R. & Gearry, R.B. (2013). The low FODMAP diet improves 
gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective 
study. International Journal of Clinical Practice, 67(9), 895-903. 
Sandstrom, M.J. & Keefe, F.J. (1998). Self-Management of Fibromyalgia:  The Role 
of Formal Coping Skills Training and Physical Exercise Training Programs. Arthritis 
Care and Research, 11(6), 432-447. 
Sheeran, P., Maki, A., Montanaro, E., Avishai-Yitshak, A., Bryan, A., Klein, W.M.P., 
Miles, E., & Rothman, A.J. (2016). The impact of changing attitudes, norms, and 
self-efficacy on health-related intentions and behavior: A meta-analysis. Health 
Psychology, 35(11), 1178-1188. 
 
 365 
 
Smits, S., McCutchan, G., Wood, F., Edwards, A., Lewis, I., Robling, M., Paranjothy, 
S., Carter, B., Townson, J. & Brain, K. (2016). Development of a Behavior Change 
Intervention to Encourage Timely Cancer Symptom Presentation Among People 
Living in Deprived Communities Using the Behavior Change Wheel. Annals of 
Behavioral Medicine, doi:10.1007/s12160-016-9849-x 
Spitzer, R.L., Kroenke, K., Williams, J.B.,& Löwe, B. (2006). A brief measure for 
assessing generalized anxiety disorder: the GAD-7. Archives of Internal 
Medicine, 166(10), 1092-1097. 
Steckler, A., & McLeroy, K.R. (2008). The Importance of External Validity. American 
Journal of Public Health, 98(1), 9–10. http://doi.org/10.2105/AJPH.2007.126847 
  
 366 
 
 
 
APPENDICES 
  
 367 
 
APPENDIX I 
Supervision Plan:  Behaviour Change Intervention 
 
Supervisee: __Katie Watts_________________ 
Supervisor: __Dr Triece Turnbull_____________ 
 
Intervention Area of work 
(*outside of 
normal work) 
Supporting 
evidence 
Changes 
Case study  10-minute 
Cognitive 
Behaviour Therapy 
intervention 
introduced to GPs 
(in order to change 
practice behaviour) 
Case study report 
(3000 words) 
 
Workplace 
supervisor’s 
evaluation report  
 
Changed to: 
Setting:   Fibromyalgia 
support groups in Dulwich, 
Wickford Essex and Ealing  
Description:  
A Cognitive Behaviour 
Therapy (CBT) leaflet to be 
introduced within support 
groups. Leaflet will include 
information on fibromyalgia 
symptoms and prevalence, 
the CBT model, and different 
techniques in order to 
manage symptoms 
(information on good sleep 
hygiene, helpful breathing 
techniques, the benefits of 
exercise, and how to 
improve eating/drinking 
habits).  
Participants will be asked to 
complete a consent form and 
questionnaires monitoring 
work and social functioning, 
depression, symptom 
severity and anxiety. They 
will be asked to read and 
follow the leaflet for one 
month, and at the next 
support group one month 
later, complete the same 
questionnaires to monitor 
improvement. 
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APPENDIX II 
 
Version Number: 2 25/11/16 
 
 
INFORMATION SHEET FOR PARTICIPANTS 
REC Reference Number: LRS-16/17-3897 
COGNITIVE BEHAVIOUR THERAPY LEAFLET FOR FIBROMYALGIA 
You are being invited to take part in a research study.  Before you decide whether to 
take part, it is important that you understand why the research is being done and 
what it will involve.  Please take time to read the following information carefully.  
 
1. What is the purpose of the study? 
We are undertaking a study to look at the effectiveness of using a Cognitive 
Behaviour Therapy (CBT) based leaflet as treatment for fibromyalgia.  More 
specifically, we are investigating whether this intervention has any effect upon 
depressive symptoms, anxiety, and physical symptom severity. We are also 
investigating to see whether the leaflet has any effect upon work and social 
functioning. 
While there is already evidence that face-to-face CBT treatment is helpful, we 
recognise that it may not be easy to commit to. Therefore, a CBT-based leaflet 
specifically tailored to treat fibromyalgia may be more suitable. However, whether it 
could be used as an effective alternative to face-to-face CBT is yet to be seen. 
 
2. What do you mean by ‘a CBT-based leaflet intervention’? 
This simply means that if you choose to take part, a new leaflet will be given to you 
that will potentially be giving you new information. We hope that this information 
would be helpful for you. 
3. Why have I been invited to take part? 
We are contacting you because we know that you have fibromyalgia.  In addition, 
we are inviting people aged 18 or older, who have not had any CBT-based 
treatment within the last 6 months.  As all information is written in English, anyone 
who takes part will need to be able to read and write in English to a good level. We 
are inviting you because we believe that you fit this description. 
 
4. Do I have to take part? 
No.  It is up to you.   
5. What will happen to me if I take part? 
If you are interested in taking part, we will take basic contact details from you and 
answer any further questions you may have. We will then provide you with a pack, 
containing an information sheet, consent form, four questionnaires, two envelopes 
and the CBT-based leaflet.  The questionnaires will be asking you about your mood, 
how frequently you are bothered by your physical symptoms, and your daily 
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functioning.  We would ask you to complete and post back your signed consent form 
and completed questionnaires to us in the two separate envelopes. This is just to 
keep your questionnaire answers separate from your personal details. We would 
then ask you to read through the leaflet and follow it for one month. At the end, we 
will get in touch (either in person at the next support group meeting, over the phone 
or via email) with the questionnaires which we will ask you to complete once more. 
This will be followed by a short evaluation form on the leaflet itself. 
 
6. How long will I be in the study? 
If you agree to take part in the study, you will be involved for one month. 
 
7. What are the possible disadvantages and risks of taking part? 
It is possible that while completing questionnaires and looking over the CBT-based 
fibromyalgia leaflet that you may end up thinking more about your feelings and your 
symptoms.  For some, this may be upsetting.  If as a result of taking part in the 
study or answering the questionnaires, you become concerned about your feelings 
you can talk to your GP. I would also strongly encourage you to raise this with us. 
9. What are the possible benefits of taking part? 
By taking part you will help us understand more about alternative ways that CBT-
based treatments can be effectively delivered to people with fibromyalgia.  We hope 
you will also get some helpful information about your condition and how to manage 
it in different ways. 
 
10. Are there any restrictions on what I can do? 
There will be no restrictions on your diet or lifestyle during the study.  However, the 
leaflet may provide you with information on possible lifestyle changes. 
 
11.Will my taking part in this study be kept confidential? 
Any information collected about you during the course of the research will be kept 
strictly confidential.  We will need to keep your contact details at the research sites 
but only for the purposes of contacting you about your questionnaires.  This 
information will be securely stored and destroyed after the study.  Any other 
information about you will have your name and contact details removed so that you 
cannot be recognised from it.  We will not identify you in our computers or 
publications by name and will only refer to you by participant number, which will be 
used in place of your name in case of any future publications.  All information will be 
stored on password protected computers and paperwork will be stored securely in a 
locked office.  Although this is unlikely, we would need to inform your GP if we 
became concerned about your well-being. We would, of course, discuss this with 
you.  
 
12. What will happen if new information becomes available? 
Sometimes, new information might become available about the treatment that is 
being tested.  In the unlikely case that this happens during the course of the study, 
we will contact you to discuss with you whether you want to continue.   
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13. What happens when the study is over? 
Once the study is over, we will see whether the CBT-based fibromyalgia leaflet has 
helped to improve your work and social functioning, your mood, and symptom 
severity.   
 
14. What happens to the results of the research study?  
There is a chance that the results will be published in scientific journals and may be 
presented at meetings.  However, we will not identify you in any report/publication.  
If you would like a copy of any published findings, we will be happy to provide this.  
 
15. Discontinuation of the study 
At any time, we have the right to end your participation in the study for any reason.  
If, later on in the month it is concluded that you do not have capacity to consent, we 
would like to be able to continue to use any information already collected in an 
anonymised form. 
 
16. Withdrawal from the study 
Taking part in this study is entirely voluntary. Although the duration of the study is 
one month, you can stop taking part in the study at any time without giving a reason 
and without this affecting your care at all, now or in the future. Should this happen, 
no new information will be collected from you.  However, information collected may 
still be used. If you decide after the one month that you are involved in the study 
that you no longer wish for your data to be included within the analysis, you have 7 
days to notify the researcher of this. 
 
17. Who is organising and funding the research? 
The study is funded by researchers at the Institute of Psychiatry, Psychology and 
Neuroscience (King's College London).  Prof. Trudie Chalder will be overseeing the 
study. 
 
18. Who has reviewed the study? 
Ethics approval has been granted by the KCL College Research Ethics Committee. 
 
19. Contact for further information? 
If you have any questions or require more information about this study, please 
contact us using the following details:  
 
Researcher: Katie Watts   Supervisor: Professor Trudie Chalder 
Dept. of Psychological Medicine   Dept. of Psychological Medicine 
London SE5 8AF    London SE5 9RJ 
Email: Katie.Watts@kcl.ac.uk  Email: Trudie.Chalder@kcl.ac.uk 
     
 
If you feel that this study has harmed you in any way, you can contact the PNM 
Research Ethics Committee, at: 
Chair: PNM Research Ethics Committee 
Email: rec@kcl.ac.uk 
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Thank you for reading this information sheet.  You will be given a copy to keep.  If 
you have understood the contents of this sheet and wish to take part, please 
complete the consent form.  If you have any questions, please feel free to ask them 
now. 
Thank you for reading this information sheet and for considering taking part 
in this research. 
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APPENDIX III 
Version Number 2. 25/11/16 
 
 
CONSENT FORM FOR PARTICIPANTS IN RESEARCH STUDIES 
 
Please complete this form after you have read the Information Sheet and/or 
listened to an explanation about the research. 
 
Title of Study:  Cognitive Behaviour Therapy Leaflet for Fibromyalgia 
King’s College Research Ethics Committee Ref: REC Reference Number: LRS-
16/17-3897 
Thank you for considering taking part in this research. The person organising the 
research must explain the project to you before you agree to take part. If you have 
any questions arising from the Information Sheet or explanation already given to 
you, please ask the researcher before you decide whether to join in. You will be 
given a copy of this Consent Form to keep and refer to at any time. 
I confirm that I understand that by ticking/initialling each box I am  
consenting to this element of the study. I understand that it will be  
assumed that unticked/initialled boxes mean that I DO NOT consent to  
that part of the study. I understand that by not giving consent for any  
one element I may be deemed ineligible for the study. 
 
 
Mandatory 
1. I confirm that I have read and understood the information  
sheet dated 25/11/2016 Version 2 for the above study.  
I have had the opportunity to consider the information and  
asked questions which have been answered satisfactorily. 
 
2. I understand that I will be able to withdraw my data up to  
1 week after my final questionnaires are completed. 
 
3. I consent to the processing of my personal information for the  
purposes explained to me.  I understand that such information  
will be handled in accordance with the terms of the UK Data 
Protection Act 1998. 
 
 
Please tick 
or initial 
Please tick 
or initial 
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4. I understand that my information may be subject to review by  
responsible individuals from the College for monitoring and audit 
purposes. 
 
5. I understand that confidentiality and anonymity will be maintained  
and it will not be possible to identify me in any publications following  
this study. 
 
6. I have informed the researcher of any other research in which I am 
currently involved or have been involved in during the past 6 months 
 
 
Optional 
 
7. I agree that the research team may use my data for future research  
and understand that any such use of identifiable data would be  
reviewed and approved by a research ethics committee. (In such  
cases, as with this project, data would/would not be identifiable in  
any report). 
 
8. I agree to be contacted in the future by King’s College London  
researchers who would like to invite me to participate in follow up  
studies to this project, or in future studies of a similar nature. 
 
9. I understand that the information I have submitted may be published 
and if so I wish to receive a copy of it. 
 
 
__________________               __________________          __________________   
Name of Participant                 Date       Signature 
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APPENDIX IV 
Version Number: 2 25/11/16 
 
 
 
DEBRIEF SHEET FOR PARTICIPANTS 
REC Reference Number: LRS-16/17-3897 
COGNITIVE BEHAVIOUR THERAPY LEAFLET FOR FIBROMYALGIA 
Thank you once again for participating in this study. Your help with the study is 
greatly appreciated. As a reminder, all your information will be stored in a secured 
location at King’s College London, and only the research team will have access to it. 
 
What happens now? 
Your information (questionnaire scores and your evaluation feedback) will be 
analysed by the researcher to see whether there has been any change in terms of 
your work and social functioning, your mood and your symptom severity since the 
introduction of the leaflet. The findings will then be written up into a report. 
 
What will happen to the research findings? 
It is possible that research findings may be published in an academic journal. A 
summary of the results will be made available to you if you would like them. 
 
What if I change my mind about the study? 
If you change your mind about your data being included in the study, you have one 
week following your questionnaires being handed in to contact the researcher at 
Katie.Watts@kcl.ac.uk, to let them know. Otherwise, your data may still be included 
within the final report. 
 
Contact for further information regarding the study? 
If you wish to discuss the study in greater detail, please contact: 
Researcher: Katie Watts 
Dept. of Psychological Medicine 
London SE5 8AF 
Email: Katie.Watts@kcl.ac.uk 
If you have any concerns in relation to your physical and psychological health, you 
can speak with your GP who will be able to advise you. 
 
Thank you once again for taking part in this research. 
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APPENDIX VI 
 
Work and Social Adjustment Scale (WSAS) 
Rate each of the following questions on a 0 to 8 scale: 0 indicates no 
impairment at all and 8 indicates very severe impairment.  
1. Because of my 
symptoms, my 
ability to work is 
impaired. 
0 Not at all impaired 
1  
2  
3  
4  
5  
6  
7  
8 Very severely impaired 
 
2. Because of my 
symptoms, my 
home management 
(cleaning, tidying, 
shopping, cooking, 
looking after home 
or children, paying 
bills) is impaired. 
0 Not at all impaired 
1  
2  
3  
4  
5  
6  
7  
8 Very severely impaired 
 
3. Because of my 
symptoms, my 
social leisure 
activities (with 
other people, such 
as parties, bars, 
clubs, outings, 
visits, dating, home 
entertainment) are 
impaired. 
0 Not at all impaired 
1  
2  
3  
4  
5  
6  
7  
8 Very severely impaired 
 
4. Because of my 
symptoms, my 
private leisure 
activities (done 
alone, such as 
reading, gardening, 
collecting, sewing, 
walking alone) are 
impaired. 
0 Not at all impaired 
1  
2  
3  
4  
5  
6  
7  
8 Very severely impaired 
 
5. Because of my 
symptoms, my 
ability to form and 
maintain close 
relationships with 
others, including 
those I live with, is 
impaired. 
0 Not at all impaired 
1  
2  
3  
4  
5  
6  
7  
8 Very severely impaired 
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APPENDIX VII 
Patient Health Questionnaire (PHQ-9) 
 
Part A 
 
Over the last 2 weeks, how often have you been bothered by any of the 
following problems? 
 
1. Little interest or 
pleasure in doing 
things 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
2. Feeling down, 
depressed or 
hopeless 
 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
3. Trouble falling or 
staying asleep, or 
sleeping too much 
 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
4. Feeling tired or 
having little energy 
 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
5. Poor appetite or 
overeating 
 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
6. Feeling bad about 
yourself – or that 
you are a failure or 
have let yourself or 
your family down 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
7. Trouble 
concentrating on 
things, such as 
reading the 
newspaper or 
watching television 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
8. Moving or speaking 
so slowly that other 
people could have 
noticed?  Or the 
opposite – being so 
fidgety or restless 
that you have been 
moving around a lot 
more than usual 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
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9. Thoughts that you 
would be better off 
dead, or of hurting 
yourself in some 
way 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
 
Part B 
 
1. If you checked off 
any problems, how 
difficult have these 
problems made it 
for you to do your 
work, take care of 
things at home, or 
get along with other 
people?  
 
0 Not difficult at all  
1 Somewhat difficult 
2 Very difficult 
3 Extremely difficult  
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APPENDIX VIII 
Patient Health Questionnaire (PHQ-15) 
 
During the past 4 weeks, how much have you been bothered by any of the following problems? 
1. Stomach Pain? 0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
2. Back pain? 0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
3. Pain in your arms, 
legs, or joints: 
knees, hips, etc.)? 
0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
4. Menstrual cramps 
or other problems 
with your periods   
[Women only]? 
0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
5. Headaches? 0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
6. Chest pain? 0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
7. Dizziness? 0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
8. Fainting spells? 0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
9. Feeling your heart 
pound or race? 
0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
10. Shortness of 
breath? 
0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
11. Pain or problems 
during sexual 
intercourse? 
0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
12. Constipation, loose 
bowels, or 
diarrhoea? 
0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
13. Nausea, gas, or 
indigestion? 
0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
14. Feeling tired or 
having low energy? 
0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
15. Trouble sleeping? 0 Not bothered at all  
1 Bothered a little 
2 Bothered a lot 
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APPENDIX IX 
Generalised Anxiety Disorder (GAD-7) 
 
Please read each statement and record a number 0, 1, 2 or 3 which indicates 
how much the statement applied to you over the past two weeks.  There are 
no right or wrong answers.  Do not spend too much time on any one 
statement.  This assessment is not intended to be a diagnosis.  If you are 
concerned about your results in any way, please speak with a qualified 
health professional. 
 
1. Feeling nervous, 
anxious or on edge 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
2. Not being able to 
stop or control 
worrying 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
3. Worrying too much 
about different 
things 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
4. Trouble relaxing 0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
5. Being so restless 
that it is hard to sit 
still 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
6. Becoming easily 
annoyed or irritable 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
7. Feeling afraid as if 
something awful 
might happen 
0 Not at all  
1 Several days 
2 More than half the days 
3 Nearly every day 
 
 
Please note: These results are intended as a guide to your health and are 
presented for information purposes only.  They are not intended to be a 
clinical diagnosis.  If you are concerned in any way about your health, please 
consult with a qualified health professional. 
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APPENDIX X 
Evaluation form 
questions 
Comments N (%) 
 
 
What did you like most about 
this leaflet and why? 
Clear and informative 
information 
3 (50%) 
Liked the information on 
pacing 
 
1 (16.7%) 
Made me think more 
positively about eating and 
drinking better, and 
exercising 
1 (16.7%) 
Liked the use of colour and 
illustrations 
1 (16.7%) 
 
What did you like least about 
this leaflet, and why? 
N/A 3 (50%) 
Already familiar with 
information (sleep hygiene) – 
does not work 
1 (16.7%) 
‘What is fibromyalgia?’ 
section does not include 
enough information/ 
explanation 
1 (16.7%) 
Would have liked more 
colour 
1 (16.7%) 
 
How engaging/unengaging 
did you find the leaflet to be? 
Engaging  4 (66.7%) 
Unengaging – hard to stay 
focused on it 
2 (33.3%) 
 
How easy/ not easy did you 
find the information to 
understand and follow? 
Easy to read and follow 4 (66.7%) 
Struggled to follow it all and 
get up at the same time as 
so tired 
1 (16.7%) 
No answer given 1 (16.7%) 
 
Would you have liked more 
information, or less 
information? 
Good amount of information 3 (50%) 
 
More information (e.g. on 
CBT) 
3 (50%) 
 
How relevant did you find the 
leaflet’s content to be for you? 
Relevant 5 (83.3%) 
Should have been written by 
someone with fibromyalgia 
1 (16.7%) 
 
How do you feel the leaflet 
cold have been improved? 
More information on 
symptoms (e.g. vertigo and 
tinnitus) 
3 (50%) 
More information in general 1 (16.7%) 
More relaxation techniques 1 (16.7%) 
Would have liked more 
examples of how CBT works 
1 (16.7%) 
More information on financial 
benefits, CA cord, Blue 
Badge, Dial A Ride, 
Freedom pass. 
1 (16.7%) 
Fine as it is 1 (16.7%) 
 
Any other comments? 
Theory behind it is good 2 (33.3%) 
Have had CBT before 1 (16.7%) 
This information is best 
given at time of diagnosis 
1 (16.7%) 
Colours soothing, and text 
size appropriate 
1 (16.7%) 
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APPENDIX XI 
Workplace evaluation reports 
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3C:  TEACHING AND TRAINING 
(TEACHING) 
 
1. Health Promotion:  Individual-
Level Interventions 
 
2. The Patient with Medically 
Unexplained Symptoms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Word count: 2197 
 
 386 
 
3C:  Teaching and Training 
 
3C:   Teaching 
In order to achieve the Teaching element of the Teaching and Training 
competency, I delivered two teaching sessions on different topics, to two different 
audiences (please refer to Appendix I for the Teaching supervision plan). Below I 
have documented the process undertaken for both teaching sessions, including how 
I have evaluated them using a reflective approach to enhance self-awareness and 
learning (Northway, 2000). Reflective practice has been demonstrated to be 
particularly helpful when attempting to comprehend complex situations (Mann, 
Gordon & MacLeod, 2007). 
 
3C.1: . Teaching session 1.  Health Promotion: Individual-Level Interventions 
 
 
3C.1.1:  The reflective framework:  The Gibbs’ Reflective Cycle (1988) 
 
In order to implement a reflective stance for this session, I referred to the 
Gibbs’ reflective cycle for guidance (Gibbs, 1988). This particular model has six 
individual stages, and has been established as an effective tool for reflection and 
learning (Wilding, 2008). The six stages include a description of the event, i.e. who 
the audience were, where and for what purpose they were being taught, and what 
happened before, during and after. It also includes an analysis of feelings, an 
evaluation of the experience, a conclusion of what could be improved in future, and 
an action plan of how to implement this in future practice. I have described and 
evaluated my experience of the first teaching session below, to loosely cover these 
stages.  
 
 
 387 
 
3C.1.2:  Planning and designing teaching programmes that enable students to 
learn about psychological knowledge, skills, and practices  
3C.1.2.1:  Assessment of teaching needs 
The opportunity to teach arose following an invitation from the MSc Health 
Psychology Programme Director at City, University of London, to deliver the majority 
of an ad hoc three hour session on ‘Individual-Level Interventions’, which forms part 
of the Health Promotion module. I was informed that individual behaviour 
interventions were still an integral part of the course and coverage was required for 
successful completion of an assessment.  In this particular case, teaching needs 
were largely directed by the Health Promotion module syllabus. 
 
3C.1.2.2:  Preparation of appropriate teaching materials 
In order to effectively deliver the required information, I received the existing 
slides from the Programme Director, and adapted them to cover each of the 
following: the different approaches to behaviour change, using examples within 
healthcare settings; steps taken when designing a behaviour change intervention, 
introducing the Behaviour Change Wheel, and the COM-B model (Michie, Maartje & 
van Stralen, 2011); how to effectively evaluate a health behaviour change 
intervention using the RE-AIM model (Glasgow, Vogt & Boles, 1999). For the latter, 
I referred to my own MSc Health Promotion assignment, which helped me to deliver 
the information in a way that was closely tailored to the needs of the audience. 
Materials for the teaching included PowerPoint slides, which were designed 
to be logical and easy to follow. Group activities were integrated to ensure the 
audience remained engaged, one of which was a three-minute mindfulness activity 
using a video where pulse rates were taken before and after. Mindfulness was 
included to demonstrate how psychological health directly impacts physical health, 
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and to demonstrate how to effectively manage stress (Chiesa & Serretti, 2009). 
Towards the end of the teaching, students formed groups and designed an 
intervention for their chosen behaviour, including how they planned to evaluate it 
using the RE-AIM framework.   
 
3C.1.3:  Planning and implementing assessment procedures, and delivering 
the teaching session 
Evaluation forms were designed and printed in advance, and administered at 
the end of the teaching to obtain student feedback. Feedback-seeking behaviour 
has been shown to facilitate adaptation and improve future performance 
(Crommelinck & Anseel, 2013). I was anxious prior to the session as I had never 
taught University students, nor been required to engage a large group for a 
substantial length of time. I was also unsure whether my real-life examples would 
effectively illustrate the different types of interventions, and whether the students 
would engage in group exercises. However, in order to appear professional and be 
prepared, I made sure to arrive early on the day, run through my slides beforehand, 
and test the mindfulness video with the sound. During the teaching session, 
students appeared to listen intently and seemed engaged, which made the 
experience positive for me and enhanced my feelings of self-efficacy for teaching 
(Bandura, 1977a). As the session concluded, I felt confident that I had delivered the 
session to the best of my ability.  
 
3C.1.4:  Evaluating the teaching session 
The evaluation forms, which were open-ended in order to obtain rich and 
detailed qualitative data, supported that belief that the teaching session had been 
successful, due to their positive comments (please see Appendix II for a summary 
of student feedback, and Appendix III for an evaluation report from Dr Turnbull). 
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Generally the mindfulness activity was well received, with one student remarking 
within their feedback: “[It was] very engaging – wish all lectures would include three 
minutes of mindfulness”. Many also expressed their appreciation that I had included 
personal examples of interventions, which I had used to place information within a 
day-to-day context. One student stated the following: “I liked how the content was 
presented and the use of examples from your own work especially”. Perhaps most 
importantly though, students were generally in agreement that learning needs were 
met: “The lecture was relevant to our assignments, so it gave us more ideas for our 
project”. All of this feedback naturally acted as positive reinforcement.  
Constructive feedback on the evaluation forms included that I should include 
less text on slides: “Some of the slides were hard to read/ text heavy”. On reflection, 
this was due to fear that I may forget key information. One student also felt that I 
delivered the lecture at a fast pace, meaning that there were infrequent pauses for 
questions. While there was group discussion, more would have facilitated 
preparation for the group work (Beard, 1997). Moving forward, I intend to continue 
including a similar ratio of slides and group activities. Key changes will be to include 
less text, speak slower, and allow for more group interaction. This experience has 
given me the confidence to make these changes for future teaching sessions. 
 
 
3C.2:   Teaching session 2:  The patient with Medically Unexplained 
Symptoms 
3C.2.1:  A reflective framework:  Rolfe, Freshwater and Jasper (2001) 
For this session, I have referred to a different reflective framework in order to 
further enhance my knowledge and professional development. The framework for 
reflective practice by Rolfe, Freshwater and Jasper (2001), has already been 
demonstrated to complement learning in practice (Lahteenmaki, 2005). This model 
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encourages consideration of thoughts and feelings, actions taken, and how these 
were consequential for the teacher and audience. It also encourages consideration 
of what the experience may teach oneself about their relationship with the audience, 
and how personal experience could contribute to the session. Furthermore, it 
requires consideration of how to improve teaching in the future and address relevant 
issues, as well as consider the consequences of not addressing them. In addition to 
this model, I was mindful to implement the constructive feedback from my previous 
teaching session.  
 
3C.2.2:  Planning and designing teaching that enables students to learn about 
psychological knowledge, skills and practices 
3C.2.2.1:  Assessment of teaching needs  
My second teaching opportunity came unexpectedly from a healthcare 
professional requesting help to run a workshop entitled “The Patient with Medically 
Unexplained Symptoms” for nurse practitioners. I was informed that the audience 
were likely to have had very little understanding of MUS, and so it was agreed prior 
to the session that I would prepare PowerPoint slides and activities for an 
introductory session on the subject. Audience expectations of the teaching session, 
as well as their perceived level of knowledge, were clarified at the beginning of the 
workshop, confirming that this particular group currently had little to no 
understanding of MUS, and were looking for general information relating to the 
impact of MUS, its presentation, and how to effectively treat MUS.  
 
3C.2.2.2:  Preparation of appropriate teaching materials 
I aimed to effectively cover the different terms for MUS, its prevalence, the 
physical/ psychological/ financial implications for patients and health professionals, 
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and how to recognise MUS in a clinical setting. In addition, I included two 
educational videos from the NHS website and a vignette, as education and 
modelling are established BCTs (Michie, van Stralen & West, 2011), due to their 
effects on self-efficacy (Bandura, 1997b). The implications of including these were 
that nurse practitioners should feel more empowered to recognise and manage 
MUS. In order to evaluate learning, pre and post-questionnaires had previously 
been produced to capture perceived knowledge and confidence of understanding 
MUS, as well as qualitative feedback for the full workshop (please see Appendix IV 
and V).  
I found the preparation stage to be somewhat stressful at first as the 
opportunity arose at short notice and I was keen to design a better teaching session 
this time around. I was also conscious that it would likely be a different teaching 
experience due to their clinical background. This feeling was only enforced when I 
was informed that the MUS teaching was the final day of a training course, which 
made me think that they were likely fatigued. This is where my previous experience 
and feedback forms were useful for preparation, as it meant that I could feel more 
confident in selecting activities and suitable media platforms to keep my audience 
engaged. I was also feeling more self-assured due to my work-based focus on 
MUS, making it easier to draw upon personal experiences.  
 
3C.2.3:  Delivery of the teaching session 
I arrived early but felt somewhat unsettled due to factors outside of my 
control, with the session delayed 30 minutes due to late arrivals. However, following 
on from quick introductions and a re-confirmation that for most the aim was to gain a 
broad overview of MUS, I was able to conduct my teaching. I definitely felt more 
confident in my own ability as the group exercises, vignette and video seemed to be 
well-received. As well as pausing occasionally to introduce anonymous examples of 
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MUS patients I had encountered, I also invited the class to share stories, of which 
some obliged.  While initially happy with my teaching plan, I realised that I needed 
to adapt in order to ensure I finished promptly. Therefore, I skimmed through the 
numerous terms for MUS, and chose to play only one selected NHS video, 
suggesting they watch the other in their own time. This worked well, as in practice 
one video felt sufficient for illustrating the point. Immediately after teaching, I felt 
drained, but happy with how the content of the session had been received. Despite 
one nurse leaving early, others appeared to enjoy learning about MUS, even if they 
did not frequently encounter it themselves.  
 
3C.2.4:  Evaluating the teaching session 
Feedback was on the whole workshop rather than my teaching session in 
particular. However, from the feedback I was able to see a great improvement in 
their knowledge of MUS, with average scores on the Knowledge questionnaire 
increasing from 4.7 out of 10, to 8.2. Confidence of recognising and treating MUS 
also hugely increased, from an average of 3.2 to 7.2 out of 10. Please see Appendix 
IV for a breakdown of Knowledge and Confidence scores. In terms of more general 
feedback, ranging from 1 to 8 where 1 was reflective of a positive outcome, content 
of the workshop and the handouts were given average scores of 2.2 and 2.1 
respectively, demonstrating that the nurses approved of the information that had 
been covered. Presentation however had a slightly weaker average score of 3.1, 
which was disappointing. As qualitative feedback generally did not provide much 
information however, it was difficult to gauge to what extent my own presentation 
style was at fault. Positive comments differed, but amongst these were statements 
that I was “friendly and helpful”, that video clips of real-life experiences were 
appreciated, and that the course was necessary as it covered information that had 
not been taught previously: “In general learning about MUS/PPS was helpful as 
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some is not discussed/ thought in university training”.  Constructive criticism was 
limited, particularly in relation to my teaching session within the workshop. However, 
within the comments it was suggested that a patient speaker be invited, rather than 
use a role play between facilitators. I felt this was an excellent idea and one that we 
could easily action. Immediately following the workshop, I put forward this 
suggestion for the next time the workshop was due to run. Please see Appendix V 
for general and qualitative feedback. 
Overall, I am satisfied with how the teaching session went. The audience 
were not as fatigued as I had feared, and I sensed a certain level of respect, which I 
perceived to be due to my knowledge of the subject. In addition, I felt my delivery 
was more relaxed, and there were no specific comments relating to the amount of 
text on slides, the speed of delivery, or the time spent on slides. Pre and post 
questionnaires indicated a marked improvement in terms of knowledge and 
confidence, indicating that needs had been met. While there did appear to be 
criticism surrounding presentation, I am confident that with more practice this will 
continue to improve and become fluid. Therefore, I will endeavour to continue 
gaining as much teaching experience as possible. 
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APPENDIX I 
 
Supervision Plan: Teaching 
 
Supervisee: __Katie Watts_______________ 
Supervisor: __Dr. Triece Turnbull_________ 
Teaching 
and training 
Area of work 
(*outside of normal 
work) 
Supporting 
evidence 
Changes 
Case study: 
Teaching 1 
Setting:  City, 
University of London.  
 
Description:  An MSc 
Health Psychology 
lecture to students as 
part of the Health 
Promotion module. 
The lecture will cover 
Individual-level 
Behaviour Change 
Interventions (BCI), 
including steps to 
designing BCIs, and 
how to evaluate BCIs 
(e.g. by using the RE-
AIM framework). 
Case study 
report (2000 
words). 
Evaluation 
forms 
completed by 
students. 
Evaluation 
form (signed 
by Dr. Triece 
Turnbull who 
was present 
for the 
teaching 
session). 
Workplace 
contact report. 
N/A 
Case study: 
Teaching 2 
Supervision of MSc 
student conducting an 
LGBT study with PPS 
patients. 
Case study 
report (2000 
words – 
combined with 
Teaching 1). 
Workplace 
contact report. 
Changed to: 
Setting:  King’s College London 
Description:  IMPARTS teaching 
session on Medically 
Unexplained Symptoms, for 
nurse practitioners from St. 
George’s Hospital 
This session will cover what 
medically unexplained symptoms 
are (including different terms), 
their prevalence, their impact 
upon patients and patients. The 
session will aim to include group 
activities, group discussion and 
relevant videos, in order to try 
and keep the audience engaged. 
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APPENDIX II 
 
Evaluation form: Teaching session 1 
 
Evaluation form 
questions 
 
 
Comments  
 
N (%) 
What did you enjoy most 
about this session, and 
why? 
 
How it was presented 
 Clear 
 Excited, motivated and 
fresh lecturer 
 Easy to follow 
 Working like a team 
5 (41.7%)  
2(16.7%) 
1 (8.3%) 
 
1 (8.3%) 
1 (8.3%) 
Helpful for assignment 4 (33.2%) 
The mindfulness exercise 
 It was relaxing 
3 (25%)  
1 (8.3%) 
Liked the use of real life examples 2 (16.7%) 
Informative 2 (16.7%) 
Interactive activities 1 (8.3%) 
Showed that behaviour change is 
possible (as shown at individual 
level) 
1 (8.3%) 
What did you enjoy the 
least about this session, 
and why? 
 
Group work 
 Hard to put together all the 
information 
4 (33.2%) 
1 (8.3%) 
Some slides difficult to read 1 (8.3%) 
Some slides were text heavy 1 (8.3%) 
Reading some slides word for word 1 (8.3%) 
Could have left out studies from 
presentation 
1 (8.3%) 
Mindfulness meditation 1 (8.3%) 
Covered too fast at times 1 (8.3%) 
Not applicable 3 (25%) 
(Left blank) 1 (8.3%) 
How engaging did you 
find this session to be? 
 
Engaging 
 Scored 8/10 
 Relevant content 
 Mindfulness helped make it 
engaging 
 Group work helped to make 
it engaging 
 New information 
11 (91.7%) 
1 (8.3%) 
2 (16.7%) 
2 (16.7%) 
 
2 (16.7%) 
 
1 (8.3%) 
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Interested in current work role 
discussed (as Research Worker) 
1 (8.3%) 
Did you feel there were 
enough / not enough 
participatory activities 
during the session? 
Enough participatory activities 9 (75%) 
 
No opinion 1 (8.3%) 
(No information given) 2 (16.7%) 
Did you find the slide 
contents to be organised 
and easy to follow? 
 
Organised / easy to follow 8 (66.7%) 
Slides too text heavy 1 (8.3%) 
Text too small on slides 1 (8.3%) 
Helpful 1 (8.3%) 
More detail could have been given 
on specific examples and studies 
1 (8.3%) 
Did you find the session’s 
content to be relevant to 
your own needs as part of 
the course? 
 
Yes 
 Helped me to think of 
presentation I have in a few 
months 
 Relevant for assignment 
12 (100%) 
1 (8.3%) 
 
 
1 (8.3%) 
How do you feel the 
lesson could have been 
improved? 
 
 
Not applicable 6 (50%) 
Could have included more group 
discussion 
1 (8.3%) 
More detail on studies/story telling 
needed 
1 (8.3%) 
More time needed on some slides 
to take notes 
1 (8.3%) 
Using sweets as rewards for good 
students 
1 (8.3%) 
(Left blank) 3 (25%) 
Any other comments? 
 
Left blank 6 (50%) 
No 1 (8.3%) 
Thank you!  1 (8.3%) 
Very well done – excellent delivery! 
Thank you  
1 (8.3%) 
Thanks for your lecture – it was 
great!  
1 (8.3%) 
Great job! 1 (8.3%) 
Well done! 1 (8.3%) 
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APPENDIX IV 
 
Teaching session 2:  Knowledge and Confidence scores 
 
 
KNOWLEDGE SCORE 
Right 
Answer 
Knowledge (Pre-
course) - No. who 
answered correctly 
per ques 
 
 
 
Knowledge 
(Post course) - 
No. who 
answered 
correctly per 
ques 
Approximately 50% of patients in secondary 
care have medically unexplained or PPS 
TRUE 4 7 
Medically unexplained or PPS are more 
common in men than women 
FALSE 5 10 
The trigger factors for Medically 
Unexplained Symptoms are different to the 
factors that maintain the symptoms TRUE 4 7 
Chronic fatigue syndrome is another form of 
depression FALSE 5 10 
Viewing the mind and body separately is 
useful when thinking about medically 
unexplained or PPS 
FALSE 5 7 
Left untreated the majority of people with 
chronic fatigue syndrome will get better 
with time FALSE 7 9 
It is important to advise patients with 
chronic fatigue syndrome to rest in 
response to their symptoms FALSE 3 7 
There is evidence that excess exertion with 
unexplained pain can cause physical damage 
FALSE 0 7 
Increasing activities even when unexplained 
or persistent symptoms are present is likely 
to be helpful TRUE 6 8 
Self-monitoring diaries are an important 
component of cognitive behaviour therapy 
(CBT) TRUE 8 10 
Total average score 
 4.7 8.2 
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CONFIDENCE SCORE (OUT OF 10) 
  
Confidence score 
(pre-course) 
 
Confidence 
(post-course) 
How confident do you feel about recognising medically 
explained or PPS? 2.5 6.2 
How confident do you feel about distinguishing 
between chronic fatigue syndrome and depression? 2.9 7.0 
How confident do you feel about giving lifestyle advice 
to patients with medically unexplained or PPS? 3.3 7.4 
How confident do you feel about giving patients advice 
about how to improve the quality of their sleep? 3.7 7.6 
How confident do you feel in using some motivational 
interviewing techniques? 3.4 7.6 
Total average score 
 3.2 7.2 
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APPENDIX V 
 
Teaching session 2:  Evaluation form  
FEEDBACK ON COURSE    
   Average score 
Content  (1=Sufficient, 8=insufficient)  N/A 2.2 
Presentation (1=well presented, 8=not well 
presented)  N/A 3.1 
Handouts (1=sufficient, 8=insufficient)  N/A 2.1 
Impact on practice (1=Strongly disagree, 
7=strongly agree)  N/A 3.3 
 
 
 
 
  
QUALITATIVE FEEDBACK 
If there is one thing I would keep for future sessions it 
would be… N (%) 
Motivational interviewing 3 (30%) 
Video clips of real life interviews 1 (10%) 
In general learning about MUS/PPS was helpful as some is 
not discussed/ thought in university training 
1 (10%) 
Facilitators are friendly and helpful 1 (10%) 
 
All the topics 
 
1 (10%) 
 
(Blank) 
 
3 (30%) 
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QUALITATIVE FEEDBACK 
If there is one thing I would change about this session it 
would be… N (%) 
Presentation style 2 (20%) 
Roleplay – a patient speaker would be better, or videos 1 (10%) 
[More] group interaction 1 (10%) 
As MI had been previously discussed in this course, less 
information would be needed on this 
1 (10%) 
 
None 
 
1 (10%) 
 
 
(Blank) 
 
4 (40%) 
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3D:  TEACHING AND TRAINING 
(TRAINING) 
 
Qualitative Research Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Word count: 1093 
 408 
 
3D:  DPsych:  Teaching and Training 
 
3D.1:   Training:  Qualitative research methods  
In order to complete the Training element of the Teaching and Training 
competency, I designed and delivered a training programme on “Qualitative 
Research Methods”. This course aimed to effectively cover relevant data collection 
methods, data sampling methods and data analysis techniques.   
 
3D.2:  The reflective framework:  Gibbs’ Reflective Cycle (1988) 
In order to reflect on my experience, I referred to the Gibbs’ (1998) reflective 
cycle, which considers a  description of the event, feelings, evaluations, analysis, 
general and specific conclusions and action plans (Gibbs, 1998). 
 
3D.3:  Planning and designing training programmes that enable students to 
learn about psychological knowledge, skills and practices 
The decision to deliver this course followed a discussion with healthcare 
professionals and academics, where I was informed that many within these 
professions had limited understanding of qualitative research. Although qualitative 
research is frequently used within physical and mental health (Crowe, Inder & 
Porter, 2015), previous uncertainty of how to assess its relevance and validity (Mays 
& Pope, 2000), and recent under-representation within top research journals 
(Gagliardi & Dobrow, 2011), may explain poor awareness. Further needs 
assessment was conducted at the beginning of the course, as the audience were 
asked to disclose their experience. The vast majority had not conducted qualitative 
research in a long time or had very limited knowledge. 
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3D.4:  Delivering the training programme 
 Training was held within South London and Maudsley (SLaM) Hospital. Due 
to limited availability, the training was conducted over three one-hour sessions on 
24th May, 21st June and 19th July 2016. Due to limited knowledge of qualitative 
research, I covered basic and more advanced information using PowerPoint slides, 
general discussion, activities and media. The relevant information was sought from 
books, journals and websites. The first session provided an overview and aimed to 
show the versatility of data collection methods and their pros and cons. Although 
largely introductory, some discussion was encouraged, as were questions. An 
evaluation form was administered to obtain initial feedback on content and delivery. 
Feedback was reviewed and the next session adapted accordingly. 
The second training session covered data sampling and how qualitative 
research has been used in healthcare. This was supported by the inclusion of a ten 
minute video of an example of ‘Participatory Action Research’. This added variety to 
the presentation, and videos in general have been shown to enhance learning 
(Willmot, Bramhall & Radley, 2012).  A second evaluation form was administered at 
the end, and reviewed to analyse whether adaptations had been effective, and to 
see what else could be improved. 
The final session included an introduction of the main qualitative analysis 
techniques: Grounded Theory, Thematic Analysis and Interpretative 
Phenomenological Analysis (IPA). It covered their pros and cons, with step-by-step 
processes demonstrating of how to do it (Braun and Clarke; 2006; Charmaz, 2006; 
Willig and Stainton-Rogers, 2008). Following the introduction of each technique, I 
invited the group to analyse passages of text (see Appendices II to IV) individually 
or in pairs, and then for themes to be discussed collectively. However, following the 
first exercise, in order to keep within time, it was agreed further exercises should be 
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completed later. An introduction to Framework Analysis followed (Gale, Heath, 
Cameron, Rashid & Redwood, 2013), which has been demonstrated to work in 
conjunction with other techniques, enabling effective analysis of sub-groups within 
data (Tonkin-Crine, Yardley, Coenen, Fernandez-Vandellous, Krawczyk  et al., 
2011). The session finished with an introduction to the role of technology within 
qualitative research, for which I selected a short promotional video for NVivo (QSR 
International, 2012). However, as the sound could not be adjusted to a moderate 
level, it was agreed that it could be watched later on. To conclude, there were 
opportunities for questions and general discussion.  
I was keen to make a good impression. As well as researching and 
preparing materials at least one week in advance, I repeatedly read through my 
slides, and opted for smart-casual dress to ensure I was comfortable and 
presentable. I also arrived early in order to be prepared. Being organised in this way 
helped me to relax, and subsequently enjoy the sessions more. The knock-on effect 
of this was greater spontaneity, disclosing my own experiences of qualitative data 
collection. I also ensured that training sessions finished on time.  
 
3D.5:  Planning and implementing assessment procedures, and evaluating the 
training course 
Although confident in my knowledge of qualitative research, I was anxious 
as I was aware that expectations were high. Evaluation forms, designed in advance 
to capture rich qualitative feedback, were distributed at the end of each session 
which helped as it enabled me to take forward positive and negative feedback. After 
the first session, I noted that further audience participation would have been 
preferred by some, as would less wordy slides and the inclusion of media (such as 
videos). In response, I included one on Participatory Action Research which 
appeared to be of particular interest, and a short promotional video on NVivo. I also 
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strived to include less text, built in further points for discussion where possible, and 
included more frequent activities, particularly within the final session. 
Overall feedback at the end of the training course was also obtained (please 
see Appendix V for overall feedback, and Appendix VI for an Observers report from 
Dr Caroline Stokes). Overall feedback was very positive, with 77.7% of attendees 
stating that their objectives had been either completely or mostly met. The training 
generally was considered “organised” and “clear”. In addition, both written and 
verbal feedback showed that the included exercises and videos really brought the 
course to life. Perhaps the biggest compliment for me personally was that I was 
described as an “informative and engaging” speaker, which I found encouraging. 
Constructive criticism was limited, but included that more exercises would have 
been preferred, and that the course should have been held over half a day. 
However, this was unavoidable due to the limited time available and difficulties with 
scheduling. 
I feel that I have gained tremendously from the experience of running this 
course, as it was my first opportunity to train healthcare professionals. 
Nevertheless, I would have preferred to run all three sessions together, as there 
were fewer attendees for the second session. Other considerations to take forward 
are that technology should always be tested beforehand. I felt embarrassed when 
the sound for the NVivo video failed, and sensed disappointment from the group. I 
also feel going forward that I should be more mindful not to be overly ambitious with 
the level of content. Overall however this was a positive experience that has 
boosted my self-regulatory efficacy for training professionals in future (Bandura, 
1989). 
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APPENDIX I 
 
Supervision Plan: Training 
 
 
 
 
 
 
 
 
 
Teaching 
and training 
Area of work 
(*outside of normal 
work) 
Supporting 
evidence 
Changes 
Case study 1 
(Training) 
Setting:  King’s 
College London 
 
Description:  
IMPARTS training on 
Medically 
Unexplained 
Symptoms, for nurse 
practitioners from St. 
George’s Hospital 
This workshop will 
cover what medically 
unexplained 
symptoms are, 
mechanisms, 
mediators/ 
moderators and 
interventions. 
Case study 
report (1000 
words). 
Observers 
report (500 
words). 
Workplace 
contact report. 
 
Changed to: 
Setting:  South London and 
Maudsley Hospital.  
 
Description:  3-part qualitative 
research training for Cognitive 
Behaviour Therapists, Clinical 
Psychologists, and academic 
researchers with limited 
knowledge of qualitative research 
Part 1: Introduction to qualitative 
research and coverage of 
qualitative methodologies. 
Part 2:  Data sampling, and how 
qualitative research has been 
used within the area of health 
Part 3:  Qualitative analysis 
techniques, including how 
software can help with analysis 
(NVivo)  
The training session will involve 
discussions, training exercises, 
and videos 
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APPENDIX II 
 
Grounded Theory Exercise 
 
 
“... Emotionally, yeah I get fed up, I find that I get irritable, and 
I will rise to anger quickly, so I need to keep that in check. I 
never used to do that. I’m not saying anything drastic, but I did 
have a big argument with my sister last year, erm, I hit her. I 
actually whacked her one, but she did say she was provoking 
me afterwards. I just completely lost it and it was over 
something really stupid. It was my younger sister I’m really 
close to, well we spend a lot of time together, and erm, and I 
just said to her “Can you just shut up now, enough is enough”, 
and she said “well, why are you saying [inaudible]”, and I just... 
Oh I felt awful, I felt awful. The minute I did it, I wanted to take 
it back, like anybody would. So she went home the next day, it 
was the weekend so she was staying with me, and I just said 
“I’m sorry” and she said “no, just leave it”, so we didn’t speak 
for a couple of weeks, but then we did, and now we’re fine, but 
she understood where it was and she could, because everybody 
notices that I’m irritable...” 
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APPENDIX III 
 
Thematic Analysis Exercise 
 
 
A participant talking about their PPS: 
 
“... It was happening every so often for a couple of years and I 
made a note of it, was this bang in my head. I’ve explained to 
the neurologist, it was... I could be doing nothing or I could be 
at work, and I’d get this, it was like, erm, oh I can’t explain it, it 
was almost like someone had banged something really loudly, 
and you jump, but that’s what it felt like and sounded like in my 
head, and it, it literally made me like, in fact, they had to take 
me down to A&E while I was at work because it happened, 
where I went completely, I was just on the verge of, of erm 
fainting. One of the women in the office she came running over 
and I went “Oh!” and she said “what’s wrong?” and I said “I 
don’t know I feel terrible”, BP had shot up and stuff, erm, and it 
was happening every so often, it would wake me in the 
nights...” 
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APPENDIX IV 
 
Interpretative Phenomenological Analysis (IPA)  
Exercise 
 
A participant talking about their PPS: 
 
 “... When it first happened I thought is this ever going to go 
away? Is it ever gonna go away, and I’d feel erm, quite, I can 
rationalise things. I’m quite good at that. Erm, but there was a 
period in, it was 2012, funnily enough it was in March again, 
and I went into a very deep depression, and it just came over 
me. People talk about a black cloud weighing down on them 
and it was just like that, and I felt terrible, absolutely awful. I 
wouldn’t speak to anybody, I was avoiding people, I was even 
avoiding my daughter, saying ‘I’m fine, don’t come up’ but I 
was suicidal, but it, I didn’t attribute it to the symptoms. It just 
came out of nowhere...” 
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APPENDIX V 
 
Evaluation form:  Training (overall feedback) 
Evaluation question Comment N (%) 
 
What was the main learning 
you were hoping to gain 
from this qualitative training 
course? 
To learn how to do qualitative 
research 
3 (33.3%) 
Open minded 2 (22.2%) 
"Overview of qualitative 
methods” 
2 (22.2%) 
Learn about methodologies 1 (11.1%) 
Wanted a refresher course on 
qualitative methods 
1 (11.1%) 
 
To what extent do you feel 
that your learning needs 
have been met/ not met? 
Completely met 6 (66.6%) 
Mostly met 1 (11.1%) 
Methods were covered in a 
simple way 
1 (11.1%) 
(Blank) 1 (11.1%) 
 
Was there anything you 
particularly liked about the 
course overall? If so, what? 
Presentation style 
 Good presentation 
style, very clear" 
 “Excellent 
presentation” 
 “Informative and 
engaging speaker” 
 
3 (33%) 
1 (11.1%) 
 
1 (11.1%) 
1 (11.1%) 
Overall structure 
 "As it was divided into 
3 sections, it was 
manageable to 
understand" 
 Well organised slides 
3 (33.3%) 
1 (11.1%) 
 
 
1 (11.1%) 
Videos and exercises 
 "The video in the first 
session, second 
session about the 
school" (Participatory 
Action Research 
example) 
2 (22.2%) 
1 (11.1%) 
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Good introduction 1 (11.1%) 
 "Very clear layout of 
information, scope for group 
discussion, video clips and 
exercises to illustrate points" 
1 (11.1%) 
 
 
Was there anything that you 
did not particularly like about 
the course overall? If so, 
what? 
Not applicable 
 N/A we just ran out of 
time 
 Nothing, it was 
excellent 
5 (55.5%) 
1 (11.1%) 
 
1 (11.1%) 
Would have liked more 
examples 
1 (11.1%) 
Run as half a day rather than 
broken up 
1 (11.1%) 
(Blank) 3 (33.3%) 
 
Is there any way that you 
feel the course could be 
improved? 
N/A 4 (44.4%) 
Inclusion of an example study 1 (11.1%) 
(Blank) 4 (44.4%) 
 
Any other final comments? 
"Very good - thanks" 1 (11.1%) 
"Many thanks!" 1 (11.1%) 
Thank you! 1 (11.1%) 
No 1 (11.1%) 
(Blank) 5 (55.5%) 
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SECTION 4:   
GENERIC PROFESSIONAL 
COMPETENCE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Word count:  2841 
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4:      Generic Professional Competence:   
Research Worker on a Cognitive Behaviour Therapy Trial  
 
4.1:  Placement and reflections on the role 
Since I enrolled on the DPsych Health Psychology programme in September 
2015, I have used the remainder of my three-year fixed-term contract at King’s 
College London within the department of Psychological Medicine as my full-time 
placement. At King’s College London, I have been employed as a Research Worker 
on an RCT, testing the effectiveness of CBT with SMC versus SMC only, amongst 
patients living with PPS (please see Appendix II and III for workplace contract and 
work attendance record). In the early stages of my placement, I familiarised myself 
with the academic literature, educating myself in terms of what PPS is, prior to  
helping with the development of the PRINCE research protocol, questionnaire 
design and other written materials. Although not originally within the job description, 
I also adopted the majority of the administrational duties, including recruitment for 
the Data Monitoring and Ethics Committee (DMEC) and the Programme Steering 
Committee (PSC), setting up meetings with the Programme Management Group 
(PMG), and taking minutes within meetings before distributing them to the team.  
 Once the recruitment for the RCT had started, my day-to-day role drastically 
changed, as it started to involve lots of travelling to participating hospitals, which at 
first included all hospitals within the King’s College Hospital NHS Trust, and Guy’s 
and St. Thomas’ NHS Trust. Following introductory presentations of the trial and 
personal introductions to clinical staff, my main responsibility was to discuss the trial 
with any patients referred following their consultations. If the clinician thought they 
may be suitable for the trial. I screened them and provided prospective participants 
with whatever information they required. If I was in attendance at the hospital clinic, 
patients were referred to me in person. If I was not able to be present, clinicians 
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were instructed to forward contact details either through the provision of clinic letters 
or patient details via email. In order to maximise recruitment of suitable patients, it 
was fundamental for me to maintain a good relationship with all clinicians and 
regularly remind them to refer. While this was challenging due the number of active 
clinics across departments and hospitals, I feel that I did manage to achieve this. 
Over the two years that I have been enrolled on the DPsych and almost 
three years working at Kings College London, I have developed on both a 
professional and personal level (please see Appendix IV for the Continuous 
Professional Development log). Prior to this role, apart from my one year working as 
an voluntary Assistant Psychologist within Child and Adolescent Mental Health 
Services, I had very little experience of working directly with patients, and no 
experience at all of working with adults with complex psychological and physical 
health problems. What I feel this position has given me first and foremost is an in-
depth understanding of the nature of PPS and the impact that these symptoms have 
upon not only the patients, but also upon the NHS. I feel that this has given me a 
unique opportunity to perceive PPS from both an academic standpoint, and from the 
patients’ perspective, which has enabled me to develop a rounded, sensitive and 
empathetic approach. Having so much direct involvement with patients within my 
role has also helped me to become more acutely aware of the importance of the 
legal, professional and ethical guidelines as outlined by the BPS Code of Conduct 
(BPS, 2009). Due to having regular access to confidential data throughout my role, 
and while completing my thesis, it was important for me to demonstrate awareness 
of the Data Protection Act (1998) (Legislation.GOV.UK, 2005). In regards to ethical 
principles, I have also ensured to demonstrate each of the following towards 
healthcare professionals, researchers and patients alike: respect, responsibility, 
integrity and competence, both within my day-to-day role and throughout my 
completion of the DPsych.  
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I also feel that my current role has enabled me to develop as a researcher. 
Prior to this position my practical research experience was predominantly 
qualitative. Whilst the opportunity arose to utilise my qualitative experience for my 
thesis, the experience of working on an RCT was completely new and an important 
learning curve, considering that RCTs are such a widely used and respected 
research design (Akobeng, 2005; Sorensen, Lash & Rothman, 2006). I also became 
extremely aware of the practical day-to-day challenges of running trials and the 
relentless effort required in order to ensure that the study is a success. What I 
learned in particular, is how challenging it can be recruiting for trials and maintaining 
patient engagement over the duration of their involvement, particularly as in the 
case of this trial participants were enrolled for a full year. This meant that flexibility 
was necessary to ensure that the required recruitment numbers were achieved. I 
also learned of the importance of strategic planning at the start of the trial, and the 
importance of a dedicated and organised Trial Manager being able to foresee 
practical challenges before they occur and knowing how to address them.  
Although my day-to-day role was somewhat limited and occasionally 
repetitive, it did open the door to new opportunities which I was able to capitalise on 
and use as evidence for professional development. For example, I requested the 
opportunity to help with the development and delivery of presentations to various 
hospital departments within King’s College Hospital and Guy’s and St. Thomas’ 
Hospital (King’s Health Partners), introducing the RCT prior to recruitment. This 
generally involved presenting to nurses, SpRs and Consultants, which greatly 
benefited me in the early stages of my role as Research Worker. As well as this, my 
thesis project itself was thirty qualitative interviews conducted with PPS patients 
already taking part in the RCT, which meant that I had a pool of PPS patients who 
had already given permission to be contacted. In addition, if I had any general 
questions relating to my research or thesis writing, or even management of stress, I 
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was already working in an environment where advice and support was readily 
available. This I found was also true when designing and conducting my systematic 
review.  
 
4.2:  Further opportunities taken 
There was frequently the opportunity to become involved in various teaching 
roles, which I often volunteered for. For example, on Tuesday mornings within the 
South London and Maudsley hospital, weekly 9-10am slots are available for 
delivering ad hoc presentations, teaching and training to all staff including Cognitive 
Behaviour Therapists, Clinical Psychologists, Psychiatrists and academic 
researchers. I therefore took the opportunity to deliver a three-part qualitative 
research training workshop, following confirmation that many regular attendees 
have limited knowledge of conducting qualitative research within healthcare. Not 
only did this opportunity enhance my confidence as a researcher with something 
new to offer the team, I was able to use this experience for the DPsych programme, 
especially the Training element. Another opportunity that arose, was to become 
involved in delivering the IMPARTS training programme for nurse practitioners from 
St George’s Hospital. For this, I produced my own slides and used them to present 
what is meant by PPS, where PPS patients are likely to be seen and how to 
recognise them, the impact that PPS has on both patients and healthcare 
professionals, and the financial implications of PPS. Once again, this was a 
fantastic opportunity for me to work with another group of healthcare professionals, 
and at the same time use this experience to fulfil part of the Teaching and Training 
competency for the DPsych.  
Although not a teaching role per se, once I had finished the analysis of my 
thesis interviews, I took opportunities to further improve my presentation skills, while 
also acting to disseminate and obtain early feedback on my work. On 1st June 2017, 
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I presented my thesis research at a Peer-Led Development (PLD) Research 
Seminar session, held by the School of Health Sciences (SHS) at City, University of 
London. Due to my workload around that time, and because I had only just finished 
analysing my data, I had had little opportunity to draw upon my discussion points 
and recommendations. Nevertheless, I was pleased that I had managed to deliver 
my presentation within the allocated time frame, and that questions following the 
presentation were more curious than critical. This made me feel more confident as I 
had already submitted a poster presentation based on the same project, which was 
due to be presented at the Doctoral Research Conference within the SHS only a 
week later.  
On the day of the poster presentation, 8th June 2017, my poster was 
criticised due the overuse of colour and text. Although I was disappointed, I 
recognised that it was a valuable take home message when designing future poster 
presentations. In addition, I was pleased that I achieved top marks for my ability to 
answer research-based queries. What was even more memorable for me during this 
conference was that I also got to speak with several individuals living with PPS 
themselves. They seemed particularly engaged with the study, which validated my 
own beliefs that this research could really help the PPS population. On 22nd June 
2017 I once again presented my research findings, this time at a PPS stakeholder 
event held within the South London and Maudsley NHS Trust. Present in the 
audience were clinical leads from London-based hospitals, CCG representatives, 
consultants, GPs, psychologists, charity representatives and service users. As well 
as it being a good opportunity for me to raise my personal profile, it was great to be 
able to disseminate my research and findings to an influential audience where the 
findings were of particular interest. Overall feedback following the meeting from 
attendees, as well as from my workplace supervisor and the organisers of the event, 
was very encouraging. In particular, the organiser, a Consultant Liaison Psychiatrist 
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known to me for the past two years, commented that he felt I had greatly improved 
as a researcher and presenter, which was lovely to hear. His comments also led me 
to reflect myself on what I have achieved in terms of research and presentations 
over the past two years, and how inexperienced I was in comparison when I 
embarked on the DPsych programme back in September 2015. 
Regarding conferences, in September 2017 I attended the BPS DHP annual 
conference to present another research study entitled “”I have genital herpes, now 
what?” Navigating the road back to psychosocial recovery”. While not directly 
related to my placement or thesis, it is still a piece of work that I believe holds great 
relevance, particularly for healthcare professionals, and the findings should be 
disseminated to those working within Public Health. At the time of doing the 
interviews, I was moved by some the open testimonies of those who volunteered to 
take part and I hope that I accurately and articulately portrayed their perspectives 
when I presented the study in September. In December 2017, I was further able to 
present my thesis research as part of the ‘Managing PPS in diverse populations’ 
symposium, at the UK Society of Behavioural Medicine (UKSBM) conference in 
Liverpool. 
 
4.3:  Further experiences and reflections  
Generally working and studying for the DPsych full-time has worked for me, 
although not without grit and determination. What I learned at any early stage was 
that the path would not always run smoothly as a Research Worker and a DPsych 
student. For example, at times it was difficult for me to meet the expectations and 
agendas of the DPsych and my role as a Research Worker, although this admittedly 
became much easier to manage over time. It is perhaps for this reason that 
opportunities to fulfil the requirements of the DPsych did not often arise during my 
placement, in stark contrast to my initial expectations that opportunities would 
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naturally present themselves. An example of where I struggled was when I was 
seeking out a consultancy project back in June 2016. I had initially sent an email to 
the research team and trial investigators, asking whether they could provide me with 
contacts within separate organisations. Although initially provided with a lead, I 
never received a response when I contacted them, leaving me frustrated and 
despondent. During my second attempt, I spoke with a Professor based at another 
University who believed I could be of help. However, a short discussion with them 
led to the conclusion that I did not have the required credentials or experience, 
which temporarily affected my feelings of self-efficacy (Bandura, 1977). I realised at 
this point that if I wanted to be able to deliver on all competencies, I would have to 
think more proactively and outside of the box. It was only after placing an 
advertisement on social media that I was provided with another name. Following 
some tentative emails and Skype discussions regarding the requirements and the 
written contract, this individual became my client for my consultancy project.   
Another issue occurred when designing my BCI. Being involved in a CBT 
trial, I had mistakenly thought that I could exercise CBT techniques with 
fibromyalgia patients face-to-face. However, as I am not a qualified CBT therapist, I 
was blocked from conducting any face-to-face CBT work with patients, which in all 
honesty I considered fair. There was also the issue of my project impeding 
recruitment for the trial. My eventual solution was to create a CBT leaflet and recruit 
participants from support groups, following approval from my workplace supervisor, 
the Director of Fibromyalgia Awareness UK, and the King’s College London Ethics 
Committee. I was unable to complete this competency during working hours due to 
its incompatibility with my role, and so this research was conducted in my own time. 
A further issue that I encountered throughout the duration of the DPsych is 
that I wanted to attend as many conferences as possible, such as the combined 
European Health Psychology Society (EHPS) and DHP conference in August 2016, 
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and the 1st Applied Health Practitioner Conference on 30th March 2017. This was at 
my own expense and so I had no choice but to limit the number of conferences that 
I attended over the two years that I was enrolled on the DPsych. Conferences, as 
well as seminars and workshops, are expensive and although students would 
obviously benefit from attending more regularly, I cannot help but feel that 
attendance is largely restricted by cost. Bursaries are often available, and I was 
fortunate enough to win one of these in order to allow me to attend the BPS DHP 
annual conference in 2017, for which I was very grateful. Nevertheless, bursaries 
are competitive and students often miss out. Having made this point, City, University 
of London and King’s College London often hold events open to students and staff 
alike. A recent example of this was the Doctoral Research Conference held at City, 
University of London in June 2017. These types of events give students the 
opportunity to present their work and answer questions, as well as review other 
research which is fundamental for students and their development.  
 
4.4:  Final thoughts and future plans 
My experiences over the last two years have also given me valuable insight 
as to how I would like my career to progress. As I approached the end of the 
DPsych, I became concerned about the future of NHS and how that will impact upon 
the recognition of Health Psychology, which is already grossly underfunded. 
However, ideally I would initially like to train as a Cognitive Behaviour Therapist, 
gain further experience of other psychological therapies, and complete training to 
become a qualified smoking cessation trainer. These active practitioner roles would 
enable me to continue with the patient contact that I currently enjoy the most in my 
Research Worker post. Following this, I would like to one day be able to combine 
these skills with my Health Psychologist training in order to eventually focus on the 
management of long-term conditions, including fibromyalgia which I have become 
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particularly familiar with over the last two years. Although not an immediate priority, 
one day I welcome the opportunity to train as a lecturer and become more involved 
in future research projects, which would help me to become a rounded and versatile 
Health Psychologist.  
To summarise, as opportunities to fulfil the requirements of my DPsych were 
not immediately made available to me over the past two years, I feel I have learned 
a valuable lesson from that. To put it simply, I have come to realise that we are 
ultimately responsible for our own professional development, for creating our own 
contacts within the Health Psychology industry and maintaining those professional 
relationships, and for disseminating our own research. Since the start of the DPsych 
I have tried to take advantage of and create as many new opportunities for myself 
as possible in order to demonstrate my own personal drive and employability, and 
deliver a good body of work for the DPsych. I am both proud and glad that I have 
taken such a proactive approach and have gained as much experience as I could 
over the last two years, as I believe that this has prepared me psychologically for 
what may be a turbulent career as a Health Psychologist, particularly if working 
within the NHS. 
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APPENDIX I 
Supervision Plan:  Generic Professional Competence 
 
 
Supervisee: ___Katie Watts____________________ 
Supervisor: ___Dr. Triece Turnbull______________ 
 
 
 
Generic 
professional 
competency 
Area of work (*outside of 
normal work) 
Supporting evidence Changes 
Supervised 
practice 
All Practice log entries 
Workplace contracts 
(signed) 
Contract of Employment 
(signed) 
Health and Safety 
procedures (signed) 
N/A 
Establishing 
the generic 
professional 
competence 
required to 
become a 
chartered 
Health 
Psychologist 
Setting:  King’s College 
London 
 
Description:   
Working as a Research 
Worker/Assistant on a 
Cognitive Behaviour Therapy 
trial for patients with 
medically unexplained 
symptoms. Main 
responsibilities include 
recruiting patients in to the 
trial, completing 
questionnaires with and 
regularly following up with 
participants, working closely 
with healthcare 
professionals.   However, the 
role is very flexible, with 
opportunities for professional 
development. 
Supplementary study 
report (3000 words) 
providing information on 
how this placement has 
facilitated the professional 
development and 
competence required to 
be a chartered Health 
Psychologist  
Continuous Professional 
Development Log 
Certificates of attended 
workshops 
Workplace supervisor’s 
contact evaluation report 
 N/A 
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APPENDIX III 
 
Work Attendance record 
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APPENDIX IV 
 
 
Professional Doctorate In Health Psychology Training Programme  
Continuous Professional Development (CPD) Log 
Trainee’s Name:  Katie Watts 
Supervisor’s Name:  Dr Triece Turnbull 
Date Activity Name Length of 
activity 
Type of activity 
12/10/2015 Professional Skills – Ethics workshop 1 day Workshop 
02/11/2015 Consultancy workshop 1 day Workshop 
18/11/2015 Initial meeting with student with plan to 
co-supervise on an LGBT study relating 
to Persistent Physical Symptoms (PPS) 
1 hour Supervision 
meeting with 
student and co-
supervisor 
26/11/2015 Meeting with supervised student to 
discuss written documents for LGBT 
study for PPS 
1.5 hours Supervision 
meeting with 
student 
07/12/2015 Quantitative Research Methods 
workshop 
1 day Workshop 
28/12/2015 Completion of Online Academies 
Cognitive Behaviour Therapy Diploma 
(with Distinction) 
Approx. 6 
months 
Course 
22/01/2016 Presentation on Persistent Physical 
Symptoms and a Cognitive Behaviour 
Therapy trial to Respiratory consultants 
at King’s College Hospital 
25 minutes Presentation 
01/02/2016 Qualitative Research Methods 
workshop 
1 day Workshop 
12/02/2016 MSc Health Psychology lecture to City 
University students on Individual-level 
Behaviour Change Interventions 
2 hours Lecture 
07/03/2016 Systematic Review workshop 1 day Workshop 
09/05/2016 CBT skills workshop 1 day Workshop 
24/05/2016 Qualitative Research Methods training 
to healthcare professionals and 
academic researchers (Part 1) 
1 hour Training 
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06/06/2016 Teaching and Training workshop 1 day Workshop 
21/06/2016 Qualitative Research Methods training 
to healthcare professionals and 
academic researchers (Part 2) 
1 hour Training 
29/06/2016 Consultancy meeting 1 hour Consultancy 
meeting 
15/07/2016 Consultancy meeting 30 mins Consultancy 
meeting 
19/07/2016 Qualitative Research Methods training 
to healthcare professionals and 
academic researchers (Part 3) 
1 hour Training 
27/07/2016 Consultancy meeting 1 hour Consultancy 
meeting 
03/08/2016 The Patient with Medically 
Unexplained Symptoms (own teaching 
session included as part of a 
workshop co-run with a colleague) 
1.5 hours 
(teaching) /  
1 day 
(workshop) 
Teaching 
delivered/ 
workshop (co-
run) 
10/08/2016 Consultancy meeting 1 hour Consultancy 
meeting 
23/08/2016 
– 
27/08/2016 
Attendance at the joint European 
Health Psychology Society and 
Division of Health Psychology (DHP) 
annual conference 
4 days Conference 
30/08/2016 Consultancy meeting 1 hour Consultancy 
meeting 
15/09/2016 Consultancy meeting 1 hour Consultancy 
meeting 
30/09/2016 Consultancy meeting 1 hour Consultancy 
meeting 
02/11/2016  Consultancy meeting 1 hour Consultancy 
meeting 
11/2016 City University student representative 
training course (online) 
1.5 hours Online training 
course 
24/11/2016 Consultancy meeting 1 hour Consultancy 
meeting 
29/11/2016 The Patient with Medically 
Unexplained Symptoms – Workshop 
co-run with a colleague 
1 day Workshop (co-
run) 
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13/12/2016 Consultancy meeting 1 hour Consultancy 
meeting 
28/12/2016 Consultancy meeting (final wrap-up 
session) 
1 hour Consultancy 
meeting 
24/01/2017 Attendance at Fibromyalgia 
Awareness UK to promote leaflet 
(Dulwich branch) 
2 hours Behaviour 
Change 
Intervention 
26/01/2017 Attendance at Fibromyalgia 
Awareness UK to promote leaflet 
(Wickford branch) 
2 hours Behaviour 
Change 
Intervention 
17/02/2017 Attendance at Fibromyalgia 
Awareness UK to promote leaflet 
(Ealing branch) 
2.5 hours Behaviour 
Change 
Intervention 
22/02/2017 Attendance at Fibromyalgia 
Awareness UK to promote leaflet 
(Dulwich branch) – Follow-up 
1 hour Behaviour 
Change 
Intervention 
23/02/2017 Attendance at Fibromyalgia 
Awareness UK to promote leaflet 
(Wickford branch) – Follow-up 
2 hours Behaviour 
Change 
Intervention 
17/03/2017 Telephone follow-up with BCI 
participants from the Ealing branch 
30 mins Behaviour 
Change 
Intervention 
30/03/2017 Attendance at the 1
st
 Practitioner 
Applied Health Psychology 
Conference 
1 day Conference 
08/05/2017 Psychological Interventions workshop 1 day Workshop 
01/06/2017 City University London - SHS PLD 
Seminar. Delivered a presentation on 
thesis 
1 hour Presentation/ 
seminar meeting 
08/06/2017 Attendance and poster presentation of 
thesis at SHS 5
th
 Doctoral annual 
conference 
1 day Conference and 
presentation 
22/06/2017 Presentation of thesis at a stakeholder 
meeting hosted by the South London 
and Maudsley hospital 
20 mins Presentation 
25/07/2017 Good Clinical Practice (GCP) training 
– Refresher 
3 hours Course 
06/09/2017 
– 
08/09/2017 
Attendance and oral presentation at 
the DHP annual conference in Cardiff 
– Presentation on 07/09/2017 
3 days Conference and 
oral presentation 
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Workplace evaluation reports 
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